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ABSTRACT
(1) The effects of tumour-bearing on the host tissues of distant 
"non-involved" organs were investigated. A previous report had demonstrated 
that the implantation of fast-growing undifferentiated mammary carcinomas 
into the hindlegs of adult rats, caused changes in the activity of a number 
of enzymes in the distant "non-involved" host livers of these animals.
These changes in enzyme activity were always observed to occur toward an 
enzyme profile that was more characteristic of "immature" livers of 1-2 
week old neonatal rats and that of the well-differentiated hepatomas. Thus 
it was proposed that host livers of tumour-bearing rats became "de­
differentiated". The research proposal of this thesis was that such changes 
in enzyme activity may be the vital link between tumour-bearing and the as 
yet unexplained whole-body wasting phenomenon of cancer cachexia. The 
effects on host tissues of rats bearing a number of tumours of different 
origin (Morris hepatomas 5123C & 7777; mammary carcinoma R3230AC and the 
primary hepatoma induced with 3'-Methyl-4N-dimethylami noazobenzene) are 
reported.
(2) Specific developmental enzymes in liver were chosen and shown 
to be good indicators of the differentiated state of this tissue. 
Measurements of these "marker" enzymes during the time-course of growth 
of all four tumours (5123C, 7777, R3230AC & MDAB) demonstrated both 
quantitative and qualitative enzyme activity changes toward an "immature" 
enzyme profile in host livers. Such changes often occurred well before 
tumours were palpable.
(3) Measurement of "marker" enzymes in host kidney and spleen
i i i
demonstrated similar changes toward an "immature" enzyme profile as a 
consequence of tumour implantation.
(4) The possibility that altered dietary status or other pathological 
conditions that may be associated with tumour-bearing caused the "immature" 
enzyme profiles in host tissues could not be demonstrated and was shown to 
be an unlikely explanation of the phenomena.
(5) I t  has been proposed in the li terature that changes in the activity 
of host tissues enzymes may be due to allosteric modification. One of the 
"marker" enzymes (ornithine aminotransferase) was purified to homogeneity 
and an antibody to this enzyme was prepared. Specific immunoprecipitation 
techniques clearly demonstrated that the activity of this enzyme was not
allosterically modified, but rather that the relative rate of synthesis was 
decreased in host livers during tumour growth.
(6) Injections of Thymosin fraction 5 (F5) have been reported to 
prevent tumour growth. This fraction was isolated from calf thymus and 
injected into animals over the time-course of bearing hepatoma 7777 or 
carcinoma R3230AC. No inhibition of tumour growth or modification of the 
changes toward an "immature" enzyme profile in host tissues was evident.
The involvement of the immune system with the production of enzyme changes 
in host tissues could thus not be directly demonstrated.
(7) Measurement of the respiratory control index and calcium transport 
in mitochondria isolated from host livers of tumour-bearing rats did not 
show "foetal" characteristics of these parameters. This apparently 
conflicting result is discussed and i t  is concluded that the results are
iv
not contrary to the proposed "de-differentiated" state of host liver.
(8) The physiological status of the host during the "clinical 
progression" of tumour growth was assessed. No gross pathological 
conditions were evident one week after tumour implantation. The "immature" 
host liver enzyme profiles during the early stage of tumour growth are not 
due to pathological conditions that may be associated with tumour-bearing. 
The most likely cause of death of these animals at the terminal stage of 
tumour growth was hepato-renal failure.
(9) The status of the "foetalism" of host liver in the light of the 
results presented in this thesis and results of similar investigations in 
the li terature is discussed. It is concluded that there are no compelling 
reasons for not accepting the proposal that host livers of tumour-bearing 
animals become "de-differentiated".
(10) The current knowledge of cancer cachexia and the present theories 
of i ts  genesis are reviewed. None of these theories can adequately explain 
the nature of this phenomenon because all propose that the primary mechanism 
involves the aberrant metabolism of the tumour. The results presented in 
this thesis have allowed the formulation of a new hypothesis of the 
pathogenesis of cancer cachexia. In contrast with other theories i t  is 
proposed that the cause of the cachexia-anorexia syndrome is the "immature" 
host liver. Evidence to support this proposal is presented.
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Cancer is a disease which is alarming both in a psychological sense and its 
destructive effect on individuals. Approximately 35,000 persons died from 
cancer or from complications developed during the course of this disease 
during 1974 in the United States of America alone and the incidence of new 
cases was estimated to be twice that number (Busch, 1974). It has also been 
reported that 25-30% of the population in West Germany dies from cancer of 
various organs (Haug eX at., 1978). In conjunction with the long duration of 
this disease and its chronically debilitating effects, it is clear therefore 
that cancer produces a serious burden both on the patient and the community. 
For these reasons the amount of cancer research utilising biological, 
biochemical, immunological or therapeutic approaches is truly enormous. 
However, most cancer research is concerned with the etiology or the mainten­
ance of the neoplastic state i.e. how a normal cell becomes neoplastic and 
why it remains to be so. For this reason a vast amount of information now 
exists that describes the phenotypic pattern of neoplastic cells. In 
particular it is clear that there are many biochemical similarities between 
tumour cells and foetal tissues. This observation led to the concept of 
the "foetalism" of tumours. Although this thesis is not concerned with 
neoplastic cells pzA but rather is concerned with the responses of the 
host organism to the imposition of a tumour, some of the most important 
results which have led to the concept of the "foetalism" of tumours are 
described in the following pages. The relevance of this approach will 
become more apparent later.
21.2 The Foetal Characteristics of Neoplasia
1.2.1 Foetal Enzyme Expressions
Greenstein was the first to collect quantitative enzyme analyses of different 
tissues in sufficient number. This allowed the generalization that each 
tissue, including neoplastic tissue, possessed its own particular pattern of 
enzymes (Greenstein, 1942-1943). Comparison of foetal, regenerating and 
adult liver enzyme profiles with those of fast growing, undifferentiated 
hepatomas led him to conclude that "Tumours tend chemically to resemble each 
other more than they do normal tissue or than normal tissues resemble each 
other" (Greenstein, 1947). In the terms of the enzyme activities he examined, 
he further continually stressed the similarity of hepatoma and foetal liver 
(Greenstein, 1942-1943, 1947, 1954). These early observations of Greenstein 
started the view of embryonic gene expression by neoplasms (although Greenstein 
would not have used these terms), a view which has gained considerable 
support over the years.
Since the demonstration of multimolecular forms of enzymes (isoenzymes) by 
Markert & Möller (1959), an ever-growing literature points to alterations 
of isoenzymic patterns in neoplastic tissues. This became evident after the 
discovery of muscle-type aldolase in a primary hepatoma (Schapira eX at.,
1963) and suggested the progressive loss of adult enzyme forms and their 
replacement by isoenzymic counter parts usually found in foetal tissues.
Such foetal isoenzyme forms associated with neoplasms have been extensively 
reviewed (Criss, 1971; Ono & Weinhouse, 1972; Schapira, 1973; Knox, 1976) 
and include oxidoreduc tases, lyases, phosphotransferases and hydrolases.
The biochemical advantages of this type of transition is self evident since 
the 'modified' expression of activity can occur without major significant 
alterations to total enzyme activity; and yet the activity of the tumour
3induced transformed enzyme can seriously alter the metabolism of the tumour 
because, in general, foetal isoenzymes are not subject to the normal dietary, 
hormonal or allosteric (adult-type) controls of the host. For example, the 
qualitative replacement of glucokinase (adult-type) with increased levels of 
hexokinase (foetal-type) activity in hepatomas allows the conversion of 
glucose to glucose-6-phosphate in these tissues without this process being 
hormonally regulated.
1.2.2 Foetal Antigens
°<M-Foetoprotein (<*FP) was the first foetal antigen found to be associated with 
cancer and was discovered in the serum of a mouse bearing a hepatoma (Abelev 
at at., 1963). Correlation between the degree of *F P  production, growth rate 
and differentiation of a series of Morris hepatomas was also found (Sell & 
Morris, 1974). This antigen is also expressed by human hepatomas (Taratinov, 
1964), human testicular and ovarian teratocarcinomas (Abelev, 1971) and 
gastric cancer metastatic to the liver (Alpert at at., 1971). With the 
emergence of the technique of radioimmune assay with its increased sensitivity 
for the quantitation of «'-Foetoprotein (Ruoslahti & Seppälä, 1971) an increased 
number of * F P  positive hepatoma-bearing patients were detected (see Uriel, 
1975) However, the presence of abnormal <xFP levels have also been observed 
in association with non-neoplastic pathologic conditions. In the human 
situation these include, amongst others, alcoholic cirrhosis (Abelev, 1971; 
Hirai at at., 1972), ataxia-telangiectasia (Waldman & Mclntire, 1972) or 
liver regeneration (Stanislawski-Birencwajg, 1967; de Nechaud & Uriel, 1972). 
In mice and rats <*FP levels are also elevated by partial hepatectomy (Sell 
at at., 1974) or acute liver poisoning with hepatotoxins (Pihko & Ruoslahti, 
1973). Therefore it can be concluded that tf-FP is not entirely pathognomic 
of neoplasia. However, in humans persistently high or increasing levels of
4serum tf-FP are strongly indicative of liver cancer and as such are used as a 
clinically diagnostic tool (see for example Haug e£ at., 1978).
Carcinoembryonic antigen (CEA) is another foetal antigen expressed in foetal 
digestive tissues and it is also present in adenocarcinomas of the human 
digestive tract (Gold & Freeman, 1965). Furthermore high concentrations of 
CEA were also found in a variety of malignant tumours, including carcinomas, 
sarcomas and their metastases, Hodgkins disease, rectocolonic neoplasms and 
lung carcinomas (Khoo eX at., 1973). Raised levels are however also found in 
non-malignant tissues (Martin & Martin, 1970; Burtin dX at., 1972; Khoo 
dX at., 1973). Elevated plasma levels of CEA have been reported in a high 
proportion of patients with cancer of the gastro-intestinal, pulmonary and 
genitourinary systems, but also with benign tumours and non-malignant diseases 
(colitis diverticulitis, alcoholic pancreatitis and liver cirrhosis) (see 
Uriel, 1975). From these observations it is again evident that CEA is not 
an antigen specific for all tumours. However again it must be pointed out 
that CEA like <*FP is diagnostically important, e.g. for the detection of 
carcinomas of the colon (see Haug dX at., 1978).
o^H-Ferroprotein ( ^ H )  is a glycoferroprotein isolated from foetal liver and 
is also presented in high amounts in hepatomas (Buffe dX at., 1972). A high 
proportion ( 80%) of patients suffering from a variety of neoplastic diseases 
were also shown to have high serum levels of o ^ H  (Martin qX at., 1971; Buffe
dX at., 1972). However, like other tumour associated foetal a n t i g e n s , o ^ H  
does not appear to be specific to the neoplastic state since elevated levels 
can also be demonstrated in almost 20% of patients with non-neoplastic 
diseases of varied origin (Martin dX at., 1971).
51.2.3 Ectopic Hormone Production
One of the most dramatic examples of misplaced protein synthesis in cancer 
is the production of polypeptide hormones by numerous non-endocrine 
neoplasms, i.e. hormones produced by the tumour that are not produced by the 
tissue of the tumours origin. Tumours of lung, prostrate, kidney, stomach, 
liver and other organs produce a wide variety of such substances (Nathanson 
& Hall, 1974; Odell & Wolfsen, 1975). There is some basis for the belief that 
the ectopic hormone production by tumours may also be embryonic in origin 
due to the common embryonic ancestry of the pituitary and the lung in the 
endoderm (Nathanson & Hall, 1974). Placental hormone production (Human 
chorionic gonadotrophin and Human chorionic somatomammotrophin) by tumours 
further suggests the embryonic origin of neoplasms as far back as the 
trophoblast (Longenecker & Williams, 1977).
1.2.4 Other Foetal Characteristics
Foetal gene expression in neoplasia is by no means restricted to enzymes, 
antigens or ectopic hormones. A variety of human tumours including HeLa 
cells contain foetal type isoferritins (Albert oX at., 1973; Drysdale &
Alpert, 1975) which also appear in animal tumours and cultured cells 
(Richter & Lee, 1970) and can be detected in the serum of tumour-bearing 
organisms (Niitsu at at., 1975). A foetal chromatin glycoprotein has also 
been detected in the Novikoff hepatoma and Walker carcinoma which is alleged 
to play a key role in cell growth and division (Yeoman zX at., 1976). 
Transformed cells in culture also produce plasminogen activators (Unkeless 
oX at., 1973) which appear very early in embryonic development (Sherman 
zX at., 1976; Strickland eX at., 1976). Plasminogen activators also appear 
in embryonal carcinoma cells and may play a role in the invasiveness of tumour 
because of their proteolytic activity (Topp oX at., 1976).
6The evidence of foeta l gene expression in neoplasia has therefore become 
exceedingly convincing, although some foetal products are also expressed as 
a consequence o f other non-neoplastic conditions. Nevertheless examples 
based on the investigations of the quan tita t ive  and q u a l i ta t iv e  changes 
in enzymes, the presence of foe ta l antigens and o f ectopic hormones are 
numerous enough to suggest tha t a major consequence of neoplasia is  a 
switchover to the formation o f foe ta l- type  prote ins. I t  is  obvious there­
fore tha t fo r  these changes to occur, foe ta l- type  genes must be preserved 
through the neoplastic transformation. Furthermore, the foe ta l- type  genes 
must be reactivated on a massive, though somewhat var iab le , scale. Since 
the changes in neoplasms involve the q u a l i ta t iv e  replacement o f adult-type 
enzymes by those found in foe ta l t issues, they can c le a r ly  be described as 
"de -d if fe re n t ia te d " (Knox, 1976). The changes represented a return o f the 
tumours enzymes and other protein composition to the components present 
during the foeta l stages of tissue development and therefore support in a 
very concrete way the conclusion reached by Greenstein (1947) tha t tumours 
have "an element of immaturity".
1.3 The Etiology of Neoplasia
The era o f modern th ink ing concerning the nature o f cancer and i t s  e t io lo g ic  
factors began with the development of the achromatic microscope in 1824.
This gave r ise  to a systematic study of spec if ic  types of cancers and th e ir  
c la s s i f ic a t io n  in to  major groups on a basis o f histopathologic character­
is t ic s .  The tendency to regard common h is to log ic  types as representing the 
same disease process, regardless of the tissue o r ig in  of the tumour, led to 
the concept that "tumours f a l l  in to  a l im ited  number of grand classes" and 
that " i t  was leg it im ate  to conceive of a universal causative agent o f malignan 
tumours" (see Ewing, 1931). Ewing vigorously combated these early  concepts
7and played a major role in the development of ideas in which neoplasia came 
to be looked upon as a complex of many specific diseases, involving a 
multiplicity of etiologic factors. It was Ewing's view (which is now an 
established fact) that there are almost countless numbers of carcinogens 
and cancerogens which will induce neoplasms. Nevertheless, the search for 
a unifying theory for the transformation of a normal cell to a neoplastic 
one is still the goal of the scientific community. It is not the intention 
here to attempt to briefly review all theories of oncogenesis but some of 
the main ideas will be portrayed.
1.3.1 Somatic Mutation Theory
Somatic Mutation, first proposed by Boveri (1929), is most commonly taken 
to indicate a sudden alteration or series of alterations in the nuclear DNA 
of a somatic cell that is similar in nature to mutation in a germ cell and 
is likewise passed on to all of its progeny. Tumours are therefore composed 
of clones of genetically altered cells (Burnet, 1973). The concept of somatic 
mutation is based on two contentions, namely that the cells of a tumour 
differ in important fundamental respects from those in normal tissues and 
that all cells in any single tumour are identical in possessing these 
abnormalities.
This theory appears to have reached the limit of its ability to advance our 
understanding of cancer since the three types of evidence on which it is 
based, have now proven to have underlying uncertainties. For example, 
chromosomal anomalies are proposed to be frequently associated with m a l i g ­
nancy, yet no consistent karyotypic patterns of cancer cells have been found, 
since aneuploidy, karyotypic variability and a significant number of normal 
diploid karyotypes are frequently presented in malignant tissue preparations
8(Hauschka, 1961; Banerjee & DeOme, 1963). Furthermore the corre la t ions 
between mutagenicity and carc inogenic ity  are now found to be less convincing 
(Burdette, 1955) and a lack of para lle lism  is  often observed even with X- 
i r ra d ia t io n  (Brues, 1954). Moreover i t  has been proposed that at least 
seven successive mutations are required fo r  a f u l l y  autonomous neoplasm to 
develop (Nordling, 1953 but see also Cairns, 1975). This process would 
require a h ighly spec if ic  targeting of mutational agents and would therefore 
be out o f character w ith the great phenotypic v a r ia b i l i t y  observed. For 
these reasons the somatic mutation theory has fa l le n  out o f favour although 
support is  s t i l l  occasionally given (Finckh, 1974).
1.3.2 The Warburg Hypothesis
More than 50 years ago i t  was noted tha t t issue s lices when incubated 
anaerobically displayed a moderate rate of g lyco lys is . When placed in to  an 
aerobic environment however, they used oxygen and g lyco lys is  was greatly  
reduced. Since th is  phenomemon resembled the in h ib it io n s  of a lcoholic  
fermentation of yeasts made aerobic, i t  was termed the "Pasteur e f fe c t"  
(Warburg, 1930). In contrast w ith the behaviour of normal t issues, s lices of 
various mouse and ra t  tumours exhibited high rates o f anaerobic g lyco lys is ;  
and although the aerobic g lyco lys is  of tumours was lowered to the level of 
normal tissue anaerobic g lyco lys is ,  i t  s t i l l  remained high. Warburg there­
fore considered tha t the elevated g lyco lys is  was a consequence o f an impair­
ment in the resp ira to ry  mechanism of ce l ls  by carcinogens (Warburg, 1931) 
whereby they lo s t  the a b i l i t y  to control g lyco lys is . From th is  he proposed 
tha t tumours resulted when ce l ls  had lo s t  th is  crucia l a b i l i t y  and proceeded 
to survive l ik e  p r im it ive  anaerobes by adopting aerobic g lyco lys is  as a 
compensatory mechanism fo r  energy transduction.
9This theory implied that damage to tumour respiration should be irreversible. 
To date however there has not been an unequivocal demonstration that 
respiration is disturbed in all neoplastic cells. Following Warburgs initial 
demonstration, it was shown that in some tumours the rate of respiration 
was normal (Aisenberg & Morris, 1961; Weber oX cut., 1961; El wood at.,
1963; but see also Burk oX oJL., 1967) and that several noncancerous tissues 
such as retina, leukocytes, kidney medulla and intestinal mucosa possessed 
appreciable rates of aerobic glycolysis. Furthermore neoplasms were shown 
to exhibit a normal Pasteur effect when measured in terms of the Meyerhof 
oxidation quotient i.e. the oxygen which is consumed by malignant cells is 
just as effective in quantitatively inhibiting glycolysis and the formation 
of glycolysis products as that consumed by normal tissues (Weinhouse, 1955). 
Overwhelming efforts by many investigators have also failed to reveal in 
cancer cells any definite defect or alteration in the quantitative extent of 
respiration, in the mechanisms or in the components of the cellular 
respiratory apparatus, or in its associated mechanism of oxidative phos­
phorylation (Aisenberg, 1961). The Warburg theory is also not well sustained 
by the presence of isoenzyme shifts in cancerous tissues. The shift toward 
a muscle-type lactate dehydrogenase isoenzyme does not always result in a 
shift towards an increase in glycolysis; and in some instances neoplasms 
exhibit a shift toward the heart-type lactate dehydrogenase (Schapira, 1973).
Despite the failure to observe a unique biochemical pattern of energy 
metabolism in all tumour cells regarding defects in glycolysis, a correlation 
of growth rate with increasing rates of anaerobic glycolysis was observed in 
hepatomas (Burk <l£ at., 1967). A large number of tumours (of varied origin) 
were also shown to possess much greater rates of anaerobic glycolysis than 
their normal tissues of origin (see for example Gold, 1966; Shapot, 1972;
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Shapot & Blinov, 1974). The question as to whether this is related to a 
primary event in oncogenesis s t i l l  remains unanswered. Furthermore, the 
high aerobic glycolysis of tumours has remained a challenging puzzle that 
has resisted rational explanation and is s t i l l  being investigated (Weinhouse 
zX a t . , 1976).
1.3.3 The Greenstein Hypothesis
In essence, the Greenstein hypothesis states that the biochemical constitution 
of tumours tend to converge to a relatively common enzymatic pattern (see 
also section 1.2.1). As Potter (1964) pointed out, the "Greenstein 
hypothesis of biochemical uniformity in tumour tissue did not represent a 
challenge to the Warburg hypothesis "but" in many respects was an extension of 
it". Warburgs ideas of convergence were limited to the area of glycolysis 
and respiration, whereas those of Greenstein extended to many enzymatic 
functions in the cell and implied some form of de-differentiation as the 
underlying mechanism of tumourigenesis.
Whereas Warburg's concept proposed and perhaps held "universality",
Greenstein (1956) was quick to point out exceptions to his theory of 
convergence. Later in a series of papers, the extreme divergence of enzymes 
of transplanted rat hepatomas was well documented thus showing that, at 
least in certain instances, divergence of enzyme patterns rather than uni­
formity is the rule (Potter zX a t., I960; Pitot, 1960; Ono zX a t., 1963). 
Examples of biochemical divergence in neoplasms of the same morphological 
type are also abundant (Mclntire & Potter, 1964; Shonk zX a t.,  1965).
The Greenstein hypothesis is also not supported by the results of extensive 
isoenzyme studies. Contrary to this proposal different patterns may be
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found in various tissues. For example, lactate dehydrogenase shows a shif t  
to an M-type isoenzyme in some tumours such as those of the digestive t rac t ,  
but an increase of the H-type was observed in hepatomas and in leukemic 
leukocytes. Aldolase "A" is also increased in hepatoma, but decreased in 
reticulosarcoma (Schapira, 1973). Greensteins idea that some degree of 
de-differentia t ion occurs in cancer is veri f ied however in the sense that 
there is often a resurgence of foetal elements i . e .  i t  is the most 
differentiated molecular form (adult-type) which disappears from a neoplasm 
and i t  is less dif ferentia ted (foetal- type) form that replaces i t  (see 
also section 2 .1) .
1.3.4 The Deletion Hypothesis
The deletion hypothesis was the result of the demonstration that certain 
carcinogens that induce hepatomas form firm complexes with normally 
occurring proteins of the l iv e r  but not with proteins of the induced tumours 
(M i l le r  & M i l le r ,  1952). Comparable results were obtained for other 
tissues and cancerogens and the further correlation between the carcinogenic 
ac t iv i ty  and the rate of binding to normal proteins was found. The concept 
was therefore advanced that the et iologic role of cancerogens was mediated 
through their  direct binding with ce l lu lar  constituents and the ir  immediate 
deletion from the in t race l lu la r  interaction systems. This is proposed to 
result in heritable modifications of the DNA genome via either; (a) direct  
modification of DNA; (b) by modification of RNA which is subsequently 
transcribed into DNA that becomes integrated into the host DNA or; (c) 
by alterations of molecules other than DNA which decrease, at least  
temporarily, the f i d e l i t y  of copying of DNA (M i l le r  & M i l le r ,  1974). The 
end result of such a mechanism is that certain ce l lu lar  components are 
ir re tr ievably  lost to a l l  descending cells . More specif ically  i t  was argued 
that the deletion of specific enzyme systems could a l te r  feed-back mechanisms
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concerned w ith normal.control of growth processes (Potter, 1958), the 
consequence of which would be unregulated growth.
The "de letion" hypothesis however, is  not consistent with a l l  experimental 
data. When a complement o f chromosomes o f a normal ce ll is introduced in to 
a cancer ce l l  by somatic ce l l  hyb r id iza t ion , supposedly correcting the 
de le t ion , the resu lt ing  hybrid s t i l l  produces tumours in animals (Davidson 
& Ephrussi, 1965). Defendi eX a J t . , (1967) therefore proposed tha t tumours 
appear in the host only when the portion o f genome carrying information 
preventing the development o f the malignant state is  lo s t  from such hybrids. 
However, examples also ex is t of malignant tumour ce l ls  which progress both 
in experimental and c l in ic a l  s itua tions to a completely benign phenotype 
(Braun, 1969). This re su lt  therefore indicates that "deleted" c e l lu la r  
components can "spontaneously" reappear, w ith the re su lt  that tumour ce l ls  
possess the a b i l i t y  to revert back to non malignant c e l ls .
The " fo e ta l"  cha rac te r is t ics  of neoplastic c e l ls  also do not support the 
de letion hypothesis. The loss of adult-type isoenzyme forms by tumours 
could be proposed to occurr due to de le tion . However, the consistent 
replacement of adult-type by foe ta l- type  isoenzymes in neoplasia (see section 
1.2.1) is  c le a r ly  inconsistent with such a proposal. The de letion hypothesis 
therefore cannot explain anything l ik e  a l l  of the experimental data that is 
ava ilab le on tumourigenesis.
1.3.5 Oncogeny as Blocked Ontogeny
This theory represents a reviva l of the "embryonic res t" hypothesis f i r s t  
proposed by Lobstein & Recamier in 1839 (see Oberling, 1946) which a tt r ibu ted  
the o r ig in  of tumours to the p ro l i fe ra t io n  of embryonic tissue tha t has
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persisted into adulthood. Ontogeny is "a time sequence of switching 
certain genes from on to o^"  and switching others from o to on, for 
transcription and translation. For example at birth, when a tissue has to 
be ready to function independently, the synthesis of adult enzymes are 
switched on while those for foetal enzymes are switched o^jj. Oncogeny 
(blocked ontogeny) then could occur by a random mutation (due to a cancerogen) 
along the switching sequence of the gene loci between the time that adult 
enzymes are switched on and before foetal enzymes (such as for replication) 
are switched off. The resulting clone would then be recognised as a tumour 
(Potter, 1969, 1970) and would have a resistance to normal feedback controls.
Uriel (1969) proposed that most (but not al l)  mature cells possess the 
potential to "retro-differentiate" ( i .e .  for a mature cell to reverse its  
differentiated state back to an immature state) in response to environmental 
damage. This worker therefore would support the blocked ontogeny theory, 
but only after an adult cell had undergone "retro-differentiation" due to 
cancerogen damage and would then lose control during reontogeny while the 
cell was s t i l l  de-differentiated and had not lost the abili ty  to divide 
(Uriel, 1976). The blocked ontogeny theory has also recently received 
considerable support since the discovery of neoplastic embryonic antigen 
expression (Coggin & Anderson, 1974; Fishman & Singer, 1976) but no exact 
molecular targets have been postulated.
1.3.6 Conclusions
This summary of the etiology of cancer is by necessity brief and imcomplete. 
No attempts have been made to include viral carcinogenesis or contributions 
from the field of immunology (for reviews on these subjects see Gross, 1978; 
Chirigos, 1977). The biochemistry of co-carcinogens and the concepts of
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"initiation" and "promotion" of tumourigenesis by different compounds have also 
also not been discussed (for a review see Slaga oX a t.,  1978). Carcinogenic 
substances other than chemicals (such as asbestos) are similarly not referred 
to. Rather i t  was fe l t  that the introduction to this thesis should remain 
within the boundaries of those biochemical observations which will bear 
relevance to some extension of knowledge and understanding of the metabolism 
of neoplastic tissue. This in turn should provide some basis for the 
understanding of the tumour-bearing host to which the investigations of 
this thesis are addressed.
In summary, the scientific community is s t i l l  far from a real understanding 
of the molecular mechanisms involved in the etiology of cancer, whether 
chemical, viral or that due to radiation. In no instance have the molecular 
mechanisms responsible for i t s  introduction or the nature or the crit ical 
target(s) been elucidated. Likewise, the essential molecular phenotype has 
not been defined for any malignant cell.  However, the main correlation of 
neoplasia as i t  is understood today is that tumours possess a large number of 
characteristics which are similar to "immature" or foetal tissues and thus 
they appear de-differentiated. Hence all mechanisms of tumourigenesis must 
try to explain such an all embracing general phenomenon.
1.4 Clinical Aspects of Neoplasia
The ultimate significance of neoplasia is the potentially lethal effects of 
this condition on the host. Neoplastic growth can cause death in a variety 
of ways. Benign tumours ( i .e .  tumours that do not metastasize) in general 
produce serious effects in the host only if  they cause a blockage at an 
important site.  For example they can be lethal if  they obstruct a natural 
passage such as the trachea, the ureter, the intestinal t ract ,  the common
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bile duct or the blood supply to a vital organ. Intra-cranial and spinal 
benign tumours are also dangerous because of their mechanical effects. They 
can also be fatal if they have ulcerated through a natural surface such as 
the skin or the mucosa of the gut with subsequent haemorrhage and the 
development of secondary infection. In general however, benign tumours are 
often amenable to surgical removal with subsequent cure of the host (Robbins, 
1974). Malignant tumours on the other hand, as well as causing local 
obstructive effects due to their rapid growth, can also invade the surrounding 
tissues. This invasiveness is often associated with haemorrhage, ulceration 
and secondary infection. Furthermore, malignant tumours possess the ability 
to spread (metastasize) to other organs of the host via the blood supply or 
the lymphatic systems. Metastasis thus transports the destructive effects of 
neoplasia to normal tissues at distant sites because the metastic implant has 
the same invasive properties, the same ability to sequester a blood supply 
and the same uncontrolled growth as the primary tumour. These metastases 
can then, in turn, give rise to further metastases. Consequently, hosts 
carrying malignant neoplasms which are at a wel1-advanced stage of tumour 
growth are often observed with metastases that are disseminated throughout 
the whole body, affecting almost every organ of the host (Robbins, 1974).
The cause of death in such patients suffering the integrated effects of 
disseminated uncontrolled growth is therefore clear. However, while the 
death of every patient with advanced cancer is in some way unique, almost 
all cancer patients suffer cachexia, a condition which is often reported as 
the most frequent cause of death (see for example: Shapot, 1972; Robbins,
1974; Morrison, 1976; Costa, 1977; Lawrence & Terz, 1977). The symptoms 
of cancer cachexia are a drastic loss of body weight, progressive weakness, 
loss of appetite and reduced dietary intake (anoA.e.)Ua), increased break 
down of tissue protein and lipid, anaemia, and a negative nitrogen balance
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(increased nitrogen excretion in conjuction with a reduced d ie ta ry  in take). 
Thus i t  is  often called the cack&xÄa-anoAzxÄCL syndrome and has been recognised 
probably fo r  as long as the natural h is to ry  of the development o f cancer 
has been described (see Ewing, 1940).
Patients with ga s tro - in te s t in a l neoplasms have a c lear reason fo r  anorexia 
and cachexia. This is  due to inadequate n u tr i t io n  based on organic path­
ology tha t prevents e ith e r the ingestion or d igestion o f food. However, a 
large number of patients die from cachexia w ithout the involvement o f the 
g a s tro - in te s t in a l t ra c t  or other v i ta l  organs, without well progressed 
neoplasms or space-occupying metastases, w ith tumours that are often less 
than 0.01% of the to ta l  body weight (Nathanson & H a ll,  1974; Robbins, 1974). 
Moreover, cachexia is  often seen as a re f le c to r  of a "hidden" neoplasm such 
as cancer o f the pancreas or carcinoma of the lung (Brennan, 1977). Further­
more, many cancer patients d isplay a s ig n if ic a n t  weight loss and cachexia 
as th e i r  f i r s t  and only symptom (Robbins, 1974). The degree o f d e b i l i t y  
and cachexia therefore , often seems to fa r  exceed that which may be reason­
ably expected on the grounds of the extent of the neoplastic process. Thus 
i t  is  acknowledged tha t cancer profoundly influences the host metabolism in 
a way which is completely separate from the physical e ffec ts  o f tissue 
organ invasion. Moreover, although several theories of the pathogenesis of 
cancer cachexia have been proposed (discussed in section 9 .1 ), none can 
s a t is fa c to r i ly  explain the nature of such a syndrome. Clearly an under­
standing o f how cancers elucidate such an e ffe c t in the host is  o f crucia l 
importance to the c l in ic a l  management of the tumour-bearing host. A fte r a l l  
i t  is  the pa tien t who is  presented fo r  treatment and not the tumour pun.
For the above reasons i t  is  the biochemical response of the host to the 
presence o f a tumour to which th is  thesis is  addressed.
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1.5 Laboratory Animals and Cancer
With the above view in mind, i t  is extremely difficult  to carry out bio­
chemical experiments with tissues of human patients. Among the most serious 
problems is the difficulty of obtaining reproducible samples which are often 
frequently acquired sometime after complex surgery has been performed. A 
constant supply of samples from patients with particular types of tumours 
may also not be available. In addition, the interpretation of data may be 
complicated by the presence of more than one type of tumour or by the presence 
of metastases or secondary infections. Moreover, the responses of the host 
to the presence of a tumour are often further complicated by chemotherapy 
which in i t s e l f  can often be iatrogenic. Thus the interpretation of data 
obtained by clinical investigations is usually extremely complex.
It was therefore considered that perhaps, herein lies the major contribution 
of animal studies in attempting to elucidate the nature of cancer cachexia. 
Namely, the opportunity provided by the use of genetically inbred strains of 
mice and rats to maintain a controlled and defined genetic background upon 
which a given tumour-host relationship can be studied. By maintaining a 
constant host genetic "substrate" upon which a given tumour cell population 
of similar genetic constitution (at least originally) can interact with 
subsequent expressions of definable and consistent responses of both host 
and tumour, i t  may be possible to establish reproducible model systems for 
a given tumour-host interaction. This, in turn, may then permit for a more 
thorough dissection of a given phenomenon at all levels of structural and 
functional integration. Thus, questions can be posed that pertain to a 
given host response with respect to altered cellular and subcellular functions 
which in addition, may lead to the possible development of diagnostic 
techniques and therapy. However, l i t t l e  work has been done in this area of 
cancer research. Although some li terature is available which documents the
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e ffec ts  of tumours on th e i r  hosts, most investigators who u t i l i z e  experi­
mental animals have usually focussed re la t iv e ly  l i t t l e  a tten tion  on the 
"c l in ic a l  course" of cancer in these animals. Instead, th e i r  a tten tion  
has been directed p r im ari ly  toward e t io lo g ica l factors o f tumourigenesis.
In fac t a large body of l i te ra tu re  compares the data obtained in a neoplasm 
to that of a host t issue , thereby assuming that host tissues are "normal".
In p a rt icu la r  i t  can be noted tha t more often than not hepatomas w i l l  be 
compared to host l i v e r  and not to a control l i v e r  o f an untreated animal 
(see fo r  example: Weber qX  a t . , 1976, 1977, a, b; Sidransky qX  a t . ,  1978).
The danges of trea ting  experimental data in th is  way w i l l  become more 
evident la te r .
Of course the question could be raised about the usefulness o f experimental 
animal studies in attempting to understand the nature of the hosts response 
to the presence of a tumour because in man these altered physiological events 
represent c l in ic a l  manifestations of the response to an autochthonous neoplasm. 
This is in contrast to the m a jority  of tumour-host animal studies that have 
u t i l iz e d  the transplanted tumour system, that is ,  the abrupt imposition upon 
essen tia lly  young healthy animals o f  the challenge of a ra p id ly  growing 
population of c e l ls ,  w ith the added fac to r that these ce lls  have been 
perpetuated through numerous hosts, often not o f iden tica l genetic o r ig in .
These systems however, allow the monitoring of host responses to a neoplasm 
during the time course of tumour-bearing over a much shorter period o f time 
and with a greater a v a i la b i l i t y  o f manipulation than is  allowed in the 
c l in ic a l  s i tu a t io n . Furthermore, the use of tumour lines transplanted in 
the same s tra in  of inbred animal in which they arose, such as the Morris 
hepatomas which were used in th is  present study, has overcome some of these 
objections.
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1.6 Enzyme Changes in the Host Livers of Tumour-Bearing Rats
As noted earlier, most cancer research concerns itself with the etiology of 
neoplastic cells and not with the responses of the host unless it is in the 
field of immunology. Little is known therefore of an extraneous tissue's 
biochemical reception of , and response to, the presence of a neoplasm in 
an animal. The livers of tumour-bearing animals however, are known to 
exhibit a variety of biochemical abnormalities. These include the loss of 
liver catalase activity (Greenstein, 1947) and changes in the activity of 
tryptophan oxygenase, tryosine aminotransferse (Suda oX cUL., 1966; Wu & 
Hornberger, 1969) and serine dehydratase (Potter at at., 1969). Such changes 
were proposed to result from associated pathological conditions such as 
abnormal nutritional or hormonal states, or necrosis, since none were proven to 
be specific for the presence of neoplastic growth in an animal. The 
direction however, in which the overall enzymic composition of liver changes, 
may be uniquely related to this condition (Herzfeld & Greengard, 1972).
These workers measured the activities of twenty randomly selected enzymes in 
adult rat liver, four to twenty three days after the hindleg implantation 
of fast growing (undifferentiated) mammary carcinomas. Their results 
indicated that a number of enzyme activities had changed as a consequence 
of tumour-bearing, before the onset of major deterioration in the health of 
these animals could be observed. The enzymes that increased in host liver 
upon tumour transplantation are among those that are relatively high in 
fast-growing hepatomas and in foetal liver. Similarly those that decreased 
are those that are low or absent in the hepatomas and foetal liver. Thus by 
gain or partial loss of these enzyme activities, the quantitative pattern 
of enzymes in host liver diverges from normal liver toward that of immature
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liver and the wel1-differentiated hepatomas (Herzfeld & Greengard, 1972). 
Therefore the host livers of tumour-bearing rats appear to "de-differentiate" 
and exhibit an enzyme profile similar to liver of 1-2 week old neonatal 
rats.  This occurs at a distant "non-involved" si te away from the tumour. 
Moreover, all of the enzymes that decrease in the host liver are adult-type 
enzymes, but they are not distributed randomly among them. None of the 
enzymes in the late foetal cluster decreased significantly in host liver and 
yet all of the enzymes that develop in liver during postnatal l ife  did 
decrease. It therefore appears that enzymes that develop late in the 
normal course of differentiation are the ones that respond to tumour bearing 
with decreases in activity. This suggests that we may be dealing with an 
almost orderly reversal of the normal process of differentiation (Herzfeld 
& Greengard, 1972).
The above observations therefore clearly indicate that tumours may exert 
systemic effects on distant "non-involved" organs of the host. Furthermore, 
such effects may be highly significant in the progression of cancer cachexia, 
since the liver is a major metabolic organ and a foetal reversion of this 
tissue may dramatically impair the hosts metabolic functions required for 
normal health. Consequently, the aims of this thesis were to investigate 
a number of tumour-host systems with which the validity of the host tissue 
reversion concept could be examined, because, in this author1 sview, i t  is 
possible that the "foetalism" of the host may be the vital link between 




2.1 Chemicals and Enzymes
A l l  enzymes, coenzymes and subs t ra tes  were obtained from Calbiochem 
( A u s t r a l i a )  P ty .  L t d . ,  C a r l in g fo rd  N.S.W. or  Boehr inger Corp. (London) 
London, UK, unless otherwise s p e c i f i e d .  Substra tes were obta ined in  the 
form o f  t h e i r  sodium s a l t s  w i th  the excep t ion  o f  phosphoenolpyruvate ( t r i ­
cyclohexyl  ammonium s a l t ) .  Ino rgan ic  reagents and so lvents  were o f  A.R. grade 
(E. Merck, A.G. Darmstadt, Germany). Rad io - iso topes were obta ined from 
Amersham, Buckinghamshire,  England. 3' Methyl-4N-dimethylaminoazobenzene 
(MDAB) was obta ined in  the c r y s t a l l i n e  form from the Tokyo Kasei Kokyo Co. 
L t d . ,  Tokyo Japan, a ' - p y r r o l in e -5 - c a rb o x y late standard was synthes ised by 
a procedure which w i l l  be descr ibed in  sec t ion  2 .7 .  Choline c h l o r i d e  and 
caseine were obta ined from Hopkin & W i l l i a m s ,  Essex, England. Aza th iop r ine  
was a g i f t  from Burroughs Wellcome & Co. ( A u s t r a l i a )  L t d . ,  Roseberry,  N.S.W. 
Freunds complete ad juvant  was obtained from the Grand Is land B io lo g ic a l  Co. 
Berke ley,  C a l i f o r n i a .  P l u r a v i t  m u l t i v i t a m in  capsules were obtained from 
S te r l i n g  Pharmaceuticals Pty.  Ltd.  Sydney, N.S.W. Soluene 350 was obtained 
from Packard Inst ruments Pty.  L td .  St .  K i ld a ,  V i c t o r i a .
2.2 „ Animals and Tumour Lines
The Morr is  hepatoma 5123C was obtained from the Waite A g r i c u l t u r a l  Research 
I n s t i t u t e ,  Ade la ide ,  South A u s t r a l i a ,  and the M orr is  hepatoma 7777 was 
obtained from Professor  Harold P. M o r r is ,  Department o f  B iochemis t ry ,  School 
o f  Medicine, Howard U n iv e r s i t y ,  Washington D.C. Mammary carcinoma R3230AC 
and inbred F ischer  r a t  seed stocks were obtained from Professor  Russel H i l f ,  
U n iv e r s i t y  o f  Rochester,  New York. Inbred B u f fa lo  r a t  seed stocks were
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obtained from Professor Gerhard Schreiber, Russel Grimwade School of 
Biochemistry, University of Melbourne, V ic toria . The 3'Methyl-4N- 
dimethylaminoazobenzene (MDAB) primary hepatocarcinoma was induced in outbred 
Wistar rats in our laboratory (see section 2 .3 ) .
The Fischer and Buffalo rats were maintained closely inbred by sibling  
matings in our animal house. Morris hepatomas 5123C and 7777 were maintained 
by serial transplantation in male inbred Buffalo rats while the R3230AC 
mammary carcinoma was maintained in male inbred Fischer rats . The trans­
plantation was achieved by the intramuscular in jection of a uniform piece 
of tumour tissue (100mg) using a 12 gauge trochar, into the hindlegs of 10 
week old animals.
Animals were bred and housed in a temperature controlled animal house which 
was maintained at 22°C. The animal house was f i t te d  with automatic lighting  
equipment which was programmed for a 12 hours light/dark cycle which 
commenced at 8 am ( l ig h t  cycle). All animals used in experiments were 
k il le d  between 8 am and 9 am to minimise diurnal variation unless otherwise 
specified.
2.3 Induction of MDAB Primary Hepatocarcinoma
The MDAB primary hepatocarcinomas were induced in outbred male Wistar rats 
(3 month, 150-200gm) by feeding 3 1-Methyl-4N-dimethylaminoazobenzene at a 
level of 0.06% of the solid d ie t for a period of 100 days ad tibdXum. After  
this period they were fed a standard laboratory ra t chow for a further 100 
days before being k il le d  and th e ir  tissues used for assays of substrate 
leve ls , enzyme a c t iv it ie s  etc. The rat chow was made 0.06% MDAB by 
dissolving the cancerogen in warm (35°C) 95% ethanol in a ra tio  of 1ml of
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ethanolic so lu tion of cancerogen to 5.5 grams of dry ra t food. This 
achieved a uniform saturation of the ra t  chow with the ethanolic so lu tion.
The cancerogen containing d ie t  was a i r  dried and stored u n t i l  required.
2.4 Measurement of Enzyme A c t iv i ty
Pyruvate kinase (E.C. 2 .7 .1 .40), hexokinase (E.C. 2 .7 .1 .1 ) ,  glucokinase 
(E.C. 2 .7 .1 .2 ), alanine aminotransferase (E.C. 2 .6 .1.2) and phosphoserine 
phosphatase (E.C. 3.1 .3.3) were assayed fo r  a c t iv i t y  in the supernatant 
f lu id  obtained by homogenising the appropriate tissue ( l - 2g l i v e r  or kidney) 
a t 0-4°C in 5-10 volumes of buffer which was 0.15 M KC1, 0.05 M KHCO3 , 0.006 
M EDTA, pH 7.6; and cen tr ifug ing th is  homogenate at 105,000g (a t 0-4°C) fo r  
1 hour. The homogenization was carried out by 5-6 passes with a glass/Teflon 
tissue d is in teg ra to r (A.H. Thomas Co., Philadelphia, P.A., U.S.A.; size A) 
which was motor driven at 900 rev./m in. Enzyme a c t iv i t y  (jumol or nmol/min/g 
wet weight fresh tissue) was measured at 30°C unless otherwise specified.
The conditions fo r  a l l  enzyme a c t iv i t y  measurements were optimised to give 
maximum c a ta ly t ic  capacities so that only added enzyme (supernatant f lu id )  
protein was ra te - l im i t in g .  A ll spectrophotometric measurements were made 
using double beam (Beckman Acta MVI or Varian Techtron Model 635) spectro­
photometers f i t t e d  with thermostatic temperature con tro l,  chart recorders 
and m u lt i-ce l 1 carriages.
2.4.1 Pyruvate Kinase (E.C. 2.7.1.40) A c t iv i ty  Assay 
Pyruvate kinase a c t iv i t y  was assayed in a medium which was 40mM N-2-Hydroxy- 
ethylpiperazine-N'-2-ethanesulphonic acid (Hepes), 40mM KC1, 40mM MgS0 4 , lOmM 
ADP, 0 .18mM NADH, pH 7.4 and contained 10 I.U. of lac ta te  dehydrogenase. The 
assay was conducted in the presence and absence o f 5mM phosphoenolpyruvate 
(PEP). The oxidation of NADH was measured by fo llow ing the change in
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e x t in c t io n  at 340nM. Pyruvate kinase a c t iv i t y  was obtained by subtracting 
the a c t iv i t y  measured in the absence of PEP from the a c t iv i t y  found in the 
presence o f PEP.
2.4.2 Glucokinase (E.C. 2.7 .1.2) and Hexokinase (E.C. 2.7.1.1) A c t iv i ty  
Assay
Glucokinase and hexokinase a c t iv i t y  was measured in a medium which was 40mM 
g lycy lg lyc in e , 5.2mM MgSO ,^ 3mM NADP, 3mM ATP, pH 7.4 ( f in a l  concentrations) 
and contained 0.2 I.U. of g lucose-6-phosphate dehydrogenase. The enzymes 
were pre-incubated (30°C) fo r  15 minutes in the above medium before the 
add ition  o f glucose ( f in a l  concentrations 0, 1.0 and lOOmM glucose). The 
reduction of NADP was then measured by fo llow ing the change in ex t inc t ion  at 
340nM. Glucokinase a c t iv i t y  was obtained by subtracting the a c t iv i t y  of the 
enzyme measured in the presence of l.OmM glucose from the a c t iv i t y  found in 
the presence of lOOmM glucose. Hexokinase a c t iv i t y  was obtained by sub­
tra c t in g  the a c t iv i t y  o f the enzyme in the absence o f glucose from the 
a c t iv i t y  measured in the presence of l.OmM glucose.
2.4.3 Alanine Aminotransferase (E.C. 2.6 .1 .2) A c t iv i ty  Assay 
Alanine aminotransferase a c t iv i t y  was measured using the method of Segal
qX  a t . ,  (1962) in a medium which was lOOmM T r is ,  7mM<*-ketoglutarate, 0.14mM 
NADH, pH 8.0 and contained 10 I.U. of lacta te  dehydrogenase. The enzyme 
a c t iv i t y  was recorded in the presence and absence of 30mM L-alanine and the 
rate o f NADH oxidation measured by fo llowing the rate of change in ex t inc ­
t ion  at 340nM. Alanine aminotransferase a c t iv i t y  was obtained by subtracting 
the a c t iv i t y  o f the enzyme in the absence of alanine from the a c t iv i t y  
measured in the presence of 30mM alanine.
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2.4.4 Phosphoserine Phosphatase (E.C. 3.1 .3.3) A c t iv i ty  Assay 
Phosphoserine phosphatase was measured using the method Knox oX a t , ,
(1969) as fo llows. 80% of the inorganic phosphate in the supernatant 
fra c t io n  (obtained by the method described in section 2.4) was removed 
immediately before assay by d ia lys is  o f a known volume (1.5ml) at 5°C fo r
1% hours against two changes of 10 volumes of 0.1M Na-acetate bu ffer (pH 6.2). 
A fte r  d ia ly s is ,  the non-d if fus ib le  material was d ilu ted  to twice i t s  i n i t i a l  
volume and phosphoserine phosphatase a c t iv i t y  measured. The reactions were 
carried out in duplicate in the presence of 40mM Na-acetate, lOmM MgC^» 5mM 
O-phospho-D-serine w ith  and without ImM L-serine. The reaction was started 
by the addition of the dialysed enzyme extract to the warmed mixture (37°C) 
and incubated at 37°C. A fte r 30 minutes the reaction was stopped by the 
addition o f 2ml of 10% tr ic h lo ro a c e t ic  acid (w/v) and the prote in removed by 
cen tr ifuga tion  at 1500g fo r  15 minutes. Inorganic phosphate was then 
determined in the resu ltan t supernatant so lu tion by the method of Ames (1966). 
One ml of the deproteinised supernatant was added to 2ml o f a 1:6 mixture of 
freshly-prepared 10% ascorbic acid in water and 0.42% ammonium molybdate in 
IN H2SO4, incubated fo r  20 minutes at 45°C and the absorbance o f the reaction 
mixture read at 820nM. The d ifference in phosphate content between the 
duplicate reaction mixture with and without the presence of L-serine was 
used to ca lcu la te the spec if ic  a c t iv i t y  of phosphoserine phosphatase.
2.4.5 Ornithine Aminotransferase (E.C. 2.6.1.13) A c t iv i ty  Assay 
Ornithine aminotransferase (OAT) a c t iv i t y  was measured by a method s im ila r
to tha t of Peraino (1972). L iver or kidney tissue ( l-2g) was homogenised by 
5-6 passes of a glass/Teflon tissue d is in teg ra to r  (Thomas size A; motor driven 
at 900 rev./m in) at 0-4°C in 4 volumes o f bu ffe r which was 0.14M KCl, 0.02M 
KH2PO4, pH 7.4. This homogenate was centrifuged at 12000g fo r  10 minutes.
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The supernatant f lu id  was discarded, the p e l le t  resuspended (two passages 
of a Teflon pestle) in the same volume and the suspension again centrifuged 
(12000g, 10 min). The p e l le t  was once more resuspended in the same volume 
o f buffer and then used fo r  determination of the a c t iv i t y  of OAT. The assay 
reaction mixture and procedure were as fo llows: to 0.7ml of so lu tion of 
0.07M L-ornithine-HCl was added 0.1ml of a so lu tion of 1 % (w/v) 0-amino- 
benzaldehyde in 10% (v/v) ethanol (heated to 40°C to dissolve the 0-animo- 
benzaldehyde) followed by 0.1ml of 0 .2 5 M k e to g lu ta ra te  (pH 6.8) and 
incubated at 37°C fo r  30 minutes with 0.1ml of enzyme extract. The reaction 
was stopped by the addition of 10% (w/v) t r ic h lo ro a c e t ic  acid, the denatured 
protein removed by cen tr ifuga tion  and the reaction product was read at 440nM. 
The m il l im o la r  ex t in c t ion  c o e f f ic ie n t  at 440nM of the reaction product of 
A '-p y r ro l ine-5-carboxylate and 0-aminobenzaldehyde is  2.71 (Strecker, 1965; 
see also section 2.7).
2.4.6 Thymidine Kinase (E.C. 2.7.1.21) A c t iv i ty  Assay 
Thymidine kinase a c t iv i t y  was measured by a modification o f the method of 
Klemperer & Haynes (1968) as fo llows: Liver or spleen tissue ( l-2g ) was 
homogenised by 5-6 passes of a glass/Teflon tissue d is in teg ra to r (Thomas 
size A; motor driven at 900 rev./m in) at 0-4°C in 5-10 volumes of bu ffer 
which was 0.1M KC1, 0.02 M Tris-HCl, pH 7.5. This homogenate was centrifuged 
at 105,000g a t 0-4°C fo r  1 hour and the resu ltan t supernatant f lu id  used fo r  
thymidine kinase a c t iv i t y  measurements as fo llows: 0 .4 -1 .0ml volumes (contain­
ing about 4.0mg prote in) of supernatant f lu id  were assayed at 37°C in a 
reaction mixture which was 50mM ATP, 2.5mM MgC^, O.lmM thymidine, pH 8.0 
( to ta l volume 2ml). The reaction was started by the addition of the
thymidine (containing O.ljjCi 2-14c -thymidine) to the warmed (37°C) reaction
mixture and incubated at 37°C. Samples were taken at 1 minute in te rva ls  over
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a period of 10 minutes, denatured by bo il ing  fo r  2 minutes at 100°C, cooled 
qu ick ly on ice and denatured protein removed by cen tr ifuga tion . 40jj1 volumes 
(2 x 20) were then applied onto 3MM Whatman chromatography paper and 
chromatographed in GW3 solvent (640ml butanol, 320ml propan-1-ol, 400ml 
acetone, 400ml 80% (w/v) formic acid, 240ml 30% (w/v) t r ic h lo ro a c e t ic  acid) 
(Wood, 1968) by the ascending technique. lOjul volumes of 24mM thymidine 
and 24mM thymidine monophosphate were used as markers and were v isua lized 
in u l t r a - v io le t  l ig h t .  The resu ltan t spots were cut out, placed in to  10ml 
Butyl PBD (see section 2.6) and the ra d io a c t iv i ty  measured by s c in t i l la t io n  
counting techniques. Results were expressed as nmol TMP formed/min/gm wet 
weight of t issue.
2.5 Estimation o f Protein
A l l  prote in concentrations were determined by the method o f Lowry eX aZ., 
(1951), except mitochondrial protein which was assayed by the B iure t method 
(Layne, 1957) fo llow ing so lu b i l iz a t io n  with deoxycholate (Jacobs eX. aJL,, 
1956). Corrections were made fo r  non-biuret colour and tu r b id i t y  by 
subsequent cyanide treatment (Szarkowska & Klingenberg, 1963). Bovine serum 
albumin (Sigma Fraction 5) was used as the standard fo r  a l l  prote in 
determinations.
2.6 Liquid S c in t i l la t io n  Counting
"Butyl PBD" contained 12gm o f 2(41- t -b u ty lp h e n y l) -5 -(4 " -b ip h e n y ly l) -1 ,3 ,4 -  
oxadiazole, 1200ml of toluene and 800ml of methoxyethanol. "Permablend" 
contained 5gm of 2,5 diphenyloxazole and 0.5gm o f /ö -b is - (0 -m ethy ls ty ry l)-  
benzene in a to ta l volume of one l i t r e  o f toluene.
Liquid s c in t i l la t io n  counting was usually done using a Beckman LS-350
28
scinti l lation counter although on occasions a Beckman LS-100 or Packard 
Tri-carb (models 2002 or 3375) was used. All counting was corrected for 
quenching by either counting in a wider channel (^C,^^Ca) or by the use of 
a quench curve and an external standard (^H).
2.7 Synthesis of A1-Pyrroline-5-carboxylate
The millimolar extinction coefficient at 440nM of the reaction product of 
Ä -pyrroline-5-carboxylate and O-aminobenzaldehyde (see section 2.4.5) has 
been reported as 2.71 (Strecker, 1956) as well as 2.45 (Peraino & Pitot,
1963). I t  was therefore decided to re-determine the extinction coefficient 
of the reaction products of these two compounds at 440nM.
A1-Pyrroline-5-carboxylate was synthesized by the method of Hasse oX a t . ,
(1971) as follows: 20mg of solid sodium was dissolved in 25ml of ethanol 
and to this 50mMoles of diethylacetamidomalonate was added. The temperature 
of this solution was kept below 35°C while 60mMoles of freshly dist i l led 
acrolein in 5ml ethanol was added dropwise. After three hours the excess 
ethanol and acrolein were removed by evaporation using a Blichi rotary 
evaporator. The residue was added to 100ml of 6N HC1 and gently boiled for 
20 minutes. The reaction was stopped by the addition of 150ml of ice cold 
water and the coloured particulate residue was removed by passing the solution 
through a column of Dowex 50w x 4/H+ (5 x 1.5cm). The colourless eluant was 
then collected and reduced to a yellow crystalline powder by freeze drying.
The resultant powder was reacted with O-aminobenzaldehyde and the millimolar 
extinction coefficient at 440nM was determined to be 2.75 + 0.15. This 
value was similar to that of Strecker (1965). The millimolar extinction 
coefficient of 2.71 was therefore used for all ornithine aminotransferase 
activity assays.
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2.8 Determination of Total Tissue Ca^ + and Mg+ Concentrations
Rats were k illed  by cervical dislocation, the liv e r was then rapidly excised, 
weighed and homogenised (5-6 passes with a Thomas size C homogeniser f it te d  
with a Teflon pestle) in 10 volumes of 0.6M HCIO .^ Protein was removed from 
th is mixture by centrifugation (10,000g, 10 min) and the supernatant solution 
was neutralised with saturated KOH. This suspension was then recentrifuged 
(10,000g, 10 min) to sediment insoluble KCIO4 . The resultant supernatant 
solution was diluted in the ra tio  of 1:1 with 5mg/ml KC1 (to enhance Ca^ + 
ionisation). The concentrations of Ca^ + and Mg+ were then determined at a 
flow rate of 3-5ml/min using an atomic absorption spectrometer (Varian 
Techtron model 1200) as follows. Calcium determinations were performed 
using a lamp current of 10 mA, at a wavelength of 422.7nm, with an 
integration time of 10 secs and a s l i t  width of 0 .2nm with a nitrous oxide/ 
acetylene flame (reducing red cone). The calcium standard solutions were 
l-5pg/ml Ca (as CaC03) containing 2.5mg/ml KC1. The absorption standard 
curve fo r calcium was linear between 1 -4>ug/ml. Magnesium determinations 
were performed using a lamp current of 3 mA, at a wavelength of 285.2nm, 
with a integration time of 10 secs and a s l i t  width of 0. 2nm with an 
acetylene/air flame (oxidising blue). The magnesium standard solutions were 
0.1-0.5pg/ml Mg (Magnesium wire) containing 2.5mg/ml KC1. The absorption 
standard curve for magnesium was linear between 0.1-0.4jjg/ml. The standard 
curves fo r calcium and magnesium were periodically checked (every 5 samples) 
and were found not to vary more than 1- 2% during estimations.
2.9 Purification of Ornithine Aminotransferase
Ornithine aminotransferase (OAT) was purified using the method of Peraino 
qX cli . , (1969). Thirty one female Buffalo rats were fed ad tlbdXum for 
five  days with a diet which consisted of 85% caseine, 12.5% crushed ra t chow
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(Allied Feeds, Pty. Ltd., Rhodes, N.S.W.), 2% NaCI, 0.5% choline chloride 
plus 5 "Pluravit" Multivitamin capsules (Sterling Pharmaceuticals Pty.,
Ltd., Sydney, N.S.W.).
The rats were then killed by cervical dislocation and their livers rapidly 
removed, chilled and homogenised in 4 volumes of ice cold buffer which was 
0.1 M Tris(hydroxymethyl)ami nomethane, 0.15 M KC1, 10"^ M pryidoxal phosphate, 
pH 8.0. Homogenization was carried out in a 4 l i t r e  Waring blender at low 
speed using four x fifteen second bursts. All subsequent steps were carried 
out near 0°C. The homogenate was centrifuged at 16,500g for 20 minutes and 
the supernatant fluid discarded. The pellet was suspended in the same 
volume of the homogenizing buffer and the suspension sonnicated (MSE 100 watt 
ultrasonic disintegrator, 24 Kc/s, 6-7 microns peak to peak, set to deliver 
100 watts at the t ip) .  Ultrasonic treatment was continued until at least 
80% of the enzyme was solubilised. This was determined by periodic activity 
measurements of the supernatant solution obtained by centrifuging small 
portions of the sonnicated suspension at 40,000g for 10 minutes. This 
treatment required four to six hours after which time the extensively 
sonnicated suspension was frozen at -70°C overnight.
After thawing (room temperature) 300ml portions of the suspension were 
rapidly adjusted to pH 5.0 with IN acetic acid and centrifuged by accelerat­
ing to top speed in the Sorvall (SS34 head, RC2B) and immediately decelerat­
ing. The sedimented precipitate was discarded and the supernatant fraction 
rapidly readjusted to pH 8.0 with IN K0H, heated at 55°C for one minute in 
a 70°C water bath, then cooled by immersion in ice water. Heat-denatured 
protein was removed by centrifuging for 10 minutes at 40,000g.
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Solid ammonium sulphate was added with s t i r r in g  to the supernatant solution 
(kept at 0°C) to a concentration o f 30% (w/v). A fte r 10 minutes of s t i r r in g ,  
the suspension was centrifuged fo r  20 minutes at 40,000g and the supernatant 
f lu id  was discarded. This step was carried out using 16 (40ml) tubes, each 
of which was centrifuged and r e f i l le d  w ith fresh suspension (without 
removing the sediment from the previous cen tr ifuga tion ) u n t i l  the en tire  
suspension had been centrifuged. The sediment in each tube was t r i tu ra te d  
with 2m 1 o f buffer which was 0.01 M T r is -ch lo r id e , 10“ ^M pyridoxal phosphate, 
pH 8.0. The resu lt ing  solutions were combined and mixed in a Thomas size A 
homogenizer (2-3 passes by hand). The f in a l  volume, approximately 50ml, 
was centrifuged fo r  one hour at 40,000g and the supernatant f ra c t io n  discarded 
The sediment was resuspended in 100ml of the 0.01 M Tris-pyrodoxal phosphate 
buffer w ith the Thomas homogenizer and centrifuged at 40,000g fo r  20 minutes. 
The Enzyme a c t iv i t y  was now in the supernatant f ra c t io n ,  which was brought to 
30% (w/v) concentration with ammonium sulphate and again centrifuged as 
described above. The sediment, which contained the enzyme a c t iv i t y ,  was 
suspended in 10ml of 0.01 M Tris-pyridoxa l phosphate buffer (pH 8.0) and 
centrifuged fo r  60 minutes at 40,000g. The enzyme a c t iv i t y  remained in the 
sediment. The supernatant f ra c t io n  was discarded, the sediment suspended in 
30ml of the same bu ffer and centrifuged at 40,000g fo r  20 minutes. Treat­
ment o f the resu ltan t supernatant so lu tion with ammonium sulphate, followed 
by double extraction with the 0.01 M Tris-pyridoxa l phosphate bu ffe r ,  was 
then carried out exactly as described above. The supernatant so lu tion from 
the f in a l  cen tr ifuga tion  contained the pure enzyme which was subjected to gel 
electrophoresis (see Plate 2) and had a spec if ic  a c t iv i t y  o f about 25-26 
jum/min/mg prote in .
2.10 Polyacrylamide Gel Electrophoresis
Sodium dodecyl sulphate (SDS) polyacrylamide gel electrophoresis (Laemmli,
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1970) was used and consisted of the following solutions and preparations: 
Separation gel (pH 8.8): 9 or 12% (w/v) acrylamide, 0.375 M Tris-HCl, 0.1% 
(w/v) SDS. Stacking gel (pH 6.8): 3 or 5% (w/v) acrylamide, 0.125 M Tris- 
HCl, 0.1% (w/v) SDS. Electrode buffer(pH 8.3): 0.025 M Tris-HCl, 0.192 M 
glycine, 0.1% (w/v) SDS. Protein dissociated buffer (pH 6.8): 0.0625 M Tris- 
HCl, 2% (w/v) SDS, 10% (v/v) glycerol, 5% (v/v) mercaptoethanol, 0.001% (w/v) 
bromophenol blue.
Proteins were dissociated by incubation at 100°C fo r 2 minutes in the 
dissociation buffer. Electrophoresis was carried out at 3-4 mA/gel. Stain­
ing was carried out using the method of Fairbanks oX a t. ,  (1971) at 37°C by 
an overnight stain in 25% (v/v) propan-2-ol, 10% (v/v) acetic acid, 0.05% 
(w/v) Coomassie b r i l l ia n t  blue, followed by a 6-9 hour period in 10% (v/v) 
propan-2-ol, 10% (v/v) acetic acid, 0.005% (w/v) Coomassie b r i l l ia n t  blue. 
The gels were destained by rotation at 37°C in 10% (v/v) acetic acid contain­
ing about0.5g of Dowex mixed bed ion-exchange resin.
2.11 Preparation of Anti-ornith ine Aminotransferase Antibody
Antiserum against the purified ornithine aminotransferase enzyme (prepared 
as described in section 2.9) was prepared as follows: 2mg (2ml) of the 
enzyme preparation was emulsified with 2ml of Freund's complete adjuvant 
(Grand Island Biological Co., Berkeley, California) by repeated passage 
through a 20 gauge needle using a 5ml syringe. This preparation was injected 
into a sheep, (0.2ml subcutaneously and 1.8ml intramuscularly into each 
hindleg). A week la te r a further 0.5ml (0.5mg) antigen and 1ml of Freunds 
complete adjuvant (emulsified as before) were injected (0.2ml subcutaneous 
and 0.5ml intramuscularly into each leg). A further week la te r, the second 
procedure was again repeated. Four weeks a fte r the f i r s t  in jection, blood
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was collected from the jugular vein, allowed to c lo t at 4°C, the coagulate 
precipitated by centrifugation (2,000g, 15 min) and the serum, containing 
antibody, stored at -20°C.
The antibody preparation from three bleeds were pooled and p a rtia lly  purified 
and concentrated as follows. Equal volumes of serum and saturated (NH4)2SO4 
(pH 7.0) were mixed. The precipitated globulins, collected by centrifugation 
(3,000g, 15 min), were then redissolved in a minimal volume of buffer (0.02M 
T ris , 0.1 M NaCl, 0.1% NaNß, pH 7.2) and applied to a column of Sephadex G-200 
(6cm x 120cm) equilibrated with the same buffer. The antibody was eluted 
with th is buffer at a flow rate of 60ml/hour; 10ml fractions were collected. 
The fractions containing antibody a c tiv ity , detected by Ouchterlony double 
d iffusion analysis (described in section 2. 11. 1) were pooled and treated 
with saturated ammonium sulphate as described above. The precipitated an ti­
body was redissolved in a minimal volume of column buffer and dialysed three 
times against ten volumes of th is buffer. The fina l protein concentration 
was 63mg/ml and th is preparation was stored in 1ml volumes at -20°C. The 
antibody was stable for 6 months.
2.11.1 Ouchterlony Gel Diffusion
Ouchterlony double-diffusion analysis of antisera was performed on glass 
microscope slides in a 3mm thick medium which was 1% (w/v) agar (DIFC0 
Laboratories, Detro it, Michigan, U.S.A.), 0.8% (w/v) sodium barbitone, 0.01% 
(w/v) Thiomersal (B r it is h  Drug Houses Ltd., Poole, England), pH 8 .6. Two 
m illimeter diameter holes (wells) were cut into the agar approximately 1cm 
apart (See Plate 2B) using a metal punch (LKB Producter A.B., Bromma, Sweden). 
The wells in the agar were f i l le d  with about 20jj1 of antigen solution or a n ti­
serum. The plates were then placed into a petrie dish containing moist
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chromatography paper (Whatman 3MM) to prevent dessication and allowed to 
stand at room temperature for 24 hours. During this time clearly visible 
immunoprecipitates were formed. The precipitated proteins were stained in 
a solution which was 1 % (w/v) amidoschwartz, 45% (v/v) methanol, 10% (v/v) 
acetic acid, pH 8.6 for 30 minutes at 25°C. Excess stain was removed by 
washing with a solution which was 45% (v/v) methanol, 10% (v/v) acetic acid. 
The plates were then dried to completion at room temperature. Gel diffusion 
plates treated in the above manner may be kept as a permanent record.
2.12 Synthesis and Degradation Techniques for Ornithine 
Aminotransferase (OAT)
2.12.1 Radioactive Labelling of Tissues
At the appropriate time prior to sacrifice (60 minutes, synthesis; 24, 48,
72 hours, degradation), each rat was injected intraperitoneally with lOOyjCi 
of l [4,5-3h1 leucine (60 Ci/mmol) in 0.9% (w/v) NaCl (0.2ml total volume).
Rats were killed by cervical dislocation, the livers, kidneys and tumours 
rapidly removed, weighed and frozen in liquid N2. The frozen tissue were 
individually wrapped in aluminium foil and stored in liquid N2 until analysis.
2.12.2 Preparation of Tissue Extracts
Each tissue as prepared in section 2.12.1 was thawed, homogenised in 1.5 
volume of buffer which was 0.1M Tris, ImM DTT, ImM EDTA, O.lmM pyridoxal-51- 
phosphate, pH7.45 (5-6 passes with a Thomas size C tissue disintegrator) 
and sonnicated at 4°C for a total of 4 minutes (24 Kc/s, 6-7 microns peak 
to peak, set to deliver 100 watts at the tip). A sample for the estimation 
of total radioisotope incorporation was taken at this time (see section 
2.12.4) and the remainder of the extract centrifuged (43,000g, 10 min). The 
supernatant solution was assayed for OAT activity and heated at 55°C for 1
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minute and then rapidly cooled to 0°C. The resultant suspension was 
centrifuged at 200,000g (60 Ti rotor, MSE centriscan) and the supernatant 
fluid frozen (-70°C). In this condition i t  was ready for immunological 
analysis (Morris & Peraino, 1976).
2.12.3 Immunoprecipitation
Each tissue extract prepared as described in section 2.12.2, was thawed 
and assayed for OAT activity.  The immunoprecipitation reaction mixture 
contained 0.375jjmol/min of OAT activity and 150p 1 antibody and was made up 
to a total volume of 3m1 with extract buffer. The antigen-antibody mixtures 
were incubated at 4°C for 18 hours, the resultant precipitates were collected 
by centrifugation (l,500g, 15min) and washed four times with 0.9% (w/v) NaCl. 
The resultant pellet was dissociated in 150pl of freshly prepared solution 
which was 6M urea, 1% SDS, lOmM DTT, 0.125 M Tris (pH 6.8) and le f t  at 500C 
for one hour (Cashman & Pitot, 1971). (This method completely separates 
antigen-antibody complexes without degradation of individual proteins).
Using Disc-gel electrophoresis the solution containing the dissociated 
proteins was electrophoresed at 4mA/gel for 12 hours (6mm x 15cm, 9% 
separation gel; 6mm x 1cm, 5% stacking gel; see also section 2.10). The 
gels were then stained, the OAT band identified and cut into 3 x 3mm slices. 
The slices were then placed into separate scinti l lation vials and the protein 
in each slice solubilized by the addition of soluene 350 (1ml/siice) (Packard 
Instruments Pty., Ltd., St Kilda, Victoria) and incubation at 60°C for 2-3 
hours. 10ml of "Permablend" (see section 2.6) was then added to each vial 
after cooling to room temperature. The radioactivity contained in each slice 
was finally determined using Liquid Scintillation counting techniques at 
50% efficiency.
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2.12.4 Determination of Radioisotope Incorporation into Total Protein 
Volumes (10, 20, 50jj1) of the sonicated extract (section 2.12.2) were 
pipetted onto 20mm glass fibre discs (Gelman type AE) and dried at 55°C.
The discs were then washed to remove non-covalently bound radioactivity and 
lipid materials as follows: (a) 3 x 10 minute washes in ice cold 10% (w/v)
TCA, (b) 2 x 10 minute washes in 5% (w/v) TCA, 0.5% (w/v) L-leucine, (c)
3 x 10 minute washes in 2:1 chloroform-methanol (Lyons & Pitot, 1976). The 
discs were then air dried and the radioactivity counted in 5ml "Permablend"
(see section 2.6) containing 200^1 Soluene 350 at 55% efficiency using 
Liquid Scintillation techniques.
2.12.5 Calibration of Antibody
The antibody preparation was standardised against the pure enzyme as follows. 
Increasing amounts of enzyme were incubated with a constant amount of anti­
body (lOOpl, 6.3mg protein) in a constant volume (3ml) at 4°C for 18 hours.
The antigen-antibody complex was precipitated by centrifugation (l,500g, 15 
min) and the enzyme activity determined in the supernatant solution. The 
largest amount of added enzyme that was fully precipitated under these 
conditions marked the equivalence point. This was found to be 0.375 to 
0.4/jm/min/1 OQul antibody (See Fig. 9A).
Liver extract was prepared as described in sections 2.12.1 & 2.12.2. Of 
this preparation 0.375pmol/min of enzyme activity was incubated with 
increasing amounts of antibody in a total volume of 3ml. The immunoprecip- 
itates were treated as in section 2.12.3 and the radioactivity in the OAT 
band determined. The amount of antibody required to precipitate all available 
radioactivity in OAT was considered to be the t i t ra t ion point and was found 
to be about IOOjjI. For all incubations i t  was therefore established that
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lOOjjl of antibody was required to fully precipitate 0.375pmol/min of OAT 
enzyme activity (See Fig.11). OAT-antibody t i t ra t ions of kidney and tumour 
tissues gave essentially the same result.
2.13 Partial Hepatectomy
Regenerating rat liver was produced by partial hepatectomy. In the usual 
form of this operation the bifurcated median lobe and the le f t  lobe of the 
liver are removed together since they share a common blood supply. These 
lobes constitute about 70% of the mass of the liver. For a detailed account 
see Waynforth (1969). Sham-operated rats were treated in the same manner as 
the hepatectomised rats but without the ligation of the blood vessels or the 
removal of the two lobes. Consequently all ligaments were cut, and the liver 
and abdominal contents manipulated in the same manner as the animals under­
going hepatectomy.
2.14 Method of Skin Graft Transplantation
Ten week old male inbred Buffalo rats received isogeneic skin grafts 
which were performed in the following way. One animal was killed by 
cervical dislocation, shaved on the ventral side, steri l ised with 70% alcohol 
and the skin on the abdomen removed in one piece. The skin was transferred 
onto a dissecting board and kept moist with physiological saline while all 
fat was removed. The piece was then cut into 2 x 3cm rectangles and stored 
in saline. The recipient rat was anaesthetised, a section of the lateral 
surface shaved, steri lised and an area of skin about 2 x 3cm removed by 
careful dissection with fine scissors. A piece of the donor skin was then 
sutured over this area and the animal bandaged. The direction of the hair 
growth of the transplant was at 180 degrees to the direction of growth on 
the recipient to aid in later recognition.
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2.15 Method of Induction of Pathological Conditions
2.15.1 Induction of Experimental Arthritis
Ten week old inbred Fischer rats were innoculated with 50pl of adjuvant into 
the ta il  within 3cm of i ts  base. The adjuvant was composed of 10mg of 
finely ground, delipidated heat-killed MyobacX&vium Tub&uiuZo&Lb per mil l i­
l i t e r  of oily vehicle (Barritt & Whitehouse, 1977). The animals subsequently 
manifested polyarthritis (see section 4.3.3). The tissues (liver and kidneys) 
of these animals were assayed for enzyme activity fourteen days after the 
inoculation of adjuvant.
2.15.2 Starvation
Ten week old male inbred Buffalo rats were starved for a period of seventy 
two hours by deprivation of all food. The animals were housed on wire to 
prevent ingestion of bedding materials or l i t t e r .  Water was given ad Libitum.
2.16 Isolation and Calibration of Thymosin
2.16.1 Purification
Thymosin was partially purified to fraction 5 from calf thymus after the 
method of Goldstein oX a t., (1972). All of the thymosin activity was found 
to elute with the f i r s t  peak of a Sephadex G150 column as determined by 
rosette assay (Dardenne oX a t.,  1977; see section 2.16.2). This fraction 
was lyophilised and redissolved in a minimal volume of a 0.01 M Sodium 
phosphate buffer (pH 7.2) and stored in 1ml aliquots at -20°C.
2.16.2 Rossette Bioassay
The in  viX/io rossette assay was used to determine thymosin containing 
fractions (Dardenne oX a t., 1977). Balb c nu/nu mouse spleen cells were 
obtained by homogenization (1 passage of a loose pestle; Thomas size C;
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which was motor driven at 900 rev./m in) in Hanks balanced s a l t  so lu tion 
containing bicarbonate (pH 7.2) (Hudson & Hay, 1976). The suspension was 
centrifuged at 50g fo r  30 seconds, the sediment was discarded and the 
supernatant f lu id  centrifuged at 100g fo r  5 minutes to sediment the c e l ls .
The p e l le t  was washed twice in the same bu ffe r by resuspension and c e n t r i fu ­
gation as before. Volumes (0.1ml) of 3 x 10® spleen ce lls  were then 
incubated at 37°C with control frac tions  or thymosin containing frac t ions  in 
the presence of 10/jg/ml Azathioprine (Burroughs Wellcome and Co., A u s tra l ia ) .  
A fte r 90 minutes 1.2 x 10^ sheep erythrocytes (co llected in Alsevers so lu tion , 
Campbell oX a t . ,  1970) were added, the suspension centrifuged at 50g fo r  3 
minutes and the p e l le t  very gently resuspended on a ro tary  tab le . Rossettes 
were than counted in a haemocytometer. Results were calculated on the basis 
of the minimal active concentration of thymosin defined as tha t quantity  
which reduces the number o f rosettes by 50% or more in a given f ie ld  when 
compared w ith contro ls . Controls consisted o f spleen ce l ls  incubated without 
thymosin or c e l ls  incubated with thymosin without azathioprine.
2.17 Iso la t ion  of Mitochondria
Rats were k i l le d  by cervical d is loca tion , exanguinated and the l iv e rs  rap id ly  
excised in to  ice-cold iso la t io n  medium (250mM sucrose, 5mM Hepes, 0.5mM EGTA, 
pH 7 .4 ). Blood and fa t  was removed by mincing the tissue and r ins ing  several 
times with the iso la t io n  medium. A ll subsequent procedures were carried out 
at 0-4°C and a l l  cen tr ifugations were of a f iv e  minute duration. The l iv e rs  
were homogenized by two passes with a g lass/Teflon tissue d is in teg ra to r  
(Thomas size C) which was motor driven at 900 rev./m in. The resu ltan t 
suspension was made up to 80ml with iso la t io n  medium and centrifuged at 900g. 
The supernatant so lu tion was stored and the p e l le t  resuspended in the same 
medium (one passage) and centrifuged at 800g. The two supernatant frac tions
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were combined and centrifuged at 4,500g. The pellet was resuspended (one 
passage) in wash medium (250mM sucrose, 5mM Hepes, pH 7.4) and centrifuged 
at 4,500g. The mitochondrial pellet was washed in this manner a second 
time and the pellet finally resuspended to give a protein concentration of 
about 60mg/ml.
2.18 Respiration
Mitochondrial state 3 and state 4 respiration (Chance & Williams, 1956) 
were measured polarographically at 25°C using a Clark-type oxygen electrode 
(Reed, 1972). The electrode medium (pH 7.5) contained 50mM K C 1 , lOOmM 
sucrose, 15mM Tris-HCl, lOmM KH2PO4, 2mM MgS04, ^  EDTA and one mg/ml 
mitochondria (total volume 2.5ml). Substrates were measured at the following 
concentrations unless otherwise specified: lOmM Na-succinate; 5mM L-pyruvate;
5mM L-malate; 5mM L-glutamate. State 3 respiration was measured by the 
addition of 150 nmoles ADP.
2.19 Calcium Transport
Calcium transport was measured using a modification of the EGTA-Ruthenium Red 
quench technique of Reed and Bygrave (1975), which measures the disappearance 
of labelled calcium from the supernatant solution of an incubation mixture 
after the mitochondria have been sedimented by centrifugation. Both calcium 
uptake and retention were measured in a thermostatically controlled, water- 
jacket incubation vessel, with a self-contained stirring bar.
2.19.1 Measurement of initial rate of Calcium uptake
Calcium uptake was measured at 4°C with constant stirring in a total final 
volume of 2ml as follows: 2mg mitochondria were incubated (4°C) in a medium 
(pH 7.4) which was 5mM Na-succinate, 130mM sucrose, 5mM K C 1 , 5mM Hepes, in
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the presence and absence o f 2mM KH2PO4. Exactly one minute la te r  the reaction
[45Ca] Cl2.was started by the addition o f 200 nmole CaCl2 containing 1.5juCi 
At ten second in te rva ls  a f te r  the s ta r t ,  over a period o f one minute, 0.1ml 
samples were taken from the incubation medium and were immediately mixed with 
0.1ml ice-cold quench mixture (150mM KCl, 3mM Hepes, 0.5mM EGTA, 2pM Ruthenium 
Red) in Eppendorf tubes. This mixture was stored on ice u n t i l  a l l  samples 
were taken. The mixtures were then centrifuged (Eppendorf microfuge, 12000g,
2 min) and the ra d io a c t iv i ty  in IOOjjI o f the supernatant f lu id  was then 
measured by l iq u id  s c in t i l la t io n  counting techniques in 5ml Butyl PBD at an 
e ff ic ie n cy  of 80%. An in teran l standard was employed to determine the to ta l 
amount of ra d io a c t iv i ty  added to the incubation. This was done using the 
fo llowing method. A 0.1ml sample of the incubation medium was taken a f te r
the addition o f the 45Ca Cl29 mixed with 0.1ml of the quench mixture as 
described before but was not centrifuged. A 0.1ml sample of th is  mixture 
was then counted d ire c t ly  in 5ml Butyl PBD using Liquid S c in t i l la t io n  
techniques and the ra d io a c t iv i ty  in th is  sample was called cpm Tota l. The 
protein present in th is  standard does not produce s ig n if ic a n t  quenching, as 
determined by external standards (personal observation).
The amount of calcium transported in to  the mitochondria was then calculated
as fo llows: cpm mitochondria = cpm p e l le t  = cpm Total - cpm supernatant
f lu id .  Where cpm Total represents the to ta l amount of calcium added i .e .
100 nmoles/mg mitochondria.
Therefore calcium transported (nmoles/mg) =
cpm Total - cpm supernatant f lu id  , nn 
cpm Total x
These resu lts  were p lo tted against time and the i n i t i a l  rate o f calcium 
transport was then calculated from the l in e a r portion o f the curve (see 
Fig. 14).
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2.19.2 Measurement of Calcium Retention
Calcium retention was measured at 25°C with constant stirring in a total 
final volume of 2ml as follows: 2mg mitochondria were incubated (25°C) in a 
medium (pH 7.4) which was 5mM Na-succinate, 130mM sucrose, 5mM Hepes, 5mM 
KC1 and 2 or 5mM KH2PO4. Exactly one minute later the reaction was started
At oneby the addition of 200 nmoles C a C ^  containing 1.5/jCi 
minute intervals thereafter, over a period of 20 minutes 0.1ml samples of 
this incubation medium were taken, mixed and stored on ice until centrifug­
ation as before. The remainder of the determination (including cpm Total) 
and calculations of calcium transported into mitochondria were performed 
as detailed in section 2.19.1. These results were plotted against time and 
the length of calcium retention was calculated from these data (see Fig. 15).
2.20 Analysis of Serum Levels of Metabolites, Electrolytes and 
Enzyme Activities
Blood was collected (6-8ml) into test tubes from rats by severing the 
jugular vein and was allowed to clot at 4°C for 2 hours. The serum was then 
obtained by carefully decanting the supernatant fluid into centrifuge tubes 
and subsequent centrifugation (2,500g, 15min) to remove any contaminating 
red cells. Serum metabolites ('urea, creatinine, glucose, cholesterol, 
triglyceride, urate, albumin, as well as total CO2, protein & bilirubin), 
electrolytes (Na+ , K+ , Cl", Ca^+ , iron & inorganic phosphate) and enzymes 
(lactate dehydrogen ase, E.C. 1.1.1.27; Glutamic-aspartic transaminase, E.C.
2.6.1.1; glutamic-alanine transaminase, E.C. 2.6.1.2; alkaline phosphatase, 
E.C. 3.1.3.1) were estimated using a high speed computer controlled bio­
chemical analyser (Technicon Sequential Multiple Analytical Computer,
S.M.A.C. ; Technicon Instruments Corporation, Tarrytown, New York, U.S.A.) 
using standard methods (Technicon Instruments Corporation Manual for S.M.A.C., 
current 1978, Tarrytown, New York, U . S . A . ).
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CHAPTER 3
ACTIVITIES OF ENZYMES IN THE HOST TISSUES OF TUMOUR-BEARING RATS 
3.1 Introduction
In the course of mammalian development, pa r t icu la r  enzymes in t issues  change 
th e i r  ac t iv i ty .  Some enzyme a c t iv i t i e s  no longer required in the developing 
or devloped t issue  are los t  while others emerge to perform functions which 
were not previously needed. In th is  respect ra t  l ive r  is well characterized 
and has been shown to exhibit  three main stages of enzyme change during 
development (Greengard, 1971).
One of these stages occurs during la te  foetal l i f e  (16th - 22nd Day of 
gesta t ion) ,  another on the f i r s t  day of b i r th a n d a  final stage occurs in the 
th ird  post-natal week (at weaning). The groups of d i f feren t  enzymes which 
emerge during these periods are usually referred to as " la te  fo e ta l" ,  
"neonatal" and " la te  suckling" c lus ters  (Greengard, 1971). For the 
purpose of th is  thes is ,  enzymes which have a high ac t iv i ty  during one of the 
stages and a low ac t iv i ty  during another, are defined as " foe ta l" ,  "neonatal" 
or "adult-type" enzymes respectively. For example hepatic ornithine amino­
transferase  has l i t t l e  a c t iv i ty  during the "foetal"  and "neonatal" stages but 
has a high a c t iv i ty  in adult r a t  l iv e r .  This enzyme is therefore designated 
as an "adult-type" l iver  enzyme. Phosphoserine phosphatase, on the other 
hand, has a high ac t iv i ty  in foetal ra t  l ive r  which diminishes to a lower 
level a t  b i r th .  Consequently, i t  is referred to as a "foetal-type" l iver  
enzyme. The s ta te  of d i f fe ren t ia t ion  can therefore be determined by 
establishing the enzyme prof i le  of a t issue  (Greengard, 1971; Knox, 1976). 
This is done by measuring the a c t iv i t i e s  of a series of such "foetal" and 
"adult" (marker) enzymes which change th e i r  a c t iv i ty  during the development
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of a tissue.
The above approach was used to measure the effects of tumour-bearing on the 
host liver enzymes-of the rat after the implantation of a tumour (Herzfeld & 
Greengard, 1972). Their results indicated that a number of activities of 
host liver enzymes had changed as a consequence of tumour-bearing. In 
particular it was noted that the quantitative pattern of enzymes in the host 
livers had diverged from the pattern observed in normal liver toward that of 
immature liver and the well-differentiated hepatomas. It was proposed there­
fore that host livers of tumour-bearing rats became "de-differentiated" due 
to the presence of the tumour (Herzfeld & Greengard, 1972). Furthermore 
this occurs at a site spacially distant from the tumour.
When this project was initiated, the above report was the only extensive 
study that had been done on the enzymic response of a host tissue to the 
imposition of a growing tumour into an animal (see also section 1.6). Since 
the central concern of this thesis was to gain a better understanding of the 
metabolism of tumour-bearing animals and patients, it was important to 
critically investigate the above earlier findings of Herzfeld & Greengard 
(1972). In particular, it was felt that such a "de-differentiating" influence 
of a growing tumour on an animal may alter the metabolism of the host tissue 
causing it to become foetal in nature. Consequently, host tissues may no 
longer be subject to the normal adult control mechanisms. Furthermore this 
"foetal" metabolic control of the host may be connected in some way with the 
cachexia that is often associated with tumour-bearing. However, the studies 
of Herzfeld & Greengard (1972) were 1imited to the effects of implanting fast 
growing, undifferentiated mammary carcinomas (DMBA 5A & Walker 256) into rats. 
It is possible therefore that host liver "de-differentiation" only occurs in
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rats as a consequence of bearing mammary carcinomas, or alternatively only 
in animals carrying very rapidly growing (undifferentiated) tumours. On the 
other hand "de-differentiation" of host tissues may prove to occur as a 
consequence of a number, i f  not a l l ,  tumours. Thus such studies may provide 
insight into the metabolic controls of the tumour-bearing host.
3.2 Results
3.2.1 Development of Transplantable Tumours
For the three transplantable tumour lines, age (10-12 week) and weight (150- 
200g) matched male rats received implants of tumours (R3230AC, 7777 or 5123C), 
one into each hindleg, as detailed in section 2.2. The growth of the tumours 
then proceeded as follows. After implantation at day 0, a period of time 
elapsed during which no tumour growth was visible or could be fe l t  by 
palpation. When the tumour size exceeded o.3cm in diameter however, i t  was 
easily palpated. The tumours had reached this limit of size at the times 
indicated in Table 1. After the tumour had grown to this init ial palpable 
size, the growth rate proceeded exponentially (Morris, 1975). The animals 
had usually developed metastases in the lungs during the transplantation 
interval, by which time the tumour weight was 35-40g wet weight (see Table 
1). No gross metastases were ever visible before this time. The health 
of the host animals appeared to be normal during the transplantation interval. 
This was monitored by coat appearance, feeding habits (stomach contents) and 
response to external stimuli. After this time the coat became dull and 
"scruffy", the animals lost body weight and gradually became less alert.
This condition became chronically worse, until death. At this time the 
animals exhibited extreme cachexia often having lost 40-50% of their body 
weight.
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TABLE 1: GROWTH RATES OF TRANSPLANTABLE TUMOURS
T u m o u r ^  P a l p a b l e ^  T r a n s p l a n t a b l e ^  Occurrence o f ^
I n te r v a l Death o f  the  Host
5123C 20 days 2 .5  -  3 .0  months 3 .0  -  4 .0  months
7777 10 days 1 .0  -  1 .5  months 1 .5  -  2 .0  months
R3230AC 7 days 1 .0  -  1 .2  months 1.2 -  1 .5  months
(a ) D e ta i ls  o f  tumours and methods o f  t r a n s p la n ta t io n  a re  d esc r ibe d
in  s e c t io n  2 .2 .
(b ) Tumours became p a lp a b le  when th e y  had exceeded 0.3cm in  d ia m e te r .
(c )  The tumours were u s u a l ly  t r a n s p la n te d  when the  tumour had
grown to  40 grams wet w e ig h t .  The t r a n s p la n ta t io n  i n t e r v a l  was 
d e f in e d  as th e  t im e  re q u ire d  f o r  a tumour to  grow to  40 grams 
wet w e ig h t  a f t e r  im p la n ta t io n .
(d) Death o f  th e  hos t u s u a l ly  o ccu rred  when th e  t o t a l  tumour w e ig h t
had exceeded 50 grams wet w e ig h t .
The t im es in d ic a te d  r e f e r  to  the  i n t e r v a l s  wh ich  had e lapsed f o l l o w in g  
im p la n ta t io n  o f  the  tum ours.
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3.2.2 Development of MDAB-Induced Primary Hepatocarcinoma 
The primary hepatocarcinoma was induced with the cancerogen MDAB as detailed 
in section 2.3. The development o f th is  tumour was b r ie f ly  as fo llows. As 
early as seven days a f te r  commencement o f the cancerogen feeding, the l iv e r  
developed a yellow colour due to the accumulation o f MDAB and i t s  metabolites. 
The external appearance o f the l i v e r  also became granular. Microscopic 
examination of these l iv e rs  up to the 28th day revealed that a most obvious 
change was perinuclear vacuolation and peripheral cytoplasmic g ranu la r ity
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o f the hepatocytes, often associated with c y to to x ic i ty .  A fte r the 28th day, 
cho lang ioce llu la r p ro l i fe ra t io n  became evident. By the 50th and 60th day 
o f cancerogen treatment, extensive cho lang ioce llu la r p ro l i fe ra t io n  was 
observed as well as, in some instances, small tumour nodules. At 80 days 
a f te r  commencement o f MDAB feeding a f a i r l y  homogeneous array of small tumours 
was present (comprising less than 5% of the l i v e r  weight) which by 100 days 
were most numerous and contributed 10-20% to the mass o f the l iv e r .  By 120 
days the tumours were large comprising 40-50% of the l i v e r  weight. At 
the time o f assay at 180-200 days a f te r  commencement o f feeding the tumour 
occassionally f i l l e d  the peritoneal cav ity  comprising 90% o f the weight of 
the l i v e r .
The MDAB hepatocarcinoma was included in the studies of th is  thesis to 
determine whether "d e -d i f fe re n t ia t io n "  also occurred in the host tissues of 
ra ts  carrying primary tumours. Host l i v e r  and tumour were designated as 
shown in Plate 1, but i t  must be kept in mind that "h o s t- l iv e r "  may be 
contaminated with ce l ls  from tumour and v^ce ucA6a . Results obtained from 
th is  tissue may therefore be compromised by allowing that there may be some 
contamination of l i v e r  w ith tumour and v-cce vzaacl. Host tissues such as 
kidney and spleen however would not be contaminated with tumour ce l ls  unless 
metastases had occurred.
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PLATE 1: MDAB-INDUCED PRIMARY HEPATOCARCINOMA
The pr im ary  hepatocarcinoma was induced with  th e  cancerogen MDAB in ou tbred  
W is ta r  r a t s  as  d e t a i l e d  in s e c t i o n  2 .3 .  The development o f  t h i s  tumour 
i s  d e t a i l e d  in s e c t i o n  3 . 2 . 2 .  The animal p i c t u r e d  had been fed  cancerogen 
f o r  100 days and had then  been fed normal r a t  chow f o r  a f u r t h e r  100 days .
T = hepatocarcinoma 
H = h o s t  l i v e r
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3.2.3 The Enzyme A c t iv i t ie s  of Adult and Foetal Rat Liver 
As indicated in the in troduction  o f th is  chapter the state of d i f fe re n t ia t io n  
o f a t issue can be determined by establishing the enzyme p ro f i le  o f a tissue. 
This is  done by measuring the a c t iv i t ie s  of a series of "marker" enzymes 
which are known to change th e i r  a c t iv i t y  during the development of a t issue . 
Seven "Marker" enzymes were therefore chosen fo r  ra t l iv e r .  These included 
three " fo e ta l- type " (hexokinase; Burch, 1968: phosphoserine phosphatase;
Jamdar & Greengard, 1969: and thymidine kinase; Klemperer & Haynes, 1968) and 
four "adu lt-type" enzymes (glucokinase; Walker & Holland, 1965: pyruvate 
kinase; Bailey et aZ., 1967; alanine aminotransferase; Götzy & Müller, 1967: 
and o rn ith ine  aminotransferase; Herzfeld & Knox, 1968). A baseline of 
enzyme a c t iv i t ie s  was then established by measuring these seven "marker" 
enzymes in adult and foeta l l i v e r  (Table 2). The enzyme a c t iv i t y  observed 
affirmed the marked differences between the two developmental stages and the 
data compared w i l l  w ith  published resu lts  ( Knox, 1976). The chosen 
enzymes therefore appeared to  be most useful as enzymic marker o f l iv e r  
d i f fe re n t ia t io n .  The l iv e rs  of the three d i f fe re n t  s tra ins o f ra ts  however, 
exhib ited marked va r ia t ion  in the a c t iv i t y  of each enzyme (see Table 2). I t  
is c lear therefore tha t any subsequent leve ls o f enzyme a c t iv i t y  tha t are 
observed in the l iv e rs  o f tumour-bearing rats (host l iv e r )  must be compared 
w ith the level of enzyme a c t iv i t y  observed in th e l iv e r s  of normal adult 
animals o f the same s tra in .  Therefore a l l  subsequent levels of enzyme a c t iv i t y  
found in host l iv e rs  were expressed as a percentage of the a c t iv i t y  found in 
the l i v e r  o f an adult animal of the same s tra in .  Enzyme a c t iv i t ie s  found in 
the tumours were also expressed as a percentage of the a c t iv i t y  found in the 
l iv e rs  o f normal adult ra ts of the same s tra in .  The Morris hepatomas and the 
host l iv e rs  of hepatoma-bearing rats were therefore compared with adult 
l iv e rs  obtained from Buffalo ra ts . S im ila r ly ,  the mammary carcinoma (R3230AC)
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TABLE 2: ACTIVITIES OF SELECTED "MARKER ENZYMES" WHICH CHANGE IN LIVER
DURING DEVELOPMENT FROM THE FOETUS TO THE ADULT RAT
ENZYME ENZYME ACTIVITY
Adult  Rat L iver F oe ta l  Rat L iver
Buffa lo F i s c h e r Wistar B uf fa lo
S t r a i n S t r a i n S t r a i n S t r a i n
A d u t t - T  y p n
Pyruva te  Kinase 79.5 + 8.1 64.3 + 2.9 77.6  + 5.7 19.2  + 1.9
A lan ine
A m in o t ra n s fe ra s e 73.7 + 2 .2 49 .4  + 4 . 2 52.9  + 2 .3 0 .7  + 0 .2
O r n i t h i n e
A m in o t ra n s fe ra s e 2.01 + 0 .14 1.37 + 0.15 1.82 + 0.13 0.17 + 0.02
G lucokinase 2.24 + 0.17 2.42  + 0.22 2.14  + 0.19 0.03 + 0.01
V o e X a t - T y p e .
P hosphoser ine
P hospha tase 331.6 + 59.5 441.6 + 21.1 262.2 + 17.1 1300 + 189
Thymidine
Kinase 1.74  + 0 .27 1.70 + 0 .30 1.68 + 0.26 62.5  + 22.1
Hexokinase 0 .118 + 0.042 0.078  + 0.031 0.097 + 0.036 0.339 + 0.046
All enzyme a c t i v i t i e s  were measured as d e t a i l e d  in s e c t i o n  2 .4 .  R e s u l t s  f o r  
a d u l t  r a t  l i v e r  were o b ta in e d  from 10-12 week old  r a t s  o f  th e  B u f f a lo ,  F i s c h e r  
and W is ta r  s t r a i n s .  R e s u l t s  f o r  f o e t a l  l i v e r  were o b ta in e d  from pooled 
l i t t e r s  o f  f o e t u s e s  of  th e  B uf fa lo  r a t  s t r a i n  o f  19-20 day g e s t a t i o n .  
Measurement o f  enzyme a c t i v i t i e s  in f o e t a l  l i v e r s  o f  F i s c h e r  or  W is ta r  r a t s  
gave e s s e n t i a l l y  t h e  same r e s u l t  (d a ta  not  shown). R e s u l t s  a r e  expressed  as 
jumol/min/g wet w eigh t  o f  t i s s u e  (mean + S .E.M.) excep t  t h e  phosphose r ine  
ph o s p h a ta s e  and thym id ine  k in a se  v a lues  which a r e  nmol/min/g wet weight  
(Mean + S .E .M . ).  R e s u l t s  were o b ta in e d  from a t  l e a s t  5 s e p a r a t e  an imals  or  
pooled l i t t e r s .  For d e f i n i t i o n s  o f  " a d u l t - t y p e "  and " f o e t a l - t y p e "  enzymes 
see s e c t i o n  3 .1 .
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and host l iv e rs  of R3230AC-bearing ra ts were compared with adult l iv e rs  
obtained from Fischer rats and the MDAB tumour and host l i v e r  o f MDAB- 
bearing ra ts with adult l iv e rs  obtained from Wistar ra ts .
3.2.4 A c t iv i t ie s  of Selected Enzymes in Tumours and Host-Livers of 
Tumour-bearing Rats
Before any resu lts  w i l l  be presented in th is  section some terms require 
d e f in i t io n .  In th is  thesis references made to "tumour" re fe r to the actual 
neoplasm. Furthermore, measurement of enzyme a c t iv i t y  or other biochemical 
functions were always performed in v iab le tumour tissue , i . e .  a f te r  any 
encapsulating or necrotic t issue had been removed. "Host" in th is  thesis 
re fers to an animal in to  which a tumour had been implanted (see section 2.2). 
"Host l i v e r "  or "host kidney" therefore re fe r  to the l iv e rs  or kidneys of 
tumour-bearing animals.
The a c t iv i t ie s  of the seven marker enzymes were measured in the host l iv e rs  
of rats bearing the four tumours (Figs. 1 & 2). The tumours in these animals 
were at an advanced stage of growth and weighed about 40g. The resu lts  of 
these experiments c le a r ly  show tha t host l iv e rs  of tumour-bearing ra ts  
deviate in enzyme p ro f i le  away from adult l i v e r  toward the level of a c t iv i t y  
found in foe ta l l iv e r .  A most obvious observation is  tha t th is  change was 
always toward the a c t iv i t y  found in foe ta l l i v e r  and never away from i t .  A ll 
of the measured adult-type enzymes decreased th e ir  a c t iv i t y  in host l i v e r  
(Fig. 1). In most instances the a c t iv i t y  found was less than one h a lf  of 
the adult a c t iv i t y  and in some cases a ten fo ld  decrease was seen. These 
changes in host l i v e r  occured even though the a c t iv i t y  of the same enzyme in 
the tumour o f the animal was more ch a ra c te r is t ic  of adult l iv e r .  For example 
pyruvate kinase a c t iv i t y  in the host l i v e r  o f an R3230AC-bearing animal had
FIGURE 1: ACTIVITIES OF SELECTED "ADULT-TYPE" MARKER ENZYMES IN TUMOURS AND
HOST LIVERS OF TUMOUR-BEARING RATS
A d u l t  (10-12 week) r a t s  were g iven an i n t r a m u s c u la r  im p la n t  o f  tumour t i s s u e  
(R3230AC, 7777 o r  5123C) as d e t a i l e d  in  s e c t i o n  2 .2 .  The a c t i v i t y  o f  each 
enzyme i n  the  hos t  l i v e r s  o f  these an imals  was measured 28,  45 and 80 days 
a f t e r  tumour i m p l a n t a t i o n  ( r e s p e c t i v e l y )  when the  tumour had grown t o  a 
t o t a l  w e ig h t  o f  about  40 grams. The a c t i v i t i e s  o f  enzymes i n  the  tumours 
d id  no t  appear t o  be a f u n c t i o n  o f  the  tumour s i z e  when measured in  the  
l - 2 0 g  wet  w e ig h t  range.  R e su l t s  f rom v a r io u s  tumour s i z e s  were t h e r e f o r e  
averaged a f t e r  the  tumour had been f r e e d  f rom e n c a p s u la t i n g  o r  n e c r o t i c  
m a t e r i a l .
The MDAB p r im a ry  hepatocarc inoma was induced as d e t a i l e d  i n  s e c t i o n  2.3 
(see a l s o  s e c t i o n  3 . 2 . 2 ) .  The a c t i v i t i e s  o f  enzymes in  the  tumours and host  
l i v e r s  o f  these  an imals  were measured 200 days a f t e r  commencement o f  dye 
f e e d in g .  Th is  occur red  a t  about  80-100 days a f t e r  p a lp a b le  neoplasms 
became e v id e n t .
Measurements o f  enzyme a c t i v i t y  were per formed as d e t a i l e d  i n  s e c t i o n  2 .4 .  
The l e v e l  o f  enzyme a c t i v i t y  i n  each t i s s u e  ( f o e t a l  l i v e r ,  tumour o r  hos t  
l i v e r )  was expressed as a percen tage (Mean + S .E .M.)  o f  the  a p p r o p r i a t e  
c o n t r o l  va lue  f o r  a d u l t  l i v e r  (see s e c t i o n  3 . 2 . 3 ) .  The mean va lu e  o f  the  
maximum c a t a l y t i c  c a p a c i t y  o f  each enzyme in  a d u l t  and f o e t a l  l i v e r  (19-  
20 day g e s t a t i o n )  i s  g iven  in  Table  2 -
The numbers r e f e r  t o  the  f o l l o w i n g  t i s s u e s :
1 . A d u l t  l i v e r
2. Foeta l  l i v e r
3. 5123C hepatoma
4. 7777 hepatoma
5. R3230AC mammary carc inoma
6. MDAB p r im a ry  hepatocarc inoma
7. 5123C hos t  l i v e r
8. 7777 hos t  l i v e r
9. R3230AC hos t  l i v e r
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FIGURE 2. ACTIVITIES OF SELECTED ’’FOETAL-TYPE” MARKER ENZYMES 
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#For experimental details and treatment of animals see the 
legend of Figure 1.
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decreased twofold. Yet the activity of this enzyme in the tumour was much 
greater than that found in adult liver. Figure 2 also shows that the 
activities of foetal-type enzymes were often elevated toward the activity 
found in foetal liver. The response of these enzymes however, was not as 
consistent as the reponse of the adult-type. Some tumours caused the 
elevation of foetal-type enzymes in host liver while others did not. This 
was true for thymidine kinase. This enzyme was increased in the livers of 
5123C and R3230AC-bearing animals, but was not affected in rats carrying the 
7777 or MDAB tumours. It is not clear why this was so, but it may be 
related to the orderly reversion of host liver differentiation that was 
proposed by Herzfeld & Greengard (1972). This will be discussed in a later 
section.
3.2.5 The Time-course of Changes of Enzyme Activity in Host Livers of 
Tumour-bearing Rats
The results presented in the previous section clearly demonstrate that a 
number of enzyme activities change in host livers as a consequence of the 
implantation of tumours. However, the use of animals bearing fully 
developed tumours will, as a consequence, always carry the uncertainty of 
whether theobserved effects are the direct result of the presence of neo­
plastic cells in an animal or whether they are an indication of non-specific 
degenerative changes resulting only indirectly from the presence of the 
neoplasm. Such non-specific changes may be the result of necrotic 
degeneration of neoplastic tissue or of secondary bacterial infection, or the> 
may be by-products of either of these processes. Moreover it was also 
important to determine whether the observed enzyme activity changes in host 
livers occurred before the metabolic requirements of the tumour become 
excessive and cause the cachexia which ensues in these animals or whether the
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changes in enzyme activity are due to the cachexia itself. The host livers 
of rats were therefore assayed for selected enzyme activities at given times 
after tumour implantation, during the tumour growth.
The results of these experiments are shown in Figs. 3-7 and clearly 
demonstrate that host liver enzyme activities are affected by tumour-bearing 
well before palpable tumours are present. It is therefore unlikely that 
these changes are due to any excessive metabolic demand by a tumour. It is 
further evident that the changes occur gradually with time as in no instance 
was the activity of an enzyme rapidly increased or decreased. Rather the 
activity of an enzyme changed gradually from an adult-type to a foetal-type 
profile.
3.2.6 The Activities of Enzymes of Other Host Organs
It is clear that the activities of certain enzymes in host livers change as a 
consequence of tumour-bearing. The question was then asked as to whether the 
liver was the only organ in the host that responds in this way or whether 
this phenomenon was manifested in a variety of host tissues. Relevant to 
this knowledge is that developmental enzymes have also been demonstrated in 
other tissues. In particular ornithine aminotransferase and phosphoserine 
phosphatase have been shown to be adult-type enzymes in the rat kidney 
(Greengard, 1971) while thymidine kinase has been shown to be a neonatal- 
type enzyme in the spleen (Machovich & Greengard, 1972). A baseline of 
enzyme activities in these tissues was therefore established by measuring 
ornithine aminotransferase and phosphoserine phosphatase activities in adult 
and foetal kidney and thymidine kinase activity in adult and neonatal spleen 
(Table 3). These results confirmed the marked differences in enzyme 
activities present during the developmental stages and the data compare well
FIGURE 3 : THE ACTIVITY OF ORNITHINE AMINOTRANSFERASE IN HOST LIVERS OF RATS
DURING THE TIME-COURSE OF TUMOUR-BEARING
A du l t  (10-12 week o ld )  r a t s  were given an in t ram uscu la r  imp lan t  o f  tumour 
t i s s u e  (R3230AC, 7777 or 5123C) as d e ta i l e d  in  s ec t ion  2 .2 .  Measurements 
o f  enzyme a c t i v i t y  was then performed a t  g iven t imes a f t e r  tumour im p la n t ­
a t io n  as d e ta i l e d  in  s ec t ion  2.4.  The mean va lue o f  the maximum c a t a l y t i c  
capac i ty  o f  each enzyme in  a d u l t  r a t  l i v e r  i s  given in  Table 1. The leve l  
o f  enzyme a c t i v i t y  found in  host l i v e r  a t  each t ime p o in t  a f t e r  tumour 
im p la n ta t io n  was then expressed as a percentage o f  the app rop r ia te  con t ro l  
value f o r  a d u l t  l i v e r  (see sec t ion  3 . 2 . 3 ) .  These r e s u l t s  were then 
p l o t t e d  (Mean + S.E.M.) aga ins t  t ime a f t e r  im p la n ta t io n .  The arrow 
present  on each graph in d ic a te s  the t ime a t  which tumours became pa lpab le  























































FIGURE 4. THE ACTIVITY OF ALANINE AMINOTRANSFERASE IN HOST LIVERS 



































FIGURE 5. THE ACTIVITY OF PYRUVATE KINASE IN HOST LIVERS OF 
RATS DURING THE TIME-COURSE OF TUMOUR-BEARING^
DAYS POST-IMPLANTATION
•«For e x p e r i m e n t a l  d e t a i l s  a n d  t r e a t m e n t  o f  a n i m a l s  s e e  t h e  l e g e n d  
o f  F i g u r e  3*
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FIGURE 6. THE ACTIVITY OF GLUCOKINASE IN HOST LIVERS OF RATS 
DURING THE TIME-COURSE OF TUMOUR-BEARING^
* For experimental details and treatment of animals see the 
























FIGURE 7. THE ACTIVITIES OF FOETAL-TYPE ENZYMES IN THE HOST
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PHOSPHOSERINE PHOSPHATASE ACTIVITY 
5123C HOST LIVER
DAYS POST-IMPLANTATION
-''-For experimental details and treatment of animals see the 
legend of Figure 3-
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TABLE 3: ACTIVITIES OF SELECTED "MARKER ENZYMES" WHICH CHANGE IN KIDNEY
OR SPLEEN DURING DEVELOPMENT FROM THE FOETUS TO THE ADULT RAT
A.________ A c t iv i t ie s  o f "A du lt- type" Kidney Enzymes
ENZYME ENZYME ACTIVITY
Adult Animal Kidney Foetal Kidney
Buffa lo Fi scher Wistar B u ffa lo
S tra in S tra in S tra in S tra in
O rn ith ine
Aminotransferase 2.53 + 0.25 1.77 + 0.11 3.02 + 0.19 0.23 + 0.05
Phosphoserine
Phosphatase 1776 + 172 1667 + 98 1385 + 52 177 + 20
B. A c t iv i t y  o f a "Neonatal - type" Spleen Enzyme
ENZYME ENZYME ACTIVITY
Adult Animal Spleen Neonatal Spleen
Buffa lo Fischer Wistar Bu ffa lo
S tra in S tra in S tra in S tra in
Thymidine Kinase 2.14 + 0.48 2.10 + 0.39 2.15 + 0.35 62.58 + 2.50
A l l  enzyme a c t i v i t ie s  weremeasured as d e ta ile d  in section 2.4. Results fo r  
adu lt r a t  kidney were obtained from 10-12 week old ra ts  o f  the B u ffa lo ,  
Fischer and Wistar s t ra in s .  Results fo r  fo e ta l  kidney were obtained from 
pooled l i t t e r s  o f foetuses o f the B u ffa lo  s t ra in  o f  19-20 day ges ta tion . 
Measurement o f enzyme a c t i v i t y  in  fo e ta l  kidneys o f  Fischer and W istar ra ts  
gave e s s e n t ia l ly  the same re s u l t  (data not shown). Results fo r  neonatal 
spleen were obtained from 6-10 day old B u ffa lo  ra ts .  Measurements o f enzyme 
a c t i v i t y  in  neonatal spleens o f Fischer and Wistar ra ts  gave e s s e n t ia l ly  the 
same re s u l t  (data not shown). Results are expressed a nmol/min/g wet weight 
o f t is su e  (Mean + S.E.M.) except the values fo r  o rn i th in e  aminotransferase 
a c t i v i t y  which are jumol/min/g wet weight. Results were obtained from at 
leas t 5 separate animals or from 3 pooled l i t t e r s .  For d e f in i t io n s  o f 
" a d u l t - ty p e " ,  " fo e ta l- ty p e "  or "neonata l-type" enzymes, see section 3.1.
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with published results (c^ Greengard, 1971; Machovich & Greengard, 1972). 
These enzymes therefore appeared to be most useful enzymic markers of 
differentiation in these tissues. The activities of these enzymes were 
therefore measured in host kidneys and spleens of animals bearing tumours 
that were at an advanced stage of growth (Fig. 8). These results clearly 
demonstrate that host liver is not the only organ that changes its enzyme 
profile as a consequence of tumour bearing. Both kidney enzymes exhibited 
a significant decrease toward foetal values. Furthermore, spleen thymidine 
kinase activity was dramatically elevated tenfold or greater by the presence 
of the tumours and toward neonatal values. Figure 9 also demonstrates that 
these changes occur in a manner similar to the observations in host liver. 
Again the enzyme changes were gradual and often occurred before palpable 
tumours became evident.
3.3 Discussion
The central argument of this chapter is concerned with the proposal that any 
tumour-bearing by an animal results in an enzymic "de-differentiation" not 
only by the growing tumour tissue, but also in the distant "non-involved" 
organs of the host animal. This proposal came about due to the work of 
Herzfeld & Greengard (1972). These workers had measured the activities of 
twenty randomly selected enzymes in adult rat liver, four to twenty three 
days after the hindleg implantation of fast growing (undifferentiated) 
mammary carcinomas. Their results indicated that a number of enzyme activ­
ities had changed as a consequence of tumour-bearing, before the onset of 
major deterioration in the health of these animals could be observed. The 
enzymes that increased in host liver upon tumour transplantation were among 
those that were relatively high in fast-growing hepatomas and in foetal 
liver. Similarly those that decreased were those that were low or absent in
HOST SPLEENS OF TUMOUR-BEARING RATS
FIGURE 8 :  A C T IV IT IE S  OF SELECTED MARKER ENZYMES IN THE HOST KIDNEY AND
Adult (10-12 week) ra ts were given an intramuscular implant o f tumour tissue 
(R3230AC, 7777 or 5123C) as deta iled in section 2.2. The a c t iv i t y  o f each 
enzyme in the host tissues was measured 28, 45 and 80 days a f te r  tumour 
implantation (respective ly) when the tumour had grown to a to ta l weight 
of about 40g. The MDAB primary hepatocarcinoma was induced as detailed in 
section 2.3 (see also section 3 .2 .2 ). The a c t iv i t ie s  of enzymes in the 
host tissues of these animals were measured 200 days a f te r  commencement 
of dye feeding. This occurred at about 80-100 days a f te r  palpable neoplasms 
became evident.
Measurements of enzyme a c t iv i t y  were performed as detailed in section 2.4. 
The level o f a c t iv i t y  o f each enzyme was then expressed as a percentage 
(Mean ±  S.E.M.) o f the appropriate control value fo r  the adult tissue (see 
section 3 .2 .3 ). The mean value of the maximum c a ta ly t ic  capacity o f each 
enzyme in adult and immature tissues is given in Table 3.
The numbers on the f igu re  re fe r to the fo llow ing t issu e s :-
1 . Adult kidney
2. Foetal kidney
3. 5123C host kidney
4. 7777 host kidney
5. R3230AC host kidney
6. MDAB host kidney
7. Adult spleen
8. Neonatal spleen
9. 5123C host spleen
10. 7777 host spleen
11. R3230AC host spleen








































FIGURE 9: THE ACTIV IT IES OF ORNITHINE AMINOTRANSFERASE AND PHOSPHOSERINE
PHOSPHATASE IN HOST KIDNEYS OF RATS DURING THE TIME-COURSE OF TUMOUR-BEARING
A du l t  (10-12 week o ld )  r a t s  were given an in t ram uscu la r  imp lan t  o f  tumour 
t i s s u e  (R3230AC or  7777) as d e ta i le d  in  sec t ion  2 .2 .  Measurement o f  
o r n i t h i n e  amino transferase (7777-bear ing r a t s )  and phosphoserine phosphatase 
(R3230AC-bearing r a t s )  a c t i v i t y  was then performed at  given t imes a f t e r  
tumour im p lan ta t ion  as d e ta i le d  in  sec t ion  2 .4 .  The mean value o f  the 
maximum c a t a l y t i c  capa c i t y  o f  each enzyme in  a d u l t  k idney is  given in  
Table 3. The leve l  o f  enzyme a c t i v i t y  found in host k idney a t  each t ime 
p o in t  a f t e r  tumour im p lan ta t ion  was then expressed as a percentage o f  the 
app rop r ia te  con t ro l  value f o r  a d u l t  k idney (see sec t ion  3 . 2 . 3 ) .  These 
r e s u l t s  were then p l o t t e d  (Mean + S.E.M.) aga ins t  t ime a f t e r  im p la n ta t io n .  
The arrow present on each graph in d ic a te s  the t ime a t  which tumours became 






























hepatomas and foetal liver. Thus by gain or partial loss of these enzyme 
activities, the quantitative pattern of enzymes in host liver diverged from 
normal liver toward that of immature liver and the w e l 1-differentiated 
hepatomas (Herzfeld & Greengard, 1972). Furthermore, all of the enzymes 
that decreased in host livers were adult-type enzymes, but they were not 
randomly distributed among them. None of the enzymes of the late foetal 
cluster, i.e. those enzymes that emerge very close to birth in the normal 
rat, decreased significantly in host liver. All of the enzymes that emerged 
in the normal developing liver during post-natal life however, responded to 
tumour-bearing by decreasing in the host liver. It appeared therefore, that 
enzymes that developed late in the normal course of rat liver differentiation 
were the ones that responded to tumour-bearing by decreasing in activity. 
These results suggest that there may be an orderly reversal of the normal 
process of differentiation in distant "non-involved" organs of tumour-bearing 
rats. Host livers therefore, were proposed to "de-differentiate" as a 
consequence of tumour-bearing and consequently deviate from the enzyme 
profile observed in adult liver toward that found in immature (1-2 week 
postnatal) liver (Herzfeld & Greengard, 1972).
The results presented in this chapter unequivocally support the above earlier 
findings by showing quantitative decreases of adult-type and increases of 
foetal-type enzymes in host liver during tumour-bearing. The decreases of 
hepatic ornithine and alanine aminotransferase activities (adult-type) were 
the earliest changes observed in host livers of tumour-bearing rats. Both 
of these enzymes exhibited significant decreases well before implanted 
tumours became palpable or visible on dissection (Figs. 3 & 4). At later 
stages of tumour growth the activities of hepatic pyruvate kinase and gluco- 
kinase (adult-type) were also decreased (Figs. 3 & 4) and activities of
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hexokinase and phosphoserine phosphatase (foetal-type) were increased 
(Fig. 7). I t  is evident therefore, that changes in enzyme profile occurred 
in the host livers of tumour-bearing rats carrying not only Walker 256 and 
DMBA 5A mammary carcinomas (Herzfeld & Greengard, 1972), but also in the 
host livers of animals carrying transplantable hepatomas 5123C and 7777, 
mammary carcinoma R3230AC as well as in animals carrying the MDAB primary 
hepatocarcinoma. It  must be remembered however that host livers of MDAB- 
bearing rats may be contaminated with cells from the tumour (see section 
3.2.2). Nevertheless, the results obtained in the host livers of animals 
carrying transplantable tumours firmly indicate that changes in enzyme 
activity in host liver toward foetal values appear not to be specific for 
just  one type of tumour, but may in fact occur as a consequence of bearing 
a large variety, if  not a l l ,  tumours.
The changes in enzyme activity observed in tumour-bearing rats also indicate 
that host livers of these animals possess enzyme profiles similar to livers 
of 1-2 week old neonatal rats. All of the adult-type enzymes studies in 
this chapter emerge in rat liver during the post-natal period of development 
(Greengard, 1971). The fact that the activ i t ies  of these enzymes decreased 
in host livers upon tumour implantation therefore supports the thesis 
proposal of this chapter. Similarly hepatic hexokinase activity was observed 
to be high in foetal liver when compared with adult liver (Table 2). The 
activity of this enzyme in liver was also shown to decrease gradually over 
the next three weeks after birth to the levels found in adult liver (Burch, 
1968). Furthermore, after tumour implantation, the activity of host liver 
hexokinase was significantly increased (Fig. 2) to levels characteristic of 
neonatal liver (Burch, 1968).
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Further evidence for the neonatal nature of enzyme activities found in host 
livers of tumour-bearing animals was provided by the study of hepatic 
thymidine kinase. In the developing rat, two days before birth, the activity 
of liver thymidine kinase had been shown to decrease from high foetal levels 
to low adult levels (Klemperer & Haynes, 1968). In tumour-bearing rats 
however, the activity of this enzyme was increased in host livers as a 
consequence of carrying some tumours (Fig. 2, 5123C, R3230AC) but not others 
(7777, MDAB). Similarly, it was demonstrated that thymidine kinase activity 
was significantly increased after lymphoma (RNC 290) implantation and also 
in host livers of rats carrying the 7777 hepatomas at an advanced stage of 
tumour growth (Herzfeld & Greengard, 1977). The implantation of Walker 256 
or renal MK1 carcinomas however, increased the activity of this enzyme in 
host livers only marginally, while the implantation of submaxillary gland 
tumours (CCC5, CCC14) had no effect on this enzyme (Herzfeld & Greengard, 
1977). The fact that this enzyme was increased in host livers as a 
consequence of bearing some tumours but not others, may therefore suggest 
that this enzyme activity isan expression of the lower limit of the enzymic 
de-differentiated state of host liver. The proposal that host livers of 
tumour-bearing rats possess enzyme activities similar to those found in the 
livers or 1-2 week old neonatal rats is still therefore consistent with 
these results.
The order in which enzymes are affected as a consequence of tumour-bearing 
appears to be indicative of orderly de-differentiation. The activities of 
the enzymes that emerged last during normal liver differentiation (adult- 
type) were decreased significantly before tumours became palpable (Figs. 
3-6). The activities of the foetal-type enzymes however, were not increased 
until later during tumour development (Fig. 7). Furthermore, during normal
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development in the rat ,  liver hexokinase activity was replaced by glucokinase 
activity (Burch, 1968). Upon tumour implantation however, glucokinase 
activity was lost f i r s t  (Fig. 6) and this enzyme was later replaced by an 
increase in hexokinase activity (Fig. 7). The normal order of differentiation 
therefore appears to be reversed in host livers after tumour implantation. 
Furthermore, Knox (1976) placed a large emphasis on the qualitative replace­
ments of adult-type enzymes with foetal-type enzymes as being concrete 
evidence for the de-differentiated state of neoplasms, hence the proposal 
of foetal ism of tumours. The qualitative replacement of glucokinase (adult- 
type enzyme) with hexokinase (foetal-type enzyme) in host livers of tumour­
bearing rats therefore (see figs. 6 & 7), may be a true reflection of the 
de-differentiated state of this tissue.
Recently further evidence of host liver enzyme changes, as a consequence of 
tumour-bearing have been demonstrated (Herzfeld & Greengard, 1977). These 
authors quantified nine developmental enzymes in host livers of rats bearing 
tumours of hepatic, lymphoid, renal, submaxillary and mammary gland origin.
All host livers exhibited signs of biochemical immaturity as indicated by 
the appropriate increases and decreases in the concentrations of the enzymes 
measured. The hepatic concentrations of ornithine aminotransferase, arginase, 
pyrroline-5-carboxylate reductase and glucokinase (adult-type enzymes) all 
diminished and those of peptidyl proline hydroxylase and hexokinase (foetal- 
type) increased. The concentration of ornithine aminotransferase was 
decreased before tumours became palpable or visible on dissection. These 
reports are similar to the findings presented in this thesis. At more 
advanced stages of tumour growth, high hepatic thymidine kinase activity 
was found in the presence of hepatoma (7777) and lymphoma (RNC-290). The 
most striking findings concerned those in lymphoma-bearing rats. The
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presence of p y r ro l ine-5-carboxylate reductase and of thymidine kinase in 
plasma were shown to be unique in the aminals carrying th is  tumour, as was 
the ra p id i ty  (4 days post-inocu la tion) o f the r ise  of hepatic thymidine 
kinase and the decrease of hepatic arginase, o rn ith ine  aminotransferase and 
alanine aminotransferase a c t iv i t ie s .  Four adult-type amino acid-cataboliz ing 
enzymes (serine dehydratase, o rn ith ine  aminotransferase, tyrosine amino­
transferase and alanine aminotransferase) have also been shown to be decreased 
in the host l iv e rs  of rats bearing the Morris 7800 hepatoma (de Rosa & P ito t ,  
1978). Serine dehydratase and o rn ith ine  aminotransferase were shown to 
decrease before neoplastic tissue was v is ib le .  These reports fu r th e r  support 
the proposal that host l ive rs  appear to become immature as a consequence of 
tumour-bearing since the a c t iv i t ie s  of a l l  o f the enzymes measured in these 
studies changed from adult levels toward those found in immature l i v e r .  
Furthermore, the apparent orderly reversal o f d i f fe re n t ia t io n  was also 
evident since the a c t iv i t ie s  of the adult-type enzymes were decreased 
f i r s t  and the a c t iv i t ie s  of the foe ta l- type  enzymes were not increased u n t i l  
a la te r  stage of tumour growth.
The evidence fo r  enzyme a c t iv i t y  changes in host l iv e rs  of tumour-bearing 
rats is  therefore now extensive. Host l i v e r  however, is  not the only 
tissue in which enzyme changes are evident as a consequence of tumour­
bearing. Ornithine aminotransferase (Herzfeld & Greengard, 1969) and 
phosphoserine phosphatase (Jamdar & Greengard, 1969) are adult-type kidney 
enzymes which were shown to emerge in th is  ra t  t issue a f te r  the post natal 
period. On tumour implantation however, the a c t iv i t ie s  of these enzymes 
were s ig n i f ic a n t ly  decreased in the kidneys o f the tumour-bearing animals 
(Fig. 8). Furthermore, host kidney phosphoserine phosphatase a c t iv i t y  was
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decreased before tumours became palpable (Fig. 9). Similarly, rat spleen 
is temporarily an erythropoetic organ during the first two weeks after 
birth. This is the interval during which the liver has high thymidine 
kinase activity (Machovich & Greengard, 1972). Furthermore, foetal 
(Machovich & Greengard, 1972) and adult spleens (Table 3) possessed low 
activities of this enzyme. Upon tumour implantation however, the activity 
of thymidine kinase was increased in host spleens to the levels normally 
observed in neonatal spleen (Fig. 8). Moreover, fifteen days after 
hepatoma 7800 implantation, ornithine aminotransferase activity was 
decreased in host kidney and muscle (de Rosa & Pitot, 1978). Mammary 
tumours (Greengard & Lempert, 1973; Herzfeld et at., 1978) as well as a 
fibrosarcoma (Herzfeld et at., 1978) also caused striking increases in the 
activity of thymidine kinase in host spleens. Evidence for enzyme changes 
in host tissues other than liver is therefore also evident. Furthermore, 
these changes in host tissue enzyme activities are also characteristic of 
the levels found in the neonatal tissue of origin and also often occur before 
tumours became palpable. It is possible therefore, that a number of other 
host tissues also became de-differentiated as a consequence of tumour bearing.
In summary, it appears that a number of different tumours of varying origin 
and growth rates, cause systemic effects in the distant "non-involved" host 
tissues of tumour-bearing rats. In particular, the enzyme activities of 
host livers change from the activity observed in normal adult liver toward 
that found in immature liver. This appears to occur by progressive reversal 
of normal differentiation until the host livers of tumour-bearing animals 




THE ACTIVITIES OF THE DEVELOPMENTAL MARKER ENZYMES IN THE LIVERS AND 
KIDNEYS OF RATS DURING PATHOLOGICAL CONDITIONS
4.1 I n t r o d u c t io n
The r e s u l t s  presented in  chapter 3 c l e a r l y  demonstrated t h a t  the a c t i v i t i e s  
o f  c e r t a in  enzymes i n t h e t i s s u e s  o f  r a t s  change a f t e r  the im p la n ta t io n  o f  
a tumour. Moreover, these enzyme changes were always toward an a c t i v i t y  
more c h a r a c t e r i s t i c  o f  the immature t i s s u e  o f  o r i g i n .  However, i t  i s  q u i te  
poss ib le  t h a t  such changes in  enzyme a c t i v i t y  were not un ique ly  assoc ia ted 
w i th  the presence o f  n e o p la s t i c  growth in  an an imal,  but  ra th e r  a r i s e  as a 
consequence o f  o the r  assoc ia ted whole body s t resses .  For example, under 
c e r ta in  cond i t ion s  the im p la n ta t io n  o f  tumours i n t o  animals have been 
repor ted to  e l i c i t  immune ( Ib rah im <i£ cut., 1977; Vaage oX cut., 1978) as 
we l l  as in f lammatory (Norman & So rk in ,  1977; Norman, 1978) responses in  the 
r e c i p i e n t  animal.  The observed enzyme changes in  host t i s sues  o f  tumour­
bear ing ra ts  t h e r e fo re ,  could have occurred as a r e s u l t  o f  such assoc ia ted 
host responses. Host t i s s u e  enzyme changes could p os s ib ly  a lso occur due 
to the im p la n ta t io n  o f  the tumour peA On the o the r  hand, such enzyme 
changes in  host t issues  may be due to  s t a r v a t i o n ,  caused by the anorex ia 
which i s  o f te n  assoc ia ted w i th  tumour-bear ing (Theo log ides , 1974, 1978).
I t  was p e r t i n e n t  th e re fo re  to  measure the a c t i v i t i e s  o f  the marker enzymes 
used in  chapter 3 under a v a r i e t y  o f  c ond i t ions  o the r  than tumour im p lan t ­
a t io n .
4.2 Resul ts
4.2.1 P re fa to ry  Statement
Values in  a l l  but  the f i r s t  column o f  each o f  the tab les  presented in  t h i s
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chapter (Tables 4-8) are expressed re la t iv e  to those obtained fo r  the 
appropriate control adult tissue (pathological cond it ion /contro l o f the 
same age and s t ra in ) ;  thus numbers greater or smaller than 1.0 re f le c t  
increases or decreases in enzyme a c t iv i t y ,  respective ly. An increase 
(>1.0) in a foe ta l-type enzyme or a decrease (<1.0) of an adult-type enzyme 
therefore re f le c t  a change in a c t iv i t y  of tha t enzyme toward the a c t iv i t y  
found in foe ta l l i v e r .
4.2.2 The A c t iv i t ie s  of the Marker Enzymes in the Livers and Kidneys of 
Syngeneic Skin-grafted Rats
Ten-week old inbred male Buffalo rats were given isogeneic sk in -g ra f ts  as 
de ta iled  in section 2.14. One week a f te r  transp lanta tion the sk in -g ra f ts  
appeared moist and so ft .  At th is  stage the donor skin could be eas ily  
removed, severing any connective tissue between the g ra f t  and the host.
Two weeks a f te r  transplantation the g ra fts  had attached more f i rm ly ,  were 
so ft  and moist and were s im ila r in appearance to the skin o f the host 
animals. The gra fts  at th is  stage could s t i l l  be removed but reguired 
greater e f fo r t .  As unsuccessful g ra fts  usually appeared dry and are shed 
eas ily  i t  was considered that the skin g ra fts  de ta iled here were successful 
and would have grown on the host fo r  an in d e f in i te  period. The l iv e rs  and 
kidneys o f g ra f t  re c ip ien t animals were assayed fo r  enzyme a c t iv i t y  seven and 
fourteen days a f te r  g ra f t  transp lanta tion . The host tissues of these animals 
at these times showed no visual signs o f abnormality when compared with 
co n tro l,  ungrafted animals. The resu lts  of these enzyme a c t iv i t y  
measurements are shown in Table 4.
Hepatic o rn ith ine  aminotransferase a c t iv i t y  was the only adult-type enzyme 
which decreased as a consequence of transp lan ta tion . This enzyme exhibited
TABLE 4: THE EFFECTS OF SKIN-GRAFTING ON THE ACTIVITIES OF THE "MARKER
ENZYMES" IN THE LIVERS AND KIDNEYS OF RATS
Ten-week old inbred male Buffalo rats were given isogeneic skin grafts as 
detailed in section 2.14. The livers and kidneys of graft recipient animals 
and control ungrafted animals were assayed for enzyme activity seven and 
fourteen days after graft transplantation as detailed in section 2.4.
(a) The values in the first column are the results of the measured tissue 
activities of the enzymes in ungrafted control rats (Mean ±S.E.M.; jumol/min/g 
wet weight). The values in the other two columns are expressed relative to 
those obtained for these control rats (see section 4.2.1); thus numbers 
greater or smaller than 1.0 reflect increases and decreases in enzyme activity 
relative to the activity in the control tissue, respectively.
73





P o s t - g r a f t i n g
14 Days 
P o s t - g r a f t i n g
A dulX-Typz
Pyruvate Kinase 51.5 + 2.1 0.99 + 0.06 1.07 + 0.06
A lan ine
Aminotransferase 52.5 + 8.3 1.03 + 0.08 1.05 + 0.02
O rn i th in e
Aminotransferase 1.08 + 0.04 0.52 + 0.02 0.71 + 0.06
Glucokinase 1.894 + 0.074 1.00 + 0.04 0.94 + 0.08
Fo&ta£-Type.
Phosphoserine
Phosphatase 0.392 + 0.075 0.73 + 0.02 0.67 + 0.02
Hexokinase 0.120 + 0.080 1.01 + 0.05 0.98 + 0.06
B. E f fe c ts  on Kidney Enzymes
ENZYME ENZYME ACTIVITY ^
Ungrafted 7 Days
Rats P o s t - g r a f t i n g
14 Days 
P o s t - g r a f t i n g
A d u tt-T  ype.




1.64 + 0.09 0.89 + 0.02 0.99 + 0.04
1.359 + 0.291 1.08 + 0.04 1.15 + 0.02
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lower enzyme activity seven days after transplantation but returned to a 
more normal activity after fourteen days. None of the hepatic foetal-type 
enzymes increased. Furthermore, the enzymes measured in the kidneys of these 
animals exhibited no change. The host livers and kidneys of animals carrying 
isogeneic skin-grafts therefore did not respond by exhibiting enzyme changes 
that had been observed in tumour-bearing animals. These results therefore 
clearly indicate that the concert of enzyme activity changes toward foetal 
values observed in tumour-bearing rats were not due to the transplantation 
of a tissue pca 4e. Similar results were obtained by Herzfeld & Greengard 
(1972). These authors implanted a mince of embryonic liver and kidney 
tissue into the hindlegs of adult rats and then measured the activities of 
a number of hepatic developmental enzymes in the livers of these animals.
The implantation of these non-neoplastic tissues was without effect on the 
hepatic enzymes studied, which include ornithine aminotransferase. As a 
consequence, these authors also concluded that the altered activities in 
host livers of tumour-bearing animals was unlikely to be due to trans­
plantation of tissue pcA 4e.
4.2.3 The Activities of the Marker Enzymes in the Livers and Kidneys 
of Starved Rats
Ten-week old male Buffalo rats were starved for a period of seventy-two 
hours as detailed in section 2.15.2. After this time the animals exhibited 
no distress or visual changes of the tissues on dissection, except the 
obvious lack of stomach contents. The activities of the marker enzymes 
were then determined in the livers and kidneys of these animals. The results 
of these experiments are shown in Table 5.
Pyruvate kinase and glucokinase were the only hepatic adult-type enzymes
TABLE 5: THE EFFECTS OF STARVATION ON THE ACTIVITIES OF THE "MARKER ENZYMES
IN THE LIVERS AND KIDNEYS OF RATS
Ten-week old male Buffa lo  ra ts  were starved fo r  a period o f  seventy-two 
hours as de ta i led  in sect ion 2.15.2. The l i v e r s  and kidneys o f  these 
animals and those o f  w e l l - fe d  normal animals were then assayed fo r  enzyme 
a c t i v i t y  as de ta i led  in sect ion 2.4.
(a) The values in the f i r s t  column are the re su l t s  o f  the measured t issue 
a c t i v i t i e s  of the enzymes in w e l l - fe d  ra ts  (Mean + S.E.M.; jumol/min/g wet 
weight) .  The values in t h e  other column are expressed r e la t i v e  to those 
obtained f o r  these contro l  ra ts  (see sect ion 4 .2 .1 ) ;  thus numbers greater  
or smaller than 1.0 r e f l e c t  increases and decreases in enzyme a c t i v i t y  
r e la t i v e  to the a c t i v i t y  in the contro l  t i s su e ,  respec t ive ly .
A. E f fe c ts  on L i v e r  Enzymes
ENZYME ENZYME ACTIVITY ^
W e l l - fed  Starved
Rats Rats
Admtt-T
Pyruvate Kinase 72.9 + 7.6 0.40 + 0.04
Alan ine
Aminotransferase 54.0 + 9.6 1.28 + 0.06
O rn i th in e
Aminotransferase 1.24 + 0.26 1.01 + 0.20
Glucokinase 1.44 + 0.18 0.17 + 0.04
Fo&taZ-Typz
Phosphoserine 
Phosphatase 0.263 + 0.046 0.92 + 0.13
Hexokinase 0.119 + 0.051 0.98 + 0.05
B. E f fe c ts  on Kidney Enzymes
ENZYME ENZYME ACTIVITY ^
W e l l - fed  Starved
Rats Rats
Adutt-Typz




1.86 + 0.27 1.18 + 0.33
1.528 + 0.016 0.65 + 0.02
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which responded to starvation by decreasing in activity, while phosphoserine 
phosphatase was the only adult-type renal enzyme which was decreased.
However, none of the foetal-type hepatic enzymes, including hexokinase showed 
an increase in activity. It is clear therefore, that a loss of glucokinase 
activity in starved rats is not replaced by an increase in the activity of 
hexokinase in these animals (Table 5). Therefore, the qualitative replace­
ment of glucokinase with hexokinase activity that was observed in host livers 
as a consequence of tumour-bearing (see Figs. 6 & 7, Chapter 3) does not 
occur in the livers of starved rats. Furthermore, the adult-type enzymes 
hepatic alanine aminotransferase and renal ornithine aminotransferase were 
seen to be elevated above normal levels by starvation (Table 5). These 
enzymes therefore were changed in activity away from, rather than toward the 
activities characteristic of the immature tissue of origin. Consequently 
these results were inconsistent with the enzyme activity changes observed 
in tumour-bearing rats. Starvation alone therefore must be considered 
unlikely to be responsible for the ordered changes observed in tumour-bearing 
animals. However, the results presented here do not discount the possibility 
that starvation due to anorexia may cause host tissue enzyme activity changes 
during the chronic terminal stages of tumour-bearing.
4.2.4 The Activities of the Marker Enzymes in the Livers and Kidneys 
of Experimentally - Arthritic Rats
Rats innoculated with Freunds adjuvant, rapdily develop signs of inflammation 
at the si te of injection. Many, but not al l ,  strains of rats subsequently 
manifest a polyarthritis as a delayed response to the adjuvant (for a review 
see Swingle, 1974). It was of interest to measure the response of liver to 
polyarthrit is , f i rs t ly  as i t  had been shown that a r th r i t i s  affects liver 
function (Morton & Chatfield, 1970; Beck & Whitehouse, 1973; Roback, 1977;
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Barritt & Whitehouse, 1977) (a change therefore in a distant "non-involved" 
organ), and secondly as tumours may also induce a inflammatory response 
(Norman & Sorkin, 1977; Norman, 1978).
There are a number of ways in which the course of polyarthritis in rats can 
be determined. For example, the metabolism of certain drugs is impaired 
within 1-2 days of the inoculation of adjuvant and this condition may 
remain so far many weeks (Baumgartner &t at, , 1974). This state is reflected 
in the prolonged sleep-times, in some instances, in increased mortality when 
inflamed rats are challenged with barbiturates (Morton & Chatfield, 1970;
Beck & Whitehouse, 1973). An objective determination can also be made of the 
course of the disease by measurement of the magnitude of swelling in the 
hindpaws of these animals after adjuvant inoculation (Winter & Nuss, 1966). 
Twelve days after the inoculation of adjuvant the sleep-times of the animals 
used in the experiments detailed here, had increased from one hour in 
controls to well over six hours in the incoluated rats. This occurred as a 
consequence of an intraperitoneal injection of sodium pentobarbital (20mg/
Kg body weight). Severe inflammation of the joints was clearly visible and 
was also confirmed by the measured increases of foot thickness using a 
micrometer screw gauge (1^-2 fold increase in the thickness of the hindpaws). 
The induction of experimental polyarthritis was therefore considered 
successful as judged by these criteria.
The selected enzyme activities of livers and kidneys of Fischer rats with 
experimental arthritis were measured fourteen days after inoculation with 
adjuvant. The results of these measurements are shown in Table 6 and 
clearly demonstrated that alanine aminotransferase was the only adult-type 
enzyme in the liver which changed exhibiting a significant decrease in
ACTIVITIES OF "MARKER ENZYMES" IN THE LIVERS AND KIDNEYS OF RATS
TABLE 6: THE EFFECTS OF EXPERIMENTALLY-INDUCED POLYARTHRITIS ON THE
Experimental arthritis was induced in ten-week old male Fischer rats as 
detailed in section 2.15.1. The livers and kidneys of these animals and 
control normal animals were assayed for enzyme activity fourteen days after 
the inoculation of adjuvant (see also section 4.2.4).
(a) The values in the first column are the results of the measured tissue 
activities of the enzymes in normal control rats (Mean + S.E.M.; >umol/min/g 
wet weight). The values in the other column are expressed relative to those 
obtained for these control rats (see section 4.2.1); thus numbers greater or 
smaller than 1.0 reflect increases and decreases in enzyme activity relative 
to the activity in the control tissue, respectively.
A. Effects on Liver Enzymes
ENZYME _______ENZYME ACTIVITY ^ _________
Normal Rats Arth r i t ic  Rats
Adult-T ypa
Pyruvate Kinase 55.2 + 6.4 0.84 + 0.07
Alanine
Aminotransferase 59.2 + 3.7 0.58 + 0.06
Ornithine
Aminotransferase 0.986 + 0.005 0.89 + 0.12
Glucokinase 1.72 + 0.11 0.93 + 0.03
Voetal-Type.
Phosphoserine
Phosphatase 0.464 + 0.019 1.56 + 0.08
Hexokinase 0.039 + 0.005 0.82 + 0.18
B. Effects on Kidney Enzymes
ENZYME _______ENZYME ACTIVITY ^ _________






1.57 + 0.19 1.58 + 0.24
1.194 + 0.058 1.04 + 0.04
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activity. Phosphoserine phosphatase activity was also increased in the 
livers of these animals. However, none of the adult-type enzymes were 
decreased in the kidneys of arthritic rats (Table 5). Furthermore, the 
activity of ornithine aminotransferase in the kidneys of these animals was 
increased i.e. away from rather than toward an activity characteristic of 
foetal kidney (see Table 3). The concert of enzyme activity changes toward 
foetal values observed in host tissues of tumour-bearing rats therefore 
cannot be demonstrated to occur in rats with experimental polyarthritis. 
Consequently the proposed "de-differentiated" enzymic profile of tissues of 
tumour-bearing animals is unlikely to be due to the result of inflammation.
4.2.5 The Activities of the Marker Enzymes in the Livers and Kidneys 
of Partially-hepatectomised Rats
Partial hepatectomy has been used by many workers to study normal liver 
hyperplasia in adult rats , a condition normally present only in foetal 
and neonatal animals. Moreover, it is well known that the enzyme patterns 
in regenerating-liver are different from those found in the normal rat 
(Bonney at at., 1973; Yanagi & Potter, 1977) and are also often described as 
"de-differentiated" (Uriel, 1975) or "undifferentiated" (Taketa at at., 1976). 
It was important to measure the activities of the marker enzymes in regen­
erating liver to determine whether these enzymes were also changed in activity 
toward foetal values in this "immature" tissue; and hence provide evidence 
whether such enzyme measurements are a good indication of the state of liver 
differentiation.
Partial hepatectomy was performed on ten-week old Buffalo rats as detailed 
in section 2.13. Twenty-four hours after hepatectomay there was extensive 
liver regeneration and the animals were quite mobile. They were eating and
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drink ing , although stomach contents were small. The l iv e rs  at th is  stage 
appeared pale and "mottled" (speckled) but the kidneys were v is u a l ly  normal. 
By fo r ty -e ig h t  hours the animals had large stomach contents but the l iv e rs  
remained pale and "mottled". The a c t iv i t ie s  of the marker enzymes were 
quantif ied  in the l iv e rs  and kidneys of these animals twenty-four and 
fo r ty -e ig h t  hours a f te r  hepatectomy. The resu lts  of these measurements are 
shown in Tables 7 & 8. The kidney enzymes of hepatectomised ra ts  responded 
with only minor decreases o f the adult-type enzymes at both twenty-four and 
fo r ty -e ig h t  hour timepoints a f te r  l i v e r  regeneration. Kidney o rn ith ine  
aminotransferase a c t iv i t y  was decreased at both 24 and 48 hours a f te r  
operation. Kidney phosphoserine phosphatase a c t iv i t y  was decreased at 24 
hours but had returned to normal by 48 hours. However, the leve ls of change 
in these enzyme a c t iv i t ie s  were not decreased to the extend tha t had been 
observed in tumour-bearing ra ts .
The leve ls  of themarker enzymes in regenera ting- live r exhibited s ig n if ic a n t  
changes. Twenty-four hours a f te r  hepatectomy, the a c t iv i t y  of o rn ith ine  
aminotransferase (adult-type enzyme) was decreased and tha t of hexokinase 
( fo e ta l- type  enzyme) was increased (Table 7). By fo r ty -e ig h t  hours the 
a c t iv i t ie s  of a l l  of the adult-type enzymes were decreased and the a c t iv i t y  
of hexokinase remained elevated (Table 8). Moreover, there was a q u a l i ta t iv e  
replacement of glucokinase a c t iv i t y  w ith hexokinase a c t iv i t y  (Table 8). I t  
is  c lear therefore that the marker enzymes measured in 48 hour regenerating 
l i v e r  were a l l  changed in a c t iv i t y  toward foe ta l values. Regenerating l i v e r  
therefore possessed the same enzyme p ro f i le  which has been described fo r  
l iv e rs  of immature (Table 2) and tumour-bearing (Fig. 1) ra ts . Furthermore, 
as regenerating l iv e r  has been described as essen tia l ly  immature (U r ie l,
1975; Taketa oX a t . ,  1976) the resu lts  found here support the theory that
TABLE 7: THE ACTIVITIES OF THE "MARKER ENZYMES'1 IN THE LIVERS AND KIDNEYS
OF RATS TWENTY-FOUR HOURS AFTER PARTIAL HEPATECTOMY
P a rt ia l  hepatectomy and sham-hepatectomy was performed on ten-week old 
male Buffa lo  ra ts  as described in section 2.13. Control normal ra ts  were 
anaesthetised at the same time in a s im i la r  manner to  the hepatectomised and 
sham-hepatectomised ra ts  but were not operated. The l iv e r s  and kidneys o f 
a l l  o f these animals were assayed fo r  enzyme a c t i v i t y  as d e ta ile d  in section 
2.4 tw en ty-four hours a f te r  the above manipulations.
(a) The values in the f i r s t  column are the re s u lts  o f the measured t issue  
a c t i v i t ie s  o f the enzymes in  the normal con tro l (Mean +.S.E.M., umol/min/g 
wet w e igh t). The values in  the other two columns are expressed re la t iv e  to 
those obtained fo r  these contro l ra ts  (see section 4 .2 .1 ) ;  thus numbers 
g reater or smaller than 1.0 r e f le c t  increases and decreases in  the enzyme 
a c t i v i t y  re la t iv e  to the a c t i v i t y  in  the contro l t is s u e ,  re sp e c t ive ly .










Pyruvate Kinase 57.2 + 10.0 0.98 + 0.07 0.89 + 0.06
Alanine
Aminotransferase 73.7 + 2.2 0.74 + 0.08 0.91 + 0.06
O rn i th ine
Aminotransferase 1.89 + 0.14 0.54 + 0.06 0.66 + 0.05
Glucokinase 2.16 + 0.15 0.96 + 0.08 0.91 + 0.04
VzotaJt-Type.
Phosphoserine
Phosphatase 0.531 + 0.021 1.05 + 0.06 0.78 + 0.07
Hexokinase 0.065 + 0.016 0.96 + 0.10 1.33 + 0.05
B. Enzyme A c t i v i t i e s  in  Kidney
ENZYME
A duZt-T ypz







1.56 + 0.16 1.06 + 0.05 0.80 + 0.02
1.24 + 0.08 0.96 + 0.05 0.78 + 0.06
OF RATS FORTY-EIGHT HOURS AFTER PARTIAL HEPATECTOMY
TABLE 8: THE ACTIVITIES OF THE "MARKER ENZYMES11 IN THE LIVERS AMD KIDNEYS
Partial hepatectomy and sham-hepatectomy was perforemd on ten-week old male 
Buffalo rats as described in section 2.13. Control normal rats were 
anaethetised at the same time, in a similar manner to the hepatectomised and 
sham-hepatectomised rats but were not operated. The livers and kidneys 
of all of these animals were assayed for enzyme activity as detailed in 
section 2.4, forty-eight hours after the above manipulations.
(a) The values in the first column are the results of the measured tissue 
activities of the enzymes in the normal control rats (Mean + S.E.M.; pmol/ 
min/g wet weight). The values in the other two columns are expressed 
relative to those obtained for these control rats (see section 4.2.1); 
thus numbers greater or smaller than 1.0 reflect increases and decreases 
in the enzyme activity relative to the activity in the control tissue, 
respectively.
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A. Enzyme A c t i v i t i e s  in  L iv e r








Pyruvate Kinase 57.2 + 10.0 0.96 + 0.06 0.71 + 0.05
Alanine
Aminotransferase 73.7 + 2.2 0.61 + 0.05 0.47 + 0.10
O rn i th in e
Aminotransferase 1.89 + 0.14 0.47 + 0.05 0.35 + 0.10
Glucokinase 2.16 + 0.15 0.98 + 0.06 0.42 + 0.06
F otto l-Type,
Phosphoserine
Phosphatase 0.531 + 0.021 1.15 + 0.10 1.09 + 0.02
Hexokinase 0.065 + 0.016 1.00 + 0.06 1.53 + 0.15
B. Enzyme A c t i v i t y  in  Kidney




O rn i th in e  
Aminotransferase 1.56 + 0.16 1.06 + 0.07 0.73 + 0.07
Phosphoserine
Phosphatase 1.24 + 0.08 0.91 + 0.04 0.94 + 0.11
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host livers of rats carrying neoplasms appear enzymically de-differentiated. 
It is interesting to note that both alanine and ornithine aminotransferase 
activities decreased in the liver of sham-operated rats. Why this is so is 
unclear. This phenomenon was also reported by Yanagi & Potter (1977).
4.3 Discussion
It is now clear that the implantation of a tumour into adult rats alters 
the activities of a number of host tissue enzymes. The question arises 
therefore as to what causes the measurable changes in the activities of host 
tissue enzymes. A possible mechanism may be that transplantable tumours 
release cells into the cirulation which travel to host tissues and are 
consequently present in the sample taken for host tissue enzyme activity 
measurements. The enzyme changes observed in host livers of tumour-bearing 
rats for example would therefore be due to a passive contribution by the 
tumour, i.e. due to the dilution of thehepatic mass by tumour cells. 
Histological examination of host livers of tumour-bearing rats however, have 
not shown the presence of tumour cells in hepatic tissues after tumour 
implantation (Herzfeld & Greengard, 1977; Longenecker, Matthaei & Williams, 
unpublished work). Furthermore a 7.5 fold increase in hepatic thymidine 
kinase activity was observed in host livers 4 days after lymphoma implant­
ation (Herzfeld & Greengard, 1977, see Chart 1). The amount of thymidine 
kinase acquired by the host liver per gram to produce such an increase had 
been calculated to be equivalent to that contained by 10^ lymphoma cells 
(Herzfeld & Greengard, 1977). The total number of cells in adult liver has 
also been estimated to be 2 x 10^ cells/g wet weight (Greengard at at., 
1972). The invasion of 10^ lymphoma cells into host livers, 4 days after 
implantation, therefore would represent 0.5% of the total number of cells 
per gram liver and would have been detectable using cytomorphometric
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techniques (Greengard eX aZ., 1972) but none were found at this early stage 
(Herzfeld & Greengard, 1977) or even 18 days after lymphoma implantation 
(Herzfeld oJL. , 1978). Furthermore, metastases were never evident until 
much later during the time-course of tumour growth and even then were 
confined to the lungs of tumour-bearing animals (see section 3.3.1). 
Furthermore, fibrosarcomas, which have also been shown to change host liver 
enzyme activities towards foetal levels after implantation, have never been 
shown to disseminate cells or metastasize (Herzfeld at at., 1978). Moreover, 
high activities of pyruvate kinase and pyrroline-5-carboxylate reductase were 
observed in mammary carcinoma R3230AC (Fig. 1) and lymphoma (Herzfeld & 
Greengard, 1977), respectively. Both of these enzymes however, decreased in 
host livers of tumour-bearing rats after tumour implantation (Fig. 1;
Herzfeld & Greengard, 1977). Similarly the activity of ornithine amino­
transferase (OAT) measured in the 5123C hepatoma was 80% of the activity 
observed in normal adult rat liver. After the implantation of this tumour 
into adult rats however, the activity of OAT decreases tenfold in the host 
livers of these animals when compared with adult liver. Therefore the 
changes in enzyme activity of host livers of tumour-bearing rats cannot 
be attributed to a passive contribution by tumour cells i.e. to the dilution 
of the hepatic mass by tumour cells. Nevertheless, it may not be a 
coincidence that the most striking hepatic responses in tumour-bearing 
animals were evoked by the implantation of lymphoma (Herzfeld & Greengard, 
1977) the tumour most likely to release cells into the circulation. It is 
therefore possible that a few tumour cells (too few to be histologically 
detectable) do reach the liver, remain viable, and release substances In aaJu 
which alter the rate of synthesis or degradation of specific proteins within 
the hepatocytes. The extent of change of host enzymes would therefore depend 
on capability of the tumour to convey cells to the host liver. This proposal
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would imply that all of the transplantable tumours so far studied, transmit 
cells to the liver (and possibly other tissues). At present however, no 
experimental evidence to support this proposal has been demonstrated.
On the other hand experiments to suggest that tumours elucidate their effects 
on host tissue enzymes via an unknown humoral factor (or factors) have been 
performed. Herzfeld zt at., (1978) united the circulations of paired rats 
by parabiosis. ^This procedure has been described in detail (Warren zt at., 
1972) and assures a uniformly effective transcirculation between parabiotic- 
ally paired rats.J After a suitable post-operative period, one of the 
parabiotic partners was given a subcutaneous implant of lymphoma or fibro­
sarcoma. Measurements of the developmental hepatic enzymes arginase, 
ornithine aminotransferase (adult-type) and thymidine kinase (foetal-type) 
clearly demonstrated that the activities of these enzymes were changed toward 
foetal values, not only in the livers of parabiotic hosts (the partner 
carrying a tumour) but also in the livers of the host partner (the animal 
not carrying a tumour). Furthermore, the activity of splenic thymidine 
kinase (neonatal-type) was also significantly increased in the spleens of 
the parabiotic hosts as well as the host partner. Coculturing experiments 
have also demonstrated the humoral nature of the tumour-host tissue enzyme 
changes. Cultured foetal liver is a system in which several enzymes have 
been reported to arise spontaneously (Ko zt at,, 1967; Wicks, 1968; Sereni 
& Sereni, 197.1). When foetal liver explants were cocultured with Walker 256 
carcinoma explants however, the normal developmental accumulation of arginase, 
tyrosine aminotransferase and alanine aminotransferase activities were 
inhibited (Farron & Lightholder, 1976). Furthermore, the foetal liver 
explants were separated from the tumour by a semipermeable membrane. The 
tumour therefore produced a diffusible factor (or factors) which inhibited
86
the normal development of the enzymes in the foetal explants. Therefore the 
systemic action of solid tumours is unlikely to depend on the release of 
whole tumour ce l ls  but rather on that  of c e l l - f r e e  agents.
Are the systemic effects  observed in tumour-bearing ra ts  however, en t i re ly  
specif ic  for  the presence of a neoplasm in an animal. The responses of the 
immune system to the imposition of a growing tumour into healthy adult animals 
may also be implicated as a possible mechanism fo r  the changes observed in 
host t i s sue  enzyme a c t iv i t i e s  as several immunological functions have been 
shown to be impaired in tumour-bearing animals. I t  is not clear  however, 
whether tumours grow progressively because of blocking fac to rs ,  blocking 
antigens,  antibodies, or antigen-antibody complexes (Baldwin qX  a t . ,  1973; 
Bowen oX aJL., 1975); because of a defect in the hosts immune response, e i ther
ce l lu la r  or humoral (Pinsky z t  aZ ., 1974; Lee eX a t . ,  1975); or due to the 
secretion of suppressor elements that  actively antagonise the response of the 
host to tumours, the source of which could be t issues such as lymphoid cel ls  
(Hersh oX a t . ,  1974; Andjargholi & Dale, 1977) macrophages (Calderon 
z t  a t . ,  1974; Kirchner oX a t . ,  1975), spleen ce l ls  (Subramanian oX aJL., 1978) 
or possibly the tumour i t s e l f  (Vaage & Agarwal, 1976). In general therefore , 
although the specific  mechanism is unknown, tumour-bearing animals carrying 
neoplasms at an advanced stage of growth exhibit  severe immunoincompetance. 
Shortly a f te r  implantation of a tumour however, tumour-bearing animals 
exhibited an early immune response which was l a t e r  blocked a f te r  the growth 
of the tumour had exceeded a certain c r i t i c a l  size (Vaage, 1974; Vaage & 
Agarwal, 1976; Vaage oX a t . ,  1978). Furthermore, the implantation of syn­
geneic tumours also e l ic i ted  an early immune response in tumour-bearing animal 
which was l a t e r  repressed during tumour growth (Churchill oX aJi., 1968;
Ibrahim eX a l . , 1977). Similarly, the imposition of syngeneic t ransplantable
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tumours into animals also e l i c i t ed  inflammatory responses early during tumour­
bearing which were la te r  repressed by the tumour (Norman & Sorkin, 1977; 
Norman, 1978). The presence of an early immune or inflammatory response 
a f te r  the implantation of the syngeneic tumours studied in th is  thes is  was 
therefore possible and may be responsible for the early host t i s sue  enzyme 
ac t iv i ty  changes that  were demonstrated in tumour-bearing animals (Figs. 3-7, 
9).
Measurements of the marker enzymes in animals with po lya r th r i t i s  (section 
4.2.4) i . e .  in animals exhibiting an immune response as well as chronic 
inflammation however, did not show the ordered enzyme ac t iv i ty  changes 
that  were demonstrated in tumour-bearing animals. Hepatic alanine amino­
transferase was the only adult-type enzyme which changed exhibiting a 
s ignif icant  decrease of a c t iv i ty  in the r a t  with experimentally induced 
a r t h r i t i s  (Table 6). The l ive rs  of tumour-bearing animals however, possessed 
decreased enzyme a c t iv i t ie s  of a number of adult- type enzymes before tumours 
became palpable (Figs. 3 to 6) which coincided with the time during which 
tumour-bearing was reported to e l i c i t  an immune (Ibrahim qX  a t . ,  1977; Vaage 
qX  a t . , 1978) or inflammatory (Norman & Sorkin, 1977; Norman, 1978) response. 
The ac t iv i ty  of the hepatic foetal- type enzyme phosphoserine phosphatase 
was also increased in po lyar th r i t ic  ra ts  (Table 6). In tumour-bearing ra ts  
however, the ac t iv i ty  of th is  enzyme was not increased s ign i f ican t ly  until  
the tumour was at  an advanced stage of tumour growth (Fig. 7) which 
corresponded to the time during which the immune and inflammatory responses 
were reported to be no longer present (Churchill oX a t . ,  1968; Ibrahim 
eX a t . ,  1977; Vaage oX a t . ,  1978; Norman, 1978). Furthermore, none of the 
a c t iv i t i e s  of the kidney adult-type enzymes were shown to decrease in the 
experimentally a r t h r i t i c  r a t  (Table 6). In fac t  ornithine aminotransferase
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a c t iv i t y  was shown to increase in kidneys o f these animals. The ordered 
enzyme a c t iv i t y  changes observed in host tissues of tumour-bearing rats 
therefore, cannot be a t t r ibu ted  so le ly  to the immune or inflammatory responses 
which may occur in animals as a consequence of tumour implantation.
Clearly the processes and whole body reaction to transp lanta tion peA 
were also not responsible fo r  the changes in enzyme a c t iv i t y  observed in 
host l iv e rs  of tumour-bearing animals as only one adult-type enzyme was 
shown to decrease in animals a f te r  the implantation of a syngeneic skin 
g ra f t  (Table 4). Seven days a f te r  transp lanta tion o f the skin g ra f t  the 
a c t iv i t y  o f o rn ith ine  aminotransferase was decreased in the l iv e rs  of the 
grafted ra ts . By fourteen days a f te r  transp lanta tion  however, the a c t iv i t y  
of th is  enzyme had returned to more normal adult leve ls . Furthermore, none 
of the a c t iv i t ie s  of other adult-type enzymes or foe ta l- type  enzymes were 
seen to change toward foeta l values in the l iv e rs  of kidneys o f skin 
grafted rats (Table 4). Moreover, none o f the enzymes (inc luding o rn ith ine  
aminotransferase), tha t were reported to change in a c t iv i t y  toward foetal 
levels in host l iv e rs  of tumour-bearing ra ts ,  exhibited any change of 
a c t iv i t y  a f te r  the implantation of a mince o f embryonic l i v e r  and kidney in to  
adult ra ts (Herzfeld & Greengard, 1972). Therefore, the resu lts  o f both of 
these studies support the proposal tha t the a ltered a c t iv i t ie s  of host 
tissue enzymes of tumour-bearing rats are not due to transp lanta tion peA ae.
The decreased food intake tha t resu lts  from anorexia which was often found 
associated with tumour-bearing animals and cancer patients (Theologides, 1972) 
may also re su lt  in host tissue enzyme a c t iv i t y  changes. The data in Table 
2 demonstrated that seventy-two hour starvation  produce enzyme a c t iv i t y  
changes in the l ive rs  of ra ts . Hepatic pyruvate kinase and glucokinase
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(adult-type) enzyme a c t iv i t ie s  both decreased in the l iv e rs  of these 
animals and phosphoserine phosphatase (adu lt- type) was decreased in the 
kidney. None of the foe ta l- type  enzymes however, responded to starvation by 
an increase in a c t iv i ty .  Furthermore, .two of the adult-type enzymes (hepatic 
alanine aminotransferase and kidney o rn ith ine  aminotransferase) both 
exhibited increases in a c t iv i t y  as a consequence o f starvation (Table 2). 
Moreover, in tumour-bearing ra ts ,  decreased glucokinase a c t iv i t y  was always 
associated with increases in hexokinase a c t iv i t y  (Figs. 1 & 2, see also the 
data of Herzfeld & Greengard, 1972, 1977). This q u a l i ta t iv e  replacement of 
glucokinase with hexokinase a c t iv i t y  was never associated with s tarvation 
(Table 2) or in animals lacking insu lin  (Manjeshwar z t aZ., 1965). Therefore, 
by comparison of the enzyme a c t iv i t y  changes observed in starved ra ts (Table 
2) and the changes demonstrated in host tissues o f tumour-bearing rats (Fig.
1) i t  is  u n l ike ly  that starvation alone could be the cause of the ordered 
host tissue enzyme a c t iv i ty  changes. From the data of Table 2 however, i t  
can not be concluded that prolonged starvation which is not severe enough to 
k i l l  an animal, such as might be present in tumour-bearing animals, could 
produce a q u a l i ta t iv e  replacement of glucokinase with hexokinase a c t iv i t y  
a f te r  a long period of time. Such a q u a l i ta t iv e  replacement of these two 
isoenzymes by a lte ra tions  in d ie t  or hormone treatment however, has to date 
not been demonstrated and therefore appears u n l ike ly .  Furthermore, the 
increases in a c t iv i t y  of the adult-type enzymes (hepatic alanine aminotrans­
ferase and kidney orn ith ine aminotransferase) i . e .  changes in a c t iv i t y  away 
from foetal values provide fu r th e r  support fo r  the proposal that the ordered 
host tissue enzyme changes were not produced by starvation .
Hormonal or d ie ta ry  a lte ra t ions  in tumour-bearing rats may also be responsible 
fo r  host tissue enzyme a c t iv i t y  changes. The leve ls of a c t iv i t y  of o rn ith ine
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aminotransferase (OAT) observed in the host livers of tumour-bearing rats 
provide evidence that i t  is unlikely that altered hormonal levels cause the 
changes observed in the levels of activity of at least this enzyme in host 
tissues. In the normal ra t ,  no significant differences between the struct­
ural properties of liver and kidney ornithine aminotransferases have been 
found. In both tissues of the rat this enzyme is located in the mitochondria 
(Herzfeld & Knox, 1968) apparently in the matrix space (Ip eX a t . , 1974), 
and both possess similar kinetic properties for the substrates ornithine 
and cx-ketoglutarate (Herzfeld & Greengard, 1969; Kalita oX a t., 1976).
Although the kidney enzyme differs from the liver enzyme in heat s tabili ty 
(Volpe eX a t.,  1974; Kalita ex a t., 1976) the enzymes isolated from liver 
or kidney had a similar crystal structure and have been shown to be immuno- 
chemically indistinguishable in the normal rat (Sanada eX a t.,  1970). The 
responses of the ornithine aminotransferases of liver and kidney to hormones 
and alterations in dietary condition however, are quite different. For 
example, increases dietary carbohydrate intake in the rat increased the 
activity of OAT in kidney but decreased the activity of this enzyme in liver 
(Peraino & Pitot, 1964; Volpe oX a t . , 1969). Starvation and transplantation 
increased the activity of OAT in kidneys but the hepatic levels of this 
enzyme was unaltered (Tables 2 & 6). Injections of hydrocortisone into rats 
on a high protein diet also decreased the activity of OAT in rat liver (Morris 
& Peraino, 1976) but had no effect on kidney levels of this enzyme (Herzfeld 
& Greengard, 1969). Similarly, injections of triamcinolone increased the 
activity of OAT found in livers of 4 to 16 day old neonatal rats (Herzfeld 
& Greengard, 1969) but had no effect on the levels of this enzyme found in 
adult kidney (Lyons & Pitot, 1976). Glucagon injections were also reported 
to increase the activity of OAT in adult rat liver (Peraino & Pitot, 1964; 
Sanada oX a t.,  1970; Lyons & Pitot, 1976) but had no effect on the activity
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of th is  enzyme in ra t kidney (Herzfeld & Greengard, 1969; Lyons & P ito t ,
1976, 1977). The normal adult level of OAT a c t iv i t y  found in female ra t 
kidney was reported to be higher than tha t found in adult male kidney, but 
the a c t iv i t y  of th is  enzyme was reduced to tha t found lin the adult male 
kidney by gonadectomy of the female (Herzfeld & Knox, 1968). Furthermore, 
in jec t ions  of estradio l in to the male ra t  caused an increase of adult male 
kidney levels of OAT to r ise  to the leve ls found in the adult female kidney 
(Herzfeld & Knox, 1968; Herzfeld & Greengard, 1969; Sanada i t  a t . ,  1970; 
Kobayashi eX cal., 1976). Gonadectomy or es trad io l in jec t ions  however, had no 
e f fe c t  on the a c t iv i t y  of OAT in male or female ra t  l i v e r  (Herzfeld & Knox, 
1968; Herzfeld & Greengard, 1969; Kobayashi oX a t . ,  1976). Furthermore 
adrenalectomy had no e f fe c t  on the a c t iv i t y  o f OAT in e ithe r adult l i v e r  or 
kidney (Herzfeld & Greengard, 1969). In jec tions  of g lucocortico ids however, 
have been shown to evoke the premature formation o f th is  enzyme in neonatal 
l i v e r  and the normal formation of OAT in developing neonatal l i v e r  can be 
prevented by adrenalectomy (Herzfeld & Greengard, 1969). Increased 
g lucocortico id  secretion was therefore proposed to be the t r ig g e r  fo r  
increased OAT synthesis in the developing l iv e r  o f neonatal ra ts . The 
formation of OAT in neonatal kidney however, could not be evoked prematurely 
by hydrocortisone in je c t io n s , and adrenalectomy was also w ithout e ffec t 
(Herzfeld & Greengard, 1969). The only incidence in which the a c t iv i t y  of 
OAT was seen to change in the same d ire c t ion  in both l i v e r  and kidney was 
the increase of OAT a c t iv i t y  induced by d ie ta ry  methionine (Volpe zX a t . ,  
1969), these observations c lea r ly  demonstrate therefore , tha t the endocrine 
regulation of OAT is  d i f fe re n t  in 1ive r when compared with kidney in the ra t .  
Furthermore, as the levels of a c t iv i t y  o f th is  enzyme are contro lled by 
d i f fe re n t  factors which are often an tagon is tic , i . e .  a stimulus increased 
the a c t iv i t y  of OAT in one tissue but decreased i t  in the other, valuable
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information about the hormonal state of the tumour-bearing host may be 
obtained. As demonstrated previously (Figs. 1 & 8) the levels of OAT 
activity in both kidney and liver were decreased as a consequence of tumour­
bearing. It is unlikely therefore (although not impossible) that the 
involvement of hormones such as glucocorticoids or estrogen could produce 
the changes observed in OAT levels in the tumour-bearing rat since none have 
been shown to decrease both liver and kidney OAT levels. In fact most 
hormones that alters OAT activities in liver or kidney, increase the activity 
of this enzyme in one tissue and decrease i t  in the other. Furthermore, the 
only other situations in which low OAT levels were observed in the rat in 
both liver and kidney, was in the foetus or neonatal animal (Table 2, 
Greengard, 1971) or in the livers and kidneys of the regenerating-!iver rat 
(Table 7 & 8), i.e .  in immature tissues. The fact that both host livers and 
kidneys also possessed low ornithine aminotransferase activities may there­
fore indicate that the levels of activity of this enzyme in host tissues of 
tumour-bearing rats are controlled in a similar manner to that found in the 
immature rat,  and consequently would be consistent with the proposal that 
host tissues become de-differentiated as a consequence of tumour-bearing.
Stress may also be implicated as the cause of host tissue enzyme activity 
changes, due to glucocorticoid secretion. Furthermore, several neoplasms 
have been shown to stimulate adrenal hormone production in the host (Costa, 
1963, 1977; Greengard a l . , 1967). Whole body irradiation also caused 
pituitary stimulation that resulted in increased glucocorticoid secretion 
(Thomson & Mikuta, 1954) and has been shown to elevate tryptophan oxygenase 
and ornithine aminotransferase levels in neonatal rat liver (Herzfeld & 
Greengard, 1972). In the livers of tumour-bearing neonatal animals however, 
although hepatic tryptophan oxygenase activity was shown to increase as a
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consequence of tumour implantation, the levels of o rn ith ine  aminotransferase 
a c t iv i t y  were shown to decrease (Herzfeld & Greengard, 1972). S im ila r ly ,  
hydrocortisone in jec t ions in to  adult ra ts have been shown to decrease 
thymidine kinase a c t iv i t y  in the spleen (Greengard & Machovich, 1972), the 
presence o f a tumour however, increased the a c t iv i t y  o f th is  enzyme in the 
host spleens of tumour-bearing animals (Fig. 8; see also Greengard & Lempert, 
1973; Herzfeld qX  a l . , 1978). Moreover, during co r t iso l induced thymus 
invo lu t ion  there was no increase in plasma thymidine kinase or pyrro line -5 - 
carboxylate reductase levels which were shown to r ise  upon lymphoma in p la n t­
ation (Herzfeld & Greengard, 1977). In jec tions of co r t iso l (which did not 
a f fe c t  the growth rate or enzymic composition o f the lymphoma) also did not 
fu r th e r  enhance the effects  o f th is  tumour on blood or l i v e r  enzymes (Herzfeld 
& Greengard, 1977). Furthermore co r t iso l in jec t io ns  did not a f fe c t  the 
hepatic leve ls of p y r ro l ine-5-carboxylate reductase, thymidine kinase or 
o rn ith in e  aminotransferase in adult ra ts (Herzfeld & Greengard, 1969;
Greengard & Machovich, 1972). These resu lts  therefore ind icate tha t the 
systemic e ffec ts  of tumours on the overall enzymic p ro f i le  changes observed 
in host tissues of tumour-bearing rats were not a t t r ib u ta b le  to increased 
g lucocortico id  secretion in these animals.
Tumour-bearing could also possibly in te r fe re  with the developmental form­
ation o f host enzymes as hydrocortisone in jec t io ns  which have been shown to 
prematurely evoke orn ith ine aminotransferase levels in l iv e rs  of normal 
neonatal ra ts ,  also prevented the usual loss of th is  enzyme a c t iv i t y  in the 
l iv e rs  of tumour-bearing neonatal animals (Herzfeld & Greengard, 1972). 
Furthermore, co r t iso l in jec t ions  prevented the usual decrease of hepatic 
p y r ro l ine-5-carboxylate reductase levels in lymphoma-bearing adult rats 
(Herzfeld & Greengard, 1977). However, c o r t is o l did not a l te r  the r ise  in
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in host l iv e r  thymidine kinase a c t iv i t y  or prevent loss o f o rn ith ine  amino­
transferase a c t iv i ty  in adult tumour-bearing ra ts (Herzfeld & Greengard,
1972, 1977). Furthermore, the response o f host tissue enzymes to hormonal 
regulatory stim u li may be altered in tumour-bearing animals. Tyrosine amino­
transferase and serine dehydratase a c t iv i t y  levels have both been reported 
to be induced in the l iv e r  by the adm inistra tion o f glucogon to adult or 
neonatal rats (Holten & Kenney, 1967; Jost eX cut., 1968; Greengard, 1971).
In tumour-bearing rats however, there was a progressive decrease in the 
in d u c ib i l i t y  of hepatic serine dehydratase by glucagon a f te r  the inoculation 
of the Morris 7800 hepatoma. Twenty f iv e  days a f te r  tumour implantation and 
the rea fte r , in jec t ions of glucagon could no longer induce the a c t iv i t y  of 
serine dehydratase in host l iv e rs  (de Rosa & P ito t ,  1978). S im ila r ly ,  
although tyrosine aminotransferase levels were s ig n i f ic a n t ly  increased by 
in jec t ions  of glucagon over control values at 10 days a f te r  inoculation 
of the tumour, by 20 days postinoculation and the rea fte r the in d u c ib i l i t y  
of th is  enzyme by glucagon was 30-50% lower than in control normal l iv e r  
(de Rosa & P ito t ,  1978). Furthermore, in jec t ions  o f glucagon in to  foetal 
rats have been demonstrated not to be capable of inducing tyrosine amino­
transferase levels in foetal l iv e rs  3 or more days before b ir th  (Greengard, 
1971). The loss of in d u c ib i l i t y  of serine dehydratase and tyrosine amino­
transferase by glucagon in l iv e rs  of tumour-bearing rats may therefore be a 
fu r the r ind ica tion  that enzymes of host tissues became immature. The numbers 
o f studies on the effects of hormones on normal and tumour-bearing animals 
therefore do not indicate that the systemic e ffec ts  of tumour-bearing are 
due to an altered hormonal status of the host.
In summary therefore, the adaption to the presence of a large tumour in an 
animal and to the consequent a lte ra t io n  in n u tr i t io n a l and endocrine states
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may result in a number of unrelated enzymic changes in host tissues.
Obviously some of these changes will clearly not be unique to the condition 
of tumour-bearing. For example the increase in host liver of the level of 
enzymes sensitive to glucocorticoids, such as tryphophan oxygenase (Greengard 
oX at., 1967), must be considered as a nonspecific phenomenon, resulting 
from stress. However, the quite remarkable decrease in ornithine amino­
transferase activity in adult liver as early as 3-4 days after tumour 
implantation (Fig. 3, chapter 3; see also the data of Herzfeld & Greengard, 
1972, 1977; de Rosa & Pitot, 1978), which occur before tumours became 
palpable, and the subsequent decreases of other adult-type enzymes within the 
next seven days, followed by increases in activity of foetal-type enzymes, 
appear to be more specifically related to the condition of tumour-bearing. 
Furthermore, as all of the developmental enzymes studied in host tissues in 
this thesis and by others (Herzfeld & Greengard, 1972, 1977; Herzfeld 
dt at., 1978; de Rosa & Pitot, 1978) were always observed to change in activity 
toward values characteristic of neonatal or foetal tissue; and could not be 
produced by transplantation, as a consequence of an immune or inflammatory 
response, or by alterations in diet or hormonal status; it appears that host 
tissues do become immature (using enzyme profiles as the criteria) as a 
consequence of tumour-bearing. The proposal that host tissues become de­




ESTIMATION OF THE SPECIFIC RATES OF TURNOVER OF A HOST TISSUE ENZYME 
5.1 Introduction
As discussed in Chapter 4, the complex and rapid changes in the enzymic 
pattern of host livers of tumour-bearing animals cannot be explained 
by alterations in the availability of any known endocrine or nutritional 
factors, nor by the trauma or the responses of the immune system to 
transplantation pcA 4e. Rather the enzyme activity changes appear to be 
specific for the presence of a neoplasm in an animal. However, all previous 
studies on the changes in enzyme profile in host tissues of tumour-bearing 
animals have relied on measurements of enzyme activty. The proposal that 
random allosteric modification (or other modification of activity) of host 
tissue enzymes by tumour by-products (Theologides, 1972, 1974) or toxohormones 
(Costa, 1963, 1977) could result in host tissue enzyme changes such as have 
been described in chapters 3 and 4 was therefore possible. The measurement 
of the specific rates of synthesis and degradation of a host tissue enzyme, 
an enzyme whose activity had been shown to change as a consequence of tumour­
bearing, would therefore give insight into the mechanism of host tissue 
enzyme activity changes.
Among the enzymes which showed altered activity in the host tissues of tumour­
bearing rats, ornithine aminotransferase (OAT) was by far the most striking 
example so far studied. The activity of this enzyme was decreased in host 
liver as early as 3-4 days after tumour implantation, well before tumours 
became palpable or visible on dissection (Fig. 3; see also the data of 
Herzfeld & Greengard, 1972, 1977; Greengard 2Ä at., 1978; de Rosa & Pitot, 
1978). This enzyme therefore appears to be a sensitive marker of the
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presence of a neoplasm in an animal. Furthermore OAT is an excellent enzyme 
for study since its biochemical parameters have been well characterised in 
both livers and kidneys of normal rats during development of the foetus to 
the adult, and in rat tissues under a variety of altered hormonal states (see 
section 4.3). Moreover, the ornithine aminotransferases obtained from normal 
liver and kidney (Sanada eX al., 1970; Kobayashi <zX al., 1976) have been 
shown to be immunochemical ly indistinguishable. The estimation of the 
specific synthesis and degradation of OAT by immunological techniques in host 
liver and kidneys as well as tumours may thus be possible using antiserum 
prepared against normal rat liver ornithine aminotransferase.
5.2 Results
5.2.1 Preparation of Ornithine Aminotransferase
Ornithine aminotransferase (OAT) was purified using the method of Peraino 
eX al., (1969) as detailed in section 2.9. Electrophoresis of this 
preparation resulted in one band of protein (Plate 2). The preparation was 
also demonstrated to precipitate as a single protein in the ultracentrifuge 
(D. Llewellyn, personal communication). The specific OAT activity of this 
preparation was 25-26 pmol/min/mg protein which is consistent with the specific 
activity of pure ornithine aminotransferase (Peraino <Xl al., 1969; Kalita 
qX al., 1976). By these criteria the OAT preparation was considered homo­
geneous. Estimation of the molecular weight of the purified OAT preparation 
using SDS-polyacrylamide techinques (Weber & Osborn, 1969; Dunker & Rueckert, 
1969) and purified protein markers of known molecular weight (bovine serum 
albumin, ovalbumin, trypsin, cytochrome c and ribonuclease a) determined that 
the isolated protein had an apparent molecular weight of 43,000 daltons (data 
not shown). This was a somewhat higher molecular weight for rat liver 
ornithine aminotransferase than was originally reported (Peraino aX al. ,
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PLATE 2: SDS - ACRYLAMIDE GEL ELECTROPHORESIS OF ORNITHINE AMINOTRANSFERASE
O rn i th ine  aminot ransferase (OAT) was p u r i f i e d  from r a t  l i v e r  using the 
method o f  Peraino eX a t . ,  1969 as d e ta i l e d  in  sec t ion  2 .9 .  A l iq u o ts  (200pg 
p ro te in )  o f  t h i s  p repara t ion  were d issoc ia ted  a t  100°C f o r  2 minutes in 
lOOjul o f  b u f f e r  which was 0.0625 M T r i s ,  2% (w/v) SDS. A f t e r  c o o l in g ,  the 
d issoc ia ted  p ro te in  v/as 1ayered onto d isc  SDS-acrylamide gels (5mm x 1cm 3% 
(w/v) s tack ing  ge l ;  9% (w/v) separa t ion  g e l ;  Laemmli, 1970) and e l e c t r o -  
phoresed a t  4mA/gel f o r  12 hours.  The gels were then s ta ined using the 
method o f  Fairbands o X  clI .  , (1971) as d e ta i l e d  in  sec t ion  2.10.  The symbol 
F is  ad jacent  to  the dye f r o n t .  O rn i th in e  amino transferase i s  designated as 
OAT.
1969) but was consistent with other (Matsuzawa oX a t . ,  1968) and la ter  
observations (Lyons & P i to t ,  1976; Peraino, 1976). The isolated protein 
was therefore considered suitable for anti-OAT serum preparation.
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5.2.2 Characterisation of Anti-OAT Serum
Anti-ornithine aminotransferase (anti-OAT) serum was prepared as detailed 
in section 2.11. This preparation was calibrated against the OAT enzyme as 
follows. The equivalence point between antigen and antibody is defined as 
the maximum amount of antigen that can be completely precipitated by a given 
amount of antiserum. When the amount of antigen exceeds the equivalence 
point, then non-precipitated enzyme a c t iv i ty  appears in the supernatant 
f lu id .  Increasing amounts of pure OAT enzyme were therefore incubated with 
a constant amount of antiserum and the equivalence concentration was 
determined (see Fig. 9A). This was found to be in the region of 0.375pmol/ 
min OAT activity/lOOjjl (6.3mg protein) antiserum. However, although this  
amount is theoret ically  suff ic ient  to precipitate 0.375pmol/min OAT a c t iv i ty  
i t  is usual to add a 50% excess of antibody. This is done to overcome any 
enzyme a c t iv i ty  modifications that may be present (eg. a l loster ic )  and to 
f a c i l i t a t e  precipitation of the antigen-antibody complex (Lyons & P i to t ,  
1976). I t  was therefore decided that 150pl (9.45mg protein) of anti-OAT 
serum would be used to precipitate 0.375jumol/min OAT a c t iv i ty .
The above 'calibrat ion'  experiment demonstrated that the p a r t ia l ly  puri f ied  
anti-OAT serum was directed against rat  l ive r  ornithine aminotransferase and 
could be used to precipitate this enzyme. However OAT may not be the only 
protein which is precipitated by the antiserum. To test this possib il i ty  
the anti-OAT serum was reacted with rat  l ive r  extract (as prepared in 
section 2.12.2) in Ouchterlony double diffusion wells. This technique
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FIGURE 9A: QUANTITATIVE IMMUNOPRECIPITATION OF RAT LIVER ORNITHINE
AMINOTRANSFERASE WITH ANTI-OAT SERUM
Increasing amounts o f  pure enzyme prepared as described in section 2.9 were 
incubated w ith  a constant amount (lOQjul, 6.3mg p ro te in )  o f anti-OAT serum 
(see section 2.11) in  a constant volume (3ml) at 4°C fo r  18 hours. The 
antigen-antibody complex was p re c ip i ta te d  by c e n tr i fu g a t io n  (1500g, 15 
minutes) and the enzyme a c t i v i t y  determined in the supernatant so lu t io n  as 
de ta iled  in  section 2 .4 .5 . The la rg e s t amount o f  added enzyme th a t  was f u l l y  
p re c ip i ta te d  under these cond it ions marked the equivalence po in t (A).
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allowed the separation of antigen^antibody complexes. When liver extract 
was reacted with a large excess of antibody (3 fold), four precipitin lines 
were formed (Plate 3A, wells 1 & 2). This experiment shows that the anti- 
OAT serum could precipitate more than one protein. When the antibody to 
antigen ratio was decreased however, two of the precipitin lines were not 
formed while the visual density of the outermost precipitin line was not 
decreased, (Plate 3A, wells 3-6). I t  is reasonable to suppose therefore 
that all of the available antigen present in the liver extract, that was 
precipitated in the outer line, had been precipitated by the antiserum. 
Furthermore, the amount of antiserum in these wells was at a large excess 
compared to that of antigen. At a lower antibody to antigen ratio there­
fore, the anti-OAT serum may act to specifically precipitate the OAT protein. 
Double diffusion chambers were prepared containing the same ratio of antibody 
to antigen as had been calibrated in Fig. 9A. (i .e .  150jul anti-OAT serum:
0.375/jmol/min OAT activity). At this ratio of antibody to antigen, a major 
and a minor precipitin line were formed (Plate 3B, well 1). However, the 
major precipitin line (Plate 3B, well 1) formed a line of complete identity 
with that of the pure enzyme (Plate 3B, well 3). These results indicate 
that two proteins were precipitated from the rat liver extract by the anti- 
OAT serum and that the major precipitin line was immunologically indist­
inguishable from rat liver ornithine aminotransferase.
From the results of the above experiments i t  is thus clear that the anti-OAT 
serum precipitates more than one antigen. Therefore this serum is disqualifie 
from use unless the contaminating antigens are removed from rat liver extracts 
that will be used for OAT immunoprecipitation. Of course contaminated rat 
liver extracts may be used if  the impurities do not incorporate radioactivity 
during the turnover-synthesis studies. However, the problems associated with
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PLATE 3: OUCHTERLONY DOUBLE DIFFUSION ANALYSIS OF ANTI-ORNITHINE
AMINOTRANSFERASE SERUM
Sheep a n t i - o r n i t h i n e  aminotransferase (ant i -OAT) serum and r a t  l i v e r  e x t ra c ts  
were prepared as d e ta i le d  in  sec t ion  2.11 and 2 .12.2 .  D i f f u s io n  was c a r r ie d  
out in  agar gel 1% (w/v) agar,  0.8% (w/v) sodium barb i tone ,  0.01% (w/v) 
th io m e rs a l ,  pH 8.6 on glass microscope s l i d e s .  The reac t ion  mix was 
incubated f o r  24 hours at  room temperature as d e ta i le d  in  sec t ion  2 .11 .1 .
(a) The cent re  we l l  contained 20jul o f  l i v e r  e x t r a c t  ( 0 . 3j jmol/min 
o r n i t h i n e  aminotransferase (OAT) a c t i v i t y ) .  The pe r iphe ra l  w e l l s  
contained anti-OAT serum ( t o t a l  volume 20jul) as fo l l o w s :  1 & 2 = 
2.52mg p r o te in ,  3 & 4 = 1.26mg p r o t e in ,  5 & 6 = l.Omg p r o t e in .
(b) The cent re  wel l  contained 20yU 1 ant i-OAT serum ( 0 .7 5mg p r o t e i n ) .
The pe r iphe ra l  we l ls  contained as f o l l o w s :  1 , 2 , 4 ,  5 & 6 = 20jul 
l i v e r  e x t r a c t  conta in ing  0 .03,  0.015, 0.008, 0.004 & 0.002jumol/min 
OAT a c t i v i t y  r e s p e c t i v e ly .  Well 3 contained 20pl o f  pure enzyme 
(0.03jumol/min OAT a c t i v i t y )  as prepared in  sec t ion  2.9.
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contamination of antigen may also be resolved by separating the different 
immunoprecipitates using SDS-acrylamide gel electrophoresis (Cashman & Pitot, 
1971). This technique not only separates different proteins but also 
dissociates antigen-antibody complexes. The anti-OAT serum was therefore 
reacted with radioactively labelled rat liver extract and separated using 
SDS-polyacrylamide disc gels. The data of Figure 10 show that a number of 
proteins were present in the immunoprecipitate. The two major protein- 
staining bands (HAb & LAb) corresponded to the heavy and light chains of the 
antibody respectively (Cashman & Pitot, 1971; Lyons & Pitot, 1976). The 
OAT band was identified by the mobility of the pure OAT enzyme in identical 
gels. SDS-acrylamide electrophoresis of pure enzyme, precipitated with the 
anti-OAT serum also possessed a mobility identical to that of unprecipitated 
pure enzyme (data not shown, see also Cashman & Pitot, 1971). The gel was 
then photographed and 1 ater cut into 2mm transverse slices. The radioactivity 
contained in each slice was then determined. The results of these deter­
minations are shown in Figure 10. Three bands staining for protein contained 
radioactivity. The major peak of radioactivity corresponded to ornithine 
aminotransferase. One minor peak of radioactivity (marked F) corresponded
,5-3h] leucine. This wasto the dye front and appeared to be free L- 
demonstrated by the fact that the radioactivity of this peak could be 
increased or decreased depending on the rigor of the washing procedure 
detailed in section 2.12.3 (data not shown). The other minor peak of radio­
activity (marked X) was an unknown protein of high molecular weight. This 
protein peak was not affected by the washing procedure, nor by lengthening 
the time of dissociation, changing the temperature or increasing the 
concentrations of either urea,orSDS in the dissociation buffer (see section 
2.12.3). This high molecular weight protein peak was however increased if 
the antibody to antigen ratio was increased. This protein therefore, appeared 
not to be a polymer of OAT but rather a separate protein.
Slice number 104
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FIGURE 10: SPS - ACRYLAMIDE GEL ELECTROPHORESIS OF 3H-LABELLED ORNITHINE
AMINOTRANSFERASE (OAT) IMMUNOPRECIPITATE
The p r e c i p i t a t e  was prepared from r a d io a c t i v e l y  l a b e l l e d  l i v e r  e x t r a c t  
con ta in ing  0 . 375pmol/min o f  OAT a c t i v i t y  which was reacted w i th  150pl (9.45mg 
p r o te in )  o f  ant iserum a t  4°C f o r  18 hours (see sec t ions  2.12.1 & 2 .1 2 .2 ) .
The r e s u l t a n t  p r e c i p i t a t e  was sedimented by c e n t r i f u g a t i o n  (1500g, 15 m in ) ,  
washed by resuspension in  0.9% NaCl s o l u t i o n  and resed imenta t ion (4X) and 
the p e l l e t  f i n a l l y  d is s oc ia ted  by incuba t ion  w i th  150pl b u f f e r  which was 
6M urea, 1% (w/v) SDS, lOmM DTT, 0.125M T r i s ,  pH 6.8 a t  50°C f o r  one hour.
The r e s u l t a n t  s o lu t i o n  was e lec trophoresed (4mA/gel) f o r  12 hours (6mm x 
15cm, 9% separa t ion  g e l ;  1cm, 5% s tack ing  g e l ;  Laemmli, 1970) and the gel 
sta ined by the method o f  Fairbanks a t a t . ,  (1971) (see sec t ion  2 .10 ) .  The 
gel was then photographed and subsequent ly s l i c e d  t ra n s v e rs e ly  ( f rom the 
s tack ing  gel end) i n t o  2mm sec t ions .  Each s l i c e  was then s o l u b i l i z e d  w i th  
Soluene 350 ( 1 m l / s i i c e )  by incuba t ion  f o r  2-3 hours a t  60°C a f t e r  which t ime 
10ml o f  "Permablend" (see sec t ion  2 .6 )  was added to  each sec t ion  a f t e r  
coo l ing  to  room temperature.  The r a d i o a c t i v i t y  in  each s l i c e  was then 
determined using l i q u i d  s c i n t i l l a t i o n  techniques (see sec t ion  2 .6 ) .  Resul ts 
were not co r rec ted  f o r  background r a d i o a c t i v i t y .
The major p ro te in  species are i d e n t i f i e d  below the ge l .  Heavy ant ibody 
subun i t  (H Ab),  l i g h t  an t ibody subun i t  (L Ab) and o r n i t h i n e  aminotransferase  
(OAT). The dye f r o n t  i s  in d ica ted  by the symbol F. The E le c t ro p h o re t i c  
m ig ra t ion  d is tance o f  o r n i t h i n e  aminotransferase corresponds to  t h a t  o f  the 
u n p re c ip i ta te d  p u r i f i e d  enzyme (not shown). The s tack ing  gel contained no 
s ta in in g  or r a d io a c t i v e  m a te r ia l  and was th e re fo re  om it ted .
E lec t ropho res is  o f  immunoprecipi ta tes ( t r e a te d  as above) o f  ant iserum reacted 
w i th  k idney or tumour e x t ra c ts  gave e s s e n t i a l l y  the same r e s u l t .
105
The experiments detailed above demonstrate that the anti-OAT sheep serum 
preparation precipitated ornithine aminotransferase from rat liver extracts 
but was not monospecific for this protein. No firm explanation can be given 
as to the reason why this serum was not directed against OAT exclusively.
The enzyme preparation used to raise antibodies was homogeneous using the 
criteria of the results from both SDS-gel electrophoresis and ultracentri­
fugation techniques and yet antiserum prepared using this preparation was 
not monospecific for OAT. The separation of OAT from radioactively labelled 
contaminants (free leucine and the unknown high molecular weight protein) 
that were present in immunoprecipitates by SDS-gel electrophoresis (Cashman 
& Pitot, 1971) was however successful (Fig. 10). All subsequent measurements 
of synthesis and degradation were therefore performed using this technique.
Sanada zt at., (1970) and Kalita zt at,, (1976) had reported that the 
ornithine aminotransferase enzymes of liver and kidney were immunochemically 
indistinguishable. Liver and kidney OAT extracts were therefore incubated 
with increasing amounts of anti-OAT serum (Fig. 11). Although the total 
amount of radioactivity present in the kidney enzyme was lower than that 
found i nthe liver enzyme, a similar amount of anti-OAT serum was required 
to fully precipitate all of the radioactivity in the kidney enzyme when 
compared with the liver enzyme. Incubations of enzyme extracts containing 
OAT acitvity obtained from tumour tissue (5123C, 7777, R3230AC or MDAB) with 
anti-OAT serum treated in the same manner as above gave similar results. No 
immunoprecipitates were formed in control experiments in which kidney, liver 
or tumour extracts (prepared as above) were reacted with non-immune serum 
obtained from a sheep that had not been injected with the ornithine amino­
transferase preparation. These results therefore support the proposal that 
OAT obtained from liver or kidney (Sanada zt at., 1970; Kalita zt aJt., 1976)
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FIGURE 11: QUANTITATIVE IMMUNOPRECIPITATION OF RAT LIVER AND KIDNEY ORNITHINE
AMINOTRANSFERASE WITH ANTI-OAT SERUM
Adult ra ts  were in jec ted  w ith  L - [4 ,5 - ^ h]  leuc ine , k i l l e d  one hour la te r  and 
kidney and l i v e r  ex trac ts  prepared as d e ta iled  in  sections 2.12.1 and 2.12.2. 
Constant amounts (0.375pmol/min OAT a c t i v i t y )  o f these ex trac ts  were then 
incubated w ith  increasing amounts o f anti-OAT serum (63mg/ml as prepared in 
section 2.11) a t 4 o c  fo r  18 hours in a to ta l  volume o f 3ml. The immuno- 
re c ip i ta te s  were sedimented, washed, d issoc ia ted , electrophoresed and the 
r a d io a c t iv i t y  in the OAT band determined as d e ta ile d  in the legend o f Figure 
10. The ra d io a c t iv i t y  in the OAT band o f l i v e r  (■) and kidney ( • )  were then 
p lo t ted  against added anti-OAT serum. Results were not corrected fo r  
background ra d io a c t iv i t y .
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or hepatoma (Tomino z t  aJL., 1974; Kobayashi z t  a j t , , 1976) or mammary 
carcinoma (see above) are immunologically indistinguishable. It  was there­
fore decided to use 150jul (9.45mg protein) of anti-OAT serum to fully 
precipitate 0.375pmol/min/ OAT activity irrespective of the tissue of origin.
5.2.3 Estimation of Ornithine Aminotransferase Synthesis in Rat 
Liver and Kidney
The previous section determined a suitable method for measuring the specific 
amount of radioactivity present in the enzyme ornithine aminotransferase. 
Before measurements of enzyme synthesis could be made however, i t  was 
necessary to determine whether radioactively labelled leucine was incorpor­
ated into OAT in a linear manner with time after injection. Animals were
therefore injected with L- ,5-3h| leucine, killed at specified times there­
after and the incorporation of radioactivity into the enzyme OAT determined 
in liver, kidney and tumour (Fig. 12). The data were calculated as follows. 
Radioactivity obtained in the enzyme OAT or in total protein was corrected 
for background radioactivity and the results expressed as dpm/g tissue wet 
weight. Radioactivity in TCA-insoluble material was taken as a measure of 
"total protein synthesis" (Lyons & Pitot, 1976) and was used to compute the 
relative rate of OAT synthesis. This was done by expressing the data as the 
ratio of the radioactivity obtained in OAT to that found in the total tissue 
protein i.e.
Relative rate of _ ____ dpm OAT/g____
OAT synthesis dpm Total Protein/g (Equation 1)
This method of expression corrects for possible changes in the size of the 
free leucine pool of tissues of animals as well as for variations that may 
occur in the uptake of labelled leucine into tissues by different animals
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FIGURE 12: RATE OF THE RELATIVE INCORPORATION OF L- 4 ,5 -3H LEUCINE INTO
RAT TISSUE ORNITHINE AMINOTRANSFER/^SE
Adult normal rats (12 week) and adult tumour-bearing rats (tumour weight 
about 40g) were in jected with lOOpCi of L-[4,5-3HJleucine, k i l le d  at 
specified times a f te r  in je c t io n ,  the l i v e r ,  kidney or tumour removed and 
OAT extracts prepared as deta iled in sections 2.12.1 and 2.12.2. Immuno- 
p rec ip ita t ions  and determinations of the spec if ic  ra d io a c t iv i ty  in the 
enzyme OAT were performed as detailed in section 2.12.3. The incorporation 
of ra d io a c t iv i ty  in to to ta l protein was determined as detailed in section 
2.12.4. Results obtained at each time-point were expressed according to 
equation 1 (see section 5 .2 .3).
Each point of the l i v e r  and tumour resu lts  represents the means of duplicate 
estimations using one animal. Kidney values were obtained by pooling the 
kidneys from two animals, preparing the extract ready fo r  immunoprecipitation 
(sections 2.12.1 and 2.12.2) and therea fter performing the remainder of the 
determinations in duplicate (section 2.12.3).
Adult l iv e r  (■), adult kidney ( • ) ,  5123C hepatoma (□) and R3230AC mammary 
carcinoma (O).
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(Schimke & Doyle, 1970). The data presented in Table 9 however, also 
clearly demonstrate that the incorporation of radioactively labelled leucine 
into total TCA-insoluble protein was similar in neonatal liver and kidney 
when compared with adult liver and kidney respectively. Moreover, in general, 
the incorporation of label into host liver and kidney was also similar to 
that observed in the normal adult tissue. The free leucine pools of host 
tissues (liver & kidney) can therefore be said to be similar to that of the 
normal tissue (Lyons & Pitot, 1976; Kobayashi oX at,, 1976). The free leucine 
pools of the tumours (R3230AC, 7777 & 5123C) as well as of the host livers of 
rats bearing the MDAB tumour appear to be different from that of normal 
adult rat liver. This was shown by the lower incorporation of radioactively 
labelled leucine into TCA-insoluble proteins of these tissues (Table 9). The 
expression for the relative incorporation of label into OAT as a ratio of 
total protein synthesis was therefore useful for the tumours and MDAB host 
liver.
The data presented in Figure 12 clearly demonstrate that after the injection
of L- 4,5-3H leucine, the label was incorporated into the enzyme OAT in a 
linear manner with time. This linear incorporation occurred in normal adult 
liver and kidney as well as into tumours 5123C and R3230AC. As there were 
no exceptions to a linear incorporation it was therefore assumed that the 
radioactively labelled amino acid would also be incorporated in a linear 
manner into the OAT enzymes of host livers and kidneys of tumour-bearing rats 
as well as into tumours 7777 and MDAB. All subsequent estimations of the 
relative rates of synthesis were therefore performed 60 minutes after the 
injection of the radioactively labelled amino acid.
Determination of the relative rates of synthesis of ornithine aminotransferase
no
TABLE 9: RELATIVE RATES OF INCORPORATION OF RADIOACTIVELY LABELLED LEUCINE
INTO THE TCA-INSOLUBLE FRACTION OF EXTRACTS FROM VARIOUS TISSUES OF THE 
NORMAL, NEONATAL AND TUMOUR-BEARING RATS
Normal a d u l t  (12-14 week old B u f f a l o ) ,  normal neonatal (14-20 day o ld  B u f fa lo )  
and tumour-bear ing ra ts  (tumour weight approx imate ly  40g; app rop r ia te  s t r a i n  
see sec t ion  2 .2) were in je c te d  w i th  100/jCi o f  L - [ 4 , 5-^Hj le u c in e ,  k i l l e d  60 
minutes l a t e r  and the s p e c i f i c  r a d i o a c t i v i t y  o f  the TCA- insolub le  p ro te in  
determined as d e ta i l e d  in  sect ions 2 .12 .1 ,  2 .12.2 & 2 .12 .4 .  Resul ts are 




4 , 5 - 3h|LEUCINE INCORPORATION (dpm/g)xlO~3
KIDNEY TUMOUR
Normal Adu l t 16.2 + 3.7 9.7 + 2.1 -
Normal Neonate 18.6 + 3.9 10.4 + 1.9 -
Host 5123C 18.7 + 4.1 11.8 + 2.4 12.6 + 5.7
Host 7777 17.6 + 3.5 9.0 + 3.3 10.3 + 3.1
Host R3230AC 16.7 + 3.2 8.8 + 3.1 5.3 . + 2.6
Host MDAB 12.1 + 2.9 9.7 + 3.0 8.7 + 4.1
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in normal, host and tumour tissues are presented in Table 10. These results 
clearly indicate that the rate of synthesis of OAT was significantly lower 
in neonatal liver and kidney than the rate found in adult liver and kidney. 
This was similar to the observed lower activity of this enzyme in neonatal 
liver and kidney when compared with the adult tissue (see Table 2, chapter 
3). Tumour-bearing also decreased the activity of OAT in the host tissues 
of rats after tumour implantation (Fig. 1, chapter 3). This was also 
reflected by decreased rates of synthesis of this enzyme in host liver and 
kidney (Table 10). The kidneys of animals carrying the mammary carcinoma 
R3230AC were the only host tissues in which the rate of synthesis of OAT 
was not decreased toward the rate observed in neonatal kidneys (Tables 10).
In fact the rate of synthesis was significantly higher in the kidneys of 
these animals. No explanation why this was so can be given at this time 
unless the rate of turnover of OAT in kidneys of Fischer rats is significantly 
different from that of kidneys of Buffalo rats. However, no measurements of 
the specific rate of OAT synthesis in normal kidneys obtained from adult 
non tumour-bearing Fischer rats were made. The comparison of kidney OAT 
synthesis between Buffalo and Fischer rats can therefore not be done at this 
time. With this one exception in mind therefore, the presence of all of the 
tumours examined had the effect of changing the rate of synthesis of OAT 
in all host livers and kidneys away from the rate observed in adult tissue, 
toward the rate of synthesis measured in neonatal tissues. These results 
were consistent with the proposal that there is a de-differentiated state 
of host tissues as a consequence of tumour-bearing. The measured rate of 
OAT synthesis in tumours was also significantly lower than that of adult 
liver and reflected the rate of synthesis found in neonatal liver (Table 10).
TISSUES OF ADULT, NEONATAL AND TUMOUR-BEARING RATS
TABLE 10 : RELAT IV E RATES OF ORNITHINE AMINOTRANSFERASE SYNTHESIS IN VARIOUS
Normal adult  (12-14 week old Buf fa lo) ,  normal neonatal (14-20 day old 
Buffalo) and tumour-bearing rats (tumour weight approximately 40g; 
appropriate s t ra in ,  see section 2.2) were injected with 100/jCi of 
L-(~4,5-3h leucine, k i l l e d  60 minutes a f te r  in jec t ion  and the spec i f ic  
ra d io a c t iv i t y  in the enzyme and in to ta l  protein was determined as detai led 
in the legend of Figure 12. The values in the f i r s t  column are the 
re la t ive  synthesis rates of OAT calculated using equation 1 (see section 
5.2.3).  The values obtained fo r  adult  l i v e r  were obtained by dupl icate 
estimations of re la t ive  rates of synthesis using f ive  separate animals. 
Neonatal l i v e r  and kidney values were obtained by t r i p l i c a t e  determinations 
of t issues using 8 pooled neonatal animals. Adult kidney and host kidney 
values were obtained by dupl icate determinations of pooled kidneys using 
three separate ra ts . Tumour and host l i v e r  values were obtained by 
dupl icate determinations using three separate animals. Al l  resul ts  are 
shown as the Mean + S.D. The values shown in the second column are the 
percentage re la t ive  rates of OAT synthesis compared with the rate of 
synthesis in the normal adult t issue. Tumour values were compared with 
adult  l i v e r .
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TABLE 10
RELATIVE RATE OF OAT
RELATIVE OAT SYNTHESIS COMPARED WITH
SYNTHESIS RATE THE NORMAL ADULT TISSUE
TISSUE (Ks x 1 q3) ________[ %  ADULT)________
LIVER
Normal Adult 4.11 + 0.15 100.0 + 3.6
Host 5123C 0.35 + 0.15 8 .5 + 3.6
Host 7777 1.55 + 0 .14 37.7 + 3 .4
Host R3230AC 2.36 + 0.26 57.4 + 6.3
Host MDAB 1.59 + 0.16 38.9 + 4 .0
Neonate 0.21 5.1
KIDNEY
Normal Adult 1.75 100.0
Host 5123C 1.43 81.7
Host 7777 1.18 67.4
Host R3230AC 5.87 335.0
Host MDAB 0.95 54.2
Neonate 0.13 7.1
TUMOUR
5123C 1.86 + 0.36 45.2 + 8.7
7777 0.22 + 0.03 5.4 + 0.8
R3230AC 0.61 + 0.01 14.9 + 0.1
MDAB 0.05 + 0.01 1.2 + 0.1
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5.2.4 Estimation of Ornithine Aminotransferase Degradation in Rat 
Liver and Kidney
The previous section determined that the specific rate of ornithine amino­
transferase synthesis was decreased in host tissues of tumour-bearing rats 
toward the rate of synthesis observed in neonatal tissues. The question 
emerges therefore, whether tumour-bearing also has an effect on the degrad­
ation of this enzyme in host liver and kidney. The rate of OAT degradation 
was determined by measuring the specific radioactivity of OAT in normal, 
tumour and host tissues at specified intervals after labelling the tissues
with L- 4,5-3H leucine. Semi logarithmic plots of changes in radioactivity of 
the enzyme OAT in these tissues were linear with time (normal liver and 
kidney data are given in Figure 13). The apparent rate constants of enzyme 
degradation (Kd) were then calculated using the equation of Segal & Kim 
(1963, 1965). The results of these measurements are presented in Table 11.
The half-life of OAT degradation in the livers of normal rats (th = 2.44 days, 
Table 11) was similar to that reported by others (th = 1.9 days, Morris oX a l . , 
1974; th = 1.8 days, Ip qX  a l . , 1976). The data presented in Table 11 
also clearly demonstrate that the rate of degradation of OAT found in 
neonatal liver was significantly less than that observed in adult liver. 
However, none of the rates of degradation of OAT measured in host livers of 
tumour-bearing rats were decreased toward the rate of OAT degradation found 
in neonatal liver. In fact the rate of OAT degradation was observed to be 
increased in host liver of rats carrying the MDAB hepatoma (Table 11). At 
this point however, i t  must be remembered that the MDAB tumour was a primary 
hepatoma, consequently the sample taken for MDAB "host-liver" may have been 
contaminated with tumour cells (see section 3.2.1). Furthermore, as the 
MDAB hepatoma possessed a higher rate of OAT degradation than normal adult 




FIGURE 13: DECREASES WITH TIME OF THE SPECIFIC RADIOACTIVITY OF ORNITHINE
AMINOTRANSFERASE IN ADULT RAT LIVER AND KIDNEY
Normal adult  (10-12 week old) Buffalo rats were given a single intraper itoneal  
in ject ion of lOOpCi of L - [ 4 , 5-3HJleucine as detai led in section 2 .12 .1 .  At 
specif ied in tervals  a f te r  in ject ion  the animals were k i l l e d  and the specif ic  
ra d io a c t iv i ty  contained in the enzyme OAT and in the to ta l  protein determined 
as deta i led in the legend of Figure 12. Results at each t ime-point  were 
calculated according to equation 1 (see section 5 . 2 . 3 ) .  Each point shown on 
the graph represents the mean value of two estimations using one animal,
9 , l i v e r ;  D ,  kidney.
TABLE 11: RELATIVE RATES OF ORNITHINE AMINOTRANSFERASE DEGRADATION
IN VARIOUS TISSUES OF ADULT, NEONATAL AND TUMOUR-BEARING RATS
Normal adult (12-14 week old Buffalo), normal neonatal (14-20 day old 
Buffalo) and tumour-bearing rats (tumour weight approximately 40g; 
appropriate strain, see section 2.2) were given a single intraperitoneal 
injection of lOOjuCi of L-[4,5-3HJleucine (see section 2.12.1) and killed 
at specified times (24, 48 and 72 hours) after injection. The specific 
radioactivity contained in the enzyme and in total protein was determined 
detailed in the legend of Figure 12. The results were plotted as shown in 
Figure 13. The apparent rate constants (K d ) and half lives of the enzyme 
(t%) were then calculated by the method of Segal & Kim (1963, 1965). The 
results are expressed as the Mean value ±  S.D. The significance of the 
difference between mean values of different animals were calculated at the 
0.01 level using students T tests. Neonatal and host tissue values were 
compared with the adult tissue. Tumour values were compared with the 
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h o s t- l iv e r  may be due to such contamination by tumour c e l ls .  I t  is 
concluded therefore tha t the measured rate of OAT degradation in host l ive rs  
was not changed as a consequence of tumour-bearing.
The h a l f - l i f e  of OAT in kidney ( th  = 3.97 days, Table 11) was s ig n i f ic a n t ly  
d i f fe re n t  from tha t of the l i v e r  enzyme ( th  = 2.44 days) and was s im ila r  to 
the rate reported by others (kidney OAT, th  = 4.0 days, Kobayashi eX a t . ,  
1967b). The rate of OAT degradation observed in neonatal kidney however 
was not s ig n i f ic a n t ly  d i f fe re n t  from that observed in adult kidney (Table 11). 
Furthermore, none of the rates of OAT degradation observed in host kidneys 
were changed as a consequence of tumour-bearing except in the host kidneys 
of Fischer rats bearing the R3230AC mammary carcinoma. The rate of OAT 
degradation observed in the host kidneys of these animals was s ig n i f ic a n t ly  
decreased when compared with the rate observed in the kidneys of adult Buffalo 
rats (Table 11). I t  is  not possible to o f fe r  an explanation fo r  th is  re su lt  
unless the rate o f OAT turnover is d i f fe re n t  in the normal adult Fischer ra t 
from the values measured in adult Buffalo ra ts . I t  is concluded from the 
results  of these experiments that the condition o f tumour-bearing did not 
change the measured rates o f OAT degradation in host tissues.
The rates of OAT degradation measured in the neoplasms did not possess any 
consistent pattern when compared with the rates fo r  adult l i v e r  (Table 11).
The 5123C hepatoma was the only tumour examined where the rate of OAT 
degradation was lower than tha t observed in adult l i v e r .  The rate of OAT 
degradation in the 7777 hepatoma was s im ila r  to adult l i v e r  while tha t of 
the R3230AC and MDAB tumours were fas te r than tha t observed fo r  adult l iv e r .  
The rates of degradation of th is  enzyme in neoplasms therefore were not 
consistently  changed from adult values and did not e xh ib it  changes in rate
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toward the value measured in immature liyer
5.3 Discussion
The problem of the reutil ization of labelled amino-acids during studies of 
protein turnover has often been discussed (Gan & Jeffay, 1967; Poole, 1971) 
and was reported as the main problem in studies on protein degradation 
(Schimke, 1970; Schimke & Doyle, 1970; Goldberg & Dice, 1974). In general 
amino-acids that are rapidly metabolized, give shorter values for the estim­
ation of protein half-lives than amino-acids that are metabolized more slowly. 
This is due to lower rates of reuti l ization ( i .e .  reincorporation into the 
protein) of the rapidly metabolized amino-acids (Schimke & Doyle, 1970; 
Goldberg & Dice, 1974). In particular NaH^cC^ was reported as a useful 
precursor for degradation studies due to its  rapid metabolism and consequent 
removal from the cell (Schimke & Doyle, 1970; Swick & Morris, 1974). Using 
NaH^ COg as a precursor, the half- life  of rat liver ornithine aminotransferase 
was determined to be 1.9 days (Morris at a t . ,  1974). This was similar to, 
although shorter than, the value obtained in this study [th - 2.44 days,
4 ,5-3H 1eucineTable 11). I t  is thus concluded that even though the L- 
used in the experiments presented here may have been reutilized slightly, i t  
is unlikely that this occurred to an appreciable extent. The rates of 
incorporation of L- 4,5-3H"jleucine into total protein were also similar in 
normal adult and host tissues (Table 9). Furthermore, the amount of radio­
activity recovered in the total protein measured at 24, 48 and 72 hours 
after injection of labelled amino acid was similar in the normal adult and 
host tissues (data not shown). Any slight reutilization of the radio-isotopic 
label, estimated by these criteria (Kobayashi zt  at . ,  1976) therefore appears 
to be similar in both normal and host tissues (liver and kidney, respectively) 
The value for the half-life of adult renal ornithine aminotransferase was
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estimated to be 3.97 days (Table 11). This was s im ila r  to the value of 
3.8 days obtained by k ine tic  studies on the increase of OAT a c t iv i t y  (Swick 
a t  c u t . ,  1968) and the value of 4.0 days obtained by measurements using 
immunoprecipitation methods (Kobayashi qX  a l . ,  1967b). The resu lts  
presented here are therefore in good agreement w ith other published values. 
Moreover, the main aim of these experiments was to compare the re la t iv e  
rates of OAT turnover of host tissues ( l i v e r  and kidney, re sp e c t ive ly ) . Any 
possible re u t i l iz a t io n  of the L-[^4,5-^H leucine used in these experiments 
would therefore not in te r fe re  with the detection of differences tha t may be 
present between host and normal tissues since the same amount of r e u t i l i z ­
ation appears to be present in both tissues. The comparison of the re la t iv e  
rates of degradation was therefore allowable between the tissues or normal 
adult rats and those of tumour-bearing ra ts . The data presented in Table 11 
thus c le a r ly  demonstrate tha t the re la t iv e  rate o f o rn ith ine  aminotransferase 
degradation is  s im ila r in host l iv e rs  and host kidneys when compared with the 
rate observed in the corresponding adult tissues (adult l iv e r  and kidneys, 
re sp e c t ive ly ) . The decreased a c t iv i t y  of OAT observed in host tissues of 
tumour-bearing rats therefore can not be a t t r ibu ted  to changes in enzyme 
degradation.
The data presented in Table 9, which was discussed in section 5.2.3 showed 
that the free leucine pools of normal adu lt,  neonatal and host tissues were 
s im ila r . The comparison of the rates of OAT synthesis found in normal and 
host tissues was therefore possible. Furthermore, when radioactive isotopes 
are used to measure the rates o f synthesis and breakdown of a protein 
d ire c t ly  w ith the aid of an antibody, i t  is the changes in the actual amount 
of enzyme protein which are being observed. There is  no danger therefore, as 
a consequence of the treatment ( in  th is  case tumour-bearing) that any changes
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in the enzymes catalytic properties that may have occurred could be inter­
preted as an alteration of the enzyme protein level (Chee & Swick, 1976).
The specific measurements of OAT synthesis in normal and host tissues (Table 
10) therefore, clearly demonstrate that the observed decreases in ornithine 
aminotransferase activity in host tissues was the consequence of tumour­
bearing (Figs. 1 & 8) and were due to decreases in the synthesis of OAT and 
not to allosteric (or other) changes in the catalytic capacity of this enzyme. 
Furthermore, the comparison of OAT activity observed in normal and host tissues 
with the relative rates of synthesis of this enzyme in the respective tissue 
(Table 12) clearly demonstrate that the relative synthesis rate of OAT was 
decreased in host tissues to a level similar to that of the enzyme activity 
measured in the same host tissues. For example, the host liver of a 5123C 
hepatoma-bearing animal possessed an activity of OAT approximately ten-fold 
lower than the activity found in normal adult liver (Table 12). This was 
reflected by a similar ten-fold lower relative rate of synthesis of this 
enzyme in the host liver of 5123C hepatoma-bearing rats (Table 12). The 
measured decreases of the level of OAT activity in host tissues may therefore 
be correlated with similar decreases in enzyme synthesis. In the tumour­
bearing rat therefore the "turnover" and hence the activity of ornithine 
aminotransferase in host liver and kidney is regulated by alteration in the 
synthesis of this enzyme.
The regulation of thelevel of OAT activity in the host tissues of tumour­
bearing rats however, is not significantly different from that observed in 
normal tissues. The simple fundamental implication of the existence of 
"turnover" of enzymes is the fact that an enzyme level represents a steady 
state determined by both the rate of synthesis and the rate of degradation 
(Schimke at., 1968). The activity of a number of liver enzymes however,
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TABLE 12: COMPARISON OF ORNITHINE AMINOTRANSFERASE ACTIVITIES AND RELATIVE
RATES OF SYNTHESIS IN VARIOUS TISSUES OF ADULT, NEONATAL 
AND TUMOUR BEARING RATS
TISSUE % ADULT ACTIVITY l  ADULT SYNTHESIS
LIVER
Normal A du l t 100.0 + 6.9 100.0 + 3.6
Host 5123C 11.4 + 2.7 8.5 + 3.7
Host 7777 58.4 + 11.5 37.7 + 3.4
Host R3230AC 31.3 + 2.1 57.4 + 6.3
Host MDAB 35.2 + 6.7 38.9 + 4.0
Neonatal 8.5 + 0.7 5.1
KIDNEY
Normal Adu l t 100.0 + 5.6 100.0
Host 5123C 89.9 + 3.9 81.7
Host 7777 53.0 + 10.6 67.4
Host R3230AC 87.5 + 2.0 335.0
Host MDAB 52.0 + 8.4 54.2
Neonatal 9.4 + 2.0 7.1
Percentages shown are the r e l a t i v e  ra tes  o f  a c t i v i t y  or synthes is  o f  OAT 
(Mean + S.D.)  compared w i th  the value f o r  the normal a d u l t  t i s s u e  ( i . e .  
l i v e r  or  k idney) .  Percentage a d u l t  enzyme a c t i v i t i e s  were ca lcu la ted  from 
the data o f  Figs.  1 & 8 (see chapter  3 ) .  Percentage a d u l t  synthes is  ra tes  
were obta ined from the data o f  ta b le  10. For o ther  d e t a i l s  see the legends 
o f  Figs.  1 & 8 and Table 10.
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have been shown to be regulated by a l te ra t ions  of only one of these para­
meters i . e .  by synthesis or by degradation. For example the a c t iv i t i e s  of 
tyrosine aminotransferase (Kenney & Flora, 1961), threonine dehydratase 
Peraino at at., 1965) and phosphoenolpyruvate carboxykinase (Ballard & 
Hopgood, 1973) were shown to change in response to a l te ra t ion  in the dietary 
or the hormonal status of the animals. Furthermore, the a c t iv i t i e s  of these 
enzymes were shown tobe regulated by a l te ra t ions  in the rates of degradation 
without changes in the rates of enzyme synthesis (Kenney & Flora, 1961; 
Peraino at at., 1965; Ballard & Hopgood, 1973). On the other hand a number 
of investigators have shown that  the changes in the a c t iv i t i e s  of both 
hepatic and renal OAT by a number of treatments were due to a l te ra t ions  in 
the rate  of synthesis while the ra te  of degradation remained constant (Chee 
& Swick, 1974, 1976; Morris & Peraino, 1976; Peraino at cut., 1976; Kobayashi 
at at., 1976b; Lyons & Pi to t ,  1976, 1977). The regulation of ornithine 
aminotransferase ac t iv i ty  in host t issues i . e .  via a l te ra t ions  in the rate  of 
enzyme synthesis without changes in enzyme degradation, was therefore no 
d ifferent  from the regulation of th is  enzyme in the t issues of the normal 
animal.
The synthesis of OAT in l ivers  compared with kidneys of normal ra ts  however, 
is regulated by dif ferent  dietary and hormonal stimuli .  For example, i n je c t ­
ions of glucagon into normal adult ra ts  increased the ac t iv i ty  and the 
synthesis of OAT in l ive r  but the kidney enzyme remained uneffected (Lyons 
& P i to t ,  1976). Treatment of male ra ts  with estrogen also increased the 
ac t iv i ty  and re la t ive  synthetic rate  of OAT in kidney but the a c t iv i ty  and 
synthetic ra te  of the hepatic enzyme remained unaltered (Kobayashi at at., 
1976b; Lyons & P i to t ,  1977). Treatment of ra ts  with triiodothyronine (T3) 
similarly increased the ac t iv i ty  of OAT in kidney but the l ive r  enzyme was
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not affected (Lyons & Pitot, 1977). Thyroidectomy also caused a 50% drop in 
the basal level of OAT activity and synthesis in kidney but not in liver 
(Lyons & Pitot, 1977). Two important points emerge from the data reported 
by the above workers. Firstly, the activity of ornithine aminotransferase 
in both liver and kidney was always regulated by changes in enzyme synthesis 
and never by allosteric modification. This observation supports the proposal 
that the changes in OAT activity measured in host tissues of tumour-bearing 
rats is not to be attributed to al losteric modification of catalytic activity, 
since the activity of this enzyme has never been demonstrated to be allosteric- 
ally modified. Secondly, the levels of OAT activity and synthesis were 
regulated by different stimuli in liver and the kidney. Thus, i f  a stimulus 
increased the synthesis of OAT in liver, then the same stimulus had no effect 
on the kidney enzyme (see also the discussion of chapter 4, page 90). The 
regulation of OAT turnover and activity therefore was significantly different 
in liver when compared with kidney in the adult rat. Since neonatal rats 
possessed low levels of activity and synthesis in both liver and kidney 
(Tables 10 & 12), the observation that host livers and kidneys also possessed 
low levels of OAT activity and synthesis (Table 12), is thus consistent with 
the proposal that host tissues may become de-differentiated as a consequence 
of the implantation of a tumour.
In summary, the specific measurements of ornithine aminotransferase synthesis 
and degradation in host tissues of tumour-bearing rats have demonstrated 
that the implantation of a neoplasm into rats changed the rate of OAT 
synthesis but not the rate of degradation in both host liver and kidney. 
Furthermore, the high correlation of the measured relative rate of OAT 
synthesis with the activity of this enzyme in the same host tissue suggests 
that the systemic effects of tumours on the activity of OAT in host tissues
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were not mediated through allosteric modification of catalytic activity.
Rather the presence of a tumour in an animal altered the rate of synthesis 
of this enzyme via an as yet unknown mechanism. Moreover the rates of OAT 
synthesis observed in host liver and kidney are consistent with the proposal 
that host tissues become de-differentiated as a consequence of tumour-bearing.
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CHAPTER 6
THE EFFECT OF THYMOSIN ON HOST-TISSUE ENZYME ACTIVITY
6.1 Introduction
The specific studies on the enzyme profiles of livers and kidneys of animals 
after the implantation of a skin graft determined that the immune responses 
alone could not be responsible for the ordered enzyme activity changes that 
were observed in the host tissues of tumour-bearing rats (see section 4.3.1). 
However, the involvement of the immune system has often been observed in 
tumour-bearing animals. In particular animals carrying neoplasms exhibit 
severe immunoincompetence (Subramainan X  at., 1978; see also discussion 
Chapter 4). Moreover, if the immune system is involved in the development 
of growth of neoplastic cells, then the thymus is most often implicated 
(Trivers & Goldstein, 1978) and occurs either directly in the case of 
cellular responses (eg. homograft reaction and immune surveillance), or 
indirectly in the case of humoral responses (eg. production of helper or T 
suppressor cells for regulation of antibody production). Furthermore, an 
extract of thymus (thymosin) was found to be a potent immunopotentiating 
preparation and can act in lieu of the thymus gland to re-constitute immune 
function in certain thymus-deprived and/or immunodeprived individuals 
(Goldstein X  at., 1977). For example thymosin has been found to induce T 
cell differentiation and enhance immunological functions in adult thymecto- 
mised mice (Bach (X at., 1971; Goldstein X  at., 1970) and in NZB mice with 
severe auto-immune reactions (Dauphinee X  at., 1974). Furthermore, clinical 
trials with thymosin fraction 5 also indicate that this hormone was effective 
in increasing T cell numbers and normalizing immune function in children with 
thymus-dependent primary immunodeficiency diseases (Wara X  at., 1975; Wara 
& Ammann, 1976; Goldstein X  at., 1976). Thymosin extracts have also been
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shown to increase T ce ll numbers in immunodepressed cancer patients 
(Goldstein z£ aZ., 1976; Schafer z t cat., 1976, 1977) as well as enhance 
immunological function in tumour-bearing mice (Z is b la t t  zX aJt., 1970; Hardy 
oX aJL., 1971) and rats (Khaw & Rule, 1973). Moreover, in jec t ions  o f thymosin 
(F3 ) were e f fe c t ive  in bringing about the to ta l remission of the Dunning 
leukaemia in inbred Fischer CD rats (Khaw & Rule, 1973). The Dunning 
leukaemia is  syngeneic in inbred Fischer rats (Dunning & C urt is , 1957) and 
the fa c t that thymosin in jec t ions  inh ib ited  the growth of th is  tumour, 
therefore indicated that the immune system of syngeneic tumour-bearing rats 
can be stimulated to f a c i l i t a t e  re jec t ion  o f neoplasms (Khaw & Rule, 1973). 
Thymosin extracts therefore , might also stimulate the immune systems of the 
host animals carrying the syngeneic tumours studies in th is  thesis and 
prevent the growth of these neoplasms. Furthermore, a p a rt ia l  in h ib i t io n  of 
tumour growth or the to ta l re je c t ion  may also be re flec ted  in the a c t iv i t ie s  
of the marker enzymes in the host tissues of these ra ts . Such a co rre la t ion  
may provide ins igh t in to  the mechanism of host tissue enzyme a c t iv i t y  changes 
which were observed as a consequence of tumour-bearing. I t  was decided 
therefore to iso la te  thymosin f ra c t io n  5 because th is  preparation was shown 
to be non-toxic and deemed to possess s u f f ic ie n t  immunopotentiating 
properties tha t large-scale human c l in ic a l  t r i a l s  with cancer patients were 
reported to be in progress (Hooper eX aJL., 1975).
6.2 Results
6.2.1 Iso la tion  and C alibra tion o f Thymosin Fraction 5
Thymosin was p a r t ia l ly  p u r if ie d  from c a l f  thymus to f ra c t io n  5 (F5 ) using 
the method of Goldstein at a t . ,  (1972) as deta iled in section 2.16.1. 
(Thymosin frac t ions  are numbered 1 to 7 during the p u r i f ic a t io n  from a crude 
extract (F-j) to a homogeneous protein (F7 ) ). The f in a l  protein concentration 
o f th is  preparation was 3.7mg/ml. The minimum active amount of th is
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preparation as determined by rosse t te  bioassay (Dardenne z t  a t . ,  1977; see 
section 2.16.2) was 1.05jjg (protein).  This was similar to the potency of 
preparations of thymosin F5 obtained by other workers (Goldstein z t  a t . ,
1972, 1977) and was therefore considered suitable for study.
6.2.2 Injection of Thymosin F5
After isolat ion of the thymosin frac t ion  i t  was necessary to se lect  a s u i t ­
able route of administration. Extracts of thymus however, had been admin­
istered via a number of routes, including intraperi toneal  (Z isb la t t  z t  a t . ,  
1970), intravenous (Khaw & Rule, 1973), subcutaneous (Goldstein, 1976) and 
intramuscular (Constanzi at a t . , 1977) in ject ions .  As no comparison of the 
effectiveness of d i f fe ren t  routes of administration were available i t  was 
decided to use the simplest method, i . e .  intraperi toneal  in jection.  Further­
more, the range of thymosin dosage used in d i f fe ren t  t r i a l s  was considerably 
variable. For example, in human t r i a l s  l-400mg thymosin Fg/M^/day (Goldstein 
z t  a t . ,  1976) and 10-250mg/M2/day (Constanzi z t  a t . ,  1977) have been used.
The re la t io n sh ip : -
Dosage (mg) Dosage (mg) x S
Surface area (M2J = Body weight (Kg)
where S is a constant and is equal to 6 for ra t  and 37 for man (Prieur,
1973) allows the conversion of dose rate  from human to r a t .  The data of
Constanzi z t  a t . ,  (1977) (see above) therefore can be calculated to be equal
to 0.3-8mg thymosin F5/200g rat/day.  Furthermore, Khaw & Rule (1973) injected
5mg thymosin F^/rat a t  48 hourly in tervals  and obtained a tota l  remission of
the Dunning leukaemia. Assuming an approximate 15 fold purif icat ion of
thymosin ac t iv i ty  from fraction F3 to F5 (Goldstein z t  a t . ,  1972) a dose
rate  of 0.33mg F^/rat/AS hours can be calculated. Thymosin F5 has also been
shown to be completely non-toxic even at  extremely high doses (Hooper z t  a t . ,
1975). Moreover recently,  human c l in ica l  t r i a l s  determined that  a dose rate
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of 4-50mg thymosin F5/M2 was adequate (Trivers & Goldstein, 1978) th is  was 
calculated to be equivalent to 0 .2 -1 , 6mg/rat using the equation o f Prieur 
(1973). I t  was therefore decided to use excess thymosin and a dose rate 
of 0. 8mg F5/rat/48 hours was u t i l iz e d .
6.2.3 The E ffect of Thymosin F5 In jec tion  on the levels of Host Liver 
and Kidney Enzyme a c t iv i t ie s  of Tumour-Bearing Rats 
In chapter 3 the systemic e ffec ts  of tumour-bearing on the levels o f marker 
enzyme a c t iv i t ie s  of host tissues were described. In the studies detailed 
there, tumours were always implanted into both hindlegs of the rec ip ien t 
animal to ensure successful growth o f the tumour. Moreover, the implant­
ation of syngeneic tumours in to  inbred rats have been shown to e l i c i t  an 
early immune response (Churchill at a t . ,  1968; Ibrahim eX a t . ,  1977). This 
immune response however was reported to be blocked during the la te r  stages 
of tumour-bearing once the tumour had exceeded a certa in c r i t i c a l  size 
(Vaage, 1974; Vaage & Agarwal, 1976; Vaage eX a t . ,  1978). A stim ulation of 
the immune system to f a c i l i t a t e  possible tumour re jec t ion  therefore , would 
have the best chance of success i f  i t  occurred before the tumour had exceeded 
th is  c r i t i c a l  size (Süss 2X a t . , 1973; Vaage oX a t . , 1978). Consequently, 
the tumours used in the study on the e ffects  o f thymosin presented here were 
implanted only in to  one hindleg of rec ip ien t ra ts .
The e ffec ts  of the thymosin F5 preparation on host tissue enzyme a c t iv i t y  
changes which normally occur as a consequence of tumour-bearing was measured 
as fo l lo w s :-  one group (host control group) of inbred Buffalo rats were given 
a single intramuscular hindleg implant of the 7777 hepatoma as detailed in 
section 2. 2 , as well as an in traperitonea l in je c t io n  of bu ffer (0.216ml, 
sodium phosphate pH 7.2). At the same time another group (thymosin tes t
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group) of animals were given a similar tumour implant as well as an intra- 
peritoneal injection of thymosin F5 (0.216ml, 0.8mg protein) as prepared in 
section 2.16.1. Forty-eight hours later and at forty-eight hourly intervals 
thereafter until sacrifice, the thymosin test group were given further intra- 
peritoneal injections (0.216ml, 0 .8mg protein) of the thymosin preparation 
(total dose 4.8mg/rat). The host control group was given 0.216ml injections 
of the phosphate buffer. A further group (normal untreated adult group) of 
rats received no thymosin or implants of tumour but were housed under 
identical conditions as the host control and thymosin test groups. Twenty- 
eight days after the implantation of the tumours, the two control groups 
and thymosin test animals were killed and the levels of activity of the 
marker enzymes measured in host livers and kidneys as detailed in section 
2.4. The results of these measurements are presented in Table 12A and 
clearly demonstrate that the presence of a single tumour altered the levels 
of activity of adult-type enzymes toward the level characteristic of the 
neonatal tissue of origin. This occurred in host liver and kidney as a 
consequence of tumour-bearing. The levels of enzyme activity observed in 
the host tissues of the thymosin injected tumour-bearing rats however were 
also changed toward levels of activity characteristic of the neonatal tissue 
of origin (Table 12A). Injections of thymosin therefore had no effect on the 
production of host tissue enzyme activity changes toward foetal values. The 
weight of tumour in the thymosin injected animals however was 3.27 + 0.92g
(wet weight) which was significantly less (0.!>p>0.05) than that of the buffer 
injected animals (5.45 j^0.19g). It  is thus possible that the thymosin 
injections had inhibited the growth rate of the 7777 hepatoma. However this 
inhibition did not result in a lesser degree of enzyme activity change because 
the difference in tumour growth rate between thymosin injected and buffer 
injected animals was not sufficiently large. Furthermore, at this early
TABLE 12A: THE EFFECTS OF THYMOSIN Fg ON THE ENZYME ACTIVITY OF HOST LIVER 
AND HOST KIDNEYS OF RATS BEARING THE 7777 HEPATOMA
Two groups of male adu l t  (10 week) Buffa lo  ra ts  were given one intramuscular 
implant o f 7777 hepatoma in to  the r i g h t  hindleg (day 0). One group was then 
also given a in t ra pe r i to n ea l  i n je c t io n s  of thymosin F5 (0.216ml, 0 . 8mg 
pro te in )  prepared as de ta i led  in sect ion 2.16.1 at 48 hourly i n te rv a ls  
s ta r t i n g  on day 0. At the same times the other  group was given i n t r a -  
peri toneal i n je c t io n s  o f  0.216ml sodium phosphate bu f fe r  (0.01M, pH 7 .2) .  
Twenty e igh t  days a f t e r  day 0 the animals of both groups were k i l l e d  and the 
leve ls  o f enzyme a c t i v i t y  o f  host l i v e r s  and kidneys measured as de ta i led  in 
sect ion 2.4.
(a) Results are expressed as l i v e r  un i ts  (L.U.)  or kidney un i ts  (K.U.) 
where one u n i t  equals the level o f  a c t i v i t y  found in adu l t  l i v e r  
or kidney respec t ive ly  (mean + S.D.) .  Absolute values of leve ls  
o f  enzyme a c t i v i t y  o f contro l  adul t  t issues are given in tab les 2 
& 3.
(b) Results are expressed r e la t i v e  to those obtained f o r  co n t ro l ,  
un in jec ted,  non tumour-bearing rats  (mean + S.D.) ;  thus numbers 
greater  or smal ler than 1.0 r e f l e c t  increases or decreases, 
respec t ive ly .  An increase (>1.0) in a fo e ta l - t y p e  enzyme or 
decrease (<1. 0) o f  an adu l t - type  enzyme there fore  r e f l e c t s  a 
change toward the level  o f a c t i v i t y  found in foe ta l  l i v e r .
*  In jec t ions  o f  thymosin F5 in to  normal, non tumour-bearing ra ts  had no 
e f fe c t  on the a c t i v i t i e s  o f  the measured enzymes (data not shown).
TABLE 12A
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A: EFFECT ON LIVER ENZYMES
ENZYMES ENZYME ACTIVITY ( u n i t s / q )
Normal a d u l t *
1 i v e r
7777 host l i v e r
F5 In jec ted  
Animals
Bu f fe r  In jec ted  
Animals
A d jJ it-typz
Pyruvate Kinase 1 . 0 0 + 0 . 1 0 ^ 0.82 + 0 . 0 6 ^ 0.83 + 0 . 0 6 ^
A1 anine
Ami no t rans ferase
1 . 0 0 + 0.03 0.77 + 0.03 0.84 + 0.03
O rn i th ine
Aminotransferase
1 . 0 0 + 0.08 0.62 + 0.06 0 . 6 8 + 0.04
G1 ucokinase 1 . 0 0 + 0.08 0.83 + 0.04 0.85 + 0.04
Fo z£aJL-£yp&
Hexokinase 1 . 0 0 + 0 . 1 0 1.06 + 0 . 1 0 1.07 + 0.04
Phosphoserine 1 . 0 0 + 0.18 0.98 + 0.08 0.99 + 0 . 01
Phosphatase
B: EFFECT ON KIDNEY ENZYMES
ENZYME ENZYME ACTIVITY ( u n i t s / g )
Normal a d u l t * 7777 host kidney
AduZt-typn
kidney F5 In jec ted  
Animals
B u f fe r  I n jec ted  
Animals




1 . 0 0  + 0 . 1 0 0.85 + 0.02 0.92 + 0.03
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stage of 7777 hepatoma growth, the to ta l  tumour burden was re la t ive ly  small 
in both groups of animals. This was ref lected by the small but s ignif icant  
changes in the levels of host t issue  enzyme a c t iv i t i e s  toward foetal values 
(Table 12A). I t  is possible therefore,  that  a s ignif icant  difference in host 
t issue  enzyme ac t iv i ty  levels may occur between thymosin injected and buffer 
injected tumour-bearing animals, i f  the tumour was allowed to grow to a more 
advanced stage. This would also need a much longer period of thymosin 
injection. The large amount of thymosin required to perform such a study 
with the 7777 hepatoma however, made the execution of such an experiment 
immpossible.
The R3230AC mammary carcinoma possesses a fa s te r  growth ra te  than the 7777 as 
was ref lected by e a r l ie r  palpatation and the shorter t ransplanta tion interval 
(Table 1). During the same period of time a f t e r  t ransplanta tion therefore , 
the R3230AC tumour is capable of growing to a s ign if ican t ly  larger size and 
weight than the 7777 hepatoma. The e ffec t  of thymosin injections on the 
growth rate  of the R3230AC tumour and on the levels of the host t issue  enzyme 
a c t iv i t i e s  in these animals were therefore measured in the same manner as the 
7777 t r i a l .  The resu l ts  of th is  experiment are presented in Table 13 and 
again c lear ly  demonstrate that  thymosin F^  in jections did not have an effect  
on the extent of changes toward foetal values in the levels of enzyme 
a c t iv i t i e s  induced by the tumour. The levels of a c t iv i ty  of the adult-type 
and foeta l- type enzymes were observed to change toward levels of ac t iv i ty  
more charac te r is t ic  of the neonatal t issue  of origin in both thymosin 
injected and buffer injected tumour-bearing animals. Furthermore, the 
degree of change away from adult enzyme a c t iv i ty  levels were similar in 
both groups (Table 13). The weight of tumour carried by the thymosin injected 
group was 10.28 + 0.53g (wet weight). This was also similar to the tumour
TABLE 13: THE EFFECTS OF THYMOSIN Fg ON THE ENZYME ACTIVITIES OF HOST LIVER
AND HOST KIDNEYS OF RATS BEARING THE R3230AC MAMMARY CARCINOMA
Two groups of male adult (10 week) Fischer rats were given one intramuscular 
implant of R3230AC mammary carcinoma into the right hindleg (day 0). One 
group was then also given intraperitoneal injections of thymosin Fg (0.216ml, 
0.8mg protein) prepared as detailed in sectin 2.16.1 at 48 hourly intervals 
starting on day 0. At the same times the other group was given intra- 
peritoneal injections of 0.216ml sodium phosphate buffer (0.01M, pH 7.2). 
Twenty eight days after day 0 the animals of both groups were killed and 
the levels of enzyme activity of host livers and kidneys measured as 
detailed in section 2.4.
(a & b) Results are expressed as detailed in the legend of Table 12.
* Injections of thymosin Fg into normal, non tumour-bearing rats had no 
effect on the activities of the measured enzymes (data not shown).
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TABLE 13
A: EFFECT ON LIVER ENZYMES
ENZYMES EMZYME ACTIVITY ( u n i t s / g )
Adatt-type.
Normal a d u l t *  
1 i ver
R323QAC host l i v e r  
Fs In je c te d  B u f fe r  in je c te d  
Animals Animals
Pyruvate Kinase 1 . 0 0 + 0 . 0 5 ^ 0 . 8 8 + 0 . 0 3 ^ 0.87 + 0 . 0 2 ^
A1anine
Aminotransferase
1 . 0 0 + 0.09 0.77 + 0.05 0.74 + 0.13
O rn i th in e
Aminotransferase
1 . 0 0 + 0.07 0.74 + 0.06 0.89 + 0.15
G1ucokinase 1 . 0 0 + 0.09 0.78 + 0.04 0.73 + 0.07
F ooJjiZ-tijpz
Hexokinase 1 . 0 0 + 0.14 1.42 + 0.84 1.36 + 0 . 0 2
Phosphoserine
Phosphatase
1 . 0 0 + 0.05 1.89 + 0.04 1.64 + 0 . 0 2
B: EFFECT ON KIDNEY ENZYMES
ENZYMES
Ad' iZt-type.




ENZYME ACTIVITY ( u n i t s / g )
Normal a d u l t *  
kidney
R3230AC host k idney 
F5 I n je c te d  B u f fe r  I n jec ted  
Animals Animals
1 . 0 0 + 0 . 0 5 ^ 0.84 + 0 . 0 9 ^ 0.87 + 0.07
1 . 0 0 + 0.06 0 . 6 8 + 0.05 0 . 6 6 + 0 . 0 2
(b)
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weight carried by the uninjected group (10.89 +_ 1.24g wet weight, p>0.005). 
Thymosin in jec t ions  therefore did not in h ib i t  the growth rate of the R3230AC 
tumour or a l te r  the systemic e ffec ts  of th is  neoplasm on host t issue marker 
enzyme leve ls .
6.3 Discussion
The importance of the thymus in the hosts an tineop lastic  defense had been 
widely discussed (see fo r  example: Goldstein & Mackay, 1969; Goldstein 
1977, a , b; Trivers & Goldstein, 1978). With respect to breast cancer however, 
experimental as well as some c l in ic a l  evidence suggests tha t a thymic influence 
may in fa c t be detrimental (Papaioannou, 1974). Neonatal thymectomy fo r  
example, reduces the known high frequency and lengthens the induction period of 
murine breast tumours due to the mammary tumour v irus (MTV) (Michie z t a t . ,  
1967; Heppner z t a t . ,  1968; Yunis 2Ä a t . ,  1969) and treatment with a n t i ­
thymocyte sera decreases the frequency of spontaneous mammary tumours (Lappe 
& B la ir ,  1970; B la i r ,  1972). Thymic transp lanta tion  also restores the capacity 
of thymectomised mice to develop breast cancer (Yunis &£ a t . ,  1969). Further­
more several investigators  have reported tha t a number of murine mammary 
sarcomas grow s ig n i f ic a n t ly  fas te r  in normal mice than those in thymus- 
deprived mice, (S quartin i, 1971; G i l le t te  & Fox, 1975) and i t  was therfore 
proposed tha t T c e l ls  were required fo r  an optimal growth of mammary tumours 
(Vail 1 ie r  <it a t . ,  1977). Likewise, observations in patients with myasthenia 
gravis (M.G.) suggest tha t some component of thymic function may contribute 
to the development of breast cancer. The basic lesion of patients with M.G. 
is an inflammation of the thymus causing excess production and release of 
thymic hormones (Goldstein & Mackay, 1969). Women with M.G. have a high 
incidence of extra-thymic neoplasms, p a r t ic u la r ly  breast cancer, which was 
d ra s t ic a l ly  reduced in these patients i f  thymectomy was performed (Papatestas
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at a t . ,  1971). Furthermore, the propensity fo r  the development of malignant 
tumours persisted i f  thymectomy was not done. I t  was therefore proposed that 
the thymus in at least these patients somehow e ithe r suppressed the hosts 
immune system or enhanced tumour growth in some other way (Papaioannou 
tX a t . ,  1978). The fa i lu re  o f thymosin F5  therapy to in h ib i t  the growth of 
the R3230AC mammary carcinoma (Table 13) may therefore not cause surprise. 
Moreover i f  a thymus-dependent stim ula tion of the growth of mammary tumours 
were to prove universal fo r  th is  type o f tumour an increase of the growth 
rate of the R3230AC tumour should have been observed. The resu lts  presented 
here cannot support or oppose any involvement o f the thymus in the proposed 
increased growth of mammary tumours due to th is  organ.
Putting the exceptions provided by research in to  mammary tumours aside, the 
importance of the thymus in the hosts an tineop lastic  defence has been widely 
discussed (see fo r  example: Goldstein & Mackay, 1969; Goldstein at a t.  , 1977a, 
b; Trivers & Goldstein, 1978). Furthermore thymosin extracts have been shown 
to increase T ce ll numbers in immunodepressed cancer patients (Goldstein 
eX a t . ,  1976; Schafer at a t . ,  1976, 1977) as well as enhance immunological 
functions in tumour-bearing mice (Z is b la t t  a t a t . , 1970; Hardy at a t . , 1971) 
and rats (Khaw & Rule, 1973). Thymosin F^  in jec t ions  in fac t accelerated the 
rate of development of resistance to the Moloney sarcoma (Z is b la t t  at a t . ,  
1970) which also s ig n i f ic a n t ly  prolong the surviva l time of tumour-bearing 
animals (Hardy at a t . , 1971). Moreover, in jec t ions  of thymosin F  ^ were 
e f fe c t ive  in bringing about the to ta l remission of the Dunning leukaemia in 
inbred Fischer rats (Khaw & Rule, 1973). L i t t l e  success however, has been 
obtained in in h ib i t in g  the growth rate of tumours in patients by thymosin 
therapy. For example Schafer at a t . ,  (1976), administered thymosin F5  to 
t h i r t y  two patients bearing tumours of diverse o r ig in .  In only f iv e  patients 
a possible benefit was observed, while in another 26 patients no e ffects
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of thymosin F5  was discernible. Furthermore, one patient with chorio­
carcinoma exhibited an accelerated tumour growth rate. These workers 
therefore concluded that the clinical effects of thymosin F5  were inconsist­
ent. Furthermore particular caution should be observed in the administration 
of this preparation to cancer patients as an accelerated tumour growth rate 
may also occur in some patients (Schafer oX a t . ,  1976). Similarly Constanzi 
2Ä aJt. (1977) reported the effects of thymosin F^  administration to 10 patients 
with disseminated malignancies. In this study only one objective tumour 
response was noted in a patient with leiomyosarcoma (smooth muscle tumour). 
This patient experienced a partial regression (>50%) of the tumour 10 days 
after the completion of two courses of thymosin F5  treatment. The regression 
however lasted for only one month after which time the tumour progression 
reoccurred (during further thymosin treatment) and the patient died with 
brain metastases. Recently, a further clinical study with thymosin F5  was 
reported (Goldstein oX a t , ,  1977b). In this t r i a l ,  although some of the 
cancer patients showed some signs of clinical improvement, i t  could not be 
determined whether such findings were merely coincidental or the result of 
thymosin activity (Goldstein eX aJL., 1977b). The exciting results of tumour 
regression and rejection which were found with experimental animals as a 
consequence of thymosin injection (Zisblatt oX aJL., 1970; Hardy qX aJL, , 1971; 
Khaw & Rule, 1973) were therefore unfortunately not obtained with clinical 
t r ia l s  in cancer patients. The question arises therefore why such a 
difference between human clinical and experimental animal t r ia ls  should exist
The f i r s t  obvious conclusion that may be drawn from the comparison of results 
obtained in clinical and experimental t r ia l s  is that experimental animals 
such as rodents respond in a quite different manner to thymosin therapy than 
man. The close investigation of these results however, showed that species
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difference was not the only variable between the clinical and experimental 
t ra i l s .  On each occasion in which thymosin therapy was reported to inhibit 
tumour growth or faci l i ta te  rejection of the tumour, the active thymosin 
preparation used was fraction 3 (F3) (Zisblatt 2X a t.,  1970; Hardy eX a t.,
1971; Khaw & Rule, 1973). Moreover, a large proportion of the li terature 
reporting enhancement of immunological function by thymosin treatment, for 
example to faci l i ta te  the allograft rejection reaction in thymectomised 
animals, the active fraction was also F3 (see for example Goldstein zX a t., 
1970; Asanuma zX a t., 1970). On the other hand t r ia ls  in which thymosin 
therapy was found to have no effect on tumour rejection or growth, which 
included clinical t ra i ls  (Schafer zX a t.,  1976; Constanzi zX a t., 1977; 
Goldstein zX a t., 1977b) and the experimental animal t ra i l s  presented in 
this thesis (Tables 12 & 13) and others (Primus zX a t.,  1978), the thymosin 
preparation was fraction 5 (F5). It  may be concluded therefore that some of 
the difference between the success and failure of thymosin preparations to 
fac i l i ta te  tumour rejection in different species may lie in a difference of 
the biological activities of fraction 3 and 5. This point made obvious by 
the results presented here and the above comments has not been featured in 
the review literature of this subject.
Thymosin fraction 5 consists of a family of mostly small acidic polypeptides 
with molecular weights ranging from 1,000 to 15,000 Daltons (Goldstein, 1976). 
Thymosin F3 contains all of the polypeptides present in F^  plus a number of 
additional polypeptides (Goldstein zX a t . , 1972). Furthermore, i t  has been 
proposed that the biological potency of F^  may be due to more than one 
peptide, acting either in concert or individually (Goldstein zX a t., 1976).
It  is this author's proposal that other biologically active peptide(s) or 
factor(s) are present in the thymosin F3 preparation which are lost during
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the purification procedure to F5. Some experimental data to support this 
suggestion are presented here.
Primus at at,, (1978) studied the effects of thymosin injection and thymus 
grafting on the capability of thymectomised mice to reject the implantation 
of a lymphosarcoma. They reported that thymosin F5 preparations were totally 
ineffective in restoring the tumour allograft response in thymectomised mice 
depleted of long lived T-derived lymphocytes and anti thymocyte serum treat­
ment. By contrast, newborn thymus grafts were completely effective (100%) 
in reconstituting tumour allograft rejection. Furthermore, thymosin F3 
therapy of the thymectomised animals resulted in allograft rejection in 10- 
20% of animals. Thymosin F3 therefore, possessed more biological activity 
than F5 under these conditions. It was possible therefore that during the 
purification of thymosin from F3 to F5, factor(s) necessary for the rejection 
of a least this tumour were removed.
Van Bekkum zt at., (1977) also reported that, although thymosin F5 preparations 
contained factor(s) that stimulated the development of T-helper cells from 
pre-thymic precursor cells, this preparation was relatively poor in factor(s) 
that promoted the development of effector (killer) T cells from their 
immediate presursor cells. Other less purified thymic hormones however
[t h f] ), which were also derived(thymic factor TF and thymic humoral factor 
from the thymus, promoted the development of effector T (killer) cells.
During the isolation of thymosin F5 from whole thymus therefore, a portion of 
the biological activity still present in other thymic hormones (TF & THF) were 
lost (Van Bekkum at at., 1977). Furthermore, as "killer" T cells play a 
major role in the rejection of tumour allografts (Ikehara <at at., 1975) the 
thymosin F5 preparation appears to be lacking factor(s) that stimulate a
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primary tumour rejection mechanism.
Experiments performed with congenitally athymic nude, mice also infer that 
thymosin F5  preparations lack the full biological activity present in the 
thymus gland. Athmyic nude, mice are incapable of rejecting allogeneic skin, 
induce graft-vs-host reactions, respond to the T-cell mitogens pytohaema- 
glutinin (PHA) and concanavalin A (conA), or respond to allogeneic cells In 
uiXao (Pantelauris, 1973; Stutman, 1974). In fact the immune system of the 
nude, mouse is sufficiently defect that these animals will accept heterologous 
skin grafts derived from animals such as chickens, lizards as well as man 
(Rygaard, 1973). Nude mice however, grafted with thymus from embryonic, 
newborn or adult normal mice donors were reported to have all of the immune 
functions fully restored (Stutman, 1974). These immune functions included 
the restoration of T cell levels and T-cell dependent function (Nieuwerkerk 
eX a t., 1974) and also the ability to reject skin grafts (Wortis eX cut.,
1971; Pritchard & Miclem, 1973; Kindred & Loor, 1974). Repeated injections 
of purified thymosin F5  by a number of workers however, have failed to restore 
any immune responses in nude. mice. Thymosin F^  injections into nude, mice 
did not result in the restoration of responsiveness to PHA (Nieuwerkerk 
eX a t . ,  1974; Stutman, 1974), or to conA, or allogeneic cells in  v.IXao 
(Stutman, 1974). Furthermore, thymosin F^  injections did not reconstitute 
the sheep red blood cell response (Mishell-Dutton assay, Ulrich eX a t . ,  1977) 
or allograft rejection (Nieuwerkerk eX a t . ,  1974; Stutman, 1974) in nude. mice. 
It is evident therefore that the thymosin F5  preparation was incapable of 
replacing the thymus in the athymic nude mouse. One thymus extract however, 
has been demonstrated to reconstitute the levels of T cells and T-dependent 
functions in cogenitally athymic mice (Ikehara eX cut., 1975). These workers 
prepared a thymus extract using a similar procedure to that used to prepare
138
thymosin F3 (Ikehara oX al., 1975; ctf Goldstein qX al., 1972). Lymphocytes 
obtained from nude mice treated with this thymosin F3-1ike fraction were 
responsive to the T-cell mitogens PHA and conA while lymphocytes from 
untreated nude mice were not. Furthermore, the F3-1ike thymus factor was 
shown to induce the production of "killer" T cells in both nude mice and 
thymectomised mice (Ikehara qX al., 1975). Moreover, the injection of this 
extract into nude mice facilitated the complete rejection of fibrosarcoma 
implants. The thymus extract of Ikehara eX al., (1975) therefore, was able 
to reconstitute the immune system of nude and thymectomised mice and 
facilitate the tumour allograft reaction which was not obtained with thymosin 
F5. It is clear therefore that this F3-1ike preparation possessed a higher 
biological activity than thymosin F5 which again indicates that the F5 
preparation does not contain all of the biological activity of the thymus.
From the specific experiments detailed above therefore, it is evident that 
a number of thymus functions can be substituted for by thymosin F3 or thymosin 
F3-1ike extracts which can not be accomplished by thymosin F^. In particular 
thymosin F5 has no demonstrated ability to reconstitute the immune responses 
of nude mice or to facilitate tumour or allograft rejection. The administ­
ration of thymosin F5 however, had a potent effect in increasing the "total" 
E-rosettes and "active" rosettes of patients with primary or secondary 
immunodeficiency diseases In vIXa o including cancer patients (Schafer 
dX al., 1975; Goldstein sX al., 1977; Constanzi oX al., 1975, 1977).
Thymosin F5 administration also resulted in increased skin test reactivity to 
recall skin test antigens (Constanzi oX al., 1977; Goldstein oX al., 1977).
The clinical improvement of cancer patients due to thymosin F5 administra­
tion however, could not be demonstrated (Schafer zX al., 1976; Constanzi 
<iX al., 1977; Goldstein at al., 1977b). It appears therefore, that functions 
of the thymus that are measured by rosette or skin test activity assays
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are not responsible fo r  tumour re jec t ion ,  as a measured improvement o f  these 
c r i t e r i a  had no e f fec t  on the course of the disease in cancer patients. 
Furthermore, as the rosette bioassay was usual ly used to id e n t i f y  act ive 
thymosin fract ions during the preparation of Fg (Goldstein oX a t . ,  1972; 
Hooper 2X a t . , 1975) i t  is possible that other bio logical  a c t i v i t i e s  of the 
thymus were los t  in the preparation of th is  thymus extract but were not 
detected by th is  assay procedure. In pa r t icu la r  those functions which 
st imulate the immune responses to f a c i l i t a t e  a l lo g ra f t  and tumour re jec t ion 
may have been los t  during the p u r i f i c a t io n  from F3  to F5 .
In conclusion therefore, the fa i lu re  of thymosin F^  administrat ion to i n h ib i t  
the growth of the 7777 or R3230AC tumours or to f a c i l i t a t e  th e i r  re jec t ion 
is in good agreement with the resul ts  of other workers. However, l i t t l e  
information about the possible de -d i f fe ren t ia t i r ig  influences of tumour­
bearing were obtained as no s ig n i f ic a n t  dif ferences were observed in the 
levels of  a c t i v i t y  of enzymes present in host t issues of thymosin treated or 
untreated animals (Tables 12A& 13). I f  however, a pa r t ia l  improvement of the 
immune system (E-rosette and hypersens i t iv i ty  tests)  which occurred in cancer 
patients (eg. Constanzi t t  a t . , 1977) also occurred in the 7777 or R3230AC- 
bearing animals (not tested here), then i t  can be said that the immune 
responses were not responsible fo r  the observed host t issues enzyme a c t i v i t y  
changes. Such a conclusion however, has to be speculat ive at th is  time.
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CHAPTER 7
STUDIES ON MITOCHONDRIA ISOLATED FROM HOST LIVER 
7.1 Introduction
As discussed ear l ie r  (see Chapter 3) the proposed "de-differentiation" of 
host tissues as a consequence of tumour-bearing part icular ly  in host l i v e r ,  
arose from specific measurements of the ac t iv i t ie s  of developmental enzymes 
in the tissues of tumour-bearing rats (Herzfeld & Greengard, 1972).
Although other biochemical indications of the "immature" state of host 
l ivers have been reported in the l i te ra tu re  (discussed in section 9.1) no 
specific experiments had been done to determine whether the proposed foetal  
reversion is reflected by other biochemical parameters of host tissues. The 
foetal reversion hypothesis of host tissues therefore re lies largely on 
enzyme ac t iv i ty  measurements (discussed in Chapter 3) or on measurements of 
enzyme turnover (Chapter 5). This situation prevails because i t  is the 
enzymic composition of tissues which is most often studied and consequently 
best understood. Moreover, the biochemical appreciation of what distinguishes 
a foetal tissue and i ts  contents from an adult tissue is almost limited to 
foetal l ive r  (Knox, 1976). What information there is ,  is largely based on 
enzyme prof i le  studies (Greengard, 1971; Knox, 1976). However, a number of 
other less defined developmental markers are potentially  available for  
study. For example during development in the ra t ,  l ive r  mitochondria undergo 
a number of changes. In part icular ,  i t  was demonstrated that Ca++ transport 
a c t iv i ty  (Bygrave & Ash, 1977) as well as respiratory control (Duck-Chong & 
Poliak, 1973; Nakazawa oX a t . ,  1973; Poliak, 1975) increased from low levels 
2-3 days before birth to high adult levels during the postnatal period.
Thus i t  was reasoned that the measurement of these developmental systems in 
host l ive r  may provide some further insight into the possible "de-different-
iating" systemic influences of the tumour on the host.
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Reports on the integrity of mitochondria as reflected by respiratory control 
indices (acceptor control ratios) using succinate as substrate in host 
livers of tumour-bearing rats are also conflicting. Mitochondria isolated 
from host livers of rats bearing Walker 256 carcinomas (Greene,1960; Baldwin 
<X a l . , 1975) or Morris hepatomas (Kaschnitz eX a l . , 1976) were reported to 
possess tightly coupled respiratory control. However, substances that 
uncouple respiratory control of normal rat liver mitochondria In vhtn.o have 
been reported in tumour extracts (Devlin & Pruss, 1958) and in the serum of 
cancer patients (Alferov at a l . , 1976) and sarcoma-bearing rats (Nanni &
Casu, 1961). Shapot zX a l . , (1976) also reported uncoupled respiratory 
control of mitochondria isolated from host livers of Sarcoma 45 and Walker 
256 tumour-bearing rats.
Recently i t  was shown that host liver mitochondria of 5123C hepatoma-bearing 
rats were unable to oxidise MAD+-1inked substrates such as pyruvate, malate 
or glutamate (Williams zX a l . , 1976). These mitochondria however would 
efficiently oxidise succinate. It  is also known that the accumulation of 
large amounts of calcium by mitochondria caused the depression of mito­
chondrial NAD+-linked substrate respiration (Vinogradov oX al. , 1972). 
Furthermore, serum hypercalcaemia is one of the most often encountered 
phenomenon associated with tumour-bearing in human patients (Gordan, 1974). 
Thus i t  is reasonable to ask whether host liver mitochondrial calcium 
metabolism is altered in tumour - bearing rats.  This question is particularly 
pertinent in the light of findings of Vinogradov zX a l . , (1972) and Williams 
zX oil., (1976). For these reasons host liver mitochondrial respiratory 
control and calcium transport were investigated.
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7.2 Results
7.2.1 Respiratory Control Indices of Host Liver Mitochondria 
Mitochondria were isolated from normal adult and neonatal l ivers as well as 
from host livers of tumour-bearing rats. Mitochondrial state 3 (addition of 
ADP) and state 4 (no ADP) respiration was then measured and the respiratory 
control indices calculated according to Chance & Williams (1956). These 
results (see Table 14) clearly demonstrate that neonatal mitochondria 
possess lower respiratory control than adult mitochondria for all of the 
substrates tested. These results are in complete agreement with those of 
other workers (Duck-Chong & Poliak, 1973; Nakazawa cut., 1973; Poliak, 1975). 
Host l iver  mitochondria however, possessed respiratory control similar to 
adult l iver mitochondria for all  three, tumours tested (Table 14). However, 
the concentrations of the NAD+-1inked substrates tested in the experiments 
presented in Table 14 were 5mM while those of Williams 2Ä cut., (1976) were
ImM (P.C. Cook, personal communication). The experiments were therefore 
repeated with the host l iver mitochondria, exactly as detailed in the 
legend of Table 14, except that the concentrations of the NAD+-1inked 
substrates present in the electrode medium was ImM and not 5mM. S t i l l ,  no 
difference in the rates of substrate oxidation could be demonstrated between 
normal and host l iver  mitochondria (data not shown). The results of Williams 
out cut., (1976), concerning the inabil i ty  of 5123C host l iver  mitochondria to 
oxidise NAD+-1inked substrates as early as one month after the implantation 
of the tumour could therefore not be confirmed. This apparently conflicting 
result is discussed in section 7.3.1.
7.2.2 In i t ia l  Rates of Calcium Transport by Host Liver Mitochondria 
Mitochondria were isolated from adult rat l iver  and calcium uptake determined 
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14. They show that after the addition of calcium, the mitochondria rapidly 
take up the calcium from the medium. This process was linear during the 
f i r s t  10 seconds after the addition of calcium and allowed an accurate 
estimation of the init ial  rate of uptake. A twofold stimulation in the 
init ial  rate of calcium uptake was observed in the presence of 2tnM KH2PO4 
(Fig. 14). These results are similar to those of other reports (Bygrave 
zt cdi., 1978).
Mitochondria were then isolated from host livers of tumour-bearing rats,  
the init ial rates of calcium uptake were determined and the results are 
presented in Table 15. These data show that there were no changes in the 
init ial  rates of mitochondrial calcium uptake in host livers as a consequence 
of the animals bearing any of the tumours tested. Moreover, the stimulation 
of the in it ial  rates of calcium uptake in the presence of 2mM KH2PO4 was 
similar in normal and host liver mitochondria. Thus the lower in it ia l  rates 
of calcium uptake by foetal mitochondria (Bygrave & Ash, 1977) were not 
observed in host liver mitochondria (Table 15).
7.2.3 Calcium Retention by Host Liver Mitochondria
In this section dealing with mitochondrial calcium retention, representative 
data are shown. From day to day the total retention time may vary, even 
in mitochondria isolated from normal adult liver. Differences in retention 
times obtained between normal, noenatal or host liver mitochondria on 
different days however, were always similar. This day to day variation has 
also been reported by others (see for example Prpic zt at., 1978).
Mitochondria were isolated from normal adult and from 2-day old neonatal rat 


















FIGURE 14: Measurement of ini t ial  rates of Mitochondrial Calcium Transport
Mitochondria were isolated from normal adult (10-12 week) rat 
liver as detailed in section 2.17. Incorporation of calcium into 
mitochondria was then determined at 4°C as detailed in section 2.19.1. The 
amount of calcium present in mitochondria at each time point was then 
plotted. The init ial  rate of calcium transport was calculated from 
the init ial  linear portion of the curve.
® , No added phosphate, ini t ial  rate = 66 nmol/min/mg protein. 
b , 2mM KH2PO4 added, ini t ial  rate = 132 nmol/min/mg protein.
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TABLE 15: Comparison of the in i t i a l  rates of Mitochondrial Calcium
Transport in l ivers of normal and tumour-bearing animals
Mitochondria were isolated from livers of normal adult (10-12 
week) and tumour-bearing rats as detailed in section 2.17. Host l ive r  
mitochondria were isolated 5,7 and 10 weeks a f ter  the implantation of the 
R3230AC, 7777 and 5123C tumours respectively, when the total tumour weight 
was about 35 grams. Calcium transport was measured in the presence and 
absence of 2mM KH2PO4 as detailed in section 2.19.1. The i n i t i a l  rates 
of calcium transport were calculated from the l inear portion of the curve 
(see Fig. 14). Results are given as the mean + S.D. nm Ca transported/ 
min/mg mitochondrial protein. The numbers in parentheses refer to the 
number of experimental animals.
TISSUE CALCIUM TRANSPORT ( I n i t i a l  rate)
without Pi with Pi
Normal l ive r 64 + 8 (3) 124 + 6 (3)
Host 5123C l iv e r 63 + 5 (2 ) 120 + 7 (2 )
Host 7777 l ive r 67 + 6 ( 2) 120 + 8 ( 2)
Host R3230AC l ive r 66 + 5 ( 2 ) 122 + 7 (2)
147
section 2.19.2 and the results presented in Figure 15. In this experiment, 
which was one of several that gave similar results, i t  was clearly evident 
that mitochondria isolated from neonatal l iver  had a much lower capacity 
for retaining calcium than mitochondria obtained from adult l ivers. In the 
adult l iver  mitochondria, calcium was accumulated within 10 seconds but 
thereafter was released into the suspending medium, slowly during the 
in i t ia l  4 min but most rapidly between 4 and 8 min. A retention time of 
approximately 6 minutes was therefore calculated from this data (see the 
legend of Fig. 15). This was similar to the data obtained by others (see 
for example Prpic zt at., 1978). Neonatal mitochondria on the other hand had 
not fu l ly  accumulated calcium until about 30 seconds (Fig. 15). This result 
confirms the reported lower in i t ia l  rate of calcium uptake by neonatal 
mitochondria (Bygrave & Ash, 1977). By 45 seconds the neonatal mitochondria 
began to quickly release calcium into the suspending medium and a retention 
time of approximately 1% minutes was obtained (Fig. 15). The ab i l i ty  of 
neonatal l iver  mitochondria to retain calcium was therefore considerably 
lower ( ^ 4  fold lower) than adult l iver  mitochondria.
Mitochondria isolated from host livers of tumour-bearing rats did not show 
a lowered ab i l i ty  to retain calcium (Fig. 16). The adult l iver mitochondria 
in this experiment possessed a retention time of about 3 minutes. Host 
l iver  mitochondria however, retained calcium for periods of 2-4 times longer 
than normal adult mitochondria (Fig. 16). In each of 3 experiments, host 
l iver  mitochondria isolated from hepatoma-bearing rats (5123C or 7777) 
retained calcium for periods 2-3 times longer, while mitochondria from 
mammary carcinoma-bearing rats (R3230AC) retained calcium for periods 4-5 
times longer than mitochondria obtained from control adult rats. Thus host 

















FIGURE 15: Comparison of Calcium Retention of Mitochondria derived from
Adult and Neonatal l iver
Mitochondria was isolated from normal adult (10 weeks) and 
neonatal (2 day, pooled l i t t e r )  rat livers as detailed in section 2.17.
The amount of calcium present in mitochondria was then determined at 25°C 
in the presence of 2mM KH2 PO4 as detailed in section 2.19.2 and the results 
were plotted against time. The calcium retention time (R .t . )  was then 
calculated as the time taken for half the total amount of accumulated 
calcium to be expelled from the mitochondria.

















FIGURE 16 Comparison of Calcium Retention of Mitochondria derived from
Adult Liver and Host Livers of Tumour-Bearing Rats
Mitochondria were isolated from normal adult (12 weeks) l iver  
and host l ivers of tumour-bearing rats as detailed in section 2.17. Host 
l iver  mitochondria were isolated 5, 5 and 10 weeks after the implantation 
of the R3230AC, 7777 and 5123C tumours when the tumour weights were 12 g,
7 g and 17 g respectively. The amount of calcium present in the mitochondria 
was then determined at 25°C in the presence of 2mM KH2 PO4  as detailed in 
section 2.19.2 and the results were plotted against time. Calcium 
retention times (R .t . )  were then calculated as described in the legend of 
Figure 15.
O, Adult l iver ,  R.t. = 3 min; R3230AC host l iver ,  R.t.  = 
12.5 min; a , 7777 host l iver ,  R.t.  = 7.5 min; a,5123C host l iver ,  R.t. 
= 6.7 min.
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"foetal-type" decreased ability to retain calcium, rather the contrary 
was observed.
7.3 Discussion
7.3.1 The Respiratory Control of Host Liver Mitochondria
The data of Table 14 clearly show that the ability of host liver mitochondria 
to oxidise succinate and NAD+-1 inked substrates tn  maXko was similar to 
normal adult liver. This result appears inconsistent with Williams oX at. , 
(1976) who had reported that host liver mitochondria of 5123C-bearing rats 
were unable to oxidise NAD+-1inked substrates. However, in that report i t  
was also stated that the concentration of calcium in 5123C host liver was 
five times that of normal liver (Williams eX a t.,  1976). But liver calcium 
levels of 5123C hepatoma-bearing rats were not increased until late during 
the time course of tumour-bearing (Table 16). The animals assayed by 
Williams at a t.,  (1976) for respiratory control and calcium content therefore, 
must have been at this wel 1-advanced stage of tumour development. This 
proposal was confirmed recently (P.C. Cook, personal communication). I t  is 
clear therefore that mitochondrial respiratory control in host livers of 
5123C-bearing rats remained normal during a large proportion of the time- 
course of tumour development (Table 14). This situation changes at the 
terminal stage of the tumour-bearing animals l i fe  span, when the animals 
became hypercalcemic (Table 16) and also possess impaired mitochondrial 
respiratory control (Williams oX a t., 1976). Evidence that this may occur as 
a consequence of bearing with other types of tumours is also evident.
Ultrastructural studies demonstrated that host liver mitochondria in rats 
bearing small tumours were morphologically similar to those of normal rat 
liver (Ghadially & Parry, 1965). In animals which were close to death and
TABLE 16: Variations in Calcium and Magnesium Concentrations in whole Host
Liver during the time-course of 5123C tumour-bearing
Calcium and magnesium concentrations of whole normal l ive r  and host l ivers  
of 5123C hepatoma-bearing ra t s  were determined as detailed in section 2.8. 
Results are expressed as jag  ion/g of l ive r  (fresh weight) (mean + S.D. or 
as individual values). The numbers in parentheses indicate the numbers of 
animals used.
Days a f te r  5123C 
Implantation
Calc i u m  
( j u g / g )
Magnesium
( u g / g )
Calcium/Magnesium
Ratio
0 44.3 ± 6.8 (5) 178  + n  ( 5 ) 0.249 + 0.044 (5)
14 46.2, 44.3 181, 180 0.255, 0.246
40 53.7, 47.6 219, 186 0.245, 0.255
48 39.6 192 0.206
55 50.2, 47.6 172, 189 0.291, 0.251
70* 82.6 + 7 . f  a ) (4) 185 + 15 (4) 0.447 + 0 . 0 2 8 ^ ( 4 )
* These animals were carrying massive tumours (>60g) , were extremely
emaciated, cachectic and metastases had occurred. The animals 
were judged close to death and i t  was judged that  they would not 
have lived longer than one or two more days.
(a) S t a t i s t i c a l ly  d i f fe ren t  from adult r a t  l ive r  (p< 0.05) by student
t  t e s t .
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who were carrying large tumours it was shown that host liver mitochondria 
were significantly swollen (Ghadially & Parry, 1965; Parry & Ghadially, 1966). 
This usually indicates the uncoupling of mitochondrial respiratory control 
(Packer & U t s u m i , 1969). Similarly, in those reports where host liver 
mitochondria were shown to possess normal respiratory control, the tumour 
burden was small (Greene,1960; Baldwin oX at., 1975; Kaschnitz oX at., 1976). 
When the tumour burden was large however, low respiratory control was 
observed (Nanni & Casu, 1961; Williams zX at., 1976; Shapot zX at., 1976). 
Furthermore, the respiratory chain disorder, as reflected by the abnormal 
respiratory control index, was reported to become normal with regression of 
of the tumour ( Shapot zX at., 1976). It is clear therefore, that the 
imposition of a tumour on an animal alters the host liver mitochondrial 
respiratory control only when the tumour has progressed to a w e l 1-advanced 
stage of growth.
The question could be asked therefore, whether the failure of host liver 
mitochondria to possess foetal respiratory control during the early stages 
of tumour development provides evidence against the proposed "de-different- 
iating" influences of tumour-bearing. Mitochondria isolated from foetal 
rat liver before birth exhibited either no (Mintz oX at., 1967; Duck-Chong 
& Poliak, 1973) or considerably lower (25% of adult) respiratory control 
than adult liver mitochondria (Nakazawa eX at., 1973; Poliak, 1975). 
Furthermore, 1-2 day neonatal rat liver was shown to possess 50-60% of 
adult respiratory control (Table 14; see also Poliak, 1975). However, the 
exact time at which this increase in respiratory control occurs, i.e. at 
birth or 1-2 days after birth, has not been demonstrated. Moreover, the 
exact time after birth at which neonatal mitochondria start to possess 
adult levels of respiratory control has also not been determined. Consequ-
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ently this may occur during the interval 1-2 weeks post-partum. Thus the 
data presented in Table 14 may be identical with the levels of respiratory 
control possessed by 1-2 week neonatal rat liver i .e .  adult levels. Hence 
these results may be consistent with the proposed "de-differentiated" states 
of host liver i.e. possessing characteristics similar to immature liver.
On the other hand another possibility is evident. Foetal and neonatal 
livers possess ATP levels considerably lower than adult liver (Ballard,
1971; Knowles & Ballard, 1974; Poliak & Sutton, 1978). Moreover, pre­
treatment of foetal (Hallman, 1971; Nakazawa oX a t.,  1973; Poliak, 1975) or 
neonatal (Poliak, 1975) rat liver mitochondria with ATP, prior to respiratory 
control measurements, significantly increased the respiratory control index 
toward adult levels. Increased ATP levels therefore were proposed to "mature" 
foetal and neonatal mitochondria and they subsequently obtained adult levels 
of respiratory control (Hallman, 1971; Nakazawa eX a t., 1973; Poliak, 1975). 
Furthermore, as host liver mitochondrial respiratory control was similar to 
adult liver (Table 14), the abili ty  of host liver mitochondria to synthesize 
ATP appears to be unaltered. Decreased levels of ATP in host livers during 
the early stages of tumour growth have also never been reported. Therefore, 
since host liver ATP levels appear normal, i t  is quite possible that "immature1 
host liver mitochondria do not exhibit respiratory control because they have 
been 'pretreated1 with ATP in Aitu. i .e .  in the host liver.
The speculative nature of the above proposal relies on the maintenance and 
normal compartmentation of ATP levels in host liver. However, tumour extracts 
(Devlin & Pruss, 1958) and serum factor(s) of tumour-bearing rats (Nanni & 
Casu, 1961) and patients (Alferov eX a t.,  1976) have been demonstrated to 
decrease the respiratory control of normal rat liver mitochondria in  vtXao.
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It  is thus possible that such factor(s) may be present in host liver and 
have been removed by the mitochondrial isolation procedure. This implies 
that alterations of host liver mitochondrial respiratory control are 
reversible. Such reversibi 1ity is not entirely unknown. When rat spleen 
mitochondria were incubated with oxidisable substrates (pyruvate & malate), 
the addition of MgCl2 markedly lowered the respiratory control ratio and the 
addition of EDTA returned i t  to normal levels (Vijayakumar & Weidemann,
1976). The demonstration of high levels of host liver mitochondrial 
respiratory control in  vi&io therefore, would not mean high respiratory 
control in  vivo. Furthermore, the ATP levels of host liver may be impaired 
by abnormal compartmentation, even though the ATP concentrations may be 
normal. This is possible since glycolysis may also be impaired due to low 
pyruvate kinase activity levels (see Figs. 1 & 5). However, ATP levels of 
normal rat liver were reported to be 4-6 millimolar (Greenbaum eX a t.,  1971; 
Bergmeyer, 1974; Siess 2X a t.,  1978), whereas micromolar concentrations were 
sufficient to pre-treat foetal mitochondria and increase respiratory 
control (Poliak, 1975). The proposed protective "pre-treatment" of host 
liver mitochondria in  Aiiu therefore appears possible.
During the terminal stages of tumour-bearing, isolated host liver mitochondria 
exhibited low respiratory control (Nanni & Casu, 1961; Williams <ii a t . ,
1976; Shapot at at. t 1976) which was similar to neonatal and foetal liver 
(Table 14; see also Nakazawa <it a t., 1973; Poliak, 1975). The proposal that 
host livers of tumour-bearing rats became de-differentiated as a consequence 
of tumour-bearing therefore was consistent with these results.
7.3.2 Initial Rates of Calcium Uptake by Host Liver Mitochondria 
During development, the in it ia l  rates of calcium uptake by rat liver
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mitochondria changed from low rates (10% of adult) 2-3 days before birth, to 
40% of adult rates at birth and thereafter gradually increased over the 
next 28 days to adult levels (Bygrave & Ash, 1977). One to two week neonatal 
liver mitochondria therefore were "immature" and possessed lower than adult 
rates of calcium uptake. Calcium uptake by host liver mitochondria however, 
was similar to that of adult liver (Table 15). This result therefore appears 
to oppose the proposed "de-differentiation" influences of tumour-bearing. 
However, pre-treatment of isolated mitochondria with ATP was shown to "mature" 
calcium uptake so that 2 days after birth, levels of transport were found 
that were indistinguishable from adult levels (Bygrave & Ash, 1977).
Similarly, decreased rates of calcium uptake by mitochondria isolated from 
dexamethasone treated rats could be restored to normal by pre-treatment with 
ATP (Kimura & Rasmusson, 1977). It was again possible therefore that normal 
levels of ATP in host liver had "pre-treated" the mitochondria tn aäX ll and 
consequently normal levels of calcium uptake were observed (but see also 
section 7.3.1).
It is also of interest that mitochondria isolated from a variety of tumours, 
tissues described as essentailly immature (Knox, 1976), were shown to 
possess initial rates of calcium transport similar to normal adult liver 
mitochondria (Bygrave, 1976). Moreover, mitochondria isolated from regener­
ating liver i.e. rapidly dividing "immature" cells (Uriel, 1975; Taketa 
qX at., 1976), also responded to calcium in a manner similar to those from 
adult rat liver (Thorne & Bygrave, 1974). The normal calcium transport of 
host liver mitochondria is therefore consistent with the proposal that host 
livers possess characteristics similar to immature liver and the well- 
differentiated hepatomas.
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7.3.3 Calcium Retention by Host Liver Mitochondria 
Liver mitochondria isolated from 2 day old neonatal rats retained calcium 
for periods of time considerably shorter (Fig. 15) while those from host 
l iver  retained calcium for longer intervals (Fig. 16) than adult mitochondria. 
Host l iver  mitochondrial calcium retention therefore was not "immature". 
However, i t  can be demonstrated that ATP can "mature" the ab i l i ty  of foetal 
mitochondria to retain calcium. Foetal mitochondria became damaged at much 
lower concentrations of calcium than adult mitochondria as reflected by the 
loss of calcium-stimulated respiratory control (Poliak, 1975). Furthermore, 
calcium-stimulated respiration is known to be closely coupled to calcium 
uptake (Rossi & Lehninger, 1964; Bygrave, 1976). Mitochondrial damage is 
also associated with the loss of calcium-stimulated control and the efflux 
of mitochondrial calcium (Bygrave, 1976). Therefore, as foetal mitochondria 
were damaged by lower concentrations of calcium (Poliak, 1975) the ab i l i ty  
of these mitochondria to retain calcium must be shorter than adult 
mitochondria. This result is similar to the data of Fig. 15 which 
demonstrated that neonatal mitochondria had accumulated less calcium than 
adult mitochondria before damage occurred with subsequent release of calcium 
to the medium. Furthermore, pre-incubation of foetal mitochondria with ATP, 
"matured" the ab i l i ty  of these mitochondria to possess calcium-stimulated 
respiratory control in the presence of adult levels of calcium (Poliak,
1975). ATP-treated foetal mitochondria therefore were not damaged by adult- 
levels of calcium and hence possessed adult calcium retention times. Thus 
the fa ilure to observe "immature" calcium retention by host l iver mitochondria 
may again be explained by a "maturation" process Jin aäX ll by normal host 
l iver ATP concentrations.
On the other hand no such "maturation" of mitochondria may be necessary as
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intra-mitochondrial ATP concentrations are cri t ical ly  important in the 
abili ty  of mitochondria to retain calcium. The addition of phosphoenol- 
pyruvate to mitochondrial incubations caused the efflux of mitochondrial 
ATP and was followed by the rapid release of calcium (Peng oX a t., 1974). 
Dexamethasone treatment of rats also resulted in the reduced abili ty of 
subsequently isolated mitochondria to retain calcium, while at the same time 
a large decrease in the endogenous mitochondrial ATP content was found 
(Kimura & Rasmussen, 1977). Similarly, glucagon treatment of rats results 
in longer mitochondrial calcium retention tn  vtX/io while a significant 
increase in the adenine nucleotide content was observed (Prpic vX a t.,
1978). Moreover, Ehrlich ascites tumour cells which were shown to be 
resistant to the uncoupling action of calcium (Thorne & Bygrave, 1974; 
McIntyre & Bygrave, 1974) were also shown to exchange only a very small 
proportion of their complement of adenine nucleotides (Thorne, 1975). The 
retention of calcium by mitochondria was therefore proposed to be dependent 
on intra-mitochondrial ATP concentratios (Kimura & Rasmussen, 1977; Bygrave, 
1978) although a qualification of this view states that other factor(s) may 
also be involved (Prpic oX a t., 1978). The normal abili ty of host liver 
mitochondria to synthesize ATP by oxidative phosphorylation (Table 14; but 
see also section 7.3.1) and the normal ATP concentrations of these mitochon­
dria should allow normal mitochondrial calcium retention. It is also of 
interest that tumour mitochondria (Bygrave, 1976) including minimum- 
deviation (well differentiated) hepatomas (Thorne, 1975) retain calcium for 
longer periods of time than adult liver mitochondria. This is similar to the 
abili ty of host liver mitochondria to retain calcium (Fig. 16). The proposal 
that host livers of tumour-bearing rats exhibit properties characteristic of 
immature liver and the wel1-differentiated hepatomas (Herzfeld & Greengard, 
1972) is therefore consistent with these results. However, recently i t  was
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shown that l iver  mitochondria isolated from foetal rats of 18-19 day 
gestation when incubated with Mg-ATP, or those from neonatal rats when 
incubated with ImM KH2 PO4 , exhibited the ab i l i ty  to takeup and retain calcium 
in a manner similar to mitochondria isolated from the livers of adult rats 
(V. Prpic & F.L. Bygrave, personal communication). I t  is clear therefore 
that the ab i l i ty  of l iver  mitochondria to retain calcium can be easily 
influenced by the manipulation of the experimental conditions. Thus the 
value of mitochondrial calcium retention as a marker of tissue differentiation  
may be doubtful, i f  useful at a l l .
7.3.4 Conclusion
The specific studies on isolated mitochondria from host l ivers of tumour­
bearing rats detailed in this chapter have given no insight into the 
proposed "de-differentiating" influences of tumour-bearing. However, the 
studies have provided valuable information about the integrity of host l iver  
mitochondria of tumour-bearing animals. In particular i t  appears that host 
l iver mitochondria during most of the time-course of tumour-bearing retain 
the ab i l i ty  to synthesize ATP (Table 14) and also control the flux of calcium 
transport in and out of mitochondria (Table 15, Fig. 16). At wel1-advanced 
stages of tumour growth however, the host l iver  mitochondria became swollen 
(Ghadially & Parry, 1965; Parry & Ghadially, 1966) and lose the ab i l i ty  to 
eff ic ient ly  synthesize ATP (Nanni & Casu, 1961; Williams et a t . ,  1976;
Shapot oX a t . ,  1976). However, whether such changes cause the death of the 
tumour-bearing host, or whether they are simply a reflection of the overall 
dying process is at this stage not clear.
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CHAPTER 8
ELECTROLYTES, METABOLITES AND ENZYMES IN THE SERUM OF TUMOUR-BEARING RATS 
8.1 I n t r o d u c t io n
With respect  to  the t r a n s p la n ta b le  tumours s tud ied  in  t h i s  th e s is  (R3230AC, 
7777 & 5123C), l i t t l e  i s  known o f  the e f f e c t s  o f  the c l i n i c a l  progress ion 
o f  the tumour which e v e n tu a l l y  r e s u l t s  in  the death o f  the host .  From the 
t ime o f  im p la n ta t io n  u n t i l  the tumours had grown to  about 40 grams (1,  1.5 
& 3 months r e s p e c t i v e l y ) , the hea l th  o f  the host appeared almost normal.
This was assessed by coat appearance, feed ing hab i ts  (stomach contents)  and 
by the host animals response to  ex terna l  s t i m u l i .  A f t e r  t h i s  t ime the coat 
became d u l l  and " s c r u f f y " ,  the animals l o s t  body weight and were less  a l e r t .  
These con d i t io n s  p rog res s iv e ly  worsend over the next 1-3 weeks (R3230AC,
7777, 5123C, r e s p e c t i v e l y )  u n t i l  death.  At t h i s  t ime the animals exh ib i te d  
extreme cachexia and had o f te n  l o s t  40-50% o f  body we igh t.  The above terms 
however are merely d e s c r i p t i v e  and the exact cause o f  death i s  q u i te  unknown. 
Moreover, the t ime a f t e r  tumour im p lan ta t ion  a t  which the hea l th  o f  the host 
s t a r t s  to  d e t e r i o r a t e  is  unc lear .  I t  i s  poss ib le  th e re fo re  t h a t  some o f  the 
changes in  enzyme a c t i v i t y  o f  host  t i s sues  which are observed a t  an advanced 
stage o f  tumour growth may be due to  necros is  o f  the host t i s s u e  or  may be 
associated w i th  the u l t im a te  mechanism o f  death.  I t  was considered p e r t i n e n t  
t h e r e fo re ,  to  determine the p h y s io lo g ic a l  s ta tus  o f  the host dur ing the t im e-  
course o f  tumour-bear ing.  This can be done by the measurement o f  s p e c i f i c  
serum e l e c t r o l y t e s ,  m e tabo l i tes  and enzymes which in  concert  are known to  be 
i n d i c a t i v e  o f  c e r t a in  pa tho log ic  c ond i t ion s  (L a tn e r ,  1975). The measurement 
o f  serum enzymes are p a r t i c u l a r l y  he lp fu l  in  the d iagnos is  o f  d isease.
Enzymes presen t in  the plasma or  serum do not f u n c t io n  as such in the blood.
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Rather they represent an "overflow" from their tissue of origin. They are 
removed from the blood-stream partly by direct excretion and partly, similar 
to other plasma proteins, by metabolic degradation. "Overflow" can be 
increased by disease (cell damage, increased membrane permeability) or 
sometimes by an excessive tissue enzyme induction. The diagnostic specificity 
of a change in the level of activity of a serum enzyme is inversely related 
to i ts  normal tissue distribution. In other words, those enzymes which 
reflect highly specialised activities of a single or very few organs have 
the greatest diagnostic value, such as for example "prostatic" acid 
phosphatase. On the other hand, those enzymes which perform important 
functions in intermediary metabolism in general and are, therefore, 
necessarily in practically all cells have somewhat less significance with 
respect to localization of disease in a specific organ, e.g. lactate 
dehydrogenase. In these instances however the total serum constituents in 
conjunction with the serum enzymes provide the crit ical clues for diagnosis.
By the measurement of serum constituents therefore, the physiological 
integrity of the tumour carrying host may be determined. In particular i t  
appears possible to endeavour to determine whether any pathologic changes have 
occurred during the f i r s t  week of tumour-bearing i .e .  at the time when host 
tissue enzyme levels have already begun to become "immature" (see chapter 
3). Insight into the host-tumour relationship may therefore be obtained.
It is this proposition which is the substance point of this chapter.
8.2 Results
8.2.1 Prefatory Statement
The results presented in this chapter were obtained by the use of a high 
speed, computer controlled biochemical analyser (see section 2.20) which
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was calibrated for the analysis of human serum. Consequently, two sources 
of possible error may prevail in the following determinations. Firstly 
serum albumin concentrations were determined by the use of a dye-binding 
(bromocresol green) technique. This method is known to bind to albumin 
obtained from different species in differing amounts. The amount of colour 
and hence the apparent concentration of albumin would therefore appear to be 
different in one species when compared with another, even if  the same 
concentration of albumin was present. As a method used to determine serum 
albumin was calibrated for human albumin, the values presented in Tables 
17-20 may not be the absolute concentrations of rat serum albumin. However, 
the values will be relative and should allow the comparison of albumin levels 
present in the serum of different rats. The second source of error concerns 
the serum enzymes. The parameter measured was the prevailing activity of 
each enzyme. The conditions for enzyme activity assay were however maximised 
for the measurement of human enzymes and may not necessarily allow the 
measurement of the maximum activity of rat enzymes. Thus, the levels of 
activity for each enzyme presented in Tables 17-20 may not represent the 
maximum catalytic capacity. However, the comparison of relative rates of 
enzyme activity should suffice for diagnostic purposes.
The clinical significance of results presented in this chapter was evaluated 
by reference to standard texts of clinical biochemistry (e.g. Latner, 1975), 
pathology (e.g. Robbins, 1974) or endocrinology (Williams, 1974). For this 
reason specific references were only cited when information was obtained 
from sources other than these.
8.2.2 Selected Serum Constituents of Adult and Neonatal Rats
The data presented in Table 17 show the concentrations of selected constituents
TABLE 17: Concentrations o f E lectro ly tes and Metabolites and A c t iv i t ie s  of
Selected Enzymes in the Serum of Adult and Neonatal Rats
Well fed adult (10-12 week) and unweaned neonatal (18 & 20, day pooled l i t t e r s )  
male ra ts  were bled and concentrations of serum e lec tro ly tes  metabolites and 
a c t iv i t ie s  o f serum enzymes determined as detailed in section 2.20. Results 
are shown as ind iv idua l values or as the mean + S.D. of f iv e  separate 
animals.
A. Concentrations o f Serum E lectro ly tes
ELECTROLYTE ____________SERUM CONCENTRATION*___________
Adult ________Neonatal______
18 day 20 day
Sodium ^  141.6 
Potassium ^  7.7 
Chloride ^  101.8 
Calcium a  ^ 2.44 
Iron ^  32.4 
Inorganic phosphate v ‘ 2.15
B. A c t iv i t ie s  o f Serum Enzymes 
ENZYME




+ 3.4 138 134
+ 0.3 7.2 7.4
+ 2.6 - 102
+ 0.14 - 2.49
+ 4.4 13.8 12.1
+ 0.18 3.21 3.10
_______ENZYME ACTIVITY ^ _______
Adult _____Neonatal_____
18 day 20 day
319 + 38 600 539
173 + 30 330 314
94 + 10 50 52
672 + 93 1677 1315
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C. Concentrations of Serum Metabol ites
METABOLITE SERUM CQNCfNTRATIQN*
Adul t Neonatal
* 18 day 20 day
Albumin ^ 59.4 + 7.4 60 54
Urate ^ 0.074 + 0.005 0.27 0.15
Urea ^ 7.8 + 1.2 6.9 7.0
Creatinine ^ 0.042 + 0.004 0.06 0.03
Glucose ' a^ 6.74 + 0.76 7.5 8.0
Cholesterol ^ 1.69 + 0.18 5.64 4.67
T r i g l y c e r i d e ^ 0.95 + 0.41 6.39 9.85
Total CO2 ^ 27.6 + 1.0 _ 22
Total protein ^ 66.4 + 3.7 39 44






present in the serum of adult and neonatal rats. The results obtained for 
adult serum are similar to those reported by other workers (Krebs, 1950;
Long, 1971). Several differences in constituent levels were observed 
between adult and neonatal serum. However the neonatal animals were not 
weaned. Moreover, maternal rat milk contains high levels of fat and protein, 
while carbohydrate levels are low (Brody, 1964). Therefore a number of the 
differences obtained between neonatal and adult serum can be explained by 
the neonatal high fat and protein diet. In the normal animal, serum 
triglyceride and cholesterol levels vary directly with dietary fat and 
inversely with dietary carbohydrate. Thus the high fat and low carbohydrate 
diet of the neonatal rats can be accepted to have caused the observed high 
serum levels of both triglyceride and cholesterol. The high protein content 
of rat milk was also reflected by high serum urate levels in the neonatal 
animals.
During pregnancy and the postnatal lactation period the requirement for 
dietary iron by the maternal female is greatly increased over normal levels. 
Usually the diet must be supplemented with iron to prevent anaemia which 
was not done for the maternal females used in these studies. The low serum 
iron levels of the neonatal rats were therefore most likely a reflection of 
low dietary iron due to the low iron levels in the maternal milk.
Some of the observed changes however, can not be attributed to differences in 
diet. The higher levels of inorganic phosphate in conjunction with high 
alkaline phosphatase activity are indicative of higher rates of bone growth 
while increased glutamate-aspartate transaminase (AST also called SGOT) and 
lactate dehydrogenase (LDH) activities reflect a general higher rate of 
growth overall.
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8.2.3 Selected Serum Consti tuents of Tumour-Bearing Rats 
The concentrations of e lec t ro ly tes ,  metabol ites and enzyme a c t i v i t i e s  were 
determined in the serum of tumour-bearing rats at d i f fe re n t  times a f te r  
tumour implantation. The resul ts  are shown in Tables 18-20.
One week a f te r  tumour implantat ion the R3230AC-bearing rats exhibited 
increases in inorganic phosphate (30%) and urate (70%) levels as well as 
30% decrease in glutamate-aspartate (AST also cal led GOT) and glutamate- 
alanine (ALT also cal led GPT) transaminase a c t i v i t y  (Table 18). The 7777- 
bearing rats exhibited a 40-50% increase in serum a lka l ine phosphatase 
a c t i v i t y  as th e i r  only abnormality (Table 19). The 51230-bearing rats 
possessed increases in inorganic phosphate (30%) and creatin ine (50%) levels 
as well as an 80-100% increase in a lka l ine phosphatase a c t i v i t y  (Table 20). 
The increased inorganic phosphate (R3230AC & 5123C) and creatin ine (5123C) 
levels may be the early  signs of  impaired kidney function. The source of 
the increased a lka l ine phosphatase a c t i v i t y  in the hepatoma-bearing animals 
may be due to mild hyperparathyroidism, secondary to the renal impairment, 
but may also possibly be of l i v e r  o r ig in .
At a la te r  stage of tumour development, when the tumour weight had increased 
to 20-30g (Tables 18-20), the serum levels of most of the e lec t ro ly tes  
remained normal. However, calcium and cholesterol levels were increased in 
some animals (R3230AC & 7777). Glucose levels were also normal (R3230AC & 
5123C) or were decreased by 20-30% (7777). Urate levels were only elevated 
in the R3230AC-bearing ra ts .  Tr ig lycer ide  levels were elevated 10-50% in 
R3230AC bearing rats and 2-8 fo ld  in hepatoma-bearing animals. However, the 
R3230AC-bearing animals also exhibited marked increases in AST (2-3 fo ld ) ,  
ALT (5-6 fo ld )  and LDH (2 fo ld )  as well as a 30-40% increase in a lka l ine
Activities of Selected Enzymes in the Serum of Rats during the 
Time-course of Bearing Mammary Carcinoma R3230AC
TABLE 18: Changes in Concentrations of Electrolytes and Metabolites and
The R3230AC mammary carcinoma was implanted into the hindleg of 10-12 week 
old Fischer rats as detailed in section 2.2. Tumour-bearing animals were 
bled on the days after transplantation indicated. The results of day 0 
are the means + S.D. of five separate animals and were taken from table 
17. All other results are those of individual estimations. Determinations 
of serum electrolytes, metabolites and enzyme activity were performed as 
detailed in section 2.20.
A. Changes in Serum Electrolytes (e)
ELECTROLYTE SERUM CONCENTRATION AFTER TUMOUR IMPLANTATION *
Day 0 Day 6 Day 9 Day 35
Sodium ^ 142 + 3 140, 141 136, 141 141, 140
P o t a s s i u m ^ 7.7 + 0.3 7.2, 7.8 COr'-CO 8.8, 6.8
C h l o r i d e ^ 102 + 3 _ 99, 99 100, 103
C a l c i u m ^ 2.44 + 0.14 2.25, 2.34 2.29, 2.40 2.79, 2.58
Iron 32.4 + 4.4 31.5, 33.0 24.1, 26.5 24.2, 8.8
Inorganic / x 
phosphate ' '
2.15 + 0.18 2.70, 2.91 2.76, 2.88 2.80, 2.93
(6)B. Changes in Serum Enzyme Activity
ENZYME ENZYME ACTIVITY AFTER TUMOUR IMPLANTATION ^
Day 0 Day 6 Day 9 Day 35
A1 kaline 
Phosphatase 319 + 38 294, 282 225, 207 459, 423
Glutamate-aspartate
Transaminase
173 + 30 117, 111 190, 174 468, 331
Glutamate-alanine 
Transaminase 94 + 10 60, 63 117, 88 576, 281
Lactate
Dehydrogenase 672 + 93 792, 663 990, 1210 1179, 1648
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(e)C. Changes in Serum Metabol ites '
METABOLITE SERUM CONCENTRATION AFTER TUMOUR IMPLANTATION*
Day 0 Day 6 Day 9 Day 35
A1bumin ^ 59 + 7 63, 69 52, 56 47, 60
Urate a^ 0.07 + 0.01 0.12 0.10, 0.09 0.10, 0.10
Urea ^ 7.8 + 1.2 9.3, 9.3 7.9, 8.4 8.6, 8.1
C r e a t i n i n e ^ 0.04 + 0.01 0.03, 0.06 0.06, 0.06 0.06, 0.07
G lu c o s e ^ 6.74 + 0.08 6.9 7.1, 7.1 6.7, 7.2
C h o ie s te r o l ^ 1.96 + 0.18 — 1.52, 1.58 2.17, 3.11
T r i g l y c e r i d e ^ 0.95 + 0.41 0.99, 1.68 1.54, 1.53 1.33, 11.19
Total C o / a) 27.6 + 1.0 30, 27 26, 29 26, 25
Total p r o t e i n ^ 66.4 + 3.7 60, 66 61, 66 60, 58
Total b i l i r u b i n ^ ) 1.8 + 0.4 <3, <3 3, 3 2, 2
* (a) mmol/1.
(b) jjmol/1.
(c) In ternat ional  Units/1.
(d) g /1 .
(e) Tumour weights carr ied by the animals on day 6, 
9 and 35 were 1, 1-2 & 20-30g respective ly .
Day 35 animals were not cachectic.
TABLE 19: Changes in Concentrations of E lectro ly tes and Metabolites and
A c t iv i t ie s  of Selected Enzymes in the Serum of Rats during the Time-course
of bearing Hepatoma 7777
The 7777 hepatoma was implanted in to the hindlegs of 10-12 week old 
Buffalo rats as deta iled in section 2.2. Tumour-bearing animals were 
bled on the days a f te r  implantation indicated and the serum constituents 
determined as deta iled in section 2.20. The resu lts  o f day 0 are the 
means + S.D. of f iv e  separate animals and were taken from Table 17. A ll 
other resu lts  are those of ind iv idua l estimations.
A. Changes in Serum E lectro ly tes (e)
ELECTROLYTE SERUM CONCENTRATION AFTER TUMOUR IMPLANTATION*
Day 0 Day 7 Day 24 Day 50
Sodium ^ 142 + 3 140, 141 141, 138 144, 144
P otass ium ^ 7.7 + 0.3 8.4, 6.9 7.6, 7.0 6.7, 6.0
C h lo r id e ^ 102 + 3 103, 100 102, 100 103, 102







32.4 + 4.4 34.8, 37.2 30.9, 23.1 22.0', 22.5
Inorganic/ v 
phosphate^3'
2.15 + 0.18 2.65, 2.22 2.91, 2.96 2.92, 2.96
( e )
B. Changes in Serum Enzyme A c t iv i ty  v
ENZYME ENZYME ACTIVITY AFTER TUMOUR IMPLANTATION ^
Day 0 Day 7 Day 24 Day 50
A1kal ine 
Phosphatase 319 + 38 468, 465 332, 301 232, 204
G1utamate-aspartate 
Transaminase 173 + 30 190, 192 1617, 1044 1680, 1480
Glutamate-alanine
Transaminase 94 + 10 78, 69 1824, >3000 3030, 2620
Lactate
Dehydrogenase 672 + 93 615, 700 789, 1140 880, 1090
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C. Changes in Serum Metabol i t es (e)
METABOLITE SERUM CONCENTRATION AFTER TUMOUR IMPLANTATION*
Day 0
A1 b u m i n ^ 59 + 7
U r a t e ^ 0 . 07 + a.,01
U r e a ^ 7 .8 + l .,2
C r e a t i n i n e ^ 0 . 04 + 0 .,01
G 1 u c o s e ^ 6. 74 + 0 .,08
C h o l e s t e r o l ^ 1 . 96 + 0 .,18
T r i g l y c e r i d e ^  
Total  C02 ^
0 . 95 + 0 .,41
27 .6 + 1 .,0
Total P r o t e i n ^ 66 .4 + 3.,7
Total b i l i r u b i n ^ 1 .8 + 0 . 4
Day 7 Day 24 Day 50
54, 52 75, 72 75
0.12,  0.06 0.10,  0.08 0.07,  0.07
7 .5 ,  7.8 10.4,  7.5 9 .4 ,  9.4
.03,  .05 .05,  .05 .05,  .05
5 .5 ,  7.0 6 .4 ,  6.7 4 .5 ,  5.0
1.86,  1.68 2.61,  2.69 3.61,  3.55
1.25,  1.22 0.74,  0.58 1.66,  2.03
27, 28 25, 25 23, 23
67, 64 71, 73 76, 75
3, 2 4,  2 5, 6
* (a) mmol/ I .
(b) jumol/1.
(c) In t e r n a t i on a l  Uni t s /1 .
(d) g/1.
(e) Tumour weights c a r r i e d  by the animals on days 7, 
24 and 50 were <1,  10-15 and 20-30g r e s p e c t iv e ly .  
Day 50 animals were not  c achec t i c .
TABLE 20: Changes in Concentration of Electrolytes and Metabolites and
Activi t ies  of Selected Enzymes in the Serum of ra ts  during the Time-Course
of bearing Hepatoma 5123C
The 5123C hepatoma was implanted into the hindlegs of 10-12 week old 
Buffalo ra ts  as detailed in section 2.2. Tumour-bearing animals were 
bled on the days a f te r  implantation indicated and the serum consti tuents 
determined as deta iled in section 2.20. The resu l ts  of day 0 are means + 
S.D. of five separate animals and were taken from Table 17. All other 
resu l ts  are those of individual estimations.
A. Changes in Serum Electrolytes (e)
ELECTROLYTE SERUM CONCENTRATION AFTER TUMOUR IMPLANTATION*
Day 0 Day 5 Day 42 Day 70
Sodium^ 142 + 3 141, 142 140, 145 145, 148
P o tass ium ^ 7.7 + 0.3 8.7, 8.6 7.0, 7.3 8.0, 10.5
C h l o r id e ^ 102 + 3 _ 110, 108 115, 115
Cal c iun/a ^ 2.44 + 0.14 _ 2.42, 2.66 2.99, 2.54
I r o n ^ 32.4 + 4.4 38.7, 33.3 30.5, 20.8 31.1, 35.1
Inorganic/ x 
phosphate^9 '
2.15 + 0.18 2.88, 2.91 2.56, 2.30 7.44, 8.97
B. Changes in Enzyme Activity (e)
ENZYME SERUM ENZYME ACTIVITY AFTER TUMOUR IMPLANTATION
Day 0 Day 6 Day 42 Day 70
A1kaline 
Phosphatase 319 + 38 573, 620 264, 309 430, 561
Glutamate-aspartate
Transaminase 173 + 30 123, 147 >6000, >6000 4450, 1842
Glutamate-alanine 
Transaminase 94 + 10 87, 78 2630, 5490 1635, 1777
Lactate
Dehydrogenase 672 + 93 528, 654 2030, 3890 2640, 1209
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C. Changes in Serum Metabolites (e)
METABOLITE SERUM CONCENTRATION AFTER TUMOUR IMPLANTATION*
Day 0 Day 6 Day 42 Day' 70
A1 b u m in ^ 59 + 7 63, 60 54, 54 47, 46
U r a t e ^ 0.07 + 0.01 0.08 0.08, 0.06 0.07, 0.08
U r e a ^ 7.8 + 1.2 8.7, 9.6 16.3, 9.3 111.9, 197
C r e a t i n i n e ^ 0.04 + 0.01 0.06, 0.06 0.05, 0.06 0.24, 0.34
G lu c o s e ^ 6.74 + 0.08 7.0 7.3, 8.0 7.6, 6.0
C h o ie s te r o l ^ 1.96 + 0.18 _ 2.27, 2.01 2.39, 2.91
T r i g l y c e r i d e ^ 0.95 + 0.41 1.62, 1.38 7.20, 4.18 0.74, 0.98
Total C02^ 27.6 + 1.0 26, 27 22, 24 7,5
Total Protein 66.4 + 3.7 60, 63 47, 58 48, 49
Total b i l i r u b i n ^ 1.8 + 0.4 <3, <3 13, 7 10, 11
* (a) mmol/l.
(b) jumol/1.
(c) Internat ional  Units/1.
(d) g /1 .
(e) Tumour weights carr ied by the animals on days 6,
42 and 70 were <1, 20-30 & >45g respective ly . Day 
70 animals were extremely emaciated and cachectic.
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phosphatase a c t i v i t y  suggesting l i v e r  damage. These animals also possessed 
increased creat in ine (50-70%) and inorganic phosphate (20%) as well as 
decreased CO2 (10%) levels which may also indicate impaired kidney function. 
Moreover, the hepatoma-bearing animals possessed dramatic increases of AST 
(8-10 fo ld ,  7777; >35 fo ld ,  5123C), ALT (20-50 fo ld )  and LDH (30-60%, 7777;
4-6 fo ld ,  5123C) a c t i v i t i e s  as well as 3-6 fo ld  increases in b i l i r u b in  levels. 
These symptoms are most ind ica t ive  of hepatocel lular jaundice. Furthermore, 
these animals also exhibited increased levels of inorganic phosphate (30-35%), 
creat in ine (25-50%) and urea (10-20%, 7777; 2 fo ld ,  5123C) which in 
conjunction with decreased CO2 (20%) levels indicates mild renal fa i lu re .
At an advanced stage of  tumour growth therefore, when the animals s t i l l  appear 
v isua l ly  to be "normal", several impaired physiological functions were 
already most apparent.
The most pronounced changes were observed in the "day 70" 51230-bearing 
animals (Table 20). These animals were carrying massive tumours (>45g) 
and were in the terminal stage of tumour-bearing. They were emaciated and 
cachectic and were judged not have l ived fo r  more than another 2-4 days. In 
these animals calcium and chloride concentrations were s l i g h t l y  elevated 
(10-20%) and a decrease (10-30%) in serum iron was observed. Albumin levels 
were decreased by 20%, to ta l  protein by 30% and cholesterol levels increased 
by 20-50%. Tr ig lycer ide levels which were elevated 4-5 fo ld  on day 42 had 
returned to normal. However, massive increases in serum AST (10-25 fo ld ) ,
ALT (8-9 fo ld )  and LDH (2-4 fo ld )  and b i l i r u b in  levels (5-6 fo ld )  indicated 
chronic hepatocel lular jaundice. Moreover massive increases in the levels 
of inorganic phosphate (4 fo ld ) ,  creat in ine (6-8 fo ld ) ,  urea (14-25 fo ld )  in 
conjunction with very low C02 (20-25% of normal) leve ls ,  increased alka l ine 
phosphatase (35-70%) a c t i v i t y  and mild hyperkalaemia exhibited the classic
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symptoms of renal failure. The high phosphate levels which are usually 
associated with renal failure,  normally induce a state of hypocalcemia. In 
the 5123C tumour-bearing rat at day 70 however, serum calcium levels were 
slightly increased. Thus i t  is possible that secondary hyperparathyroidism 
was also present. I t  appears therefore that the hepatoma induced hepato­
cellular jaundice as well as renal failure. Both of these diseases are often 
lethal and may therefore be considered to be most likely causes of the 
death of these animals.
8.3 Discussion
The results presented in Tables 18-20 clearly demonstrate that no serious 
gross pathological changes had occurred in the tumour-bearing rat one week 
after the implantation of any of the tumours (R3230AC, 7777 or 5123C). The 
changes in the activity of enzymes toward foetal levels during the early 
stages of tumour-growth therefore (see Chapter 3, Figs. 3-7 & 9) could not 
have been caused by gross physiological changes (as judged by the analysis 
of conventional serum parameters), since none were found. These results and 
this conclusion supports the conclusion of Chapter 4 which proposed that the 
"immature" enzyme profiles of host tissues were not due to pathologic 
conditions associated with tumour-bearing, but rather to the presence of a 
neoplasm pe/i -de.
At an advanced stage of tumour development however, several pathological 
conditions were most evident. This occurred even though the physical 
appearance of these animals seemed normal. The mammary carcinoma-bearing 
rats exhibited serum abnormalities indicative of liver damage and impaired 
renal function (Table 18). The hepatoma-bearing animals exhibited renal 
failure as well as abnormalities pathognomic of hepatocellular jaundice 
(Table 19 & 20). However, serum cholesterol levels were also elevated in
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these animals which is  more consistent w ith a diagnosis of obstructive 
jaundice. This type of jaundice is  usually associated with hyperb il irub - 
inaemia and hypercholesterolaemia without attendent increases in the leve ls 
of AST, ALT or LDH. However, these enzymes only remain at normal levels 
in the serum during the early stages of th is  disease. Before long, a 
variable degree of hepatocellu lar damage occurs due to increased in traducta l 
pressure (due to the b i l ia r y  obstruction) and consequently the leve ls of 
serum AST, ALT and LDH also increase. I t  is  possible therefore tha t the 
o r ig in  o f the observed jaundice was obstruct ive , but la te r  also acquired 
abnormalities of the hepatocellu lar type. However, an important feature of 
obstructive jaundice is  tha t high concentrations of b i le  sa lts  also accumulate 
in the blood. This produces itch ing  in most human patients with th is  
disease. The tumour-bearing animals however, did not e xh ib it  th is  symptom 
as no excessive scratching or i r r i t a t i o n  was observed. Thus the jaundice 
in these animals did not simply exh ib it  symptoms of e ither uncomplicated 
b i l ia r y  obstruction or hepatocellu lar o r ig in  but a mixture of both. There­
fore the exact nature of the jaundice in these animals could not be de ter­
mined.
From the data presented here i t  was not possible to determine whether the 
jaundice or the renal impairment had occurred f i r s t .  Moreover, i t  is  well 
known tha t under certa in circumstances hepatic damage can induce renal 
fa i lu re  and vu.ce ve/L6c. Of course both hepatic and renal damage may have 
occurred due to the same stimulus and at about the same time. In sp ite  of 
the above uncerta in ties i t  is  c lear tha t the most l i k e ly  cause of death was 
hepato-renal fa i lu re  caused by tumour-bearing.
The next obvious question to emerge from the above observation is  how the
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tumours produce such disease. L iver necrosis can not be the answer because 
the observed normal (7777, R3230AC) or increased (5123C) levels o f serum 
urea are inconsistent w ith th is  diagnosis. I t  is  also common experience 
tha t focal lesions no matter how numerous, ra re ly  destroy s u f f ic ie n t  hepatic 
parenchyma to delete the functional reserves of th is  organ (see Robbins,
1974, p992). This is  exemplified by the fac t tha t experimental animals can 
survive hepatectomy of 80-90% of the mass of the l i v e r  without obvious signs 
of l i v e r  fa i lu re .  Metastases from the tumour in to  the l iv e r  may also be a 
cause. However, cancerous metastases throughout the l i v e r ,  sometimes 
increasing the weight of th is  organ 2-3 fo ld ,  are not uncommon in patients 
with no evidence o f hepatic fa i lu re  (see Robbins, 1974, p992). I t  is 
u n l ike ly  therefore that metastasis caused the observed hepatic disturbances.
The presence of hepato-renal fa i lu re  in these animals is  s t r ik in g ly  s im ila r 
to the abnormalities observed in human patients su ffering  the e ffec ts  of 
poisoning by tox ic  agents such as carbon te trach lo r ide  or heavy metals 
(see Williams, 1974; p993). The production o f a "toxohormone" by the tumour 
(Nakahara & Fukuoka, 1958; Costa, 1963; 1977) can therefore not be discounted 
by these re su lts . I t  is  also of note tha t patients with pathological 
neonatal jaundice also occasionally exh ib it  serum abnormalities s im ila r  to 
those observed in the hepatoma bearing rats described here. This can occur 
even i f  the jaundice is  not due to congenital a tresia of the b i le  ducts, but 
due to disturbed hepatocellu lar function with respect to dig!ucuronide 
formation and/or b i l i r u b in  excretion. The jaundice in th is  case is  due to 
"immaturity" of the l i v e r  and i t s  manifestion is  due to the defic iency of 
key "adu lt-type" enzymes concerned with b i l i r u b in  excretion (glucuronyl 
transferase and ur id ine diphosphate glucose dehydrogenase). In apparent 
disagreement o f th is  in te rp re ta t io n  is the fa c t  tha t serum levels o f AST, ALT
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and LDH, which were shown to be elevated in tumour-bearing animals (Tables 
18-20), are not usually elevated as a consequence of neonatal jaundice (see 
Latner, 1975, p646). However, the elevation of the levels of these enzymes 
in the serum of tumour-bearing ra ts  may be due to the "immaturity" of the 
host,  as neonatal animals also possess increased levels of these enzymes 
in the serum (Table 17). Thus the proposed "de-differentia ted" s ta te  of 
host l ive r  due to the presence of a tumour in an animal is consistent  with 
neonatal jaundice. However, the proposal that  the jaundice observed in 
the hepatoma bearing animals was t ru ly  neonatal is speculative a t  th is  time 
and is merely suggested as being consistent with th is  theme.
Of course, all  of the above diagnosis may be further  complicated by the 
release of enzymes into the serum by the tumours themselves. In part icu lar  
i t  is possible that  the diagnostic " liver-type" enzyme ( i . e .  AST, ALT & LDH) 
may be released by the hepatomas. However, the R3230AC mammary carcinoma­
bearing animals also exhibited increases of these enzymes in the serum, 
a lb e i t  to a lesser  degree. Thus some, but certain ly  not all  of the observed 
increases in "l iver-type" enzyme may be due to release from the hepatomas.
To what extent th is  occurs ( i f  at  a l l )  is quanti tat ively  unclear at  this  
stage.
In summary no gross pathological changes appear to occur during the f i r s t  week 
a f te r  the implantation of the tumours studied here. However, at  an advanced 
stage of tumour growth all  animals exhibited serum abnormalities indicative 
of l ive r  and kidney damage. Furthermore, and more importantly, all  of the 
tumour-bearing animals exhibited pathognomic serum changes at  a re la t ive ly  
early stage of tumour growth (20-30g tumour). This occurred when the health 
of these animals appeared normal as judged by physical examination. I t
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is c lear therefore that extreme care must be taken in the in te rpre ta t ion  of 
resu l ts  obtained in the host t issues of tumour-bearing animals. This point 
cannot be emphasized in a too strong a manner. There are l i t e r a l l y  hundreds 
of reports in the l i t e ra tu r e  (see fo r  example, Weber eX a t . ,  1976, 1977a, 
b; Sidransky &£ a t . ,  1978; Sul oX a t . ,  1979) which apparently ignore the 
systemic (or other) effects  of the tumour on the host (and voxxa).
These studies compare resul ts  obtained in tumour t issue with those of so 
cal led "normal" host t issue, usual ly host l i v e r .  Such comparisons are 
c lea r ly  not va l id  unless the host t issue was also compared with normal 
t issue and hence proven to be "normal" fo r  the parameters measured. Further­
more, i f  comparisons of host t issues with normal t issues were not made, then 
the s c ie n t i f i c  i n te g r i t y  of such studies must be questioned.
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CHAPTER 9
GENERAL DISCUSSION AND CONCLUSIONS
9.1 The Foeta l  ism of  Host  Liver
The r e s u l t s  p r es en t e d  in  t h i s  t h e s i s  have c l e a r l y  shown t h a t  t he  a c t i v i t i e s  
of  c e r t a i n  enzymes in hos t  t i s s u e s  change as  a consequence of  t umour -bear ing .  
Moreover ,  t h e se  changes in enzyme a c t i v i t y  were always toward the  a c t i v i t y  
found in t he  f o e t a l  t i s s u e  of  o r i g i n  ( see  Chapter  3) and could not  be 
a t t r i b u t e d  to  a l t e r a t i o n s  in hormonal or  d i e t a r y  s t a t u s  t h a t  may be 
a s s o c i a t e d  wi th  t he  i m p l a n t a t i o n  of  a tumour ( s ee  Chapter  4 ) .  However,  the  
q u e s t i o n  emerges whether  or  not  t he  t endency  o f  hos t  l i v e r  t o  resemble  
immature l i v e r  as a consequence of  tumour -bear ing  i s  a r e f l e c t i o n  of  the  
t r u e  d e - d i f f e r e n t i a t e d  s t a t e  of  t h i s  t i s s u e .
The co n c l us i on  a l r e a d y  r eached  t h a t  t umours ,  p a r t i c u l a r l y  hepatomas,  a r e  
d e - d i f f e r e n t i a t e d  (Knox, 1976) was based on t h e  o b s e r v a t i on  t h a t  a l a r g e  
number o f  f o e t a l - t y p e  p r o t e i n s  such as f o e t a l  i soenzymes,  e c t o p i c  hormones 
and f o e t a l  a n t i ge n s  were p r e s e n t  in or  were a s s o c i a t e d  wi th  neoplasms ( see  
s e c t i o n  1 . 2 ) .  In g e n e r a l ,  t h e  composi t ion o f  tumours can be under s tood  to  
r e s u l t  from a s p e c i f i c  l o s s  o f  a d u l t - t y p e  components and a s p e c i f i c  ga in  of  
f o e t a l - t y p e  components.  In p a r t i c u l a r ,  a l a r g e  emphasis was placed on t he  
q u a l i t a t i v e  r ep l acemen t s  in tumours of  a d u l t - t y p e  enzymes by t hose  found in 
f o e t a l  t i s s u e s .  T h e r e f o r e ,  such q u a l i t a t i v e  r ep l acement  o f  enzymes 
demons t r a t ed  f o e t a l - t y p e  gene e x p r e s s i o n s  in n e o p l a s t i c  t i s s u e s  and hence 
p rov ide  ev idence  t h a t  d e - d i f f e r e n t i a t i o n  had occur r ed  (Knox, 1976).
The ev i dence  of  the  d e - d i f f e r e n t i a t e d  s t a t e  of  hos t  l i v e r  as a consequence 
of  t umour -bea r i ng  i s  no t  y e t  as comprehensive nor  as compel l i ng s i n c e  fewer
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studies have concerned themselves with host t issues of animals carrying 
tumours. Nevertheless, twenty developmental enzymes have now been measured 
in host l ivers  of tumour-bearing animals and all  have been shown to change 
the i r  ac t iv i ty  toward that  found in foetal l iver  (see Chapter 3). Further­
more, s t a t i s t i c a l  analysis of the data of Herzfeld & Greengard (1972) have 
shown that  i t  is highly unlikely that  the enzyme changes in host l ivers  of 
tumour-bearing ra ts  were random events. In th is  study twenty enzymes were 
chosen at  random and the ac t iv i ty  of these enzymes measured a f te r  tumour 
implantation. Of the sixteen adult-type enzymes measured in these animals,
8 s ign if ican t ly  decreased and none increased in host l ive rs .  Of the 6 
foetal- type enzymes measured, 5 s ign i f ican t ly  increased and none decreased. 
There were 9 enzymes with unchanged values in host l ive r .  A random 
d is t r ibu t ion  of the enzyme levels in foetal and host l ivers in th is  manner 
is extremely unlikely ft2=l9.61; 2d.f;  pcO.OOl). The data of Herzfeld & 
Greengard (1977); de Rosa & Pi to t  (1978); Herzfeld 2Ä  aJL ., (1978) and the 
resu l ts  presented in th is  thesis  (see Chapter 3) further  support the 
proposition that  host l ivers  of tumour-bearing ra ts  resemble immature l iver  
in enzyme prof i le  and therefore appear to be de-d ifferent ia ted .
Although the changes in enzyme ac t iv i ty  in host l ive r  are generally limited 
to quanti tat ive  decreases or increases of enzyme a c t iv i ty ,  a few qual i ta t ive  
replacements of an adult-type by a foetal- type enzyme have been demonstrated. 
For all  of the tumours examined, (and the l i s t  now includes more than 11 
tumours of varying origin and growth rates)  there was a qua l i ta t ive  replace­
ment of glucokinase (adult-type) with hexokinase (foetal- type) enzyme ac t iv i ty  
in the host l ivers  of ra ts  carrying tumours (Figs. 1 & 2; see also Herzfeld 
& Greengard, 1972, 1977; Shapot, 1974; Shapot o£  aJL ., 1976b). Furthermore, 
variants of hexokinase isoenzymes also r e f l e c t  the s im ila r i ty  of host l iver
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to hepatoma since isoenzyme I I I  is the prominent form of hexokinase in both 
host l i v e r  and hepatomas (Herzfeld & Greengard, 1972). S im i la r ly ,  in the 
foeta l  ra t  at term, the prominent isoenzyme form of pyruvate kinase in the 
l i v e r  changes from the K form ( foe ta l- type)  to the L form (adult- type) of 
th is  enzyme (Susor & Rutter, 1971; Middleton & Potter, 1972). This normal 
developmental pattern is reversed in de-d i f fe ren t ia ted  neoplasms, i . e .  the 
charac te r is t ic  L form (adult - type) is replaced by the K form ( foeta l- type) 
of th is  enzyme (see fo r  example, Shapira & Gregory, 1971; Farron at cut.,
1972; I rv ing & Will iams, 1974). Furthermore, noncancerous host l i ve rs  of 
tumour-bearing animals (Suda eX cut., 1966, 1972; Yanagi out c it., 1971; Tanaka 
&£ cut., 1972; Ibsen cut., 1975') or l i ve rs  perfused with the blood of tumour­
bearing animals (Suda at cut., 1968) were also shown to undergo a s h i f t  in 
the isoenzyme pattern of pyruvate kinase; again the a c t i v i t y  of the L iso­
enzyme form was found to be decreased and the a c t i v i t y  of the K isoenzyme 
form increased. I t  is  c lear therefore tha t  the q u a l i ta t ive  replacement of 
adult -type enzymes by foe ta l - type enzymes not only occurs in neoplastic 
t issues, but also in host l i v e r  as a consequence of  tumour-bearing and 
hence (using the c r i t e r i a  of Knox, 1976) provides concrete evidence fo r  the 
t ra ns i t ion  to a de-d i f fe ren t ia ted state of  th is  t issue.
The possible de -d i f fe ren t ia t ion  of host t issues as a consequence of tumour­
bearing is not res t r ic ted  only to the examples of enzyme changes detai led 
above. A number of studies have shown an increase of incorporation of radio- 
ac t ive ly  label led precursors in to the DMA of host tissues such as l i v e r ,  
kidney and spleen (Parsons & Warren, 1941; Kelley a t cut., 1951; Stewart & Begg, 
1953; G r i f f i n ,  1957; Rev-Kury a t cut., 1966; Barb i ro l i  at cut., 1972; Morgan 
& Cameron, 1973; Oxner at cut., 1978). Several investigators have also noted 
an increase in size or weight of host l i v e r  or spleen in tumour-bearing
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animals (Parsons & Warren, 1941; Yeakel , 1948; Kelley zX cut., 1951; Stewart 
& Begg, 1953; Tyner oX a t . ,  1953; Baserga & K is ie lesk i ,  1961; Boberg cX a t . ,  
1977). Furthermore, an increase in the m i to t ic  rate of host l i ve rs  (Malmgren, 
1956; T ro t te r ,  1961; Rosene, 1968; Theologides & Zaki , 1969) has suggested 
that the increase in size, in the host l i ve rs  of tumour-bearing animals 
is due to an increase in ce l l  p ro l i fe ra t io n .  Morover, th is  increase in 
p ro l i fe ra t io n  has now been shown to be due to an increased synthesis of 
parenchymal ce l ls  as well as l i t t o r a l  and kupffer ce l ls  (Morgan & Cameron, 
1973). The increased DNA synthesis and m i to t ic  rate therefore suggests that 
several enzymes that are involved with ce l l  rep l ica t ion  and which are highly 
act ive in normal foetal  l i v e r  may also increase in host l i v e rs .  Thus 
increased cel l  p ro l i f e ra t io n ,  a foetal cha rac te r iS t ic , provides fu r the r  
evidence of the de-d i f fe ren ta i ted  state of host l i v e r .
Foetal antigens such as carcinoembryonic antigen (CEA), °<-Foetoprotein (c<FP) 
and ^ 2"^"Globul in are often found in the serum of tumour-bearing animals 
and cancer patients (see section 1.2.2).  Although the presence of these 
foetal antigens has been c lea r ly  demonstrated in a number of neoplasms, the 
exact o r ig in  of these c i rcu la t ing  antigens i . e .  whether they are produced 
and secreted sole ly by the tumour, remains unknown (U r ie l ,  1975; Law &
Apella, 1975). Adult l i v e r  however, has been shown to produce CEA ando<FP 
during pathological conditions such as l i v e r  regeneration (de Nechaud &
U r ie l ,  1971; Sell eX a t . ,  1974) or a lcohol ic c i r rhos is  (Abelev, 1971; Hirai 
qX  a t . ,  1972). I t  has also been demonstrated that ^FP concentrations increase 
s ig n i f i c a n t l y  during the very early  stages of experimental hepatocarcino- 
genesis, well before the appearance of malignant ce l ls  became evident (Hirai & 
A lper t ,  1975). Furthermore, adult  l i v e r  has been proposed to de-d i f fe ren t ia te  
in response to such l i v e r  damage (U r ie l ,  1975). Given the correct stimulus
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therefore, adult liver has the capability to de-differentiate and produce 
foetal antigens. The presence of foetal antigens in host tissues would thus 
provide evidence for de-differentiation as a consequence of tumour-bearing. 
This indeed appears to be the case since o^H-globulin was detected not only 
in hepatomas but also in cell extracts prepared from livers of patients with 
tumours, regardless of their histologic type or location (Buffe it at., 1968, 
1970). The production of foetal antigens by host liver as consequence of 
tumour-bearing therefore, provides further evidence of the de-differentiated 
state of this tissue.
Recent work has also demonstrated that enzyme changes toward values 
characteristic of foetal liver occur in the host livers of human cancer 
patients. The major isoenzyme form of pyruvate kinase in adult human liver 
is PK-L (Hammond & Balinsky, 1978), in "immature" tissues however, such as 
human tumours (Hammond & Balinsky, 1978), rat hepatomas (Criss, 1971; Schapira, 
1973) or foetal and regenerating rat liver (Tanaka it at., 1967; Walker 
& Potter, 1972) the major form of this enzyme is PK-M2 and PK-L is absent. 
Moreover, in some hepatoma-bearing patients the only isoenzyme form of 
pyruvate kinase that was found in the "uninvolved" liver was PK-M2 (Hammond 
& Balinksy, 1978). Similarly, the major isoenzyme form of hexokinase in 
human foetal liver is HK-11 f (Benson & de Jong, 1968) which was also found to 
be increased preferentially in both human hepatomas and in the host livers 
of these patients (Hammond & Balinsky, 1978). These changes toward foetal 
isoenzyme forms therefore are consistent with the view that host tissues 
of tumour-bearing animals are in a de-differentiated state. Furthermore, 
the fact that this also occurred in human patients with hepatomas supports 
the view that host tissue de-differentiation may occur in a number of 
organisms as a consequence of bearing tumours.
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In summary therefore, the evidence for host liver de-differentation as a 
consequence of tumour-bearing is accumulating and the case strengthens, 
although there is insufficient evidence to make i t  conclusive. However, 
most of the foetal characteristics that were presented as concrete evidence 
for the de-differentiated state of tumours (see for example Knox, 1976; and 
section 1.2), were also present in the host liver as a consequence of tumour­
bearing. There appears to be no good reason therefore, for not accepting 
the proposal that host livers become de-differentiated in response to the 
presence of a tumour.
Evidence also exists that some enzymes in other host tissues such as kidney, 
spleen and muscle, change their activity from that present in the adult 
tissue toward that found in the foetal tissue of origin (see Chapter 3). The 
limited number of such studies however, precludes a definite conclusion at 
this time, and more investigational work needs to be done in this area. 
However, i t  is now abundantly clear that host tissues of tumour-bearing 
animals are not "normal" i.e .  they do not possess the enzymic composition 
of normal tissues, but are also often more characteristic of the immature 
tissues of origin. The possibility that other host tissues may also become 
de-differentiated in response to the presence of a tumour is therefore 
consistent with the results presented in this thesis.
Although reference was made to host liver de-differentiation (Herzfeld & 
Greengard, 1972), no attempts have been made in this study or by others to 
determine whether host liver truly de-differentiates. That is , no attempts 
have been made to determine whether mature adult liver cells reverse their 
differentiated state and therefore become immature. The apparent orderly 
reversal of the differentiated state of host liver, as reflected by the loss
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of adult-type enzymes during the early stages of tumour-bearing and their  
subsequent replacement by foetal-type enzymes at a la ter  time would support 
such a proposal (see the discussion section of Chapter 3). However, i t  is 
just  as l ike ly  that during the normal turnover of cells in the host l iv e r ,  
that "new" cells become arrested in an immature state of d i f ferent ia t ion  
and subsequently remain immature. Both of these conclusions are consistent 
with the results and the discussions presented here. Moreover, no attempts 
have been made to determine whether a l l  of the cells of the host l i v e r  are 
in a de-dif ferent iated state, or whether only a certain population of cells  
in the host l iv e r  respond to tumour-bearing in this manner. How the tumour 
produces such effects in the host have also not been investigated. Clearly,  
a great deal of work must be done to c la r i fy  this area. However, this was 
not the purpose of this thesis. The main aims here were to c r i t i c a l l y  
investigate the proposal by Herzfeld & Greengard (1972) that host l ivers  
of adult rats , in response to the implantation of a tumour, change in enzyme 
prof i le  and move away from values and enzymes character found in adult l ive r  
toward an enzyme prof i le  more characterist ic of immature 1-2 week neonatal 
l i v e r .  Such a proposal can be clearly  supported by the results of this thesis.
9.2 Current Concepts of the Mechanism of Cancer Cachexia
As was discussed in the introduction of this thesis (see section 1.4) cancer 
cachexia, at least in part,  is due to anatomical alterations that are often 
present in the cl in ical  cancer patient,  the extent and distr ibut ion of 
which can span a l l  parts of the anatomy. However, i t  has been repeatedly 
observed that the degree of cachexia bears no simple correlation to the 
tumour burden, the tumour cell type, or the anatomical site of involvement 
unless a v i ta l  organ is being impaired In  aaX ul. I t  is not this type of 
cachexia i . e .  due to the anatomically obstructive type of lesion which must
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c lea r ly  be treated ( i f  possible) by surgery, to which th is  thesis was 
addressed. Rather i t  was directed at the less obvious, c lea r ly  systemic 
(see Chapter 4) type of cachexia, which can often occur in the absence of 
any v is ib le  neoplasm. How then does the presence of a tumour produce chronic 
wasting of the host.
I t  is not reasonable to ascribe cancer cachexia simply to the nu t r i t ion a l  
demands of the tumour. This point is most easi ly  demonstrated i f  the 
metabolic requirements of tumours are compared with those of the conceptus 
during pregnancy. In both of these instances there is rapid growth, made 
possible by a supply of nutr ients  from the host. Overt cachexia can appear 
in patients with tumours which are less than 0.01% of  the to ta l  body weight 
(Nathanson & Hall ,  1974). I t  has also been reported that the to ta l  mass of 
the tumour in the majori ty of terminal cancer patients (without obstruct ion 
of a v i t a l  organ) seldom exceeded 500g (see Costa, 1977). Tumours therefore, 
are often lethal although s t i l l  being a small f rac t ion  of the to ta l  biomass 
of the host (see also Shapot, 1972; Robbins, 1974; Morrison, 1976). On the 
other hand, the mean b i r th  weight of the human foetus is 3.5Kg (Widdowson, 
1968). Cancers also never grow as rap id ly  as the foetus (see Robbins, 1974), 
yet the maternal mother does not become cachectic, on the contrary she often 
gains body weight (LIewellyn-Jones, 1971). The human body therefore, is 
able to compensate fo r ,  and support a much larger and more rap id ly  growing 
“ paras i t ic "  mass of t issue than is often fa ta l  in the case of cancer. 
S im i la r ly ,  studies with experimental animals have shown that the maternal 
organism increases the intake of food and is therefore not c a lo r ic a l l y  
depleted (Blaxter, 1957; Naismith, 1969). Paras i t izat ion of nutr ients by a 
tumour pcA therefore is  not l i k e l y  to be an important cause of cancer 
cachexia unless a spec i f ic  (as yet unknown) nu tr ien t  is being sequestered 
by the tumour.
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In th is  l i g h t ,  i t  is common experience that animals with tumours, i f  housed 
together, w i l l  eat one another's tumours, especial ly i f  the tumours have 
ulcerated (see fo r  example, Richter, 1942/43). This observation led to 
the proposal that cachexia was produced as a resu l t  of the removal by the 
tumour of spec i f ic  nu tr ien t  material which is essential fo r  the l i f e  of the 
host (Moreshi, 1909). Furthermore, the inclusion of l y o p h i l ized tumour in 
the die ts of tumour-bearing rats resulted in the improvement of appet i te, 
a resumption of food intake, and body weight gains (Mider, 1955; Haven & Bloor, 
1956; M i l l a r  oX a t . ,  1957, 1959; White z t a t . ,  1960; ToaT z t a t . , 1961).
These workers concluded therefore that tumours may have an excessive demand 
fo r  a cer ta in as yet unknown substance, thus causing a d e f i c i t  in the host 
and thereby cachexia. However, no substantial  pool of material that is 
essential to the host has been detected in malignant t issues (see also 
Theologides, 1972; Morrison, 1976). No explanation can be given therefore, 
fo r  the increase in food intake and regression of cachexia that  resul ts  from 
the ingestion of tumour t issue by tumour-bearing animals. Moreover, no 
st imulat ion of food intake occurs when normal rats ingest tumour t issue 
(M i l la r  z t  a t . ,  1957). However the regulat ion of  food intake appears altered 
in tumour-bearing animals.
Gold (1968, 1974), concluded that excessive tumour-supporting gluconeogenesis 
by the host appeared to be a v i t a l  l in k  in the cachexia process. He suggests 
that a s ig n i f ica n t  and progressive energy loss from host tissues could occur 
by v i r tue  of the establishment of a systemic energy-deplet ing-cycle, 
dependent on a in terp lay  of tumour g lyco lys is and host gluconeogenesis.
This is achieved by an increase in the a c t i v i t y  of the Cori cycle, i . e .  
the breakdown of glucose to lacta te  by a t issue such as muscle or brain (or 
in th is  case, the tumour) and the reformation of glucose from lacta te  via
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gluconeogenesis in liver and kidney cortex. Moreover, a number of tumours 
show a high rate of anaeorbic glycolysis producing large quantities of 
lactate (Gold, 1966; Shapot, 1972; Shapot & Blinov, 1974) and essentially 
all or most of the lactate that enters the blood in tumour-bearing animals 
(Hiatt, 1957) or patients (Reichard t t  a l . , 1963) is converted back to glucose. 
Tumours also possess a low rate of gluconeogenesis (Morris, 1975; Knox,
1976) and therefore this resynthesis must occur in the host tissues, more 
specifically liver or kidney cortex. Thus for each Cori cycle the tumour 
gains a net of two ATP molecules via non-oxidative glycolysis, while the 
host tissues lose six ATP molecules required for gluconeogenesis, as well 
as the provision of the two ATP molecules that could have been obtained in 
host tissues from the metabolism of the glucose. As the tumour enlarges, 
consuming ever increasing amounts of glucose, the energy resources of the 
host become increasingly depleted by the fu t i le  effort to maintain the 
normal blood glucose level (Gold, 1968, 1974).
It was also proposed that such a wastage could be prevented by blocking the 
gluconeogenic pathway at i ts  most vulnerable point i.e. at the conversion of 
oxaloacetate to phosphoenolpyruvate by phosphoenolpyruvate carboxykinase 
(Gold, 1968, 1974). Furthermore, results obtained by blocking this process 
with excess tryptophan (Gold, 1970) or with hydrazine (Gold, 1973) did show 
reduced rates of tumour growth. However, this hypothesis, as i t  stands can 
not entirely explain cancer cachexia since remarkably small primary lesions 
can produce notable cachexia (Robbins, 1974; Nathanson & Hall, 1974; Costa,
1977) . Furthermore, some Morris minimum-deviation hepatomas, although 
exhibiting low rates of glycolysis (Ainsberg & Morris, 1961, Weber eX a l . , 
1961) also produce a marked cachexia in tumour-bearing animals and therefore 
would not be expected to produce, based on the consideration of tumour mass
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only, an extensive energy-depleting " fu t i le  substrate" Cori cycle. More­
over, the proposal of Gold does not offer an explanation of why the host 
does not increase the food intake to overcome such an energy loss in the manner 
that a maternal female does to support the conceptus. An increased " fu t i le  
substrate" Cori cycle alone therefore, offers only a poor and unconvincing 
explanation of the pathogenesis of cancer cachexia.
Theologides (1972, 1974, 1976, 1977, 1978) proposes that cancers produce as 
yet unknown metabolites which a llos te r ica l ly  activate and inactivate various 
enzymes in the tissues of the host. This results in alterations in the 
metabolic patterns of the host due to changes in various metabolic equilibria . 
The cancer is therefore proposed to throw the metabolism of the host into a 
chaotic state; "biochemical reactions are activated and inactivated without 
a purpose, a need or a plan for the host". This metaoblic chaos, Theologides 
proposes, results in the release of essential metabolites by the host which 
are preferentially trapped by the tumour because the tumour is geared mainly 
for growth. Moreover, (he proposes) because the tumour is geared for growth 
i t  is less vulnerable and less affected by the small molecules i t  produces, 
(although no mechanism of why this should occur are given). Therefore, he 
suggests the tumour is able to grow while the host is wasting. In conjunction 
with the production of a llosteric  enzyme a c t iv i ty  modifiers, the tumour is 
also proposed to produce anorectic peptides, which are interpreted by the 
brain (the hypothalamus) as signalling satiety. Consequently, the intake of 
food is suppressed in tumour-bearing organisms. This suppression occurs at a 
time when there is an increased energy expenditure because of the systemic 
derangement of the hosts metabolism. Thus, Theologides proposes, a 
suppression of food intake in conjunction with metabolic "chaos" results in
cancer cachexia.
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The results presented in this thesis and those of other workers in this field 
cannot fully support the above proposal as i t  stands. The data presented in 
Chapter 3 of this thesis clearly demonstrate that the changes in activity of 
enzymes in host tissues in response to the implantation of a tumour were not 
chaotic. Rather, the enzyme changes were orderly and highly predictable 
because they were always directed toward an activity more characteristic of 
the immature tissue of origin (see also section 9.1). Moreover, the data 
presented in Chapter 5 clearly demonstrate that the activity of at least 
one host tissue enzyme (ornithine aminotransferase) was not altered 
allosterical ly  in host livers or host kidneys. I t  was the synthesis of 
this enzyme that was altered as a consequence of tumour implantation. No 
allosteric modification of activity of host tissue enzymes of the type 
described in this thesis, could therefore be demonstrated (or have been 
reported in the l i terature) .  The qualitative replacements of adult-type 
isoenzyme forms by foetal-type isoenzyme forms in host tissues (see section 
9.1) is also clearly contrary to the allosterically  induced "chaos" of 
Theologides. Moreover, the proposal that tumours escape the effects of 
the metabolites that they (are proposed to) produce due to their immature, 
rapidly growing nature is unlikely. This is because the metabolism of 
tumours and host tissues such as the liver may in fact be similar ( i .e.  
"immature") in a number of instances(see section 9.1). The metabolic 
"chaos" of the tumour-bearing host can therefore not be substantiated. 
Furthermore, the primary mechanism of cancer cachexia proposed by 
Theologides, is anorexia. He claims that this is caused by the production 
by the tumour of anorectic peptides which are interpreted by the ventro­
medial hypothalamus as signalling satiety, and hence the food intake is 
decreased in tumour-bearing organisms. Other workers have also suggested 
that tumours directly or indirectly produce as yet unknown substances which
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reduce food intake in the same manner (Liebelt z t  a t . ,  1971; Nathanson & 
Hall,  1974). To date however no such substances have been ident i f ied .  
Moreover, i f  th is  were the case, then i t  should be possible to block such 
an effect  by destroying the central loci that  respond to sa t ie ty  signals. 
However, destruction of the ventro-medial hypothalamus, a procedure which 
blocks some of the normal sa t ie ty  signals ,  does not prevent the cachectic 
hypophagia of tumour-bearing animals (Bail l ie  z t  a t . ,  1965; Liebelt z t  cut., 
1971). However, i t  must be pointed out tha t  the mechanisms of the regulation 
of food intake and sa t ie ty  are not c learly  understood (for a review see 
Novin z t  a t . ,  1976) and may not be en t i re ly  regulated by the ventro-medial 
hypothalamus (Rogers & Leung, 1973; Booth z t  a t . , 1976; Harper, 1976). The 
poss ib i l i ty  tha t  tumours produce substances or cause substances to be 
produced by the host that  are interpreted as signalling sa t ie ty  can therefore 
not be discounted. Moreover, the decline of voluntary food intake is a 
major immediate cause of cachectic wasting of the host during growth of the 
tumour (Costa, 1963; De Wys, 1970, 1977; Morrison, 1973, 1976; Brennan, 1977). 
The question emerges therefore , why the tumour-bearing host decreases the 
food intake a t  a time when the metabolic demands on the host have been 
increased ( i . e .  normal body weight plus the weight of the tumour).
Stein (1978) explains th is  enigma in the following way. He proposes that  
the host-plus-tumour requires more nutrients  than the host alone. Moreover, 
during the early stages of tumour growth the host is unaware of th is  
increased demand and therefore the nutr i t ional  input is not increased. 
Eventually a competition for metabolites develops between the tumour and the 
host,  with the tumours needs being met p re fe ren t ia l ly ,  pa r t icu la r ly  with 
respect to certain  (unknown) amino-acids. This resu l ts  in an amino acid- 
imbalance ( i . e .  a d e f ic i t  of some amino acids) ,  which then causes the well-
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known tumour-associated anorexia. Moreover, Stein then proposed tha t the 
removal of one or more amino acids from the hosts amino acid pool by the tumour 
leaves the host w ith the problem o f disposing o f the remainder of the amino 
acids. This occurs because normal protein synthesis requires a f u l l  
complement of amino acids, and even i f  one amino acid is  missing then the 
rate of protein synthesis is  depressed. Therefore, as the body has no means 
o f sorting amino acids i t  must dispose of a l l  of the excess amino acids.
Hence the host exh ib its  the well known negative nitrogen balance. Stein then 
prosposes that the regulatory processes of the cachectic cancer patient with 
progressive weight loss are d is to rted  to favour gluconeogenesis. This is  
due to l ip id  m obiliza tion in the tumour-bearing host which increases the 
levels o f acetyl CoA. Increased acetyl CoA levels then, in tu rn , in h ib i t  
the pyruvate dehydrogenase complex and thus block the oxidation of amino 
acids to CO2 and hence th e i r  removal from the host. Therefore, he proposes, 
the amino acids are converted to carbohydrate and are not oxidised to CO2 .
Thus, as the removal of amino acids via gluconeogenesis is  an energy 
requiring process, whereas the oxidation o f amino acids to CO2 would produce 
energy, the host becomes energy d e f ic ie n t.  As a re s u lt ,  Stein proposes that 
the host is  in an energy-depleting negative nitrogen balance, cannot increase 
his food intake and hence becomes cachectic.
The above hypothesis as i t  stands, cannot adequately explain the mechanism 
of cancer cachexia. Again, as was pointed out e a r l ie r ,  i t  must be 
remembered tha t overt cachexia can occur in patients with remarkably small 
tumours (Robbins, 1974; Nathanson & H a ll,  1974; Costa, 1977). I t  is un like ly  
therefore tha t a chronic amino acid-imbalance could re su lt  form the demands 
of such small neoplasms peA A substantial excess u t i l i z a t io n  of an amino 
acid by a tumour has also not been demonstrated. Furthermore, normal animals
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can easily adapt to an amino acid imbalance by increasing the activity of 
amino acid-catabolizing enzymes and food intake subsequently returns to 
normal (for reviews on this subject see Harper qX at., 1979; Harper, 1976). 
Stein gives no explanation as to why such a compensatory mechanism should 
not occur in cancer patients. However, an amino acid-imbalance in the blood 
of tumour-bearing animals may well be the cause of cancer cachexia and 
anorexia.
Food intake by animals has been shown to be depressed as a result of feeding 
amino acid-imbalanced diets, high protein diets (Anderson oX at,, 1968), 
amino acid-deficient diets (Frazier eX at., 1947) or diets containing an 
excess of a single amino acid (Harper eX at., 1970). The common feature 
of all of these experiments was that at least one amino acid was found to be 
in excess in the plasma of the anorectic animals. This observation led to 
the porposal that food intake is regulated by plasma amino acid levels 
(Rogers & Leung, 1973; Harper, 1976) and that the excess of only one amino 
acid in the blood is sufficient to cause a rapid depression of food intake 
and a progressive loss of body weight (Harper, 1976). Furthermore, this 
regulatory mechanism is in the prepyriform cortex and not the ventro-medial 
hypotholamus (Rogers & Leung, 1973; Harper, 1976). These observations and 
the data presented in this thesis have led to a new hypothesis which may 
explain the pathogenesis of cancer cachexia.
Clinical lore describes a dislike by cancer patients for the taste of high- 
protein foods, particularly meat (De Wys, 1970, 1974). A relationship has 
also been reported between the extent of cancer cachexia and the patients 
sense of blandness or tastlessness of food in general, involving hypergeusia 
to bitter (characteristic of protein metabolites) and a hypogeusia to sweet
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(De Wys, 1977). A taste preference fo r  higher sucrose concentrations by 
tumour-bearing animals which increases with the growth of the tumour was 
also found (De Wys, 1977). Such taste preferences are consistent with a 
plasma amino acid-imbalance (Harper at., 1970). Increased concentrations 
of several amino acids ( including alanine) were also reported in the blood 
(Sassenrath & Greenberg, 1954) and in the urine (Wu & Bauer, 1960) of 
tumour-bearing animals. Increased concentrations of alanine were also 
observed in the blood of patients with moderate (Björnesjö, 1968) or advanced 
cancer (Björnesjö, 1968; De Wys, 1970). I t  is possible therefore that 
increased alanine concentrations in the blood of tumour-bearing organisms 
cause an amino acid imbalance and thus the commonly observed anorexia of 
cancer. Furthermore, the cause of the increased concentrations of alanine 
may not be the tumour pe/i 4e.
The resul ts  presented in th is  thesis and the data of other workers have 
shown that host l i ve rs  of tumour-bearing animals possess an enzyme p r o f i l e  
charac te r is t ic  of l i ve rs  of 1-2 week old neonatal rats (see Chapter 3 and 
also section 9.1). Furthermore, Snell (1975) has demonstrated that neonatal 
rats possess an increased a b i l i t y  ( in comparison with adult  rats) to u t i l i z e  
substrates such as pyruvate and lacta te  fo r  gluconeogenesis. However, an 
impaired a b i l i t y  to u t i l i z e  high concentrations of alanine fo r  the production 
of glucose was observed. This is due, Snell proposes, to a deficiency of 
enzymic capacity to convert alanine to pyruvate because of the low a c t i v i t y  
of alanine aminotransferase in neonatal ra t  l i v e r .  These observations are 
s im i la r  to the s i tua t ion  that is present in host l i ve rs  of tumour-bearing 
rats. Gluconeogenesis from lacta te  is increased in tumour-bearing organisms 
(Gold, 1968, 1974). However, the a c t i v i t y  of alanine aminotransferase is 
low in host l i v e r  (Figs. 1 & 4, see also the data of Herzfeld & Greengard,
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1972; de Rosa & Pitot, 1978). Gluconeogenesis from ^C-alanine was also 
shown to be impaired in the host livers of tumour-bearing mice (Shapot,
1974). These results therefore are again consistent with the proposal that 
host livers of tumour-bearing organisms are similar to livers of 1-2 week 
old neonatal animals. Furthermore, as the liver is the major gluconeogenic 
organ and as alanine is the major gluconeogenic substrate during starvation 
(Felig aZ., 1970; Felig, 1975), the quantitatively most important pre­
cursor for glucose synthesis during gluconeogenesis may be impaired in the 
tumour-bearing host. Furthermore, such a lesion may cause an amino-acid 
imbalance and thus anorexia. This could occur even i f  the size of the 
tumour is small because changes in the activities of host tissues enzymes 
(including alanine aminotransferase) often occur well before palpable 
neoplasms are evident (see Chapter 3). Even during the early stages of 
tumour growth therefore, the host liver may become "immature" and be unable 
to uti l ize alanine. At a later stage of tumour growth this situation 
chronically worsens. This is because the tumour may also secrete lactate 
and an increased "Futile substrate Cori cycle" as proposed by (Gold, 1968, 
1974, see above) could further deplete the host. Of note is also that 
lactate is an anorectic agent in monkeys (Baile eX a l . , 1970). It  is also 
common knowledge that food intake in man is reduced after severe exercise, 
presumably due to increased blood concentrations of lactate (see Baile 
eX at. ,  1970). Lactate concentrations and an amino acid-imbalance could 
therefore easily explain the anorexia associated with cancer. Furthermore 
the "immature" host liver possesses an impaired abili ty  to synthesize glucose 
from alanine, but must s t i l l  try to regain a normal amino acid balance. 
Therefore the host must dispose of the excess amino acids. Hence urinary 
nitrogen excretion is increased without an increased dietary intake and 
thus the host becomes cachectic.
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The above hypothesis is at  this  time clear ly speculative,  although consistent  
with the current knowledge of cancer cachexia. However, not all  tumours 
cause cachexia in the host. Bashford cU L .  , (1905) reported that  mice 
bearing some transplanted tumours were able to l ive for months without 
vi s ib le  inconvenience, the weights of these neoplasms having often exceeded 
the weight of the host. Of course i t  may be possible that  such tumours do 
not cause the host to become "immature" and thereby provide evidence that  
the "foetalism" of host t i ssues is not universal for all  types of tumours.
I t  would be naive to expect that  al l  tumours behave in a similar manner 
because of the wide divers i ty  of t he i r  origin and cell  type. However, in 
the human cl inical  s i tuat ion i t  is common knowledge that  most i f  not all  
cancer pat ients  exhibi t  symptoms of cachexia at  some stage of thei r  disease 
(Robbins, 1974; Lawrence & Terz, 1977) and that  two thirds of pat ients who 
die of cancer are cachectic at  death (see Morrison, 1976). I t  is such 
wasting that  the above hypothesis is attempting to explain. Moreover, the 
above proposal provides a very important addition to the knowledge of cancer 
cachexia. In par t icular  i t  provides for the development of new experimental 
approaches to this  problem and a fresh evaluation of old evidence. The 
investigat ion of gluconeogenesis from alanine and blood alanine concentrations 
in cachectic and non-cachectic cancer pat ients  would clear ly shed l ight  on 
this  problem. No such experiments have been done. Of course other metabolic 
implications of an "immature" l iver  (and possibly other t issues)  have not 
been ful ly  explored, therefore other "foetal" metabolic lesions may exis t .
For example, the a c t i v i t i e s  of other "adult-type" developmental enzymes 
involved in amino acid catabolism (serine dehydratase,  tyrosine amino­
t ransferase)  are also decreased toward foetal  values in host l ivers of 
tumour-bearing rats  (de Rosa & Pi tot ,  1978) and may fur ther  enhance an amino 
acid imbalance. However i t  must be pointed out that  the a c t i v i t i e s  of enzymes
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assayed in  vWio under optimal conditions may bear l i t t l e  quantitative 
relation to the activi t ies operating in  vivo, therefore such an interpretation 
must be viewed with some caution at this time. This criticism could also 
be directed at the decreased alanine aminotransferase levels in host livers 
indicating decreased alanine metabolism. However, the increased levels of 
this amino acid in the blood of cancer patients and the impaired gluconeo- 
genesis from ^C-alanine in the livers of tumour-bearing mice clearly 
support such a conclusion. At the present time therefore, the above 
hypothesis of cancer cachexia is merely proposed as a working hypothesis and 
as such must serve its purpose.
If cachectic patients do waste due to a mechanism similar to the one proposed 
here, then the clinical management of such wasting would be problematical.
This is due to the limited knowledge that is available about the mechanisms 
that are involved in determining the state of differentiation in the tissues 
of normal animals. Moreover, the mechanism by which the tumour reverses 
this procedure and causes the host liver to become "de-differentiated" is 
unclear. Thus the prevention of such a process is obscure. Of course i t  
may be possible to limit the dietary intake by cancer patients of alanine 
(and other amino acids that are readily converted to alanine by tissues 
such as muscle or gut) and by compensating the caloric intake with increased 
carbohydrate. This may improve the amino acid-imbalance and hence prevent 
the progressive weight loss. However, only temporary improvements were 
found in force fed cancer patients (Dudrick qX  a t.,  1968) or tumour-bearing 
animals (Terepka & Waterhouse, 1956). The inclusion of alanine in these 
force fed diets may however explain their failure to alleviate the cachexia.
In conclusion the mechanism of cancer cachexia as proposed here is at this
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time at best a working hypothesis. Clearly i t  is simplistic and does not 
include effects which may also be present in the tumour-bearing host due to 
the secretion for example by the tumour of ectopic hormones (Nathanson &
Hal l ,  1974; Longenecker & Williams, 1977). However, the hypothesis allows 
a fresh look at the problem of cancer cachexia. Clearly this area of cancer 
research warrants c r i t ic a l  investigation. This should be done to determine 
whether the physical well-being of the cancer patient can be improved, even i f  
the growth of the neoplasm cannot be fu l ly  controlled. After a l l  i t  is the 
patient who is presented for treatment and not the tumour pcA -6e. Clearly 
a better qual ity  of 1i fe  for cancer patients would be a significant break­
through in the c l in ica l  management of cancer.
194
LIST OF FIGURES
Figure N o . __________________ T i t l e _____________________ Page
1 A c t i v i t i e s  of Selected "Adult-Type" Marker 
Enzymes in Tumours and Host Livers of Tumour-
Bearing Rats 52
2 A c t i v i t i e s  of Selected "Foetal-Type" Marker
Enzymes in Tumours and Tumour-Bearing Rats 53
3 The A c t i v i t y  of Ornithine Aminotransferase in
Host Livers of Rats during the Time-course of 
Tumour-Bearing 56
4 The A c t i v i t y  of Alanine Aminotransferase in 
Host Livers of Rats during the Time-Course
of Tumour-Bearing 57
5 The A c t i v i t y  of Pyruvate Kinase in Host Livers
of Rats During the Time-Course of  Tumour-Bearing 58
6 The A c t i v i t y  of Glucokinase in Host Livers of
Rats during the Time-course of Tumour-Bearing 59
7 The A c t i v i t i e s  of Foetal-Type enzymes in the
Host Livers of Rats during the Time-Course of 
Tumour-Bearing 60
8 A c t i v i t i e s  of Selected Marker Enzymes in the Host
Kidney and Host Spleens of Tumour-Bearing Rats 63
9 The A c t i v i t i e s  of Ornithine Aminotransferase 
and Phosphoserine Phosphatase in Host Kidneys
of Rats during the Time-course of Tumour-Bearing 64
9A Quanti tat ive Immunoprecipitation of Rat Liver
Ornithine Aminotransferase with Anti-OAT Serum 100
10 SDS - Acrylamide Gel Electrophoresis of ^H- 
Labelled Ornithine Aminotransferase (OAT)
Immunoprecipi tä te 104
11 Quanti tat ive Immunoprecipitation of Rat Liver 
and Kidney Ornithine Aminotransferase with
Anit-OAT Serum 106
12 Rate of the Relat ive Incorporation of L - [4 ,5 - ^ h]
Leucine in to  Rat Tissue Ornithine Aminotransferase 108
13 Decreases with Time of the Specif ic  Radioactiv i ty  
of Ornithine Aminotransferase in Adult Rat Liver
and Kidney 114
195
F i q u r e  No. T i t l e P a g e
14 M e a s u r e m e n t  o f  I n i t i a l  R a t e s  o f  M i t o c h o n d r i a l  
C a l c i u m  T r a n s p o r t 145
15 C o m p a r i s o n  o f  C a l c i u m  R e t e n t i o n  o f  M i t o c h o n d r i a  
D e r i v e d  f r o m  A d u l t  an d  N e o n a t a l  L i v e r 148
16 C o m p a r i s o n  o f  C a l c i u m  R e t e n t i o n  o f  M i t o c h o n d r i a  
d e r i v e d  f r o m  A d u l t  L i v e r  a n d  H o s t  L i v e r s  o f  













T i t l e ______________________ Page
Growth rates o f  Transplantable Tumours 46
A c t i v i t y  o f Selected "Marker Enzymes" which 
change in L ive r  during Development from the 
Foetus to the Adult  Rat 50
A c t i v i t i e s  of selected "Marker Enzymes" which 
change in Kidney or Spleen during development 
from the Foetus to the Adult  Rat 61
The Ef fects  o f  S k in -g ra f t in g  on the A c t i v i t i e s
of the "Marker Enzymes" in the L ivers and
Kidneys of Rats 73
The E ffec ts  o f  S ta rvat ion on the A c t i v i t i e s
of the "Marker Enzymes" in the Livers and
Kidneys o f  Rats 75
The Effects  of Experimental ly-Induced
P o l y a r t h r i t i s  on the A c t i v i t i e s  o f  "Marker
Enzymes" in the Livers and Kidneys o f  Rats 78
The A c t i v i t i e s  of the "Marker Enzymes" in  the
Livers and Kidneys o f  Rats Twenty-Four hours
a f te r  P a r t ia l  Hepatectomy 81
The A c t i v i t i e s  o f  the "Marker Enzymes" in the
Livers and Kidneys o f  Rats For ty -E igh t  hours
a f te r  Pa r t ia l  Hepatectomy 82
Relat ive Rates of Incorporat ion o f  Radioact ive ly  
Label led Leucine in to  the TCA-Insoluble Fract ion 
of Extracts from Various Tissues of the Normal,
Neonatal and Tumour-Bearing Rats. 110
Relat ive Rates of Orn i th ine Aminotransferase
Synthesis in Various Tissues o f  Adu l t ,  Neonatal
and Tumour-Bearing Rats 112
Relat ive Rates of Orn i th ine  Aminotransferase 
Degradation in Various Tissues of Adu l t ,
Neonatal and Tumour-Bearing Rats 115
Comparison of Orn i th ine Aminotransferase 
A c t i v i t i e s  and Rela t ive  Rates of Synthesis 
in Various Tissues of Adu l t ,  Neonatal and 
Tumour-Bearing Rats 120
The Ef fects  of Thymosin F5 on the Enzyme
A c t i v i t y  o f  Host L iver  and Host Kidneys of











No. T i t le
The Effects of Thymosin F5 on the Enzyme 
A c t iv i t ie s  of Host Liver and Host Kidneys 
of Rats Bearing the R3230AC Mammary Carcinoma
Comparison of the Respiratory Control Index 
of Rat L iver Mitochondria derived from Adult, 
Neonatal and Tumour-Bearing Animals
Comparison o f the I n i t i a l  Rates o f Mitochondrial 
Calcium Transport in Livers o f Normal and 
Tumour-Bearing Animals
Variations in Calcium and Magnesium Concentrations 
in v/hole Host L iver during the Time-course of 
5123C Tumour-Bearing
Concentrations of E lectro ly tes and Metabolites and 
A c t iv i t ie s  of Selected Enzymes in the Serum of 
Adult and Neonatal Rats
Changes in Concentrations of E lectro ly tes and 
Metabolytes and A c t iv i t ie s  o f Selected Enzymes 
in the Serum of Rats during the Time-course of 
Bearing Mammary Carcinoma R3230AC
Changes in Concentrations of E lectro lytes and 
Metabolites and A c t iv i t ie s  of Selected Enzymes 
in the Serum of Rats during the Time-course 
of Bearing Hepatoma 7777
Changes in Concentration o f E lectro ly tes and 
Metabolites and A c t iv i t ie s  of Selected Enzymes 
in the Serum of Rats during the Time-course 












Plate No. T i t l e Page
1 MDAB-Induced Primary Hepatocarcinoma 48
2 SDS - Acrylamide Gel Electrophoresis  of 
Orn i th ine Aminotransferase 98
3 Ouchterlony Double D i f fus ion  Analysis of 
A n t i -O rn i th in e  Aminotransferase Serum 102
199
REFERENCES
ABELEV, G . I . (1971)
Adv. Cancer  Res. 14: 295 -358 .
ABELEV, G . I . ,  PEROVA, S . D . ,  KHRAMKOVA, N . I .  POSTNIKOVA, Z .A .  & IRLIN , 
I . S .  (1963)
T r a n s p l a n t a t i o n  1_: 174-180 .
AISENBERG, A.C . (1961)
i n  "The G l y c o l y s i s  and R e s p i r a t i o n  o f  Tumours" .
Academic P ress .  New Y o rk .
AISENBERG, A.C . & MORRIS, H.P.  (1961)
N a tu re  191: 1314-1315 .
ALPERT, E . ,  PINN, V.W. & ISSELBACHER, K . J .  (1971)  
New Eng. J .  Med. 285: 1058-1059 .
ALPERT, E . ,  COSTON, R.C. & DRYSDALE, J . E .  (1973)  
N a tu re  242: 194-195 .
ALFEROV, A . N . ,  PALIUKH, A.R.  & DZIUBKO, N.Ya.  (1976)  
Vrachebnoe Delo  7_: 27 -2 9 .
AMES, B.N. (1966)
Methods i n  E nzym o l . 8^ : 115 -116 .
ANDERSON, H . L . ,  BENEVENGA, N . J .  & HARPER, A . E . ,  (1968)  
Am. J .  P h y s i o l .  214:  1008-1013.
ANDJARGHOLI, M. & DALE, M.M. (1977)
B r .  J .  Cancer  3J5: 59 -67 .
ASANUMA, Y . ,  GOLDSTEIN, A . L .  & WHITE, A. (1970)
E n d o c r i n o l o g y  86^: 600 -610 .
BACH, J . F . ,  DARDENNE, M . ,  GOLDSTEIN, A . L . ,  GUHA, A. & WHITE, A. (1971)  
P roc .  Na t .  Acad. S e i .  USA 68: 2734 -2738 .
BAILE, C . A . ,  ZINN, W.M. & MAYER, J .  (1970)
Am. J .  P h y s i o l .  2T9: 1606-1613.
BAILEY, E . ,  TAYLOR, C.B. & BARTLEY, W. (1967)  
Biochem. J .  103: 78P.
B A IL L IE , P . ,  MILLAR, F .K .  & PRATT, A.W. (1965)  
Am. J .  P h y s i o l .  209: 293 -300 .
BALLARD, F . J .  (1971)
Biochem.  J .  124: 265 -274 .
BALLARD, F . J .  & H0PG00D, M.F. (1973)  
Biochem.  J .  136: 259 -264 .
200
BALDWIN, R . W . , PRICE, M.R. & ROBINS, R.A.  (1973)
I n t .  J .  Cancer  1_1_: 527-535 .
BALDWIN, P . E . ,  GEORGE, D.T.  & CUNNINGHAM, C.C. (1975)
E x p e r i e n t i a  3 j k  1333-1334 .
BANERJEE, M.R. & DE OME, K.B.  (1963 )
Cancer  Res. 23; 546-550 .
BARBIROLI, B . ,  POTTER, V.R.  & MORRIS, H.P.  (1972)
Cancer  Res. 32; 7 - 1 0 .
BARRITT, G .J .  & WHITEHOUSE, M.W. (1977 )
B io c h e m ic a l  M e d ic in e  1_7: 99 -115 .
BASERGA, R. & KIS IELESKI,  W.E. (1961 )
A r c h .  P a t h o l .  72;  142-148 .
BASHFORD, E . F . ,  MURRAY, J . A .  & CRAMER, W. (1905 )
Second S c ienc e  R e p o r t ,  P a r t  I I .  Imp. Cancer  Fund. pp40-41 
T a y l o r  & F r a n c i s :  London.
BAUMGARTNER, W . A . , BECK, F . W . J . ,  LORBER, A . ,  PEARSON, C.M. & WHITEHOUSE, 
M.W. (1974 )
P roc .  Soc. Exp. B i o l .  Med. 1 4 5 : 625 -630 .
BECK, F . J .  & WHITEHOUSE, M.W. (1973)
Biochem. Pharmacol .  22;  2453-2468 .
van BEKKUM, D.W.,  BETEL, I . ,  BLANKWATER, M . J . ,  KRUISBEEK, A.M. & SWART, 
A.C.W. (1977 )
T r a n s p l .  P roc .  9; 1 197 -1199.
BENSON, P.F .  & de JONG, M. (1968 )
Biochem. J .  106: 15P.
BERGMEYER, H.U. (ed )  (1974 )
i n  "Methods i n  Enz y m a t ic  A n a l y s i s "  V4, see p2293,  Academic Press 
New York .
BJÖRNESJÖ, K.B.  (1968)
C l i n .  Chim. Ac ta  20; 17 -22 .
BLAIR, P.B.  (1972)
J .  Nat .  Cancer  I n s t .  48:  1121-1124 .
BLAXTER, K .L .  (1957)
Proc .  N u t r .  Soc. 16; 52 -58 .
BOBERG, C . ,  McLEAN, J . E . ,  GRIGOR, M.R. & THOMPSON, M.P. (1977)
Proc .  U n i v .  Otago Med. Sch. 55; 4 3 - 4 5 .
BONNEY, R . J . ,  HOPKINS, H . A . ,  WALKER, P.R. & POTTER, Van R. (1973)
Biochem. J .  136: 115-124 .
201
BOOTH, D. A . , TOATES, F.M. & PLATT, S.V.  (1976)
in  "Hunger:  Basic Mechanisms and C l i n i c a l  I m p l i c a t i o n s "
(N o v in ,  D . ,  Wyrwicka, W. & Bray ,  G. eds) 
p p l 27-143.  Raven Press.  New York.
BOVERI, T. (ed)  (1929)
in  "The O r ig in s  o f  M a l ig n an t  Tumours" W i l l i a m s  & W i l k i n s ,  B a l t im o r e .
BOWEN, J . G . , ROBINS, R.A. & BALDWIN, R.W. (1975)
I n t .  J .  Cancer 15_: 640-650.
BRAUN, A.C.  (ed)  (1969)
in  "The Cancer Problem: A C r i t i c a l  A n a ly s i s  and Modern S y n th e s i s " ,  
p i 60 Columbia U n i v e r i s t y  Press.  Mew York.
BRENNEN, M.F. (1977)
Cancer Res. 37_: 2359-2364.
BRODY, S. (1964)
i n  "B io e n e r g e t i c s  & Growth" see p807 
Hofner P u b l i s h in g  Co. I n c .  New York.
BRUES, A.M. (1954)
Adv. Cancer Res. 2 \ 177-195.
BUFFE, D . ,  RIMBAUT, C. & BURTIN, P. (1968)
I n t .  J .  Cancer 3_: 850-856.
BUFFE, D . ,  RIMBAUT, C. ,  LEMERLE, J . ,  SCHWEISGUTH, 0. & BURTIM, P. (1970)
I n t .  J .  Cancer 5_: 85-87 .
BUFFE, D . ,  RIMBAUT, C. ,  FUCCARO, C. & BURTIN, P. (1972)
Ann. I n s t .  Pasteur 123: 29-42.
BURCH, H.B. (1965)
Adv. Enzyme Reg. 3_: 185-197.
BURDETTE, W.J. (1955)
Cancer Res. 1_5: 201-226.
BURK, D . ,  WOODS, M. & HUNTER, J .  (1967)
J .  Nat .  Cancer I n s t .  38_: 839-863.
BURNET, F.M. (1973)
A u s t .  N.Z.  J.  Med. _3: 71-77.
BURTIN, P . ,  MARTIN, E . ,  SABINE, M.C. & KLEIST, S. (1972) 
J .  Nat .  Cancer I n s t .  48: 25-32.
BUSCH, H. (1974)
i n  "The M o lecu la r  B io lo g y  o f  Cancer" p p l -35 .  
Academic Press.  New York.
BYGRAVE, F .L .  (1976)
in  "C o n t ro l  Mechanisms in  Cancer"
( C r i s s ,  W.E. ,  Ono, T. & Sab ine,  J .R .  eds) 
pp401-423.  Raven Press.  New York.
202
BYGRAVE, F.L. (1978)
Biol. Rev. 53; 43-79.
BYGRAVE, F.L. & ASH, G.R. (1977)
FEB5 Letters 80: 271-274.
BYGRAVE, F.L., HEANEY, T.P. & RAMACHANDRAN, C. (1978)
Biochem. J. 174: 1011-1019.
CAIRNS, J. (1975)
Nature 255: 197-200.
CALDERON, J ., WILLIAMS, R.T. & UNANUE, E.R. (1974)
Proc. Nat. Acad. Sei. USA 7J_: 4273-4277.
CAMPBELL, D.H., GARVEY, J.S., CREMER, N.E. & SUSSDORF, D.H. (1970) 
in "Methods in Immunology" 2nd Ed. see p425,
W.A. Benjamin Inc. Publishing Co. Reading Massachusetts.
CASHMAN, D. & PITOT, H.C. (1971)
Anal. Biochem. 44: 559-569.
CHANCE, B. & WILLIMAS, G.R. (1956)
Adv. Enzymol. \7_: 65-134.
CHEE, P.Y. & SWICK, R.W.
J. Biol. Chem. 25]_: 1029-1034.
CHIRIGOS, M.A. (ed) (1977)
in "Control of Neoplasia by Modulation of the Immune System".,
V 1&2, Raven Press, New York.
CHURCHILL, W.A. Jr., RAPP, H.J., KRONMAN, B.S. & BORSOS, T. (1968)
Cancer Res. 3; 326-333.
COGGIN, J.H. Jr. & ANDERSON, N.G. (1974)
Adv. Cancer Res. J9_: 105-165.
COMSTOCK. J.P., CHAN, L. & MEANS, A.R. (1976)
in "Hormone Action and Molecular Endocrinology Workshop Syllabus" 
(O'Malley, B.W. a Schrader, W.T. eds).
CONSTANZI, J., GAGLIANO, R., LOUKAS, D., SAKAI, H., THURMAN, G., HARRIS, N.
& GOLDSTEIN, A. (1975)
Proc. Am. Assoc. Cancer Res. 1J5; 135.
CONSTANZI, J.J., GAGLIANO, R.G., DELANEY, F., HARRIS, N., THURMAN, G.B., 
SAKAI, H.S., GOLDSTEIN, A.L., LOUKAS, D., COHEN, G.B. & THOMSON, P.D. (1977) 
Cancer 40: 14-19.
COSTA, G. (1963)
Prog. Exp. Tumour Res. 3_: 321-369.
COSTA, G. (1977)
Cancer Res. 37: 2327-2335.
203
CRISS, W.E. (1971)
Cancer Res. 31_: 1523-1542.
DARDENNE, M., PLEAU, J . ,  MAN, N.K. & BACH, J. (1977)
J. B io l .  chem. 252: 8040-8044.
DAUPHINEE, M.J.,  TALAL, N., GOLDSTEIN, A.L. & WHITE, A. (1974)
Proc. Nat. Acad. Sei. USA 7T_: 2637-2641.
DAVIDSON, R.L. & EPHRUSSI, B. (1965)
Nature 205: 1170-1171
DEFENDI, V.,  EPHRUSSI, B.,  KOPROWSKI, H. & YOSHIDA, M.C. (1967)
Proc. Nat. Acad. Sei. USA 57: 299-305.
DEVLIN, T.M. & PRUSS, M.P. (1958)
Fed. Proc. 17_: 211. (Abs trac t ) .
DE WYS, W. (1970)
Cancer Res. 30: 2816-2818.
DE WYS, W.D. (1974)
Ann. N.Y. Acad. Sei. 230: 427-434.
DE WYS, W.D. (1977)
Cancer Res. 37_: 2354-2358.
DRYSDALE, J.W. & ALPERT, E. (1975)
Ann. N.J. Acad. Sei. 259: 427-434
DUCK-CHONG, C.G. & POLLAK, J.K. (1973)
in "The Biochemistry o f Gene Expression in Higher Organisms"
(Po l iak ,  J.K. & Lee, W.J. eds). pp305-319, Aus t ra l ia  & New Zealand 
Book Publ ishing Co., Sydney.
DUDRICK, S .J . ,  WILMORE, D.W., VARS, H.M. & RHOADS, J.E. (1968)
Surgery 84: 134-142.
DUNKER, A.K. & RUECKERT, R.R. (1969)
J. B io l .  Chem. 244: 5074-5080.
DUNNING, W.F. & CURTIS, M.R. (1957)
J. Nat. Cancer In s t .  T9_: 845-853.
ELWOOD, J .C . ,  LIN, Y.C., CRISTOFALO, V .J . ,  WEINHOUSE, S. & MORRIS, H.P. (1963) 
Cancer Res. 23_: 906-913.
EWING, J. (1931)
Neoplast ic Diseases. W.B. Saunders Co., Phi ladelph ia .
EWING, J. (1940)
in "Neoplast ic Diseases: A Trea t ise  on Tumours". 4th ed.,  Chapter 1. 
W.B. Saunders Pub. Co., Ph i ladelphia & London.






















, SHATTON, J . B . ,  MORRIS, H.P. & WEINHOUSE, S. (1974) 
Cancer Res. 3A_: 1439-1446.
& LIGHTHOLDER, J .R .  (1976)
Nature 260: 628-630.
, HSU, H.H.T.  & KNOX, W.E. (1972)
Cancer Res. 32_: 302-308.
(1975)
Ann. Rev. Biochem. 44: 905-955.
POZEFSKY, T . ,  MARLISS, E. & CAHILL, G.F. J r .  (1970) 
Science 167: 1003-1004.
S. (1974)
The Medical  J .  o f  A u s t r a l i a ,  1_: 438-441.
f.H. & SINGER, R.M. (1976)
Cancer Res. 36_: 4256-4261.
. . E . , WISSLER, R.W., STEFLER, C .H . ,  WOOLRIDGE, F .L .  & CANNON, P.R.
J.  N u t r .  33_: 65-83.
& JEFFAY, H. (1967)
B iochim. B iophys.  Acta 148: 448-459.
R.K. (1974)
Contemporary Top ics  Immunol. _3: 1-40
, F.N. & PARRY, E.W. (1965)
Cancer J_8: 455-495.
R.W. & FOX, A. (1975)
C e l l .  Immunol. 1_9: 328-335.
& MULLER, K.P. (1967)
Acta B i o l .  Med. Germ. 1_8: 351-358.
(1966)








Ann. N.Y. Acad. Sei. 230: 103-110.
205
GOLD, P. & FREEMAN, S.O. (1965)
J. Exp. Med. J 2 2 . :  467-481.
GOLDBERG, A.L. & DICE, J.F. J r .  (1974)
Ann. Rev. Biochem. 43_: 835-869.
GOLDSTEIN, A.L. (1976)
Trans. Am. C l in .  Chem. Ass. 88: 79-94.
GOLDSTEIN, G. & MACKAY, I .R. (1969) 
in "The Human Thymus"
Wi l l iam Heineman Medical Books L td . ,  London.
GOLDSTEIN, A .L . ,  ASANUMA, Y.,  BATTISTO, J .R . ,  HARDY, M.A., OUINT, J. & WHITE, 
A. (1970)
J. Immunology 104: 359-366.
GOLDSTEIN, A .L . ,  GUHA, A.,  ZATZ, M.M., HARDY, M.A. & WHITE, A. (1972)
Proc. Nat. Acad. Sei. USA 69: 1800-1803.
GOLDSTEIN, A .L . ,  COHEN, G.H., ROSSIO, J . L . ,  THURMAN, G.B., ULRICH, J.T.
& BROWN, C.N. (1976)
Med. C l in .  N. Am. 60: 591-606.
GOLDSTEIN, A .L . ,  COHEN, G.H. & THURMAN, G.B. (1977b)
in "Control  o f  Neoplasia by Modulation o f  the Immune System" 
(C h i r ig o s , M.A. ed) pp241-253. Raven Press, New York.
GOLDSTEIN, A .L . ,  LOW, T .L .K . ,  McADOO, M., McCLURE, J . ,  THURMAN, G.B.,
ROSSIO, J . ,  LAI, C-Y., CHANG, D., WANG, S.,  HARVEY, C., RAMEL, A.H. & 
MEIENHOFER, J. (1977)
Proc. Nat. Acad. Sei. USA. 74: 725-729.
GORDAN, G.S. (1974)
Ann. N.Y. Acad. Sei. 230: 181-186.
GREENBAUM, A .L . ,  GUMAA, K.A. & McLEAN, P. (1971) 
Arch. Biochem. Biophys. 143: 617-663.
GREENE, A.A. (1960)
Cancer Res. 20; 233-236.
GREENGARD, 0. (1971)
in "Essays in Biochemistry"
(Campbell, P.N. & Dickens, F. eds) V.7 p p l59-205, 
Academic Press. New York.
GREENGARD, 0. & LEMPERT, N. (1973)
Enzyme T4: 229-237.
GREENGARD, 0 . ,  BAKER, G.T. & FRIEDELL, G.H. (1967)
Enzymol. B io l .  C l in .  8_: 241-247.
GREENGARD, 0. FEDERMAN, M. & KNOX, W.E. (1972)
J. Cell B io l .  52: 261-272.
206
GREENSTEIN, J .P .  (1942-1943)
J .  Nat.  Cancer I n s t .  .3: 419-447.
GREENSTEIN, J .P .  (1947)
in  " B io c h e m is t r y  o f  Cancer"
Academic Press.  New York.
GREENSTEIN, J .P .  (1954)
i n  "B io c h e m is t r y  o f  Cancer" 2nd ed. 
Academic Press.  New York.
GREENSTEIN, J .P .  (1956)
Cancer Res. j j5 :  641-653.
GRIFFIN, A.C.  (1957)
Texas Rept.  B i o l .  Med. 15_: 161-168.
GROSS, L. (1978)
Cancer Res. 38_: 485-493.
HALL, T.C.  (1974)
Ann. N.Y. Acad. S e i .  230: 1.
HALLMAN, M. (1971)
B iochim.  B iophys .  Acta 253 : 360-372.
HAMMOND, K.D. & BALINSKY, D. (1978)
Cancer Res. 38: 1323-1328.
HARDY, M .A . ,  ZISBLATT, M . , LEVINE, N . ,  GOLDSTEIN, A . L . ,  LILLY, F. & WHITE, 
A. (1971)
T r a n s p la n t .  Proc.  3_: 926-928.
HARPER, A.E.  (1976)
in  "Hunger:  Bas ic  Mechanisms and C l i n i c a l  I m p l i c a t i o n s "
(Nov in ,  D . ,  Wyrwicka,  W. & Bray ,  G. eds) p p l 03-113,
Raven Press,  New York.
HARPER, A . E . ,  BENEVENGA, N.J .  & WOHLHUETER, R.M. (1970) 
P h y s i o l o g i c a l  Reviews _50: 428-558.
HASSE, K . ,  HESS, J.  & HORNIG, H.W. (1971)
Chem. Ber. 104: 2420-2426.
HAUG, H . ,  LÜTHGENS, M.,  SCHLEGEL, G. & PETER, G. (1978) 
A n t i b i o t i c s .  Chemother . ,  22_: 85-97 .
HAUSCHKA, T.S.  (1961)
Cancer Res. 2J_: 957-974.
HAVEN, F .L .  & BLOOR, W.R. (1956)
Adv. Cancer Res. 4_: 237-314.
HEPPENER, G.H.,  WOOD, P.C. & WEISS, D.W. (1968) 
I s r e a l  J .  Med. Se i .  4: 1204-1209.
207
HERSH, E . M . , McCREDIE, K.B.  & FREIREICH,  E . J .  ( 1974)  
C l i n .  Exp.  Immunol .  V7: 4 6 3 - 4 7 3 .
HERZFELD, A. & GREENGARD, 0 .  ( 1 9 6 9 )
J .  B i o l .  Chem. 244:  4 8 9 4 - 4 8 9 8 .
HERZFELD, A. & GREENGARD, 0 .  ( 1972)  
C a n c e r  Res .  32_: 1 8 2 6 - 1 8 3 2 .
HERZFELD, A. & GREENGARD, 0 .  ( 1977)  
C a n c e r  Res .  37:  2 3 1 - 2 3 8 .
HERZFELD, A. & KNOX, W.E. ( 1 9 6 8 )
J .  B i o l .  Chem. 243:  3 3 2 7 - 3 3 3 2 .
HERZFELD, A . ,  GREENGARD, 0 .  & WARREN, S.  ( 1 9 7 8 )
J .  Na t .  C a n c e r  I n s t .  USA 60:  8 2 5 - 8 2 8 .
HIATT, H.H.  ( 1 9 5 7 )
C a n c e r  Res .  1_7: 2 4 0 - 2 4 4 .
HICKIE,  R . A . , WALKER, C.M. & CROLL, G.A.  ( 1 9 7 4 )
Bi ochem.  B i o p h y s .  Res .  Comm. 59_: 1 6 7 - 1 7 3 .
HIRAI , H. & ALPERT, E. ( 1975)
Ann.  N.Y.  Acad.  S e i .  259:  5 - 6 .
HIRAI ,  H . ,  NISHI ,  S.  & WATABE, H. (1972)
i n  " P r o t i d e s  o f  t h e  B i o l o g i c a l  F l u i d s "  
( P e t e r s ,  H. ed )  p p 5 7 9 - 5 8 7  
Pergamon P r e s s .  O x f o r d .
HOLTEN, D . ,  & KENNEY, F . T .  ( 1 9 6 7 )
J .  B i o l .  Chem. 242:  4 3 7 2 - 4 3 7 7 .
HOOPER, J . A . , McDANIEL, M. C . ,  THURMAN, G . B . ,  COHEN, G . H . ,  SCHULOF, R. S .  
& GOLDSTEIN, A. L.  ( 1975)
Ann.  N.Y.  Acad.  S e i .  249:  1 2 5 - 1 4 4 .
HUDSON, L. & HAY, F .C.  e d s  ( 1 9 7 6 )
i n  " P r a c t i c a l  Immuno l ogy" ,  s e e  p 2 7 3 ,
B l a c k w e l l  S c i e n t i f i c  Pub.  Co. O x f o r d .
IBRAHIM, A . B . ,  TRIGLIA,  R . ,  DAU, P . C.  & SPITLER,  L . E .  ( 1977)
i n  " C o n t r o l  o f  N e o p l a s i a  by M o d u l a t i o n  o f  t h e  Immune Sys t em"  
( C h i r i g o s ,  M . A . e d )  P r o g r e s s  i n  C a n c e r  R e s e a r c h  & T h e r a p y  V2. 
p p 8 1 - 9 6 .  Raven P r e s s .  New York.
IBSEN, K . H . ,  BASABE, J . R .  & LOPEZ, T . P .  ( 1 9 7 5 )
C a n c e r  Res .  35:  1 8 0 - 1 8 8 .
IKEHARA, S . ,  HAMASHIMA, Y. & MASUDA, T.  ( 1 9 7 5 )
N a t u r e  258:  3 3 5 - 3 3 7 .
I P ,  M.M. ,  CHEE, P.Y.  & SWICK, R.W. ( 1 9 7 4 )
B i o c h i m.  B i o p h y s .  Ac t a  354:  2 9 - 3 8 .
208
IRVING, M.G. & WILLIAMS, J . F .  (1974 )
I .  R .C .S .  2:  1215.
IRWIN, C . C . ,  MALKIN, L . I .  & MORRIS, H.P. (1978 )
Cancer  Res. 38: 1584-1588 .
JACOBS, E . E . ,  JACOB, M. ,  SANADI, D.R. & BRADLEY, L .B .  (1956)
J.  B i o l . Chem. 223:  147-156 .
JAMDAR, S.C.  & GREENGARD, 0.  (1969 )
A r c h .  Biochem. B io p h y s .  134 : 228 -232 .
JOST, J . P . ,  KHAIRALLAH, E.A.  & PITOT, H.C.  (1968)  
J .  B i o l .  Chem. 243:  3057-3066 .
KALITA, C . C . ,  KERMAN, J .D .  & STRECKER, H .J .  (1976)  
B io c h im .  B io p h y s .  A c ta  4 2 9 : 780 -797 .
KASCHNITZ, R .M . ,  HATEFI, Y. & MORRIS, H.P.  (1976)  
B io c h im .  B io p h y s .  A c ta  4 4 9 : 224 -235 .
KELLY, L . S . ,  PAYNE, A . H . ,  WHITE, M.R. & JONES, H.B.  (1951)  
Cancer  Res. T_l_: 694 -696 .
KENNEY, F .T .  & FLORA, R.M. (1961 )
J .  B i o l .  Chem. 236:  2699-27 02 .
KHAW, B .A .  & RULE, A.H.  (1973 )
B r .  J .  Cancer  2<3: 288 -292 .
KHOO, S . K . ,  WARNER, N . L . ,  L I E ,  J . T .  & MACKAY, I . R .  (1973 )  
I n t .  J .  Cancer 1_1_: 681 -687 .
KIMURA, S. & RASMUSSEN, H. (1977 )
J .  B i o l .  Chem. 252:  1217 -1225 .
KINDRED, B. & LOOR, F. (1974 )
i n  " P r o c .  1 s t  I n t .  Workshop on Nude M ice"
(R y gaa rd ,  J .  & P o v l s e n ,  C.O. eds)  p p l 4 9 -1 5 4 ,
Gustav F i s c h e r  V e r l a g ,  S t u t t g a r t .
KIRCHNER, M . ,  MUCHMORE, A . V . ,  CHUSED, T . M . ,  HOLDEN, H.T .  & HEVERMAN, R.B.  
(1975 )
J .  Immunol .  114: 206 -215 .
KLEMPERER, H.G. & HAYNES, G.R. (1968 )  
Biochem. J .  108: 541 -546 .
KNOWLES, S.E .  & BALLARD, F . J .  (1974 )  
B i o l .  Neonate Z4: 4 1 - 4 8 .
KNOX, W.E. (1974)
Cancer  Res. 34: 2102-2108 .
209
KNOX, W.E. (1976)
in "Enzyme Patterns in Foeta l ,  Adu lt  & Neoplast ic T issues",  2nd ed. 
Karger, Basel.
KNOX, W.E., HERZFELD, A. & HUDSON, J. (1969)
Arch. Biochem. Biophys. 132: 397-403.
KO, V.,  DUTTON, G.J. & NEMETH, A.M. (1967) 
Biochem. J. 104: 991-998.
KOBAYASHI, K . , MORRIS, H.P. & KATANAUMA, N. (1976a) 
J. Biochem. 80: 1085-1089.
KOBAYASHI, K . , KITO, K. & KATANUMA, N. (1976b)
J. Biochem. 79_: 787-793.
KREBS, H.A. (1950)
Ann. Rev. Biochem. 1_9: 409-430.
LAEMMLI, U.K. (1970)
Nature 227: 680-685.
LANG, W., ZOBL, H. & GEORGII, A. (1978)
Europ. J. Cancer ]_4: 431-437.
LAPPE, M.A. & BLAIR, P.B. (1970)
Proc. Am. Assoc. Cancer Res. Vh 47.
LATNER, A.L. (1975)
Cantarow & Trumper "C l in i c a l  Biochemistry",  7th ed, 
W.B. Saunders Co. Toronto.
LAW, L.W. & APELLA, E. (1975).
in "Cancer: A Comprehensive Trea t ise"
(Becker. F.F. ed) V.4 pp l35-157.
Plenum Press. New York.
LAWRENCE, W. Jr .  & TERZ, J .J .  (1977)
in "Cancer Management", pp523-546.
Grune & S tra t ton  Inc. New York.
LAYNE, E. (1957)
Methods in Enzymol. 3_: 447-454.
LEA, M.A., MORRIS, H.P. & WEBER, G. (1966)
Cancer Res. 26_: 465-469.
LEE, Y-T.N., SPARKS, F.C., EILBER, F.R. & MORTON, D.L. (1975) 
Cancer 35: 748-755.
LIEBELT, R.A., LIEBELT, A.G. & JOHNSTON, H.M. (1971)
Proc. Soc. Exp. B io l .  Med. 138: 482-490.
LLEWELLYN-JONES, D. (1971)
in "Everywoman", see p i 75.
The Riverside Press Ltd. Kent, Gt. B r i t i a n .
210
LONG, C. ed (1971)
in "Biochemists Handbook", pp839-892.
E. & F.N. Spon Ltd. London.
LONGENECKER, J.P. & WILLIAMS, J.F. (1977)
I .  R.C.S. Journal o f  Medical Science !5: 347-349.
LOOR, F.,  ROELANTS, G.E., KINDRED, B., MAYOR, K.S. & HAGG, L.-B. (1976) 
in "Progress in D i f f e r e n t ia t i o n  Research"
(Mül le r -B e ra t ,  N., Rosenfeld, C., Tavin, D. & Viza, D. eds). 
pp559-566. North Holland Pub. Co., Amsterdam.
LOWRY, O.H., ROSEBROUGH, W.L., FARR, A.L. & RANDALL, R.J. (1951)
J. B io l .  Chem. 193: 265-275.
LYONS, R.T. & PITOT, H.C. (1976)
Arch. Biochem. Biophys. 174: 262-272.
LYONS, R.T. & PITOT, H.C. (1977)
Arch. Biochem. Biophys. 180: 472-479.
MeINT I RE, K.R. & POTTER, M.J. (1964)
J. Nat. Cancer In s t .  33^ : 631-639.
McI ntyre, h . & bygrave, f . l . ( 1974)
Arch. Biochem. Biophys. 165: 744-748.
MACHOVICH, R. & GREENGARD, 0. (1972)
Biochim. Biophys. Acta. 286: 375-381.
MALMGREN, R.A. (1956)
Cancer Res. Ij6: 232-236.
MANJESHWAR, R . , SHARMA, C., MORRIS, H.P. & DONNELLY, A.J. (1965)
Adv. Enzyme Reg. _3: 317-324.
MARKERT, O.L. (1968)
Cancer Res. 28: 1908-1914.
MARKERT, C . I .  & MÖLLER, F. (1959)
Proc. Nat. Acad. Sei. USA 45: 753-762.
MARTIN, J .P . ,  CHARLIONNET, R. & ROPART, Z. (1971)
Presse. Med. 79p 2313-2316.
MARTIN, F. & MARTIN, M.S. (1970)
In t .  J. Cancer 6^ : 352-360.
MATSUZAWA, T. , KATSUNUMA, T. & KATUNUMA, N. (1968)
Biochem. Biophys. Res. Comm. 3 2 : 161-166.
MICH IE, W., BECK, J .S . ,  MAHAFFY, R.G., HONEIN, E.F. & FOWLER, G.B. (1967) 
Lancet 691 -695
MIDDLETON, M.C. & WALKER, D.G. (1972)
Biochem. J. 127: 721-731.
211
MIDER, G.ß.  (1953)
Ann. Rev.  Med. 4_: 187-198.
MILLAR, F . K . ,  WHITE, J . ,  BROOKS, R.H. & MIDER, G.B. (1957)  
J .  Nat .  Cancer  I n s t .  ]9j. 957-967.
MILLAR, F . K . ,  BROOKS, R.H. & WHITE, J . (1959)
J .  Na t .  Cancer  I n s t .  22_: 685- 696 .
MILLER, E.C.  & MILLER, J . A .  (1952)
Cance r  Res.  12_: 547-556.
MILLER, E.C.  & MILLER, J . A .  (1966)
Pha r maco l .  Rev. 1_8: 805- 838 .
MILLER, E.C.  & MILLER, J . A .  (1974)
in "The M o l e c u l a r  Bi o l ogy  o f  Cancer"
( Bus ch ,  H. ed)  pp377-402.
Academic P r e s s .  New York.
MINTZ, H. A. ,  YAWN, D.H. ,  SAFER, B. ,  BRESNICK. E . ,  LIEBELT, A. G. ,  BLAILOCK, 
Z . R . ,  RABIN, E.R.  & SCHWARTZ, A. (1967)
J .  C e l l .  B i o l .  34:  513-523.
MORESHI, C. (1909)
Z. I m m u n i t ä t s f o r s c h .  2_: 651- 685 .
MORGAN, W.W. & CAMERON, I . L .  (1973)
Cance r  Res.  33:  441- 448 .
MORRIS, H.P.  (1975)
i n  "Handbuch Der Al l geme i nen  P a t h o l o g i e "  
( Al tman ,  H.W. e t  a l . ,  eds )  V6_ pp277- 3 3 4 ,  
S p r i n g e r  V e r l a g ,  B e r l i n .
MORRIS, M. ,  CHEE, P.Y.  & SWICK, R.W. (1974)  
Biochim.  Bi ophys .  Acta  3 5 4 : 29- 38 .
MORRIS, J . E .  & PERAINO, C. (1976)
J .  B i o l .  Chem. 251:  2571-2578.
MORRISON, S.D.  (1973)
J .  Na t .  Cancer  I n s t .  5]_: 1535-1539.
MORRISON, S.D.  (1976)
Cancer  Res.  _36: 228-233.
MORTON, D.M. & CHATFIELD, D.H. (1970)
Biochem.  Pharmocol .  J_9: 473-481.
NAISMITH, D . J .  (1969)
Pr oc .  Nu t r .  Soc.  28^ : 25- 31 .
NAKAHARA, W. & FUKUOKA, F. (1958)
Adv. Cancer  Res.  5: 157-177.
NAKAZAWA, T . ,  ASAMI, K . , SUZUKI, H. & YUKAWA, 0 .  (1973)  
J .  Biochem.  (Tokyo) 73:  397- 406 .
212
NANNI, G. & CASU, A. (1961)
Experient ia ] 7_: 402-404.
NATHANSON, L. & HALL, T.C. (1974)
Ann. N.Y. Acad. Sei. 230: 367-377.
de NECHAUD, B. & URIEL, J. (1972)
In t .  J. Cancer 1_0: 58-71.
NIEUWERKERK, H.T.M., LÖWENBERG, B. & van BEKKUM, D.W. (1974) 
in "Proc. 1st I n t .  Workshop on Nude Mice"
(Rygaard, J. & Povlsen, C.O. eds) pp l75-181 - 
Gustav Fischer Verlag, S tu t tg a r t .
NIITSU, Y.,  KOHGO, Y.,  Y0K0T0, M. & URUSHIZAKI, I .  (1975) 
Ann. N.Y. Acad. Sei. 259: 450-452.
NORDLING. C.O. (1953)
Br. J. Cancer 7_: 68-72.
NORMAN, S.J. (1978)
J. Nat. Cancer In s t .  60: 1091-1096.
NORMAN, S. & SORKIN, E. (1977)
in "Perspectives in Inflammation: Future Trends & Developments". 
(Wil loughby, D.A., Giroud, J.P. & Velo, G.P. eds), pp303-313.
MTP Press L imited, Lancaster, England.
NOVIN, D., WYRWICKA, W., & BRAY, G.A. eds (1976)
in "Hunger: Basic Mechanisms & C l in ic a l  Imp l ica t ions"
Raven Press. New York.
OBERLING, C. (1946)
in "The Riddle of Cancer", pp26-27.
Yale U n ive rs i ty  Press. New Haven.
ODELL, W.D. & WOLFSEN, A. (1975)
in "Cancer: A Comprehensive Treat ise"
(Becker, F.F. ed) V_3: pp81 -97. Plenum Press. New York
ONO, T . ,  BLAIR, D.G., POTTER, V.R. & MORRIS, H.P. (1963)
Cancer Res. 23^ : 240-249.
ONO, T. & WEINHOUSE, S. (1972)
Gann Monograph 13:
"Isoenzyme & Enzyme Regulat ion in Cancer"
U n ive rs i t y  o f  Tokyo Press.
OSTERMAN, J . ,  FRITZ, J.P. & WUNTCH, T. (1973)
J. B io l .  Chem. 248: 1011-1018.
OXNER, A.G., THOMPSON, M.P. & GRIGOR, M.R. (1978) 
Proc. Univ. Otago Med. Sch. 56; 93-95.
PACKER, L. & UTSUMI, K. (1969)
Arch. Biochem. Biophys. 131: 386-403.
PANTELOURIS, E.M. (1973)
D i f f e r e n t ia t i o n  1: 437-450.
213
PAPAIOANNOU, A.N. ed (1974)
in  "Thymus and B reas t  Cancer" p p l lO -11 7 .
S p r in g e r  V e r la g ,  B e r l i n .
PAPAIOANNOU, A .N . ,  TSAKRAKLIDES, V . ,  CRITSELIS, A.N. & GOOD, R.A. (1978) 
Cancer 41_: 790-796.
PAPATESTAS, A . E . ,  OSSERMAN, K.E. & KARK, A.E.  (1971)
Br.  J .  Cancer 25; 635-645.
PARRY, E.W. & GHADIALLY, F.N. (1966)
Cancer 1_9: 821 -830.
PARSONS, L.D.  & WARREN, F .L .  (1941)
J.  P a th o l .  B a c t e r i o l .  52; 305-321.
PENG, C . F . ,  PRICE, D.W., BHUVANESWARAN, C. & WADKINS, C.L.  (1974) 
Biochem. Biophys.  Res. Comm. 56; 134-141.
PERAINO, C. (1968)
B ioch im. B iophys .  Acta 165: 108-112.
PERAINO, C. (1972)
Bioch im. Biophys.  Acta 289: 117-127.
PERAINO, C. (1976)
Personal  communicat ion i n  Lyons & P i t o t  (1976)
PERAINO, C. & PITOT, H.C. (1963)
Bioch im. Biophys.  Acta 7_3: 222-231.
PERAINO, C. & PITOT, H.C. (1964)
J .  B i o l .  Chem. 239: 4308-4313.
PERAINO, C . ,  BLAKE, R.L.  & PITOT, H.C. (1965)
J .  B i o l .  Chem. 240: 3039-3043.
PERAINO, C . ,  BUNVILLE, L.G. & TAHMISIAN, T.N.  (1969)
J.  B i o l .  Chem. 9: 2241-2249.
PERAINO, C . ,  MORRIS, J .E .  & SHENOY, S.T.  (1976)
L i f e  Se i .  19; 1435-1437.
PIHKO, M. & RUOSLAHTI, E. (1973)
I n t .  J .  Cancer 1_2: 354-360.
PINSKY, C .M.,  DOMEIRI, A . E l . ,  CARON, A . S . ,  KNAPPER, W.H. & OETTGEN, H.F.  
Recent  R esu l ts  Cancer Res. 47_: 37-41.
PITOT, H.C. (1960)
Cancer Res. 20: 1262-1268.
POLLAK, J .K .  (1975)
Biochem. J .  150: 477-488.
POLLAK, J .K .  & SUTTON, R. (1978)
Biochem. B iophys .  Res. Comm. 80: 193-198.
POOLE, B. (1971)




Fed. Proc.  ] 7 _ :  691-697.
POTTER, V.R.  (1964)
Cancer Res. 2A_: 1085-1098.
POTTER, V.R.  (1969)
Proc.  Can. Cancer Res. Conf.  8; 9 -30.
POTTER, V.R. (1970)
in  "Homologies in  Enzymes and M e ta b o l i c  Pathways: M e ta b o l i c  
A l t e r a t i o n s  in  Cancer" .
(Whelan,  W.J. & S c h u l t z ,  J .  eds)
Nor th  Ho l land  Pub. Co. Amsterdam.
POTTER, V .R . ,  PITOT, H .C. ,  ONO, T. & MORRIS H.P. (1960)
Cancer Res. 2JD: 1255-1261.
POTTER, V .R . ,  WATANABE, M.,  PITOT, H.C. & MORRIS, H.P. (1969)
Cancer Res. 29: 55-78.
PRIEUR, E .J .  (1973)
Cancer Chemotherapy Reports 4_: 1-39.
PRIMUS, F . J . ,  MARTINO, L . ,  MacDONALD, R. & HANSEN, H.J .  (1978)
C e l l .  Immunology 35_: 25-33.
PRPIC, V . ,  SPENCER, T .L .  & BYGRAVE, F .L .  (1978)
Biochem. J.  176: 705-714.
PRITCHARD, H. & MICKLEM, H.S. (1973)
C l i n .  Exp. Immunol. 1_4: 597-607.
RAHMAN, Y.E.  & PERAINO, C. (1973)
Exp. G e r o n to l .  8: 93-100.
RECHCIGL, M. J r . ,  HRUBAN, Z. & MORRIS, H.P. (1969)
Enzym. B i o l .  C l i n .  1JD: 161-180.
REED, K.E. & BYGRAVE, F .L .  (1975)
A n a l .  Biochem. 67_: 44-54.
REICHARD, G.A. J r . ,  MOURY, N . J . ,  HOCHELLA, N . J . ,  PATTERSON, A . L . &
WEINHOUSE, S. (1963)
J.  B i o l .  Chem. 238: 495-501.
REV- KURY, L . H . ,  KURY, G. & FRIEDELL, G.H. (1966)
A rch .  P a t h o l . 82: 77-79.
RICHTER, C.P. (1942 /43)
Harvey Lec tu res  38-: 63-103.
RICHTER, G.W. & LEE, J .C .K .  (1970)
Cancer Res. 3CH 880-888.
ROBAK, J.  (1977)
B iochemica l  Pharmacol .  27: 531-533.
215
ROBBINS, S .L .  (1974)
in  " P a t h o lo g i c a l  Bas is o f  D is e a s e " ,  Chapters 4 & 5, 
W.B. Saunders.  P h i l a d e l p h i a .
ROGERS, Q.R. & LEUNG, P.M-B. (1973)
Fed. Proc.  32: 1709-1719.
de ROSA, G. & PITOT, H.C. (1978)
Cancer Res. 38: 950-954.
ROSENE, G.L.  (1968)
Cancer Res. 28: 1469-1477.
ROSSI, C.S. & LEHNINGER, A . L . (1964)
J.  B i o l .  Chem. 239: 3971-3980.
RUOSLAHTI, E. & SEPPALA, M. (1971)
I n t .  J .  Cancer 8_: 374-383.
RYGAARD, J.  (1973)
in  " Thymus & S e l f :  Immunobiology o f  the  Mouse Mutant  Nude". 
F .A .D .L .  Copenhagen.
SANADA, Y . ,  SUEMORI, I .  & KATANUMA, N. (1970)
B ioch im .  Biophys.  Ac ta  220 : 42-50.
SASSENRATH, E.N. & GREENBERG, Ü.M. (1954)
Cancer Res. 1_4_: 563-569.
SCHAFER, L . A . ,  WASHINGTON, M.L.  & GOLDSTEIN, A .L .  (1975)
Proc.  Am. Soc. C l i n .  Oncol .  1_6: 233.
SCHAFER, L . A . ,  GOLDSTEIN, A . L . ,  GUTTERMAN, J .U .  & HERSH, E.M. (1976) 
Ann. N.Y. Acad. Se i .  277: 609-620.
SCHAFER, L . A . ,  GUTTERMAN, J . U . ,  HERSH, E .M.,  MAVLIGIT, G.M. & GOLDSTEIN A .L .  
(1977)
i n  "C o n t ro l  o f  Neop las ia  by M o d u la t io n  o f  the  Immune System in  
Progress in  Cancer Research and Therapy"
( C h i r i g o s ,  M.A. ed) V . 2: pp329-346 
Raven Press.  New York.
SCHAPIRA, F. (1973)
Adv. Cancer Res. 1_8: 77-153.
SCHAPIRA, F . ,  DREYFUS, J .C .  & SCHAPIRA, G. (1963)
Nature  200: 995-997.
SCHIMKE, R .T . (1970)
in  "Mammal. P ro t .  Metab . "
(Munro, H .N . ,  ed) V .4 :  p p l 78-228 
Academic Press ,  New York and London.
SCHIMKE, R.T.  & DOYAL, D. (1970)



















R.T., GANSCHOW, R., DOYLE, D. & ARIAS, I. (1968) 
Fed. Proc. 27_: 1223-1230.
G. & STÖRIKO, K. (1965) 
in "Laboratory Notes for Medical Diagnostics" 
(Bösel, B., Gerring, H. & Neumann, H. eds) pp6-l 1 
Behringwerke A.G. Marburg/Lahn.
L. & KIM, Y.S. (1963)
Proc. Nat. Acad. Sei. USA 50: 913-918.
L. & KIM, Y.S. (1965)
J. Cell. & Comp. Physiol. 66: 11-22.
L., BEATTIE, D.S. & HOPPER, S. (1962)
J. Biol. Chem. 237: 1914-1920.
& MORRIS, H.P. (1974)
Cancer Res. 34: 1413-1417.
NICHOLS, M., BECKER, F.F. & LEFFERT, H.L. (1974) 
Cancer Res. 34j 865-871.
., & SERENI, L.P. (1971)
Adv. Enzyme Reg. 8; 253-267.
F. & GREGORI, C. (1971)
Compt. Rend. 272: 1169-1172.
r.S. (1972)
Adv. Cancer Res. 1_5: 253-286. 
r.S. (1974)
Adv. Enzyme Reg. T3: 67-75.
f.S. & BLINOV, V.A. (1974)
Cancer Res. 34: 1827-1832.
r.S., MOROZKINA, T.S. & CHUMAKOV, V.N. (1976)
Vopr. Onkol. 22: 43-51.
'.S., GOROZHANSKAYA, E.G. & LYUBIMOVA, N.V. (1976b) 
Biokhimiya 41_: 1766-1772.
M.I., STRICKLAND, S. & REICH, E. (1976)
Cancer Res. 36:4208-4216.
C.D. Jr., ELSEBAI, I., ESCHWEGE, F., PADOVAN, I., 
C.G. & VERONESI.U . eds (1978) 
in "Clinical Oncology" 2nd ed.
Springer Verlag. Berlin.
,E., MORRIS, H.P. & BOXER, G.E. (1965)
Cancer Res. 25: 671-676.
SALVADORI,
SIDRANSKY, H., MURTY, C.N. & VERNEY, E. (1978) 
Cancer Res. 38: 1645-1653,
217
SIESS, E. A . , BROCKS, D.G. & WIELAND, 0. (1978)
Hoppe-Seylers Z. Phys io l .  Chem. 359: 785-798.
SLAGA, T . J . ,  SIVAK, A. & BOUTWELL, R.K. eds (1978)
in "Carcinogenesis Vol. 2 Mechanisms of  Tumour Promotion and 
Co-carcinogenesis"
Raven Press .  New York.
SNELL, K. (1975)
in "Normal & Pa tho log ica l  Development of Energy Metabolism" 
(Hommes, F.A. & Van den Berg, C.J.  eds) pp77-95.
Academic Press .  New York.
SQUARTINI, R. (1971)
I s r e l  J .  Med. Se i .  7: 26-35.
ST AN ISLAWS KI- BIRENCWAJG, M., URIEL, J .  & GRABAR, P. (1967)
Cancer Res. 27: 1990-1997.
STEIN, T.P.  (1978)
J .  Theore t .  Biol.  7_3: 51-59.
STEWART, A.G. & BEGG, R.W. (1953)
Cancer Res. T3: 560-565.
STRICKLAND, S . ,  REICH, E. & SHERMAN, M.I. (1976) 
Cell 9: 231-240.
STRECKER, H.J.  (1965)
J . Bio l.  Chem. 240: 1225-1230.
STUTMAN, 0. (1974)
Fed. Proc. 33_: 736. (A b s t ra c t ) .
SUBRAMANIAN, C. ,  YU, S. & McKHANN, C.F. (1978)
Cancer Res. 38; 1996-2002.
SUDA, M., TANAKA, T . ,  SUE, F . ,  HARANO, Y. & MORIMURA, H. (1966)
Gann Monograph 1_: 127-141.
SUDA, M., TANAKA, T . , SUE, F . ,  KURODA, Y. & MORIMURA, H. (1968)
Gann Monograph 4: 103-112.
SUDA, M., TANAKA, T . ,  YANAGI, S . ,  HAYASHI, S . ,  IMAMURA, K. & TANUICHI, 
(1972)
Gann Monograph ] 3_ : 79-93.
SUL, H.S.,  SHRAGO, E.,  GOLDFARB, S. & ROSE, F. (1979)
Biochim. Biophys. Acta 551: 148-156.
SUSOR, W.A. & RUTTER, W.J. (1971)
Anal.  Biochem. 3: 147-155.
K.
218
SÜSS, R . ,  KINZEL, V. & SCRIBNER, J . D .  (1973 )  
i n  "C ance r :  E x p e r im e n ts  & C oncep ts "  
S p r i n g e r  V e r l a g .  New Yo rk .
SWICK, R.W. & MORRIS, M.P. (1974)
J .  B i o l . Chem. 249:  6836 -6841 .
SWICK, R .W .,  REXROTH, A .K .  & STANGE, J . L .  (1968 )  
J .  B i o l .  Chem. 243:  3581-3587 .
SWINGLE, K .F .  (1974)
i n  " A n t i i n f l a m m a t o r y  A g e n ts "
( S c h e r r e r ,  R.A.  & W h i te h o u s e ,  M.W. eds)  V.2 pp92 -122 .  
Academic P ress .  New York .
SZARKOWSKA, L.  & KLINGERBERG, M. (1963 )
Biochem. Z. 338:  674 -697 .
TAGI-ZADE, S .B .  & SHAPOT, V .S .  (1970)
V op r .  Med. Khim. JJ5; 254 -258 .
TAKETA, K . ,  TANAKA, A . ,  WATANABE, A . ,  TAKESUE, A . ,  AOE, H. & KOSAKA, K. (1976 )  
Enzyme 21_: 158-173 .
TANAKA, T . ,  HARANO, Y . ,  SUE, F. & MORIMURA, H. (1967)
J .  Biochem. (Tokyo)  62;  71 -9 1 .
TANAKA, T . ,  YANAGI, S . ,  MIYAHARA, M . ,  KAKU, R . , IMAMAMURA, K . ,  TANUICHI,  K.
& SUDA, M. (1972)
Gann 63: 555-562 .
TARATINOV, J . S .  (1964)
V op r .  Med. Khim. ]_0: 90.
THEOLOGIDES, A. (1972)
Cancer  29; 484 -488 .
THEOLOGIDES, A. (1974)
Ann. N.Y.  Acad. S e i .  230:  15 -22 .
THEOLOGIDES, A. (1976)
Am. J .  C l i n .  N u t r .  29;  552 -558 .
THEOLOGIDES, A. (1978)
Cancer  Forum 15; 155.
THEOLOGIDES, A. & ZAKE, G.F.  (1969 )
Cancer  Res. 29: 1913-1915 .
THOMSON, J . F .  & MIKUTA, E.T .  (1954 )
P ro c .  Soc. Exp. B i o l .  Med. 85:  29 -32 .
THORNE, R.F.W. (1975)
PhD T h e s i s ,  A u s t r a l i a n  N a t i o n a l  U n i v e r s i t y .  
C a n b e r ra .  ACT. A u s t r a l i a .
219
THORNE, R.F.W. & BYGRAVE, F .L .  (1974)
Biochem. J.  144: 551-558.
TOAL, J . N . ,  MILLAR, F .K . ,  BROOKS, R.H. & WHITE, J.  (1961) 
Am. J .  P h y s io l .  200: 175-181.
TOMINO, I . ,  KATANUMA, N . ,  MORRIS, H.P. WEBER, G. (1974) 
Cancer Res. 34: 627-636.
TOPP, W., HALL, J . D . ,  MARSDEN, M . , TERESKY, A . K . ,  RIFKIN, D . ,  LEVINE, A .J .
& POLLACK, R. (1976)
Cancer Res. 36/. 4217-4223.
TRIVERS, G.E. & GOLDSTEIN, A .L .  (1978)
in  "B a s ic  Immunological  Mechanisms in  Cancer"
In Press.
TROTTER, N.A. (1961)
Cancer Res. 2J_: 778-782.
TYNER, E .P . ,  HEIDELBERGER, C. & Le PAGE, G.A. (1953)
Cancer Res. 1J3/ 186-203.
ULRICH, J .T .  e t  a l . (1977)
Personal  communicat ion i n  T r i v e r s  & G o ld s te in  (1978)
UNKELESS, J . C . ,  TOBIA, A . ,  OSSOWSKI, L . ,  QUIGLEY, J . P . ,  RIFKIN, D.B. &
REICH, E . ,  (1973)
J .  Exp. Med. 137: 85-111.
URIEL, J . (1969)
P a th o l .  B i o l .  ] 7_: 877-884.
URIEL, J.  (1975)
in  "Cancer:  A Comprehensive T r e a t i s e "
(B e cke r ,  F.F.  ed) V3, pp21-55.
Plenum Press.  New York.
URIEL, J.  (1976)
Cancer Res. 36/ 4269-4275.
VAAGE, J .  (1974)
Cancer Res. 84: 2979-2983.
VAAGE, J.  & AGARWAL, S. (1976)
Cancer Res. 36: 1831-1836.
VAAGE, J . ,  AGARWAL, S. & REINERTSEN, J . L .  (1978)
Cancer Res. 38.: 2253-2258.
VAILLIER, D . ,  VAILLIER, J.  & BISCHOFF, P. (1977)
Europ,  J .  Cancer 1_3: 1025-1032.
VIJAYAKUMAR, E.K. & WEIDEMANN, M.J.  (1978)
Biochem. J.  160: 383-393.
VINOGRADOV, A . ,  SCARPA, A. & CHANCE, B. (1972) 
A rch .  Biochem. Biophys.  152: 646-654.
220
VOLPE, P., SANAMURA, R. & STRECKER, H.J. (1969) 
J. B io1. Chem. 244: 719-726.
VOLPE, P., MENNA, T. & PAGANO, G. (1974)
Europ. J. Biochem. 44: 455-458.
WALDMAN, T.A. & McINTIRE, K.R. (1972)
Lancet 2_: 1112.
WALKER, D.G. & HOLLAND, G. (1965)
Biochem. J. 97_: 845-854.
WALKER, P.R. & POTTER, V.R. (1972)
Adv. Enzyme Reg. 1£: 339-364.
WARA, D.W. & AMMANN, A.J. (1976)
P ed ia tr ics  57_: 643-646.
WARRA, D.W., GOLDSTEIN, A .L . ,  DOYLE, W. & AMMANN, A .J. (1975) 
N. Eng. J. Med. 292: 70-74.
HARREN, S., HURST, E.E. J r .  , BROWN, C.E. & CHUTE, R.N. (1972) 
Cancer Res. 32: 983-987.
WARBURG, 0. ed. (1930)
"The Metabolism o f Tumours"
Arnold Constable, London.
WARBURG, 0. ed. (1931)
"The Metabolism o f Tumours"
R.R. Smith Inc. New York.
WAYNFORTH, H.B. (1969)
in "Techniques in Prote in B iosynthes is".
(Campbell, P.N. & Sargent, J.P. eds), pp232-233. 
Academic Press. New York.
WEBER, K. & OSBORN, M. (1969)
J. B io l . Chem. 244: 4406-4412.
WEBER, G., BANERJEE, G. & MORRIS, H.P. (1961)
Cancer Res. 2J_: 933-937.
WEBER, G., MALT, R.A., GLOVER, J .L . ,  WILLIAMS, J .C .,  PRAJDA, N. & WAGGONER, 
C.D. (1976)
in "B io lo g ica l C haracterisa tion  o f  Human Tumours"
(Davis, W. & M a lton i, C. eds) p60.
Excerpta Medica. American E lsev ie r.
WEBER, G., GOULDING, F .J . ,  JACKSON, R.C. & EBLE, J.N. (1977a) 
in "B io lo g ica l Character isa tion  o f  Human Tumours"
(Davis, W. & M a lton i, C. eds). V2.
Excerpta Medica. American E lsev ie r.
221
WEBER, G. ,  JACKSON, R.C. ,  WILLIAMS, J . C . ,  GOULDING, F . J .  & ELBERTS, T. J .
(1977b)
Adv. Enzyme Reg. J_5: 53-77.
WEBER, G. ,  HARUTOSHI, K. , TAIICHI, S . ,  TZENG, D. & WILLIAMS, J .C.  (1978) 
in "Adv. Experimental  Medicine and Biology"
(Morr i s ,  H.P. & Cr i s s ,  W.E. eds) .  V.92 pp89-116.
Plenum Press .  New York.
WEINHOUSE, S. (1955)
Adv. Cancer Res. 3; 269-325.
WEINHOUSE, S . ,  GOSALVEZ, M., SHATTON, J .B.  & MORRIS, H.P. (1976) 
in "Control  Mechanisms in Cancer"
( C r i s s ,  W.E., Ono, T. & Sabine,  J .R.  eds) pp303-315.
Raven Press .  New York.
WHITE, J .  TOAL, J . N . ,  MILLAR, F.K. & BROOKS, R.H. (1960)
J .  Nat.  Cancer I n s t .  84: 197-209.
WICKS, W.D. (1968)
J .  Bio1. Chem. 243: 900-906.
WIDDOWSON, E.M. (1968)
in "Biology of Gestat ion"
( A s s a l i ,  N.S. ed) V.2,  ppl-49 
Academic Press .  New York and London.
WILLIAMS, R.H. (1974)
in "Textbook of  Endocrinology"
W.B. Saunders Co. Ph i l ade lph i a .
WILLIAMS, J . F . ,  COOK, P.C. MATTHAEI, K.I.  & HALLEY, J.B.W. (1976) 
in "Control  Mechanisms in Cancer"
( Cr i s s ,  W.E., Ono, T. & Sabine,  J .R.  eds) pp425-439.
Raven Press .  New York.
WINTER, C.A. & NUSS, G.W. (1966)
A r t h r i t i s  Rheum. 9_: 394-404.
WOOD, T. (1968)
J .  Chromatog. 85: 352.
WORTIS, H.H.,  NEHLSON, S. & OWEN, J . J .  (1971)
J .  Exp. Med. 134: 681-692.
WU, C. & BAUER, J.M. (1960)
Cancer Res. 20: 848-857.
WU, C. & HOMBERGER, H.A. (1969)
Br. J .  Cancer 23^ : 204-209
YANAGI, S. & POTTER, V.R. (1977) 
Li fe  Sei .  20: 1509-1520.
222
YANAGI, S., KAMIYA, T., IKEHARA, Y. & ENDO, H. (1971) Gann £2: 283-291.
YEAKEL, E.H. (1948)Cancer Res. 8; 392-396.
YEOMAN, L.C., JORDAN, J.J., BUSCH, R.K., TAYLOR, C.W., SAVAGE, H.E. & 
H. (1976) Proc. Nat. Acad. Sei. USA 73: 3258-3262.
YUNIS, E.J., MARTINEZ, C., SMITH, J., STUTMAN, 0. & GOOD, R.A. (1969) Cancer Res. 29/. 174-178.
ZISBLATT, M., GOLDSTEIN, A.L., LILLY, F. & WHITE, A. (1970)Proc. Nat. Acad. Sei. USA 66: 1170-1174.
BUSCH,
